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HIV policy states that palliative care is required from diagnosis onward, but evidence 
of the prevalence, severity and duration of patient-centred problems at HIV diagnosis 
is very limited, particularly in Africa. This thesis aims to determine palliative care-
related problems reported by outpatients over three months from diagnosis, taking a 
patient-centred approach. 
Methods 
A prospective observational cohort was conducted in Kenya and Uganda. Twelve 
HIV facilities each consecutively recruited 100 adults and those diagnosed within 14 
days previously were selected. Outcomes were the seven patient-response items of 
the APCA African POS, a validated instrument completed at four monthly intervals. 
Cross-sectional analysis used ordinal logistic regression (cross-sectional 
multivariate), proportion of net change (longitudinal univariate) and population-
averaged fixed-effects conditional logistic regression (longitudinal multivariate).  
Results  
Among 438 participants (aged 18-59, 67% women), problems are highly prevalent at 
diagnosis (47% received no help and advice, 11% severe worry, 6% severe pain). 
Problems decrease over time on average but many persist after three months (e.g. 
28% unable to share feelings). Physical problems decrease most rapidly, 
psychosocial more slowly. Poverty is a risk factor for pain, symptoms and difficulty 
finding life worthwhile(OR=0.8-0.9). Five outcomes are exacerbated by limited 
physical function(OR=1.6-3.1) but none are associated with CD4 count. Uniquely, 
difficulty sharing feelings is more common over time for those with full physical 
function (OR=0.7) and the highest relative wealth(OR=1.2). Psychosocial and 
spiritual problems are more severe in Uganda (OR=2.7-3.3). Patients taking 
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This thesis presents the highest quality evidence of patient-reported problems at HIV 
diagnosis. Physical, psychological, social and spiritual problems are common and 
severe, requiring holistic assessment and management. The findings are relevant to 
service development in the context of scaled-up testing services for access to 
antiretroviral therapy. Staff need palliative care training, with support from specialist 
centres for intractable problems. This research contributes longitudinal analysis 
techniques appropriate for resource-limited settings, helping overcome research 
barriers.     
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UNCST Uganda National Council for Science and Technology 
USAID United Stated Agency for International Development 
VAS Visual Assessment Scale 
VCT Voluntary counselling and testing 




   
Questionnaires  
 
BDI Beck Depression Inventory 
BSI Brief Symptom Inventory 
CES-R Centre for Epidemiological Studies - Depression 
CSRI Client Services Receipt Inventory  
ECOG Eastern Cooperative Oncology Group global performance scale 
HADS Hospital Anxiety and Depression Scale 
HRDS Hamilton Rating Depression Scale 
IES Impact of Events Scale 
MINI Mini International Neuropsychiatric Interview 
MOS-HIV Medical Outcomes Scale – HIV version 
MOS-SF Medical Outcomes Scale – Short Form 
MSAS-SF Memorial Symptom Assessment Scale-Short Form 
POMS Profile Of Mood States 
POS Palliative Outcome Scale 
QL-Index Quality of Life Index 
SC-90 Symptom Checklist-90 
SRS Social Relationship Scales 
SSC-HIVrev Revised Sign and Symptom Checklist for Persons With HIV Disease 





   
My contributions to this thesis 
 
The data used in this thesis were collected for a longitudinal quantitative study as 
part of Phase 2 of a Public Health Evaluation (PHE) of the Care & Support activities 
of the President’s Emergency Plan for AIDS Relief (PEPFAR), which was conducted 
in Kenya and Uganda. I was employed on this project for a year before beginning my 
PhD, and my contributions are detailed below. I contributed to many aspects of the 
study design and I was heavily involved in its execution. 
 
The original concept of the PhD thesis was mine. I developed the aim, objectives 
and research questions, and conducted the systematic review. I identified the 
subsample of newly diagnosed participants from the total sample of quantitative data 
in the PHE, wrote the analysis plan and carried out all the analysis. All interpretations 
and conclusions are my own.  
 
My contributions to Phase 2 of the PHE were: 
 
Study design  
I was involved in the study design discussions. I designed the sampling method for 
selection of Phase 2 sites and contributed to the selection of the outcome 
instruments.  
Questionnaire pack design and layout 
I led the design of the demography tool and the modification of the CSRI, 
incorporating other people’s contributions. The APCA African POS and MOS-HIV 
were pre-existing instruments. I converted them into a format that was compatible 
with the database and easy for health care staff to complete. The questionnaire pack 
was piloted and modified, and has proved successful with a very low error rate. 
Ethics clearance 
I wrote the applications to King’s College Research Ethics Committee, the Kenya 
Medical Research Institute (KEMRI) and the Uganda National Council on Science 
and Technology (UNCST), and obtained approval from all three. 
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Training 
The data were collected by health care workers (HCWs) trained and supervised by 
research assistants who in turn were trained and supervised by myself and my 
colleagues. I was responsible for writing a manual and training research assistants in 
Uganda and Kenya in the use of EpiData and the principles of double entry and 
validation. As well as writing the programme for data management training, I also 
worked on the manuals for training of HCWs who would collect the data, and 
research assistants who would support them. I ran a five-day course in Kenya 
including training of trainers, and conducted seminars on a similar course in Uganda. 
Data management 
I designed a preformatted database with consistency checks using EpiData 3.1, 
ensuring that data could be entered safely at a distance. Throughout the study I 
received regular reports from the field, monitored data accuracy and managed 
problems from day to day. 
Analysis 
I contributed to the development of an analysis plan, with help from professor Peter 
Fayers and colleagues. I conducted the majority of descriptive analysis and all the 
multilevel modelling on the complete datasets, and presented the results in the form 
of graphs and tables, with interpretation. 
Dissemination  
I wrote the introduction, methods, longitudinal quantitative analysis, discussion and 
recommendations chapters for both the Uganda and Kenya Phase 2 reports, 
incorporating sections written by others and designing the finished product. In 
acknowledgement of this I am listed as the first author of the Uganda report. I also 




   
A Introduction 
 
HIV is a life-limiting, progressive disease, for which there is currently no prospect of 
a cure. Worldwide 33 million people have HIV, two thirds of whom live in sub-
Saharan Africa(1), and it is the sixth most common global cause of death(2).  
 
Relative to the standard care of other diseases, HIV clinical care is frequently 
marked by holistic, patient-centred care and support in both high-income and low-
income contexts, However, perhaps as a response to the magnitude of the 
epidemic, there is a trend in the published HIV research literature to adopt a 
disease-centred approach, and to measure risks and benefits at the level of the 
population rather than the individual, and with more emphasis on prevention than 
care(3). HIV research has arguably centred on disease-centred outcomes such as 
immune system markers, as a proxy for mortality.  
 
The past 25 years have seen great advances in HIV treatment, and as a result, 
mortality and morbidity have been greatly reduced in areas where this treatment is 
accessible(4). Quality of life (QoL) gained importance as a secondary outcome of 
clinical trials(5, 6), but much of the research into patient-centred outcomes such as 
QoL appears to operate from a disease-centred paradigm which is distant from 
reported patient experience(7). 
 
Palliative care takes a patient-centred approach to improving the lives of people 
with HIV and their families(8). Traditionally, palliative care was seen as applicable 
in the end stages of HIV and AIDS(9). Indications are emerging that multi-
dimensional problems such as physical symptoms, pain, anxiety and depression, 
social isolation and spiritual distress, are prevalent throughout the HIV illness, not 
only at the end stages. Antiretroviral therapy (ART) may reduce disease burden for 
the individual patient but there is evidence it is not associated with symptom 
prevalence(10). The importance of palliative care throughout the disease trajectory, 
which has long been recognised in policy by global organisations including the 
World Health Organization(11) and UNAIDS(12), has been neglected in research 
and practice. As a result there is little information or evidence on which to base 
palliative care in the earlier stages of disease and specifically at HIV diagnosis. 
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Evidence is needed to inform patient-centred palliative care prior to and alongside 
ART. In particular, patient experience of HIV diagnosis and the immediate post-
diagnosis period is very poorly understood.  
 
Routine and regular HIV testing is encouraged in areas of high prevalence, as part 
of strategies for prevention and care. It is important to plan services to establish 
optimal care for this group, whose numbers are unrecorded, but known only to be 
large and growing. To this end, quality patient-centred care requires an 
understanding of the multidimensional problems and symptoms experienced by 
people newly diagnosed with HIV, and whether they abate or intensify over time. 
 
The aim of this thesis was to determine the palliative care related problems 
experienced by adults in East Africa following diagnosis of HIV and how those 
problems changed over the subsequent months, taking a patient-centred 






   
B Background 
 
This chapter summarises the epidemiology and natural history of HIV, as currently 
understood. Existing evidence of the multidimensional symptoms and problems 
associated with living with HIV is critically appraised. The development of palliative 
care, and the evolution of a sub-discipline of HIV palliative care, is described in 
general and within Africa specifically. Reasons for the limited research base for HIV 
palliative care in Africa are outlined. Potential benefits of palliative care at HIV 
diagnosis are presented with policy recommendations.  
 
 
B.1 Introduction to HIV 
 
 
B.1.i Epidemiology of HIV 
 
HIV is a major global public health issue, the sixth most common cause of death 
worldwide in 2004, and the fifth highest cause of morbidity and mortality measured 
in disability adjusted life years (DALYs)(2). At the end of 2009 around 33 million 
people were living with HIV, over 22 million of them in sub-Saharan Africa(1). Table 
B-1 shows that sub-Saharan Africa has an adult HIV prevalence five times higher 
than any other world region. In 2008 70% of new infections and 70% of deaths due 




   
Table B-1: HIV prevalence worldwide. Reproduced from UNAIDS ‘AIDS Epidemic Update 2009’ (1) 
Region People living with HIV, 
10,000s (95% CIs) 
New infections in 2008, 
10,000s (95% CIs) 
Deaths in 2008, 
10,000s (95% CIs) 




2240 (2080-2410) 190 (160-220) 140 (110 -170) 5.2% (4.9%-5.4%) 
South and 
Southeast Asia 
380 (340-430) 28 (24-32) 27 (22-31) 0.3% (0.2%-0.3%) 
Latin America 200 (180-220) 17 (15-20) 7.7 (6.6-8.9) 0.6% (0.5%-0.6%) 
Eastern Europe 
and Central Asia 
150 (140-170) 11 (10-130) 8.7 (7.2-11.0) 0.7% (0.6%-0.8%) 
North America 140 (120-160) 5.5 (3.6-6.1) 2.5 (2.0-3.1) 0.6% (0.5%-0.7%) 
East Asia 85 (70-100) 7.5 (5.8-8.8) 5.9 (4.6-7.1) <0.1% 
Western and 
Central Europe 
85 (71-97) 3.0 (2.3-3.5) 13 (10-15) 0.3% (0.2%-0.3%) 
North Africa and 
Middle East 
31 (25-38) 3.5 (2.4-4.6) 20 (15-25) 0.2% (<0.2%-0.3%) 
Caribbean 24 (22-26) 2.0 (1.6-2.4) 1.2 (0.9-1.4) 1.0% (0.9%-1.1%) 
Oceania 6 (5-7) 0.4 (0.3-0.5) 0.2 (0.1-0.3) 0.3% (<0.3%-0.4%) 






In 2008 approximately 2.7 million people worldwide were infected with HIV, in line 
with an ongoing decrease from the peak of 3.5 million infections in 1996(1). 
Following this, the number of deaths per year has also begun to fall slightly (2.0 
million in 2008, down from 2.2 million in 2004). Advances in treatment have given 
people with HIV a longer life expectancy. As a result, the number of people living 
with HIV continues to rise although incidence and population prevalence are 
declining. Annual UNAIDS reports (1, 13-16) track the number of infections and 
deaths using epidemiological techniques including sentinel sites and representative 
surveys. Information on the number of people diagnosed with HIV is not collected 
or presented.  
 
The end stage of HIV infection, AIDS, was first recognised as a new condition in 
the USA in 1981, as a cluster of unusual opportunistic infections in previously 
healthy gay men(17). Epidemiological research showed the cause was likely to be 
a blood-borne pathogen causing immune dysfunction, and within the next few 
years the virus was isolated and an antibody test developed. HIV is a retrovirus, 
meaning that its genetic code is stored as RNA rather than DNA. It preferentially 
infects lymphocytes, particularly the CD4 cell or helper T cell which coordinates 
immune response to infection.  
 
The most common route of infection is via sexual transmission, followed by 
infection from mother to child, either across the placenta in pregnancy, at birth, or 
via breastfeeding(18). Blood transmission can take place by transfusion or shared 
injecting equipment. As a retrovirus, HIV is unstable, with a very high mutation rate. 
It is also fragile and cannot remain viable outside a host cell. Its rapid mutation, and 
its method of preferentially infecting those cells most equipped to combat it, make 
HIV enormously difficult to remove after infection. Despite three decades of 
research, no cure exists.  
 
There are two main types of HIV: HIV-1, the most common, and HIV-2, a 
somewhat less virulent strain found primarily in West Africa(18). The most likely 
hypothesis is that HIV-1 is descended from a simian immunodeficiency virus (SIV) 
in the pygmy chimpanzee, the primate most closely related to humans, while HIV-2 
appears to have developed from a virus of the sooty mangabey monkey. The 




species barrier into humans several times during the first half of the twentieth 
century. The earliest certain reference point is an HIV-positive blood sample taken 
in the Democratic Republic of Congo(DRC) in 1959(18). Its long dormancy period 
and highly variable expression prevented the recognition of AIDS as a disease until 
1981, by which time HIV had reached 10% population prevalence in parts of 
Africa(19) and had spread around the world. 
 
Epidemiological surveys have identified two patterns of HIV distribution. In sub-
Saharan Africa the epidemic was generalised, with heterosexual transmission 
driving infections, and a slightly higher prevalence in women than men. In all other 
regions of the world the epidemic was concentrated into vulnerable populations; 
sex workers, injection drug users (IDU), men who had sex with men, and 
haemophiliacs. More detailed research has shown that this distinction between 
patterns was overly simplistic. HIV prevalence is higher than average among men 
who have sex with men in Zambia(15), while in China, heterosexual transmission 
has overtaken injections as the primary cause of new infections(1).   
 
In Kenya and Uganda the HIV pandemic is generalised, or mature(14). HIV is 
highly prevalent throughout the population, a distribution found only in sub-Saharan 
Africa(15). The main route of infection is heterosexual sex, followed by vertical 
transmission. HIV is more prevalent among women than men(Table B-2). 
 
Table B-2: Demographic characteristics of Kenya and Uganda(20-22) 
 Uganda Kenya 
Median age 15 years 18.7 years 
Mean life expectancy 52.7 years 57.9 years 
People living with HIV (thousands) 
- Men (15+) 
- Women (15+) 









Population size 32.4 million 39.0 million 
GDP per capita (US$) 1300 1600 
Below poverty line (%) 35 50 







B.1.ii Natural history of HIV 
 
HIV infection begins with a flu-like illness of variable severity and a spike in viral 
load (the concentration of virus in blood). Thereafter the presence of the virus is 
diminished to a very low level, and gradually rises over several years. Apart from 
the effects caused by HIV itself, immune system suppression leads to opportunistic 
infections caused by pre-existing pathogens as well as an increased susceptibility 
to infection by new ones.  
 
Great advances in treatment have been achieved since the development of the first 
antiretroviral (ARV) drug in 1984. A leap forward was made in 1996 with the 
development of triple combination therapy, which suppresses viral load to 
undetectable levels. A collaboration of high-quality, long term cohort studies has 
shown that highly active antiretroviral therapy (HAART) halves mortality rate(4). It 
is said that HAART makes HIV into a chronic, manageable condition if ART is 
initiated early(23), although, according to current evidence from cohort studies, 
mortality remains higher than in the general population(24). An increasing 
proportion of people with HIV die prematurely from other causes such as liver 
disease, cancer and non-AIDS-defining infections(25), particularly in developed 
countries(26). In medical literature the term ‘AIDS’ is now used less frequently and 
is usually replaced by ‘HIV’, in recognition of the view that the illness comprises the 
whole period of HIV infection, and not only the end stage.  
 
Progression of HIV is monitored by the number of CD4 cells per millilitre of blood, 
by the proportion of lymphocytes which are CD4 cells, and by viral load – number 
of RNA copies per millilitre of blood. The optimal time of ART initiation is a focus of 
research and debate(27). On the one hand HIV is progressive, and observational 
cohort studies have shown that mortality is higher if treatment is delayed until CD4 
count falls below 200 and higher still below 100 or 50(28); on the other hand, ART 
has severe side effects and the utility of each drug for an individual is limited by the 
development of resistance. The point at which benefits outweigh costs is affected 
by the quality of current treatments and those which may be developed in the 
future. Recent WHO guidance raised the recommended threshold of ART initiation 





Treatment guidelines for ART initiation are based on observational cohort studies, 
as prospective trials with randomisation are not ethical for an intervention with the 
proven benefits of ART. The results of two large observational cohort 
collaborations were published in 2009. In North America, patients who began ART 
with a CD4 above 500 showed a 69% reduction in all-cause mortality compared to 
those with a CD4 count of 351-500(30). However, at the same time the When to 
Start Consortium in Europe found no association between CD4 count at initiation 
and mortality(31), after accounting for lead time bias (the fact that those with a 
lower CD4 count have been HIV positive for longer). In both studies, patients who 
began ART earlier than usually advised may have differed from the others in ways 
which could have biased the results.  
 
The course of HIV disease is heavily influenced by the social environment, most 
obviously in availability and accessibility of ART, but also in the prevalence of other 
infectious diseases(32), nutritional security, and access to general medical 
care(33). Farmer calls into question the idea of a ‘natural history’ of HIV, and 
suggests that it has instead a biosocial history(33). This raises the issue of the 
extent to which research findings can be generalised across cultural and economic 
barriers, a problem in many health conditions.   
 
 
B.1.iii Physical problems in HIV disease 
 
At present, verifiable evidence of symptom prevalence in HIV is scant, and it is 
necessary to generalise across cultures and settings. A 2003 review of HIV 
palliative care in the era of ART presented the evidence of HIV symptom 
prevalence, derived from five studies based in Europe and North America(34). 
These populations largely consisted of people with advanced HIV and AIDS. The 
Selwyn review found consistent evidence of highly prevalent weight loss, anorexia, 
pain, cough, and fatigue(Table B-3). Diarrhoea, respiratory symptoms, nausea/ 
vomiting, and dry skin were also frequent. The extent of symptoms earlier in the 
course of infection were unknown. Even though the aim of the review was to 




development of HAART and there was very little evidence from resource-poor 
settings, home to 90% of people with HIV.  
 
The table from the 2003 review is presented below without alteration (Table B-3) to 
illustrate the extent and also the limitations of knowledge at the time it was written. 
Review and comparison of symptom prevalence research, as done by Selwyn et al, 
has several methodological challenges. Tools used to record symptoms vary in the 
information recorded and the detail with which they are reported. For example, pain 
could be classified by the body region affected(35), the type of pain (ache, tingling, 
etc.)(36), the probable cause(37), or the intensity(38). This variation makes 
aggregation and comparison difficult. Even worse, many symptom reports do not 
give any methodological details, making it impossible to assess the reliability of the 
findings. The five papers summarised in Table B-3 give very little information on 
data collection methods beyond statements such as ‘medical symptoms were 
assessed with a standard checklist’(9), with no indication of the time period, the 
intensity, or how symptoms were selected or defined. 
 





















Symptom  % (rank) 
Fatigue - 77 (2) 50 (2) 55 (1) - 
Weight loss 85 (1)a 91 (1)b 31 (6) - 58 (1) 
Pain 71 (2) 63 (3) 52 (1) 29 (4) 55 (2) 
Anorexia 44 (3) - - 34 (2) 38 (3) 
Anxiety - - 40 (3) - - 
Incontinence - 55 (4) - - - 
Insomnia - - 37 (4) - - 
Hemiparesis/ataxia - - - - 23 (5) 
Mouth sores - - 33 (5) - - 
Cognitive dysfunction 32 (4) 43 (6) - - 19 (7) 
Cough 30 (5) 34 (8) 27 (8) 32 (3) 19 (6) 
Nausea/vomiting 24 (8) 35 (7) 28 (7) 22 (5) 17 (8) 
Dyspnoea/ respiratory  17 (11) 48 (5) 22 (12) 19 (6) 15 (9) 
Constipation 22 (10) 23 (12) - - 25 (4) 
Fever/sweats - - 27 (9) - - 
Pruritus/dry skin 27 (6) 24 (11) 23 (12) 17 (7) - 
Visual loss - 25 (10) - 12 (9) - 
Diarrhoea 23 (9) - 24 (11) 11 (8) 14 (10) 
Depression  26 (7) 32 (9)c 26 (10) - 10 (12) 
Headache 11 (12) - - - 11 (11) 





Research into the clinical symptoms of HIV sometimes attempts to exclude 
symptoms of other, presumed unrelated conditions and diseases(42). This 
approach is problematic. Firstly, a clear division between symptoms caused by HIV 
and those with external causes is difficult because HIV increases susceptibility to 
other infections and the pathophysiology of many symptoms is unclear. A symptom 
review of HIV-related nausea and vomiting in 1998 emphasised the need for 
research to better understand the aetiology of these common symptoms(43). 
Secondly, such an approach inevitably underestimates the symptom burden of 
individuals by measuring only a part of their total experience.   
 
Table B-4 below updates the evidence for prevalence of physical symptoms in HIV. 
Symptoms which appear in five or more studies are sorted by average prevalence, 
from pain (61%) to breathlessness (32%). Four of these studies used the Memorial 
Symptom Assessment Scale-Short Form (MSAS-SF), and one used the SSC-
HIVrev(44). Another study adapted an instrument (the HIV Symptom List) 
developed in the USA(35). No details of this process are given and the adapted 
instrument was apparently not validated in South Africa. The remaining studies 
developed new symptom assessment instruments, which were not validated. All 
ten studies were cross-sectional, giving no indication of how symptoms changed 
over time. All studies show that symptoms are extensive and varied.  
 
Compared to the evidence in the 2003 review, these studies tend towards larger 
sample sizes, and the majority were conducted in Africa. Also, while some studies 
were aimed at measuring symptoms among those with advanced disease(45, 46), 
others recorded symptoms in HIV generally(47, 48). The study by Makoae et al, for 
example, used a cross-sectional, community based design, recruiting patients 
through home-based care programmes and outpatient clinics, which should have 
been more representative than a hospital-based sample because a wider 
proportion of patients would have access to the services and hence to the 
sampling frame(44). However, the cross-sectional survey design was applied 
without the use of a sampling frame or a systematic sampling method such as 


































N 504 4042 84 103 743 64 347 731 250 778 
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Unclear Unclear Previous 
week 
Measure MSAS-SF Novel  MSAS Novel  SSC-HIVrev HIV-SL MSAS-SF Novel  Novel  MSAS-SF 
Pain (all) 76  48 98  89b 43 41c 47 53 
Fatigue  85  41 43 56 65    68 
Difficulty 
sleeping 
74  21  32 55 59   62 
Weakness    66 54  72 14 18 71 
Weight 
change 
43 37 16 81 57 74 28  4  
Skin 
problems 
52 24 17 56 34 72 39 23   
Night 
sweats 
56  12  41 44 40    
Cough  60  10 45 45 58 42 26 10  
Anorexia  51  26 71 44 33  9 8  
Diarrhoea 35 51 18 53 30 23 51 7 8 54 
Fever  52 19  32 58   2  
Nausea/ 
vomiting 
43 50 12 45 28 55 30 14 11  
Breathless 62  19  31 42  6   






The prevalence of symptoms clearly depends on the period of time over which they 
are observed. Symptoms are more likely to occur within six months (as for the 
Mathews survey) than one week. On the other hand, long periods of time increase 
the probability that symptoms will be forgotten. The use of the MSAS in four studies 
here and the consistent time period of one week makes comparison more feasible. 
The Selwyn sample were receiving palliative care, and have fewer symptoms than 
the Vogl sample who were not.  
 
The largest study used a probabilistic sampling method to randomly select a 
representative sample of people with HIV in the USA(48). In this case the 
weakness lay in the symptom assessment. A list of 14 symptoms was compiled, 
which was not based on piloting or previous research. As a result, symptoms such 
as pain and fatigue, which other studies found to be prevalent and bothersome, 
were not included. Despite its limitations, the evidence shows a very high 
prevalence of a wide variety of physical symptoms in HIV, in diverse settings and at 
different stages of disease.  
 
Symptoms appear to be just as common with ART. In a large online UK survey 
using the MSAS-SF, gay men with HIV experienced a range of severe symptoms 
including pain, and those taking ART reported altered but equally burdensome 
symptoms(10), probably caused partly by side effects(51). In open-ended 
questions, participants said that they envisaged a future of shortened life and 
limited options, and many were “living without hope”(52). The most recently 
published study(50), based on data collected in 2006, reported on only the ten 
most common symptoms (of which three were psychological). Participants reported 
a mean of 17.9 symptoms and ART was not associated with symptom burden. In 
Zimbabwe, a cross-sectional study compared 96 women taking ART with 31 who 
were not yet eligible and 73 eligible but not taking it(53). Nurse-reported symptoms 
in the previous week were significantly fewer in the ART group (5.5 compared to 
10.1 and 8.6, ANOVA p<0.001), but self-reported symptoms in the past year were 
only slightly lower (5.0, 5.8 and 6.0 respectively, p=0.05). Using the MOS-HIV, all 
groups had very similar physical health. These results suggest that health care 




reflected in patient experience. In the USA, Justice et al showed that health care 
workers detect only a third of patient-reported symptoms in HIV(54). 
 
ART regimen change was associated with a particularly high symptom burden in 
the Women’s Interagency HIV Study cohort in the USA(55). Due to the cross-
sectional design it was not possible to establish whether participants had changed 
regimens because of a high symptom burden, or had experienced symptoms as a 
result of the new drug combination. Both could be contributing factors.   
 
In 1999, a non-systematic review of fatigue in HIV derived a prevalence range from 
20% to 60% from eleven published papers, but gave no information on the 
methodology or quality of these studies(56). The paper described fatigue as the 
‘most frequent and debilitating complaint of HIV positive people’(56). A large cross-
sectional survey in London with a good response rate found fatigue to be highly 
prevalent(65%), associated with psychological factors more than disease 
progression or use of ART(57). In South Africa, Voss et al discovered that the 
symptoms most closely correlated with fatigue were fever and depression, while a 
diagnosis of AIDS was also predictive of fatigue(58). The connection to depression 
supports the London findings, and the additional association with fever could be 
caused by environmental factors such as malaria. 
 
A multi-centre study based in Colombia, Norway, Puerto Rico, Taiwan and the USA 
used the Revised Sign and Symptom Check-List for Persons With HIV Disease 
(SSC-HIVrev) to examine the prevalence of eight symptom clusters, including 
gastrointestinal (diarrhoea, gas, abdominal pain, nausea, vomiting), fatigue 
(weakness, muscle aches, painful joints, fatigue), and fever (chills, night sweats, 
fever)(59). Symptom cluster prevalence was consistently around 40% (plus or 
minus 3%) for those with no comorbid condition, and 50% (plus or minus 3%) for 







B.1.iv Psychological problems in HIV disease 
 
The issue of HIV-related psychological morbidity in resource-limited countries has 
been neglected(60), while receiving more attention in the developed world due to 
the well documented association of depression with ART non-adherence(61, 62). 
In 2007 The Lancet launched a series on global mental health(63), including one 
paper which reviewed the interaction between mental health and HIV, particularly 
in low- and middle-income countries(64). A 2006 systematic review of mental 
health and HIV in developing countries(60) identified, in Africa, five studies of 
QoL(65-69), three of prevalence(70-72), three of cognition in children, two of 
association with adherence(73, 74), and one tool validation(75). Two of these 
papers were different analyses of the same dataset(67, 71). More recently, other 
epidemiological studies of disease prevalence and risk factors have been 
published for mental health in Africa (76, 77).  
 
Information on mental health conditions and symptoms in sub-Saharan Africa is 
summarised in Table B-5. The majority of evidence relates to depression, which is 
highly prevalent, and is often combined with anxiety. Two major limitations are the 
issue of tool validity, and a lack of longitudinal data. Only one validation study was 
identified(75) and several other studies imported an instrument from a different 
context without checking its properties. The first stage in the development of a tool 
to measure prevalence of psychological morbidity is to establish whether the 
cultural and linguistic context has a concept of mental illness that maps onto those 
conditions. An ethnographic study in Uganda found that people identified two HIV-
related syndromes; one causing people to feel lonely, hopeless and uninterested, 
the other causing sadness, worthlessness and low energy, with both overlapping 





Table B-5: prevalence of mental health conditions with HIV in sub-Saharan Africa 
Author, 
date 









23% severe anxiety 






within 1 year, 
South Africa 
MINI 56% psychiatric disorder 
35% depression 















WHO stage 3/4, 
ART naive 
EQ-5D 29% some anxiety/depression problems 




with children <5, 
Uganda 


































for ART and 
ART-naive 
CESD 47% depressive symptoms (CESD >22) 








Schedule  - 
Revised 
(CESD) 
16% depression or anxiety/depression 










38% moderate depression or above 
53% elevated symptom distress 
 
Only one longitudinal study was identified(74), and it had methodological 
limitations. The sample was not large (n=114), with attrition over time, and no 
statistical analysis was conducted, so the results could be due to chance. The 
paper found 28% of participants reported ‘some problems’ on the 
anxiety/depression question of the EQ-5D and 3% reported ‘severe problems’. 
These results are very close to those found in a cross-sectional study which also 
used the EQ-5D(68). 
 
Long-term observational cohort studies have linked depression to hastened 




better mental health outcomes. In Zimbabwe, a cross-sectional study compared 
three groups of women; those taking ART, not yet eligible, and eligible but not 
taking it(53). Women on ART were significantly less likely to have depression 
according to a validated instrument, the Shona Symptom Questionnaire, and those 
on ART had better mental health with the MOS-HIV (56.0 compared to 44.1 for the 
non-eligible and 44.6 for the untreated). However, the direction of effect is not 
clear. People with depression may find it more difficult to maintain treatment, thus 
the effect of ART on mental health may be overestimated. A meta-analysis of ten 
studies of depression and ART adherence (80) found that people with depression 
symptoms were less likely to be classified as ART adherent (OR=0.45, 95% CI 
0.31-0.66). Poor adherence could be the mechanism by which depressive 
symptoms are associated with mortality in people with HIV. It is also possible that 
people with depression may not be prescribed ART, which would also inflate the 
apparent benefits of ART on mental health in prevalence studies. 
 
Alcoholism and addiction are risk factors for HIV infection in South Africa(81), and 
therefore are common comorbidities of HIV. There is evidence that alcohol use and 
abuse are also associated with ART non-adherence, although a meta-analysis was 
not conducted(80).  
 
Mental health is affected biologically by HIV (and ART) and psychologically by the 
diagnosis of HIV(82), and these two effects can be confused. In the 1980s, 
neurocognitive symptoms such as forgetfulness, depression and personality 
change were observed in people who had been recently diagnosed with HIV and 
showed few physical symptoms, leading to the hypothesis that HIV often 
manifested first in the central nervous system(83). The Multicentre AIDS Cohort 
Study recruited and tested 4954 gay men of whom 36% were HIV positive, 
withholding their HIV test results until the end of the study(84). Self-reported 
physical symptoms and the lack of someone to talk to were associated with 
symptoms of depression in the cohort, but HIV status was not(85), showing that the 
early negative effects were more psychological than organic. It is likely that 
symptoms were also caused by the climate of fear, oppression, discrimination and 






B.1.v Spiritual problems in HIV disease 
 
Spirituality is often a central issue for those with life-limiting or chronic disease(87) 
and palliative care has always held spirituality to be a discrete and necessary 
domain of care. In South Africa and Uganda, palliative care patients (81% HIV 
positive) reported that feeling at peace and having a sense of meaning were more 
important to them than physical comfort or being active(88). 
 
A systematic review of spirituality measurement in palliative care(89) identified and 
34 individual tools and four tool ‘families’, consisting of a number of versions of the 
same tool. Of these, the four quality of life tool families (the WHOQOL-HIV, the 
POS, the MVQOLI and the McGill QoL Questionnaire) plus eight individual tools 
were used in HIV populations(Table B-6).  
 
Table B-6: Spirituality tools used in HIV populations, from Selman et al 2011(89) 
 Cross-culturally 
validated 
Not cross-culturally validated 













Substantial measures of 
spirituality 
Ironson-Woods(97) Spiritual Activities Scale(98) 
Spirituality & Religion Survey(99) 





Measure of coping in HIV(102) 
 
 
Studies of spirituality and HIV have been conducted primarily in the USA, and have 
found both positive and negative outcomes associated with spiritual beliefs and 
practices. Positive religious coping involves finding meaning in illness, reaching 
peace, and a concept referred to as transcendence. Spiritual struggle leads to 
feelings of guilt, anger, fear, and a sense of punishment(103). Negative religious 




outcomes such as lower CD4 count(104). People with HIV may also experience 
ostracism from their religious community, although others derive great comfort and 
support from it(105).   
 
A longitudinal study in the USA of over 400 people with HIV attempted to overcome 
the methodological weaknesses of previous studies by including a battery of 
spirituality tools(106). However, only two time points were used, limiting 
longitudinal analysis to a series of paired t-tests. Positive religious coping was 
associated with optimism and life satisfaction(106). These relationships may simply 
indicate the overlap between conceptions of coping and optimism inherent in the 
tool items(7).    
 
 
B.1.vi Social problems in HIV disease 
 
It has generally been thought that poverty was a risk factor for HIV infection in 
resource-poor countries, but more recent research has cast doubt on this 
claim(107). However, there is little doubt that poverty limits access to health care, 
hampers adherence, and is associated with greater symptom burden(108, 109). In 
the UK, a qualitative survey in 2004 concluded that the most salient needs for 
many people with HIV were food, transport, a safe place to live, addiction 
programmes, and mental health treatment(110). Social problems were more 
burdensome than physical symptoms. Physical and psychological symptoms can 
impair ability to work, which in resource-poor environments may limit the 
household’s income and access to medication, transport and food(111).   
 
De Waal and Whiteside proposed that HIV has altered the parameters of food 
production and famine risk in resource-poor countries, imposing both costs of care 
and loss of labour which reduce the resilience of rural households to external 
events such as low rainfall(112). Ill health reduces ability to work and therefore 
reduces income, as shown in a series of case studies which also demonstrated the 
effect on families of medical bills and the burden of caring for sick relatives and 
orphans(113). While the case studies lacked methodological rigour, the approach 




that as financial resources decrease, the proportion of total income spent on food 
increases(114), with the result that in extreme poverty a drop in income causes 
malnutrition.  
 
A longitudinal survey of income and expenditure in 181 South African households 
found that the financial burden from death of a family member, both in cost of a 
funeral and the loss of income, posed the greatest challenge to the 
household(115). HIV is the primary cause of death in South Africa, and in 2004 
caused 56% of deaths of working-age adults (aged 15-59), making HIV the major 
threat to families’ economic survival(116). 
 
Informal carers also have increased burdens as a result of HIV. In Namibia, carers 
of people with HIV were asked to keep diaries for an in-depth qualitative 
study(117). The paper argued that patients’ increased dependency, morbidity from 
‘invisible’ symptoms such as pain and fatigue, and loss of self-esteem caused great 
interpersonal stress within families. Social isolation as a result of inability to 
participate in reciprocal networks contributed to this stress for both patients and 
carers, and resulted in unsustainable damage to social bonds. This argument was 
given credibility by the use of quotes revealing fatigue and lack of resources on the 
part of carers. 
 
 
B.1.vii Stigma and HIV 
 
The consequences of being identified as HIV positive can include ostracism, verbal 
and physical abuse, and neglect(118). University students in South Africa reported 
in focus group discussions (FGDs) that fear of stigmatisation deterred them from 
testing(119). Farmer argues persuasively that HIV stigma is decontextualised, and 
should be seen as the visible manifestation of deep social inequality(120). In Haiti, 
stigmatisation was reduced when ART became available. The theory is that ART 
eliminates the equation of HIV with death, returns HIV to the nature of an ordinary 





The Siyam’kela project in South Africa attempted to understand stigma from 
internal and external perspectives. FGDs with patients and nurses in Lesotho, 
Malawi, South Africa, Swaziland and Tanzania explored the subject of stigma. 
Topics included the words and phrases used to refer to HIV(121), perceptions and 
experiences of status disclosure(122), experience of abuse and neglect(118), and 
coping strategies(123). Based on these findings, a conceptual model of stigma was 
developed(124), identifying three types of HIV stigma: received, internal and 
associated stigma. Received stigma is behaviour by others towards a person with 
HIV, internal stigma includes thoughts and behaviour by the person with HIV as a 
result of their own negative perceptions, and associated stigma is directed towards 








B.2 Palliative care 
 
 
B.2.i Definition of palliative care 
 
The defining features of palliative care are pain control and holistic, person-centred 
care(125). It is devoted to delivery of high-quality, person-centred, multi-
professional care alongside curative treatment for people with life-limiting 
progressive illness and their families. Palliative care affirms life, accepts death and 
provides integrated, holistic support and symptom management(126). Palliative 
care is defined by the WHO as 
“an approach that improves the quality of life of patients and their families 
facing the problem associated with life-threatening illness, through the 
prevention and relief of suffering by means of early identification and 
impeccable assessment and treatment of pain and other problems, physical, 
psychosocial and spiritual” (11). 
 
 
Figure B-1: The four domains of palliative care 
 
 
Palliative care originated in the care of the terminally ill at the end of life, 
particularly those dying from cancer(127). The original model of palliative care in 
the 1960s, represented in Figure B-2, conceived it as an option only when curative 





Figure B-2: sequential model of palliative care 
 
     Time Æ 
 
As it was realised that people have palliative care needs before curative treatment 
has ended, the model became one of gradual shift in priorities, as in Figure B-3 
from the new palliative care definition of 2002(11): 
 




However, in both these models, palliative care is not present at the time of 
diagnosis, even though the modern definition of palliative care is clear that it should 
be provided throughout the course of any life-limiting disease(8). The diagram 
below (Figure B-4) has been adopted by the American Thoracic Society to model 
individualised, integrated palliative care in conditions with an unpredictable 
course(128). In this model, palliative care begins immediately after diagnosis, and 
the balance between curative and palliative care can shift back and forth during the 










B.2.ii Definition of HIV palliative care 
 
Everyone diagnosed with HIV faces the problems associated with life-threatening 
illness. HIV palliative care begins at diagnosis, as made clear by the WHO and 
UNAIDS in their definitions of palliative care for HIV. The WHO defined HIV 
palliative care in 2006: 
• “Palliative care is a core component of comprehensive HIV/AIDS care. 
• Access to palliative care should not be artificially restricted due to political or 
social constraints. 
• All patients needing and wanting it should receive it, without exception. 
• Palliative care should be provided in accordance with the needs of the 
patient and WHO standards of care. 
• Treatment for illnesses and conditions should not be withheld at any stage 
of the disease (for example, tuberculosis (TB) treatment, antiretroviral 
treatment (ART) or substitution therapy for injecting drug users). 
• Palliative care should be incorporated as appropriate at every stage of HIV 
disease, and not only when the patient is dying”(129). 
 
The WHO also establishes that  
Ideally, palliative care and disease-specific treatment should be integrated 
throughout the course of chronic, life-limiting illness.” (129) 
 




“Palliative care should be an integral part of the comprehensive care and 
support for people living with HIV/AIDS (PLWHA) and cancer patients. It 
should be provided in the framework of a continuum of care from the time 
the incurable disease is diagnosed until the end of life.”(8) 
 
UNAIDS published a technical update on palliative care in HIV: 
“Palliative care is a philosophy of care which combines a range of therapies 
with the aim of achieving the best quality of life for patients (and their 
families) who are suffering from life-threatening and ultimately incurable 
illness. Central to this philosophy is the right that everyone has the right to 
be treated, and to die, with dignity, and that the relief of pain – physical , 
emotional spiritual and social is a human right and essential to this 
process.”(12) 
 
In a palliative care toolkit for resource-limited settings, the importance of diagnosis 
was reiterated: 
“Many people think that palliative care is just about looking after someone in 
the last few days of their life, but in fact it is about relieving suffering and 
improving quality of life right from the time when a person first finds out that 
they have an incurable illness.”(130) 
 
Finally, the Cape Town Declaration, written by African palliative care trainers at the 
founding of APCA, began “palliative care is a right of every adult and child with a 
life-limiting disease”(131). HIV remains incurable and life-limiting. All these policies 
and definitions agree that palliative care begins from the moment of diagnosis and 






B.3 Palliative care at HIV diagnosis 
 
The prime and sufficient reason to provide palliative care from diagnosis is that 
there is no justification for withholding palliative care from people who are known to 
have a progressive terminal illness. Palliative care at HIV diagnosis is a policy 
requirement, as shown in the previous section. A number of specific benefits of 
delivering palliative care at HIV diagnosis are discussed below.   
 
 
B.3.i Patient-centred care 
 
Palliative care is patient-centred by definition(132, 133). HIV care and research has 
been criticised as disease-centred(134), exemplified by the vertical approach to 
funding adopted by PEPFAR (135). In the literature, the time of diagnosis is often 
used as a proxy for seroconversion, a disease-oriented event which frequently 
goes unrecognised(136). Seroconversion, the development of antibodies specific 
to HIV, is the clinically detectable aspect of infection. Outcomes such as CD4 count 
and viral load are disease-centred, while mortality and QoL are patient-centred 
outcomes. From the patient’s point of view HIV begins with diagnosis, not 
infection(137), and patient-centred care should address this by making diagnosis a 
key focus of research and care. Palliative care is also centred on the patient rather 
than the HCW, involving a multidisciplinary team.  
 
Patient-centred care is also distinct from care provider-centred care. In South 
Africa, small pilot studies, followed by larger observational studies, have shown 
that patient empowerment results in excellent adherence(138). Patients are 
encouraged to take responsibility for their own health, including ‘treatment literacy’, 
training patients to understand their own drugs and to know the side effects and 
interactions of each. This programme was described as patient-centred. Mukherjee 
et al argue that breakdown in health systems is often blamed on the demand side 
(the patient), but that the problem is more likely to be on the supply side (the health 






B.3.ii Effectiveness  
 
In order to deliver appropriate, effective palliative care at diagnosis it is essential to 
understand the problems which occur at this time. The clinical care and public 
health approaches to HIV can appear to be in conflict. Maher and Harries proposed 
looking at HIV through a ‘quality lens’ to bridge the two(139). Quality clinical care is 
integral to palliative care(11). 
 
It would be difficult to argue for palliative care in HIV without evidence that palliative 
care improved outcomes for people with HIV. A systematic review of the 
effectiveness of HIV palliative care was carried out in 2005(140). The search 
strategy found 17 service evaluations of which one was graded ‘strong evidence’, 
two ‘fairly strong evidence’, seven ‘weak evidence’, and six were qualitative. The 
best-quality study, a randomised controlled trial(RCT) of multiprofessional home 
care over standard care, showed improved wellbeing and survival in the 
intervention group but this did not reach statistical significance. The variety of 
systems by which palliative care can be implemented, coupled with the wide range 
of evaluation methods, made meta-analysis unsuitable. Services included home 
care, inpatient hospice care and community support teams, usually in Europe and 
North America, with three in sub-Saharan Africa. The most consistent evidence 
showed high patient satisfaction and lowered symptom prevalence.  
 
 
B.3.iii Retention, ART adherence, and mortality 
 
Morbidity and mortality risks are much higher for patients who begin ART with a 
very low CD4 count(141), and the most common reason for this is late presentation 
for care. Late HIV diagnosis is often not distinguished from late entry into 
care(142). To avoid late initiation of ART, the connection between the patient and 












Diagnosis CD4 test pre-ART care ART eligible begin ART  
Time 
 
Figure B-5 represents the health care services of a patient from HIV diagnosis to 
the initiation of ART, assuming that the patient is not eligible for ART at diagnosis. 
The patient completes a CD4 test and returns for the result, and is admitted into 
pre-ART care with regular tests to check for disease progression. When CD4 count 
and clinical criteria indicate that the patient is eligible, then ART treatment is 
initiated. 
 
In reality, the majority of patients are not retained in care continuously for this time. 
Rosen and Fox conducted systematic reviews of LTFU from HIV care in Africa both 
before (143) and after (144)ART initiation. 
 
Pre-ART care was grouped into three stages; from positive test to CD4 result 
(stage 1), pre-ART care until eligibility (Stage 2) and, for ART eligible patients, pre-
treatment to initiation (Stage 3). Of all patients tested, a median of 59% (range 35-
88%) received a CD4 count result or a clinical staging. From this point, 46% (31-
95%) of ineligible patients were retained in pre-ART care until they became eligible. 
Of those identified as eligible, 68% (14-84%) completed ART initiation.  
 
The reviewers identified a lack of standardised indicators and outcomes for 
retention in care, and few papers could be idnetified, given the wealth of 
experience in the area and the critical importance of retention in care for patient 
wellbeing. Severeal papers used data censoring as an endpoint, i.e. determining 




the sruvey. This simplistic method does not make the best use of the data. A 
patient-relevant endpoint such as ART initiation of a fixed period of time would be a 
better way of estimating LTFU.  
 
Retention in ART programmes is more closely and systematicelly monitored, which 
enabled Fox and Rosen to use a random effects meta-analysis of the 226,307 
patients from 33 identified sources. Using this approach, retention in care was 86% 
six months after ART initiation, 80% at twelve months, and 77% at 24 months.  
 
Table B-7 summarises the evidence for LTFU of pre-ART patients by CD4 count, 
showing that a higher CD4 count is predictive of even worse retention. For example 
in Johannesburg the great majority(85%) of patients with CD4 greater than 200, 
and half of those with lower CD4, do not return for their CD4 test result within six 
months after their HIV diagnosis(145). To some extent this shows a sensible 
prioritisation of those in greatest need but it also reveals that the high LTFU is more 
likely to be caused by structural differences in care than patient inability to remain. 
Tayler-Smith et al explained that monitoring and follow-up of pre-ART patients in 
Malawi was carried out by the general outpatient department rather than the HIV 
clinic. After six months, retention was 90% for patients on ART versus 16% for pre-
ART. Clinic resources were focused on retaining patients on ART, and less 
physically sick patients were not actively encouraged to return for care.  
 
This much lower LTFU of ART patients shows that retention is possible. ART 
patients gained access to the HIV clinic facilities, including trained counsellors, 
community-level peer to peer counselling, and a much lower ratio of patients to 
clinicians. This care had an immediate effect on retention (and thus reduced 
morbidity and mortality) from the first point of contact. Similarly, the very simple 
intervention of free cotrimoxazole (a broad-spectrum daily antibiotic) was 
associated with a significant (p<0.001) improvement in pre-ART patient retention in 
Kenya(146). These findings show that good care can reduce LTFU. Reported 
obstacles to retention include pain, sickness, hunger and hopelessness(147). 
Palliative care can help to ameliorate these problems. Patient-centred assessment 






After patient retention, ART adherence is the second major concern of HIV 
programmes(148). Patient-centred outcomes such as quality of life are not part of 
routine follow-up of ART patients(149), even though adherence is known to be 
affected by perceived quality of care, mental health(150), and social support(151, 
152). A third of HIV patients in South Africa are eligible for ART at diagnosis using 
the criteria of CD4<200(153), and the new WHO guideline of initiation at 350 
cell/ml can only increase the number of patients who require immediate ART. 
Patient-centred palliative care at diagnosis would identify and manage problems 
that limit patients’ ability to adhere to treatment.  
  
The reasons why people fail to maintain treatment have been explored through 
qualitative research, finding that the main impediments to ART adherence are lack 
of money, problems obtaining transport, and shortage of food(154). Nutrition and 
poverty reduction are elements of holistic palliative care. Symptom burden is 
associated with reduced ART adherence(155) and with a greater probability of 
switching ART regimens in settings where this is a possibility(55). A qualitative 
study of barriers to adherence in Tanzania analysed the results with a socio-
ecological framework, identifying structural, programmatic and community 
barriers(147). However, in the interview quotes, participants spoke of hunger, 
fatigue, hopelessness, confusion, vomiting and pain. Symptom management could 





As quoted above, palliative care incorporates the prevention, as well as the relief, 
of suffering(11). Meeting care needs promptly and appropriately might prevent 
other health problems later. The initiation of palliative care immediately after 
diagnosis would allow problems to be identified and managed quickly. The result of 
pre-ART LTFU is that patients either die or return with advanced disease, as ‘late 
presenters’. In Malawi, patient tracing revealed that of 694 pre-ART patients lost to 
follow-up, 49% had died, and 54% of the 451 ART patients had died(156). Median 
time from default to death was respectively 47 and 52 days. Some of these deaths 




Table B-7: retention at HIV diagnosis, CD4 testing and pre-ART care by CD4 count and care 
Author, date, setting Intervention  n CD4 Retention (%) 
    3 months 12 months 
Larson 2010 (145), urban South 








Bassett 2010(157), urban South 
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Larson 2010 (158), urban South 







Lessells 2011(159), South Africa, time 







 35 (95% CI 32-37) 
43 (95% CI 41-46) 
52 (95% CI 49-54) 
Kohler 2011(146) Kenya, pre-ART Free cotrimoxazole 
No free cotrimoxazole 
414 
610 










B.4 The history of HIV and palliative care 
 
 
B.4.i 1960s: Origins of palliative care 
 
Palliative care had its nineteenth-century beginnings in small homes for the dying, 
where nursing, companionship and spiritual support were given to the terminally ill 
whom hospitals would not accept(160, 161). Modern palliative care came into 
being through the efforts of Cicely Saunders. Practising firstly as a nurse, then a 
social worker and later as a doctor, she introduced effective pain and symptom 
control(162), and in 1967 opened the world’s first modern hospice. She later 
recalled that to the existing model were added three key ingredients: listening to 
and systematic recording of patients’ experiences(163); an emphasis on pain 
control as a preventive rather than responsive measure; and the concept of ‘total 
pain’, the inseparability of physical and mental suffering(164). While palliative care 
has been redefined over the years its core values remain preventive pain control 
and interdisciplinary, patient-centred holistic care.  
 
Early work by Hinton in the 1960s had explored the experience of dying in general, 
from any disease(165), but palliative care was initially focused on end-of-life cancer 
care, because Saunders felt that these patients were the most neglected by 
medicine(164). The typical hospice patient received symptom relief, pain control 
and psychosocial care, usually in the few weeks of rapid physical deterioration from 
a diagnosis of terminal cancer to the end of life(163). Home care was developed in 
the 1970s and greatly expanded following the publication of the Wilkes Report in 
1980(166), which recommended integration between the primary sector, hospitals 
and the hospice movement. The first palliative care hospital support team was 
formed at St Thomas’ in 1978, transferring the principles of hospice care to a new 
setting. 
 
By the beginning of the 1980s palliative care was established in the UK, in 
numerous semi-independent hospices as well as specialist hospital teams(164). By 




of palliative care had expanded to other progressive diseases besides cancer. In 
the USA, hospice care was seen as counter-cultural, delivered more by nurses 
than by doctors. Congress added hospice benefit to the Medicare scheme for over-
65s in 1982. Palliative care also developed in Canada (where the phrase was 
coined), pioneered by Balfour Mount(167). 
 
 
B.4.ii 1980s: Development of AIDS palliative care 
 
The hospice movement had found a respected place in the care of people with 
cancer(168). Expansion into other diseases was always intended, but there was no 
immediate haste to do so while the nascent hospice movement was still developing 
its skills and expertise. The recognition of AIDS in 1981 forced the issue. The 
hospice movement was faced with a new, universally terminal condition with 
severe symptom burden and a life expectancy of nine months from diagnosis(169). 
Many of the first HIV care providers were palliative care specialists(170-172).  
 
There was considerable debate around whether people with AIDS should be 
admitted to the existing, predominantly cancer-based hospices or whether they 
would be better cared for in HIV-specific units(168, 173). Independent or semi-
autonomous hospices and palliative care teams made the decision individually. In 
1987, the hospice movement told a parliamentary committee it was unable to 
manage AIDS care(174), although Princess Alice Hospice had already been 
admitting HIV patients for two years. The movement was diverse and 
accommodated different perspectives. The same year, the American Journal of 
Hospice and Palliative Care hosted a debate on the suitability of hospice for AIDS 
patients. While aware that many hospices were already accepting people with 
HIV(175), the editorial pointed out that the decision should not be taken lightly and 
that if a hospice was to take AIDS patients it must be able to provide effective 
care(176). The Ritter Scheuer Hospice described the process by which it decided 
to accept HIV positive intravenous drug users and the training program it put in 
place for staff(177). 
 





• The rising number of people with HIV and the urgency of the need(175) 
• The history and ethos of palliative care, whose principles were always 
meant to apply to non-cancer conditions(168) 
• The skills developed in caring of for the dying, making HIV care a logical 
extension of the procedures already in place(176) 
• The scarcity of supportive care. HIV fell between three traditionally under-
resourced specialities – infectious disease, genito-urinary medicine, and 
palliative care – the first two of which had no experience of terminal care. 
Furthermore, hospice staff thought that stigma and fear caused neglect in 
many health care settings and homes(178). Nurses were fearful, 
homophobic, ill-informed and unwilling to care for people with AIDS(179).   
 
However, there were strong arguments against taking people with HIV into 
hospices which predominantly served cancer patients. In the 1980s, the fledgling 
hospice movement had yet to be universally recognised as a valid health care 
provider. It was argued that the movement should focus its resources on the area 
of end-stage cancer, in which it had developed skills, confidence and expertise. 
Rapid expansion could result in diminished quality of services which would damage 
the reputation of palliative care as a whole(168). Furthermore, stigmatisation of 
people with HIV was rife. A hospice which accepted patients with AIDS could lose 
the goodwill and financial support of the community. In the USA, local residents 
near to hospices campaigned to prevent them accepting HIV patients, and were 
often successful(180).  
 
At Ritter Scheuer Hospice in New York, unexpected problems in the care of people 
with HIV (around half of whom were infected through injection drug use) 
included(177) 
- homelessness(181) or a home that lacked basic sanitary requirements for 
care, requiring inpatient care until death 
- continuing narcotic abuse by family members, necessitating limit-setting by 
staff which was contrary to the ethos of palliative care 
- increased psychological stress on staff due to the young age of patients 
- secrecy, which frustrated attempts to support bereaved families who were 




- discrimination from funeral directors and other service providers who 
refused to accept people with HIV   
 
Hospice staff were concerned that they lacked the skills to manage HIV effectively 
(168, 178). Physically, people with AIDS experienced hitherto rare problems 
including cytomegalovirus, Kaposi’s sarcoma, and HIV encephalopathy(9), as well 
as challenging conditions such as cognitive dysfunction, ataxia, blindness and 
chronic diarrhoea(182, 183). Rather than the predictable decline characteristic of 
cancer, HIV was subject to sudden fluctuations, and the end of life was difficult to 
identify(39). In the last six weeks of life, patients suffered from dyspnoea, cough, 
weakness, diarrhoea, weight loss, anxiety and depression(184). Treatment 
regimens were frequently complex and burdensome, including long-term 
intravenous drugs(39).   
 
Psychosocial and spiritual problems were also challenging. HIV patients were 
younger than typical hospice patients, with the reputation of being vocal and 
‘difficult’ (185). Hospice staff reported(186) that people dying of AIDS were typically 
younger than their usual patients, with more restricted financial resources, less 
social support, and very different spiritual needs(187). Mildmay staff in the UK 
found that their patients often needed practical support such as help with welfare, 
housing and disability benefits, will writing, visas, and funeral planning(187). There 
were social problems for patients with distant or estranged families, and with same-
sex partners who had very few legal rights or recognition. Psychological and 
counselling issues included guilt and anger, self-blame, the consequence of 
changed body image(39), fear of dementia and fear of dying young.   
 
Feelings ran high. At the first Annual American Conference on Hospice Care in 
1985, Kubler-Ross gave the keynote speech, in which she said “A hospice that 
doesn’t accept AIDS patients should not be called a hospice”(178). Kubler-Ross 
believed hospices’ reservations were primarily based on prejudice, fear and lack of 
compassion(173). When she called HIV “the ultimate challenge” to palliative 
care(188), she referred to the challenge of offering love and care to people with 
HIV, not the technical management of symptoms. Saunders later regretted that the 
palliative care movement had been slow to accept the challenge of caring for 





More hospices began to accept people with HIV(189), but specialist centres were 
also developed(187). Coming Home Hospice in San Francisco set aside ten of its 
15 beds for AIDS patients when it opened in 1987(39). The following year saw the 
opening of Casey House Hospice in Toronto (186). In London, Mildmay 
deliberately based its programme of interdisciplinary, patient-centred care on the 
terminal care at St Christopher’s(187). Specialist HIV community support teams 
and day centres(7) were developed following the model of palliative care for 
cancer(184). People with HIV or AIDS were referred for specialist care with 
symptom control, anxiety or patient support problems(172). Anecdotal evidence 
suggested that in the UK people with HIV preferred to be treated at a designated 
HIV centre(183), believing their needs would be best met there.  
 
In contexts that did not explicitly refer to palliative care, AIDS nursing emphasised 
holistic issues such as home based care, family support, pain management, 
anxiety control, spiritual care and bereavement issues(190). User-led services(191) 




B.4.iii 1990s: Divergence of palliative care and HIV care  
 
HIV challenged the definitions of palliative care(193), and its boundary with 
curative care(194). Interviews with health care providers and patients in London 
revealed the problems of co-management between HIV specialists and palliative 
care teams(195). Each professional group saw itself as best placed to coordinate 
services and prevent duplication.   
 
In 1995 the Journal of Palliative Care devoted a special issue to HIV, revealing 
some of the emerging tensions between palliative care and HIV care. Grothe 
identified three challenges to palliative care for people with HIV: the disease, the 
person, and the context(196). Firstly, the unpredictable trajectory of HIV, compared 
with the more predictable decline typical of cancer, led to difficult decision-making 




treatment with palliative care in a blend that satisfied patient autonomy and 
comfort. From Foley et al (186):  
“In the 1980s, treatments were complex enough. Now in the 1990s, PHAs 
may live with multiple infections, increased longevity, multiple cancers … 
and a higher burden of suffering than ever before. This raises questions 
such as: what is the purpose of our care? Is multiple drug therapy truly 
palliative?” (p20) 
 
Aggressive treatment could be necessary even in late stages of illness to prevent 
or cure infections. Intravenous therapy to combat viral retinitis, for example, might 
continue until death (197). This simultaneous provision of aggressive and palliative 
treatment was problematic for some. Kuhl asked (198) 
“[S]ome of the infections experienced by a person with AIDS are reversible 
while the disease itself and the depletion of CD4 cells continues. When does 
palliative care begin? … Does palliative care mean that all symptoms will be 
treated only symptomatically when symptoms are due to a reversible 
infection?”(p27)  
 
His solution was that the palliative care team must combine both components, 
active treatment and palliative care, as appropriate. This approach endures as a 
principle of palliative care. 
 
Secondly, people presenting with HIV had different needs from the typical hospice 
patient. In the USA and Canada at this time, most people with HIV were gay men, 
injection drug users or people from ethnic minorities (black or aboriginal Canadian), 
cultures with which most hospice workers had very little experience. Robb asked 
“how can we provide hospice care for persons for whom AIDS is just one 
problem in a long list of overwhelming, life-threatening concerns?” (199) 
 
This comment referred to injection drug users who might also contend with 
homelessness, mental health problems, lack of family and social support, addiction 
and poverty (200). People with HIV might have a history of activism and 
challenging medical authority to obtain treatment(194), and they sometimes 
experienced grief and emotional exhaustion from over a decade of 





Lastly, the context of care provision was not always suitable for HIV. Advocacy 
groups lobbied for a separate HIV service, and generalist palliative care staff were 
unsure of their ability to manage HIV patients(197). American hospices were faced 
with financial issues; hospice care was funded for the last six months of life and 
was expected to exclude active treatment, but HIV palliative care might require 
expensive medication and the end of life was unpredictable.  
 
There was concern that if HIV palliative care was delivered at all stages of illness 
and should include aggressive therapy when appropriate, then it would take on an 
unmanageable responsibility for all care, rather than establishing core generalist 
palliative care skills across the various HIV care settings. This dilemma was 
resolved by the separation of HIV care from palliative care, as the advent of 
HAART made HIV potentially a chronic (though still incurable and life-limiting) 
condition, rather than a predictably terminal disease. Mortality from AIDS dropped 
rapidly after 1995 in developed countries where HAART was available(201). AIDS 
hospices adapted to the changed disease; Mildmay specialised in HIV brain 
infection rehabilitation, the Sydney Sacred Heart Hospice reverted to generic 
palliative care, and the London Lighthouse closed its residential unit (202). In 1999 
the closure of Chicago House (one of the last HIV-only hospices in the USA) was 
hailed in the media as a triumph for protease inhibitors, although the manager of 
Coming Home Hospice in San Francisco warned that the number of HIV patients 
had begun to rise again(203). 
 
 
B.4.iv 2000s: Rollout of ART and relationship with palliative care 
 
By the end of 2007 around three million people worldwide were receiving ART, and 
a further six million were estimated to be in need of it(204). In the new era of ART, 
HIV care lost contact with its palliative care origins(205). Selwyn, a palliative care 
specialist who described himself as having become an HIV physician by accident, 
warned that “we run the risk of forgetting what we learned about healing, from a 
disease that we could not cure”(206). He was concerned about the relationship 




been complementary but were often viewed as exclusive alternatives. This false 
dichotomy, common to many diseases, was particularly apparent in HIV because 
aggressive treatment for infections could be required until the end of life, and 
because HIV care had begun in the spirit of palliative care. The separation was 
widened by the common view which equated palliative care with terminal care and 
death, rather than seeing it an approach to improve patients’ QoL from diagnosis 
onwards. While palliative care was considered a last resort, there was a reluctance 
to do anything that suggested ‘giving up’(39), particularly as most people who died 
of AIDS were young(208).   
 
B.4.v 2010s: HIV palliative care evolves 
 
Palliative care was redefined to return to its original purpose, delivering care based 
on need rather than on diagnosis (i.e. cancer) or prognosis(209). Services were 
developed for patients with heart failure, COPD and other non-cancer 
conditions(210), and care protocols and policy for the management of incurable 
progressive non-cancer diseases began to stipulate the inclusion of palliative care. 
HIV was included likewise, but palliative care was now one of a number of 
services, not a core provider of HIV care as it had been in the past.  
 
Despite high prevalence of pain and symptoms throughout the trajectory of 
HIV(34), and the high mortality rates(15, 24), less than one percent of the papers 
presented at the last four biennial International AIDS Society conferences related 
to palliative care(211-214). The journal AIDS has published only five articles on 
palliative care in its 20-year history(39, 103, 212, 215, 216), even though the first of 
these opened with the sentence (equally true today): 
“it could be said that all care in AIDS is necessarily palliative, since no 
specific cure has yet been found.” (39) 
 
While expanding into heart failure and other non-malignant diseases, the palliative 
care movement aimed to provide palliative care to everyone in the world who 
needed it, by adopting a public health approach(217). In 2007 the method of 
integrating palliative care into existing healthcare services which had been 




applicable to all life-limiting disease(217). The WHO also produced guidelines for 
community based HIV palliative care as part of the series on Integrated 
Management of Adult/Adolescent Illnesses (IMAI)(126), and UNAIDS published a 
palliative care manual(12). 
 
In 2000, a conference on ‘palliative care in the age of HIV/AIDS’ brought together 
the palliative care experience of the UK and the HIV experience of the USA (219, 
220). More than the age of HIV, the conference was set in the era of ART(221). 
Palliative care had gone from being a central provider of HIV care to having a 
minor role, generally in terminal stages. Now, redefined, its appropriateness 
depended on need rather than diagnosis or prognosis. The increasing life 
expectancy of people with HIV also made them more vulnerable to comorbidities 
such as malignancies and liver disease(222). However, mortality for people with 
HIV remained higher than average even with the best health care(223).  
 
Selwyn summarised the evolution of HIV care: 
“For a brief period in the early years of the AIDS epidemic in the developed 
world, AIDS care and palliative care clinicians worked closely together, or 
were even the same people, in many settings where the only care for AIDS 
was palliative and end-of-life care. Thankfully, with the advent of highly 
active antiretroviral therapy (HAART) and the expansion of other therapeutic 
options in the past two decades, the field of HIV has developed its own 
expertise, just as palliative care has further established itself as a clinical 
and academic discipline. However, as the disease has evolved, we have 
seen the emergence of a false dichotomy between curative and palliative 
care, which does not serve the patient well and does not fit the evolving 
nature of the disease”(224) 
 
Selwyn and Rivard called for “the distance which has developed between HIV and 
palliative care to be bridged”(34) in a 2003 review of the literature, but the evidence 
they cited for pain and symptom experience dated from the pre-ART era(9, 39-41). 
The paucity of research investigating the effectiveness of palliative care post-ART, 
or even the prevalence of multidimensional symptoms and problems, demonstrated 





B.4.vi HIV palliative care development in Africa 
 
Early African HIV care was relatively multidimensional and community-based, with 
services including counselling and family support, but limited control of pain and 
symptoms(225). In the UK, holistic HIV care, modelled on Saunders’ palliative care 
but evolving independently, had become the accepted way to care for people with 
AIDS. That method was transferred to Africa, as from 1989 onwards UK Mildmay 
staff conducted study tours and training partnerships in Africa, opening the Uganda 
Mildmay Centre in 1998.   
 
Meanwhile, specialist palliative care grew alongside HIV care in Africa, expanding 
its services from cancer to HIV as HIV became the primary cause of adult death. 
Island Hospice in Zimbabwe took its first AIDS patient in 1986, and South Africa 
soon followed, followed by Kenya in 1990. The following year, Saunders was the 
guest editor of a special palliative care issue of Contact, the magazine of the 
Christian Medical Commission. Dr Anne Merriman contributed an article describing 
her experiences at Nairobi Hospice(226), which led to the founding of Hospice 
Africa Uganda, a ‘model hospice’ for resource-poor countries(227), delivering 
home-based care for people with terminal cancer(225) and, very soon, for HIV. In 
Uganda, palliative care spread using the WHO Public Health Strategy(217) to 
integrate palliative care into the healthcare system. Medical students have received 
palliative care training since 1994. It has been suggested that the successful 
expansion of palliative care in Uganda was directly related to its connection with 
the HIV epidemic(228).  
 
Facilities were scattered and unconnected. In 2001, the Diana, Princess of Wales 
Memorial Fund launched a Palliative Care Initiative to champion and support the 
growth of palliative care in sub-Saharan Africa, particularly in HIV(131). A review of 
African palliative care in 2005(229) identified four countries where palliative care 
was approaching integration with mainstream health services, eleven with localised 
provision of hospices, eleven where capacity building was underway and 21 
without palliative care activity(230). The founding of the African Palliative Care 
Association(APCA) in 2002(131) represented a major step forward for the 




coordination, collaboration and advocacy”, linking the small and disparate palliative 
care services into health care systems and with each other.  
 
In Africa, palliative care developed alongside the rollout of ART, and as a result 
has been more integrated and less restricted to the terminal phase. A survey in 
2003(231) found that 91% of responding HIV end-of-life services were integrated 
with prevention programmes, 77% addressed the effects of poverty on care, and 
65% accepted patients from the point of HIV diagnosis, in line with WHO policy. 
The majority of programmes conducted education, training and advocacy as well 
as care. Integration of palliative care with HIV care allowed HIV care services to 
refer their patients for specialist palliative care without needing to meet rigorous 
opioid prescription standards themselves(232). A paediatric hospice in South Africa 
used specialist palliative care and symptom management to initiate children onto 
ART(233). Coverage expanded through referral networks and training, facilitated 
by the production of practical guidelines such as the Palliative Care Toolkit for 
resource-limited settings(130). The definition of palliative care has expanded to 
include provision of food, income generation programmes(231), orphan care, and 
similar social interventions(234), underpinned by the concept of patient-centred 
total care.  
 
The President’s Emergency Plan for AIDS Relief(PEPFAR), the US$15 billion fund 
developed by George Bush, took guidance from HIV physicians from the pre-ART 
years of the pandemic, and gave palliative care equal standing with prevention and 
treatment as a third essential and complementary goal. A special issue of the 
Journal of Pain and Symptom Management focused on social justice(133, 224, 
235, 236), emphasising that palliative care must always be accompanied by ART.   
 
The same lessons about the importance of multidimensional care were being 
learned by care providers outside the palliative care movement. In an observational 
study, a package including home-based symptom management, support for family 
carers, referral of patients with risk signs, continuous adherence counselling and 
defaulter tracing alongside ART resulted in 97% survival (of all those registered in 
the previous 21 months) compared to 85% with ART alone(237). Loss to follow-up 
(LTFU) became a key area of importance to HIV care(158), and the programmes 




level(238) through primary health clinics(239). The DART cluster-randomised 
controlled trial found that home-based ART was just as effective as a clinic-based 
programme in terms of mortality and virologic failure (although, notably, QoL and 
symptom burden were not measured)(240). These programmes were successful 
because they delivered holistic, quality care, including social support, counselling 
and medical treatment. The same principles were observed in Cameroon where 
decentralisation of ART services resulted in better psychological outcomes and 
quality of life(241). 
 
 
B.4.vii Conclusions  
 
At the beginning of the HIV pandemic, palliative care was still widely understood as 
care for those with terminal illness, and as so interpreted it was central to HIV care. 
Treatment innovations changed the nature of HIV disease, and with improved life 
expectancy it was only appropriate that terminal care should assume less 
significance. HIV care diverged from palliative care while maintaining the holistic 
principles of the hospice movement at its heart. HIV clinicians and researchers, 
and people with HIV, lost contact with palliative care specialists and overlooked the 
evolution of palliative care to its more modern definition, now encompassing all 
those with a progressive life-limiting condition. As a result, contemporary HIV care 
aims to be holistic but is no longer palliative. HIV care specialists do not recognise 
a need for palliative care other than at the end of life. People with HIV do not have 
access to palliative care before the terminal phase, although there is evidence they 







B.5 Challenges to HIV African palliative care research 
 
Surveys of African palliative care (232) illustrated the processes taking place and 
revealed a wealth of experience for both HIV and cancer, but evidence of 
effectiveness was undeveloped(232). Two papers in 2008 identified challenges to 
African palliative care research(242, 243). Many of these challenges were common 
to all health research, while palliative care also faced concerns from its connection 
with opioids, and was not seen as a priority in HIV research(244). 
 
 
B.5.i Logistical problems 
Logistical problems include limited and dysfunctional infrastructure, limited 
research funding, shortage of trained local researchers and lack of a career path 
allowing them to progress(243). Palliative care associations from around the world 
signed the Declaration of Venice in 2006, affirming the importance of palliative care 
research in developing countries to ensure maximum benefit for patients(245). 
High quality research producing robust evidence was seen as essential for the 
changes in policy and practice required to develop palliative care, especially in a 
situation of limited resources and competing demands(242).  
 
Only one study has been identified which attempted to measure the proportion of 
people with HIV who would benefit from palliative care(47). ‘Needs appropriate for 
palliative care’ were defined as an unresolved symptom, pain, or a complex 
psychosocial or spiritual need, as recorded by a HCW. Appropriate needs were 
identified in 52% of 731 patients who visited the hospital. The severity of problems 
and the requirement for generalist versus specialist palliative care could not be 
established. Furthermore, need assessment was limited by the use of a closed 
checklist to record symptoms. A paper in 2002 calculated that if 6% of the 
population of Uganda was HIV positive and a sixth of these had AIDS, while 0.1% 
had cancer (half of whom also had HIV), then at any one time 240,000 people in 
Uganda were in pain(246). The estimates of disease and pain prevalence were 
highly unreliable, and the calculation did not allow for the fact that people with HIV 
experience pain prior to AIDS. This limited information hampers service planning. It 




a tenth as many with cancer, demonstrating the primacy of HIV/AIDS in African 
palliative care.  
 
 
B.5.ii Methodological problems 
Methodological problems included inadequate mechanisms for ethical clearance, 
sources of bias such as the diversity of languages, power imbalance between 
health workers and patients, and lack of sampling frames to allow probabilistic 
sampling(242). Studies reported process data only, such as the evaluation of an 
inpatient palliative care unit which reported the average length of stay but no 
patient outcomes(247). 
 
The absence of a validated outcome measure was a major problem, identified as a 
need by African researchers(231). The lack of appropriate, validated measures 
hampered the development of a rigorous evidence base (242). Outcome measures 
used in palliative care settings in Africa include: 
• The MOS-HIV – a health related QoL instrument developed in the USA(248) 
and adapted and validated in Uganda(249). 
• A symptom questionnaire for people with HIV, not described or validated(45) 
• The HIV-SL and HIV-SP - an HIV symptom list and symptom profile, piloted 
in the USA, adapted in South Africa but not validated(35) 
• A questionnaire to identify needs of people with terminal illness, developed 
in Uganda(250) and adapted in Rwanda(36) 
• The MVQoLI(93), developed in the USA for use in end of life care  
 
These instruments were inadequate for palliative care research, either because 
they were one-dimensional, too long, unvalidated, or because insufficient evidence 
had been provided to judge their worth. Tools were often developed at one service 
and not adequately validated or shared for general use. The MVQoLI, a palliative 
care instrument, was designed for clinical use and of limited value as a research 
instrument, as well as being relevant only to those with advanced illness(92).  
 
Symptom questionnaires such as the MSAS-SF, while very useful, have limitations 




closed list of symptoms. Closed lists are useful for generalisation and comparison, 
but they limit data to the expectations of the researcher. Thus, important areas 
such as psychological or spiritual problems may be absent. Some QoL instruments 




B.5.iii Confusion around QoL 
 
A more general problem with QoL instrument design also emerged in the quest for 
a suitable outcome measure. Bowden and Fox-Rushby described how adaptation 
of QoL instruments for a new cultural context can suffer from ‘misguided pre-
occupation with scales rather than the concepts being scaled and too much 
reliance on unsubstantiated claims of conceptual equivalence’(251). Gatter 
describes the methodological difficulties with much of the research on coping and 
QoL, particularly when subjective concepts of wellbeing or social inclusion are 
reduced to multi-item scales for covariance analysis(7). Firstly, correlations are 
misinterpreted as causative relationships, while the correlations themselves may 
be generated by the overlapping cultural meanings of concepts (such as self-
esteem and social support), amounting to tautology. Secondly, in being quantified, 
concepts also be reified, decontextualised, stripped of meaning, and 
unrepresentative of the social environment they were meant to express. A way to 
avoid these problems may be to measure patient experience more directly, rather 
than creating multi-dimensional summary scores.  
 
 
B.5.iv Development of an outcome measure: the APCA African POS 
 
The APCA African POS was created to meet African palliative care providers’ 
expressed need(231) for a multidimensional palliative care scale(252). It is based 
on the original POS, which was developed to address the multidimensional 
problems of patients with incurable progressive disease and subsequently adapted 




Treatment Assessment Schedule (STAS), which was the main tool for evaluation of 
palliative care needs in the 1990s and was used at the first HIV palliative care 
service in the UK. 
 
To create the African POS, an expert panel representing four African countries 
reviewed the WHO definition of palliative care(11), identified five key domains and 
developed a draft set of twelve items to capture relevant information on these 
domains(255). After two rounds of piloting in eight countries, and a meeting of the 
expert panel to establish content and consensus validity, the list was revised to ten 
items. Piloting showed the tool was culturally acceptable and brief enough for use 
in an understaffed health care system.   
 
Rigorous validation of face and construct validity, test/re-test reliability and internal 
consistency was conducted in five palliative care facilities in Uganda and South 
Africa(256). Cognitive interviews found good face validity, and qualitative interviews 
identified that the POS items mapped well onto patients’ needs and concerns. 
Using Spearman’s rank test, POS scores were compared with the MVQoLI which 
had been validated in Uganda(93). Correlation coefficients were low to moderate, 
reflecting the fact that the tools were developed for different audiences and with 
different purposes. Cronbach’s alpha was 0.6, indicating a moderate internal 
consistency, which was expected given that the ten-item tool was deliberately 
multidimensional. Test/re-test reliability was assessed using 342 pairs of 
observations a mean of two days apart. Intraclass correlation coefficient for the 
combined score was 0.89 and the lowest score for a single item was 0.78, 







HIV is a progressive, life-limiting and incurable condition, and people with HIV 
experience burdensome multidimensional problems throughout the trajectory of 
disease. Palliative care is the holistic management of such problems and therefore 
palliative care is appropriate for people with HIV, as needed. Internationally 
accepted HIV policy requires palliative care from diagnosis to the end of life(8), 
which involves detailed assessment and management of symptoms and 
multidimensional problems. Potential impacts include improved service provision, 
better patient-reported outcomes, reduced loss to follow-up following diagnosis, 
improved patient retention in care, hence timely ART initiation and reduced 
mortality. Most people with HIV in Africa (and hence the majority worldwide) do not 
receive palliative care.  
 
Better understanding of the problems experienced by people newly diagnosed with 
HIV is required to deliver appropriate care. The evidence base in Africa is 
particularly poor, lacking information on prevalence and severity of palliative care-
related problems. Knowledge of the prevalence of multidimensional problems at 
HIV diagnosis is needed, with a patient-centred focus. The APCA African POS is 




Palliative care-related problems at HIV diagnosis: systematic review 
 




C.1 Introduction  
 
An understanding of needs at HIV diagnosis is essential in order to provide 
effective, quality care. Research into the problems and palliative care needs of 
newly diagnosed people has received very little attention. Most studies of palliative 
care problems in HIV either focus on advanced disease(9) or do not report 
separately on the individuals recently tested(58). Therefore a systematic review 
was conducted to identify and appraise the evidence of multidimensional problems 
at HIV diagnosis, to meet the two goals of informing care provision and identifying 
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C.2 Framing the question 
 
 
C.2.i Preliminary scoping of the literature 
 
During unsystematic literature searches and reference list searches over a period 
of eighteen months, a body of literature was identified on the subject of palliative 
care problems at HIV diagnosis. This literature informed the development of a 
systematic search strategy. No standard term was in use to describe the newly 
diagnosed population. In a selection of relevant papers, the simplest descriptive 
phrases of the population included ‘newly diagnosed’(257, 258), ‘recently 
diagnosed’(67), ‘after the information regarding their HIV status was revealed to 
them’(259), ‘at the moment of diagnosis’(260), and ‘had recently learned they were 
HIV positive’(137). This diversity of descriptions meant that keyword searches 
would be an impractical means of identifying relevant papers.  
 
Major databases (PubMed, Medline and PsychInfo) did not use any subject 
heading for recent diagnosis, and more general keywords such as ‘diagnosed’ 
returned thousands of irrelevant papers. The lack of consistency in keywords, 
search terms and descriptions, coupled with the fact that many studies of newly 
diagnosed people did not identify themselves as such in the abstract, was in itself 
evidence that the needs of this group have not been clearly defined and that newly 
diagnosed people have traditionally not been considered a subject of research. 
 
 
C.2.ii Definition of ‘newly diagnosed’ 
 
Diagnosis was defined as a patient-centred event; the moment when the patient 
became aware of their own HIV status. This definition was used to continue the 
patient-centred perspective of the thesis. 
 
Definitions of ‘newly diagnosed’ in the literature included those diagnosed within 
the previous twelve months (261), twelve weeks(67), twelve days(262) or twelve 
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hours(263). Owing to the paucity of longitudinal studies, the rate of change over 
problems over time is not known. For the inclusion criteria of the systematic review, 
‘newly diagnosed’ was operationalised to mean ‘from the time a patient was 
informed they were HIV positive to six months later’. Six months was selected 
because it is common in the literature for observational studies and controlled trials 
to exclude those diagnosed within the previous six months(264, 265). Similarly, a 
period of more than six months between HIV diagnosis and entry into HIV care is 
referred to as delayed care(142, 266). 
 
During data collection, several studies were found which recruited pregnant women 
who had been diagnosed with HIV during their pregnancy. The category 
‘diagnosed during ongoing pregnancy’ was added to the definition of ‘newly 
diagnosed’. Although ‘during pregnancy’ could extend to nine months, it was 
thought women were less likely to consent to recruitment into a study in the final 
weeks of pregnancy, or to have an HIV test in the very first weeks.  
 
 
C.2.iii Definition of ‘palliative care-related problem’ 
 
To focus the systematic review into a specific, manageable question, while 
maintaining the broad scope of palliative care related problems, seven specific 
areas of multidimensional burden were identified. These elements were taken from 
the seven patient-directed items of the APCA African POS(255) (henceforth the 
POS). The POS is the only multidimensional tool validated for Africa, where two 
thirds of people with HIV live(14). The POS items were derived from the WHO 
definition of HIV palliative care, which is the same as that for cancer(11). They 
cover all four dimensions of palliative care: physical, psychological, social and 
spiritual. 
 
The purpose of using specific problems was firstly to identify literature which was 
relevant to the question but outside the context of palliative care, and secondly to 
ensure that the papers in the review represented problems across the full range of 
multidimensional patient experience. Preliminary scoping showed that the majority 
of studies relevant to palliative care problems at HIV diagnosis were not conducted 
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in the context of palliative care, and that studies of physical symptoms 
outnumbered those of psychological and spiritual problem, which was not in line 
with study aims. 
 
 
C.2.iv Contemporary and retrospective research 
 
Several studies were based on qualitative interviews of people who have been 
diagnosed with HIV for several years and were asked to recall the experience, 
either qualitatively(267) or by completing retrospective questionnaires(268). For 
example, one study asked participants with HIV to compare their present spiritual 
state with that prior to their diagnosis several years previously, and claimed that an 
increased interest in spirituality following diagnosis predicted slower disease 
progression(269). Memory construction research shows that emotionally charged 
events, such as HIV diagnosis, are remembered with heightened vividness and 
intensity but impaired accuracy(270).  
 
Another reason to reject retrospective data collection is derived from medical 
sociology. Illness narrative theory posits that people assimilate damage to physical 
integrity into their sense of self through constructing a rational narrative out of 
memories(271-273). According to this theory, accurate emotional recall of the time 
before HIV diagnosis is likely to be impossible, which invalidates the post hoc 
instrument completion method (268). In recognition of these problems, studies 
using retrospective data collection were not accepted for this systematic review. 
The method can be used to observe the processes of response to biographical 
disruption(272, 274), including interpretation of HIV diagnosis, but is not an 
appropriate technique for the study of HIV diagnosis as a lived experience. 
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The systematic review method is detailed in full in the published paper(275), 
included in Appendix E. The method followed the PRISMA recommendations(276). 
C.3.i Review question 
 
The primary review question is ‘What palliative care-related problems do adults 
[defined as aged 18 or over] experience at the time of HIV diagnosis?’ 
 
This was addressed through seven more specific questions which were taken from 
the seven patient-completed questions of the POS: 
1. What proportion of adults experience pain at the time of HIV diagnosis?  
2. What proportion experience other symptoms?  
3. What proportion experience worry?  
4. What proportion are able to share their feelings? 
5. What proportion experience wellbeing?  
6. What proportion experience peace?  
7. What proportion receive enough help and advice for their family to cope? 
 
 
C.3.ii Literature identification 
 
The following databases were searched: OVID Medline (1966 to September 2009), 
PSYCHInfo (1967 to August 2009), Embase (1980 to September 2009) and 
PubMed. In addition, papers identified through non-systematic means were added 
if they met the inclusion criteria. There were no limitations regarding study design.  
 
C.3.iii Search strategy 
 
From each POS question item, a word was identified which summarised the patient 
problems, and these words were used as search terms. Where possible, they were 
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linked to subject headings, and if no suitable subject heading existed they were 
used as keywords. The search terms were 
• Pain – using the accepted palliative care definition that pain is what the 
patient says hurts(218) 
• Symptoms - representing physical problems from a patient-centred 
perspective. Self-reported symptoms have been shown to be more complete 
and clinically relevant than health provider-reported problems(277)  
• Worry – representing psychological problems. Worry is a symptom of all 
anxiety disorders(278) and is frequently associated with depression(279). 
• Wellbeing – identified in the POS as ‘feeling life is worthwhile’, and 
representing QoL and wish to live. In principal components analysis, this 
question loaded into a factor with items from other scales measuring positive 
outlook, goals, inner strength, loving, sense of direction, and the beliefs that 
days have potential and life has value(254).  
• Support – the family and informal caregivers are important aspects of 
palliative care. Social support in the literature is divided into two concepts: 
emotional and tangible/information support. This POS question was 
correlated against the interpersonal domain of the MVQoLI(256).  
• Peace - the question ‘are you at peace?’ is a measure of spiritual wellbeing, 
validated independently in Uganda, South Africa(256) and the USA(280).   
• Information - represents informational and tangible support, as distinct from 
emotional support(281).  
 
Each of the seven subject headings/keywords was combined with HIV 
seropositivity using AND.  
 
The abstracts were read to exclude those papers which did not relate to the newly 
diagnosed. It was expected that the abstract would not be sufficient to identify all 
relevant papers, so abstracts were only used to eliminate the clearly irrelevant 
articles. The results of all seven subject heading searches were combined, with a 
keyword linking them to the relevant problems area, to remove duplicates. All 
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C.3.iv Inclusion and exclusion criteria 
 
The inclusion criteria were: 
• Original study (qualitative or quantitative) or review 
• Peer-reviewed publication 
• Study of people with HIV (any country or group) 
• Adults (18 or over) 
• Includes at least one of the seven problems 
• Not a case study 
• English language 
• Does not exclude those diagnosed within six months 
 
Exclusion criteria were: 
• Analysis group includes people diagnosed with HIV more than six months 
previously 
• Analysis group includes people who are HIV negative 
• Analysis group includes people who do not know they are HIV positive 
• No results are self-reported measures of patient experience 
• Retrospective data collection. For example, a study which asked people four 
months after diagnosis to recall their experience two weeks after diagnosis 
would be excluded. 
• False positive tests or HIV delusion 
• Full paper could not be retrieved(e.g. dissertation abstracts) 
 
The language of palliative care was used to develop the seven search terms, while 
the great majority of the literature is based in other disciplines which may use 
different terms to refer to similar concepts. One example which arose in the review 
process was the term ‘coping’. The theory of coping, developed by Lazarus and 
Folkman(282), describes the means by which people ‘deal with demands taxing or 
exceeding the resources of the person’(283)(p121). The various responses to 
stress are defined as negative or positive coping strategies. Many studies of coping 
strategies in HIV were identified in the review process. Coping, in itself, is not a 
part of the inclusion criteria, as the aim was to measure patients’ problems and 
experiences at diagnosis, rather than the means by which they overcame them. In 
studies of coping, HIV diagnosis alone was used as the variable denoting stress.  
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C.3.v Data extraction 
 
Data were extracted into a standard proforma. Variables included authors, date of 
publication, setting, time from diagnosis to data collection, aim, study design, 
population, tools, analysis, and findings.  
 
 
C.3.vi Analysis  
 
For preference, findings were presented as the percentage of participants to report 
a problem. Alternatively, mean scores were presented, for example in the case of 
QoL instruments. The findings in control groups who did not meet the inclusion 
criteria, and the results of statistical tests comparing the two, were only presented if 
they were necessary in order to interpret the findings in the newly diagnosed 
group. In the case of longitudinal studies, findings from all time points which fell 
within six months after diagnosis were presented. Analysis of change over time 
was not presented, because it did not answer the review question.  
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The search elicited 5443 unique hits (Figure C-1). Review of titles reduced this 
number to 1403 papers and the abstracts of these were read to identify and 
exclude papers which were not relevant to the review. Because the default position 
in the absence of clear information was to retain the paper (an opt-out design 
rather than opt-in), abstract screening only excluded 390 papers, and 1002 were 
retrieved in full.  
 
The method section of a paper was often the most useful to assess its relevance, 
while the abstract and aims could be unclear. Some papers which recruited newly 
diagnosed participants only made this fact clear in their description of the 
recruitment process. Sixty-five papers were retained in this way, of which 31 met 
criteria for exclusion on detailed study, leaving 34 for review.  
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 -Not a study of  
  patient problems in HIV  
 -Dissertation abstracts 
Excluded n=4140 
 -not an original study 
 -not listed language 
Excluded n=31 
 -Not concerning newly  
  diagnosed n=17 
 -No descriptive data  
  presented n=1 
 -no data on patient experience 
  (lab results only) n=4 
 -seroconversion without  
  knowledge of diagnosis n=5 
 -date of diagnosis not clear n=4 
Full copies 







Unable to obtain n=11 
Excluded n=937 
 -not a study of newly  
  diagnosed population 
 -newly diagnosed not 
   analysed separately 






 and screened 
n=5443 Figure C-1: PRISMA 
review flowchart 
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C.4.i Study designs and methodologies 
 
Seven studies were patient chart reviews and 27 collected primary data. Two 
papers presented qualitative results(105, 284), and two collected data using in-
depth interviews but presented it quantitatively(137, 285). Study designs comprised 
eleven cohorts (usually with only two or three time points), eight observational 
cross-sectional studies, two case-control studies, one before-and-after trial, and 
one RCT. In many cases the research question, analysis and design used in the 
paper were not all relevant to the review. For seven cohorts, only one time point fell 
within six months of diagnosis, so these data were presented as cross-sectional. 
Likewise, only the baseline results from the RCT and before-and-after trial were 
reported.   
 
Sixteen studies included some element of comparison or control group of people 
who were not newly diagnosed with HIV. The most common design (seven studies) 
was a prospective unmatched two-arm cohort, with a newly diagnosed HIV positive 
group compared to one which was HIV negative. The same comparison was also 
used in a retrospective record review(286), a cross-sectional survey(287), a 
matched cohort(288) and a matched case-control study(136). Additionally, two 
cross-sectional surveys(289, 290) and one prospective cohort(291) compared 
newly diagnosed participants with people with a pre-existing HIV diagnosis. 
 
One prospective cohort compared newly diagnosed participants who were IDU to 
newly diagnosed non-IDU(292). Similarly, a case-control study used three control 
groups to separate the effects of new HIV diagnosis and IDU on health(293). 
Cases were newly diagnosed IDU; the control groups consisted of newly 
diagnosed non-injecting men, HIV negative IDU, and HIV positive IDU who already 
knew their status. For these studies, the results are presented separately for the 
IDU and non-IDU newly diagnosed groups. 
 
Results from control groups or study arms are only presented if they are needed to 
interpret the findings in the newly diagnosed group, such as QoL scores, which are 
essentially comparative. When the outcomes were symptom prevalence or score 
on a validated instrument with clinical utility, then only results from the newly 
diagnosed arm are presented.  
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C.4.ii Populations and settings 
 
Two case-control studies(136, 293) and one two-arm cohort study(292) recruited 
only patients with recent or current seroconversion. These three were all conducted 
in high-income countries (Canada and the Netherlands), and measured the 
prevalence of pain and physical symptoms. Between 13% and 56% of participants 
were IDU. 
 
Five studies in low-income countries recruited only pregnant women. Three of 
these used a cohort design(79, 289, 294), but in each case only one time point was 
within six months of diagnosis, so the results are shown as cross-sectional. The 
other two pregnancy studies were qualitative(65, 105). Findings covered all areas 
except the domain of peace. Three further pregnancy studies were conducted in 
the USA, and measured, respectively, physical symptom prevalence(295), 
QoL(288), and psychiatric diagnosis(285). 
 
Three studies took place in inpatient settings, all in low- and middle-income 
countries (the Democratic Republic of Congo, Kenya and Jamaica). All three 
assessed prevalence of physical signs and symptoms; one in patients with 
comorbid TB(286), another in patients with comorbid herpes zoster(296), and the 
third accepting all newly diagnosed inpatients(297). Three further studies took 
place in low-income countries. Two were analysed as cross-sectional prospective 
observational studies(298, 299), the other was a retrospective chart review of 
patients’ emotional reactions to HIV diagnosis(300).  
 
There were six studies of outpatients in middle-income countries. Four were cross-
sectional prospective observational studies, two using validated outcome measures 
(287, 301) and two unvalidated(302, 303). The fifth was an observational 
prospective cohort with validated tools(304) and the sixth was a retrospective chart 
review of physical symptoms(260). 
 
Finally, eleven studies took place in high-income countries. Seven of them, all 
based in the USA, predated the introduction of ART in 1996. Perry conducted three 
prospective cohort studies using structured questionnaires, although only the HIV 
positive arm of the cohorts was presented in the review(263, 305, 306). Two other 
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pre-1996 studies also used structured questionnaires to record psychological state 
as well as symptom burden(307, 308), and one study recorded status 
disclosure(290). The last used secondary analysis of a prospective cohort to 
compare newly diagnosed to previously diagnosed people in terms of worry and 
mood disturbance(291).  
 
Of the four post-1996 high-income country outpatient studies, two used patient 
records to establish physical symptom prevalence at diagnosis(257, 309) and the 
others were qualitative studies, of peripheral neuropathy(284) and the experience 
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a) pain                b) symptoms           c) worry        
d) wellbeing       e) emotional support 




Aim: determine the commonest symptoms 
and signs at presentation in HIV-infected 
individuals at a hospital 
Design: cross-sectional prospective study 
of outpatients at HIV clinic (n=200) 
Tools: a symptom checklist 
Population: outpatients 
(middle-income countries) 
Time: ‘newly diagnosed’ 
 
b) 66% weight loss, 42% fever, 39% chronic cough, 
32% diarrhoea, 21% oral thrush, 20% wasting,18% 





Aim: determine the prevalence of HIV 
infection in patients with pulmonary TB at a 
hospital 
Design: retrospective study of patient 
records (n=47 HIV+ve, n=359 HIV-ve) 
Population: inpatients 
(middle-income countries) 
Time: diagnosed during 
current hospital stay 
 





Aim: assess the influence of HIV infection 
on pregnancy outcomes and effect of 
pregnancy on short-term course of HIV 
infections 
Design: Two-arm prospective cohort. Data 




Time: diagnosed during 
current pregnancy 
b) 28% genital candida, 13% condylomata, 12% 
oral herpes, 12% fatigue, 11% night sweats, 11% 





Aim: examine the burden of depressive 
symptoms among HIV+ve women (n=996) 
Design: prospective cohort embedded in 
RCT (only 1 data point within 6 months of 
diagnosis) 




Time: mean 2.5 months after 
diagnosis 
 





Aim: assess changes in psychological 
distress, plasma cortisol and blastogenic 
responses following serostatus notification, 
to examine disparity between psychological 
and immune responses evident in HIV+ve 
individuals 
Design: Prospective two-arm cohort of 
HIV+ve (n=25) and HIV-ve (n=46) gay men  
Tools: Impact of Events Scale (IES), 
Population: outpatients 
(high-income countries) 
Time: 2, 3 and 5 weeks after 
diagnosis 
Analysis: means presented. 
Higher score = worse 
symptom 
 
c) STAI state anxiety 
  POMS anxiety 
  POMS depression 
  IES intrusion 
  IES avoidance 









































a) pain                b) symptoms           c) worry        
d) wellbeing       e) emotional support 
f) peace              g) practical support
State/Trait Anxiety Inventory(STAI), Profile 





Aim: Establish whether there are ethnic 
differences at HIV diagnosis in demographic 
characteristics, disease stage and reasons 
for testing 




Time: within 3 months after 
diagnosis 
 
b) ‘symptomatic’: 35% of whites, 30% black 
Africans, 25% black Caribbeans.  
Tested because of symptoms: 19% of whites, 37% 





Aim: understand the circumstances 
surrounding HIV testing among recent 
seroconverters (n=80) compared to HIV-ve 
controls 
Design: Retrospective case-control. 
Controls matched by gender, HIV exposure 
and geographic region 
Population: seroconversion 
(high-income countries)  
Time: median 3 months since 
diagnosis 
 
a) Of the 66% with symptomatic primary HIV 
infection (SPHI), 62% had severe headache 
b) 43% tested because of symptoms or illness, 8% 
because of STD diagnosis 
Of the 66% (n=53) with SPHI, 100% had fever, 
98% fatigue, 96% myalgia, 85% night sweats, 79% 




Aim: study factors related to anxiety, 
depression and suicidal ideation among 
HIV+ve heterosexuals soon after being 
tested for the first time 
Design: Observational cross-sectional 
study (n=51) 
Tools: Hospital Anxiety and Depression 




Time: 4-6 weeks after 
diagnosis 
 
a) 31% severe pain 
b) 55% painful symptoms 
c) 36% anxiety disorder, 40% depressive disorder 
d) 20% death wish, 12% occasional suicidal 
ideation, 8% attempted suicide 






Aim: Evaluate the effectiveness of 
avoidance of serostatus information as a 
coping strategy by examining psychological 
wellbeing of gay men before and after they 
learned the results of an HIV test.  
Design: Secondary analysis of prospective 
two-arm before & after study. Only HIV+ve 
results presented (n=45 newly diagnosed)  
Tools: POMS, Hopelessness Scale 
Population: outpatients 
(high-income countries) 
Time: within six months of 
diagnosis 
Analysis: higher score= 
worse result 
 
c) Concern about 
developing AIDS 
c) Subjective risk & 
lack of control 
c) Mood disturbance 

























Aim: examine long term changes in 
psychological symptomology from 6 to 24 
months after notification of HIV+ve 
serostatus among injection drug users (IDU) 
Population: outpatients 
(high-income countries) 
Time: within 6 months after 






























a) pain                b) symptoms           c) worry        
d) wellbeing       e) emotional support 
f) peace              g) practical support
Design: two-arm prospective cohort 
(HIV+ve IDU n=16, HIV-ve IDU n=81). First 
data point presented only 
Tools: Symptom Checklist-90 (SCL-90), 
Beck Depression Inventory (BDI) 
Analysis: means presented, 
t-tests by reviewer 
Fitzgerald 




Aim: determine whether information 
collected at HIV notification during VCT can 
predict patients’ future adherence  




Time: on day of diagnosis 
 
b) 26% recorded HIV symptom free 
c) emotional reaction: 42% acceptance, 35% 
shock, 31% resigned, 16% sadness, 14% denial, 
10% fear, 5% tearful 





Aim: Describe prevalence and determinants 
of HIV infection among low-risk subject 
seeking their first test 




Time: data collected during 
pre- or post test counselling 




Aim: describe the experience of testing 
positive for HIV  
Design: qualitative interviews (n=50)  
Population: outpatients 
(high-income countries) 
Time: mean 6.7 weeks since 
diagnosis 
b) 8% physical response to diagnosis (dry mouth, 
dizziness, sweating, cognitive impairment) 
c) 32% felt shock/surprise at diagnosis. 14% 
sadness, depression or crying on diagnosis. 2% felt 
relief 
d) 4% felt suicidal 
e) 14% said health provider (HP) provided 
emotional support at diagnosis. 14% said HP’s 
delivery of result was distressing. 10% said HP was 
very encouraging. 10% said HP was upset 




Aim: describe psychosocial problems 
encountered in patients referred for 
psychiatric evaluation during pregnancy 
following HIV diagnosis 




Time: 13/15 diagnosed 
during current pregnancy  
c) 14 have psychiatric diagnosis (8 adjustment 
disorder, 8 antisocial personality, 6 borderline 
personality, 1 dysthymia, 1 cyclothemia, 1 major 
depression, 1 R/O borderline intellect). 3 modd 
disorder, 11 unstable personality, 13 drug/alcohol 





Aim: describe specific HIV-related needs of 
a sample of HIV+ve women and describe 
impact of HIV in their lives over a period of 
time 
Design: repeated in-depth qualitative 
interviews (n=55). Data from post-diagnosis 
Population: pregnancy (low-
income countries) 
Time: at post-test counselling 
 
c) Most pressing concern: 43% childcare.   
80% said HIV status caused a great deal of 
concern 
d) 94% glad to know their test result 
e) 24% thought partner would be supportive, 46% 
not sure. 35% said neither partner nor family would 
81















a) pain                b) symptoms           c) worry        
d) wellbeing       e) emotional support 
f) peace              g) practical support
interview only reported 
 
take in their children if they died. 
g) 73% said relatives could not help with future HIV 
problems. 94% said no services available outside 
family. Current needs: 55% housing, 45% 
employment, 32% money, 30% childcare, 26% 






Aim: investigate how pregnancy affects 
mental health and perceived quality of life 
(QoL) of HIV+ve women who receive 
diagnosis when already pregnant (n=40) 
and those already informed  
Design: Two-arm prospective cross-
sectional study 
Tools: a structured questionnaire 
Population: pregnancy (low-
income countries) 
Time: diagnosed during 
current pregnancy 
 
c) 95% at least one somatic manifestation of 
anxiety, 25% poor concentration and lethargy 
d) 100% continuous suicidal thoughts, 95% lost 
interest in life and felt worthless 
 




Aim: describe perceived QoL and functional 
status of women with HIV during the 
antenatal, perinatal and postpartum periods  
Design: Two-arm observational cohort. 
HIV+ve pregnant women (n=21) matched 
on age, race, parity, education to HIV-ve 






Time: diagnosed during 
current pregnancy 






b) physical function 
    fatigue 
c) mental health 
    cognitive function 
d) overall health 
     QoL 
    Health distress 
g) role function 





































Aim: examine differences in sexual risk 
reduction among newly diagnosed people 
with HIV who receive care and support, 
compared to regular services 
Design: RCT of enhanced care and support 
services. Baseline data presented (n=154) 
Population: outpatients (low-
income countries) 
Time: 4 weeks after post test 
counselling 
 
b) 33% tested because of symptoms, 35% STD 
symptoms at baseline, 23% genital sores 
e) 19% had disclosed at baseline 
 






Aim: Understand ways in which people 
living with HIV in Africa turn to religion for 
support  




Time: diagnosed during 
current pregnancy (those 
quoted) 
e) disclosing to church pastor initially helped to 
disclose to partner 
f) Women received support from religious beliefs 
and practices after HIV diagnosis 
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a) pain                b) symptoms           c) worry        
d) wellbeing       e) emotional support 
f) peace              g) practical support
Mansergh 




Aim: to assess self-disclosure of HIV+ve 
serostatus among asymptomatic and 
symptomatic men who vary in length of time 
since diagnosis.  
Design: cross-sectional observational 




Time: 2-4 months after 
diagnosis 
 
b) 27% (n=21) self-reported ‘symptomatic’ stage 
e) Symptomatic group: 100% disclosed status to 
lover (where relevant), 75% friend, 57% mother, 
28% father, 43% sister, 39% brother, 10% none of 
above.  
Asymptomatic group: 75% disclosed to lover, 58% 
friend, 32% mother, 7% father, 28% sister, 19% 
brother, 21% none of above 




Aim: study the clinical symptoms 
associated with HIV seroconversion (SC) 
among IDU 
Design: Case-control. Cases were SC IDU 
(n=18), controls SC MSM (n=27), HIV-ve 
IDU and long term HIV+ve IDU. Data 
presented for the 2 SC groups 
Population: seroconversion 
(high-income countries) 
Time: within 6 months after 
diagnosis 
 
a) IDU: 11% pain with swallowing, 11% headache. 
MSM: 26% pain swallowing, 15% headache 
b) IDU: 22% tiredness, 33% fever, 11% night 
sweats, 28% bacterial pneumonia, 28% skin 







Aim: Describe clinical and virological 
characteristics of acute/early HIV infection  
Design: Two-arm prospective cohort study 
comparing newly diagnosed IDU (n=33) and 
non-IDU (n=26). Symptoms reported at 




Time: within six months of 
seroconversion 
 
a) IDU: 58% headache. Non-IDU: 28% headache 
b) IDU: 65% pharyngitis, 50% lymphadenopathy, 
81% fever, 58% rash, 73% anorexia, 54% 
diarrhoea. Median symptoms 10.  
Non-IDU: 50% pharyngitis, 44% lymphadenopathy, 
53% fever, 28% rash, 25% anorexia, 13% 







Aim: study the effect of HIV infection on 
QoL during pregnancy and puerperium 
Design: two-arm prospective cohort study 
of HIV+ve (n=132) and HIV-ve women. 
HIV+ve arm results presented here 
Tools: Dartmouth COOP 
Population: pregnancy (low-
income counties) 
Time: 72% diagnosed during 
current pregnancy 
Analysis: ‘poor’ = score 3/4 
on 0-4 scale 
 
a) 28% poor pain score  
b) 76% poor physical fitness score 
c) 12% poor feelings score 
d) 30% poor change in health score, 27% poor 
overall health score  
g) 36% poor social support score, 15% poor daily 
activities score, 9% poor social activities score 




Aim: Examine association of QoL to 
negative life events, trauma and sexual risk 
in HIV+ve patients in the air force (n=56) 
compared with HIV-ve air force personnel 
(n=69) 
Design: Comparative cross-sectional study 
Tools: MOS-HIV-30, Davidson Trauma 
Scale for PTSD 
Population: outpatients 
(middle-income countries) 
Time: recruited at diagnosis 





b) phys. function. 
c) PTSD 
   mental function  
d) hlth perception 
g) role function  









































a) pain                b) symptoms           c) worry        
d) wellbeing       e) emotional support 





Aim: Explore everyday life experiences 
related to peripheral neuropathy in people 
with AIDS 
Design: In-depth qualitative interviews 
using grounded theory (n=19 of whom at 
least 3 newly diagnosed) 
Population: outpatients 
(high-income countries) 
Time: within 6 months after 
diagnosis for those quoted 
a) recognising and rationalising neuropathic pain 
f) assimilating annoyance through seeking spiritual   
meaning in the pain 
  pain interpreted as punishment from God 
g) modifying behaviour, conserving energy, 




Aim: to determine the emotional impact of 
serological testing for HIV 
Design: prospective two-arm cohort. n=39 
HIV+ve, n=179 HIV-ve 
Tools: VAS,STAI, Brief Symptom Inventory 




Time: immediately(T0), 2 
weeks(T1) & 10 weeks(T2) 
after diagnosis 
Analysis: t-tests comparing 
HIV+ve to HIV-ve at 10 
weeks. Data presented for 
HIV+ve arm only. 
c)  
VAS: mean 
   anxiety 
   depression 
   fear of AIDS 
   fear infecting 














































Aim: to examine the effect of HIV testing on 
suicidal ideation 
Design: prospective two-arm cohort. n=49 
HIV+ve 
Tools: BDI, item 9 
Population: outpatients 
(high-income countries) 
Time: 1 week after and 2 





















Aim: measure psychiatric effects of testing 
for HIV and assess what information 
feasibly available at intake might predict 
more severe psychiatric symptoms a year 
later 
Design: prospective two-arm cohort. 
Second data point presented for HIV+ve 
arm only (n=106) 
Tools: HRDS, BDI, BSI, STAI 
Population: outpatients 
(high-income countries) 
Time: 6 months after 
diagnosis 
 
c) 20% >13  HRDS 
 18% >13 BDI 
 16% >10 BSI  
31% >45  STAI state anxiety 
28% >45  STAI trait anxiety 







Aim: understand demographic and clinical 
profile of people presenting with HIV 
infection 
Design: retrospective chart review (n=377) 
Population: outpatients  
(middle-income countries) 
Time: ‘the moment of 
diagnosis’ 
b) 47% asthenia, 44% cachexia, 32% fever, 31% 
anaemia, 25% persistent dermatitis, 24% oral 
thrush, 17% diarrhoea, 16% pulmonary TB, 13% 
persistent cough, 6% herpes zoster 
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a) pain                b) symptoms           c) worry        
d) wellbeing       e) emotional support 






Aim: examine the impact of HIV+ve results 
on HRQoL and social support 
Design: observational prospective cohort 
(n=30 at week 12, n=27 at week 24)  
Tools: Social Relationship Scale(SRS), 
Quality of Life Index (QL-Index) 
Population: outpatients  
(middle-income countries) 
Time: 12 weeks and 24 
weeks post-diagnosis 
Analysis: means presented, 
























Aim: assess predictive value of WHO case 
definition for HIV 




Time: diagnosed during 
current hospital stay 
b) 70% weight loss, 36% diarrhoea for >1 month, 
53% fever, 25% cough and TB, 19% pruric 
dermatitis, 17% herpes zoster, 14% 





Aim: determine clinical features, degree of 
immunosuppression, and prevalence of HIV 
associated with herpes zoster 




Time: diagnosis within a 
week for 193/196 
a) 69% severe pain 
b) 57% fever, 14% cough, 9% rash other than 






Aim: measure symptom burden prior to 
starting ART in adults presenting for HIV 
care with CD4<200 (n=212) 
Design: cross-sectional survey as part of 
double-blinded RCT 
Tools: MSAS-SF 
Population: outpatients  
(low-income countries) 
Time: ‘at the time of initial 
HIV testing and diagnosis’ 
a) 76% pain 
b) 70% weight loss, 67% itching, 61% drowsy/tired, 
61% lack of energy, 57% numbness/tingling in 
hands/feet, 53% cough, 52% skin changes, 49% 
lack of appetite, 43% dizziness, 42% problems with 
sexual interest/activity 
c) 51% worry, 47% feeling sad 





Aim: Describe multidimensional health-
related issues of HIV+ve patients 
Design: cross-sectional study with 
convenience sampling, n=138 
Tools: a structured questionnaire 
Population: outpatients  
(middle-income countries) 




a) 53% problems due to pain, 44% suffering due to 
body pain 
b) 96% lack of energy, 40% active TB, 22% oral 
candidiasis, 20% persistent diarrhoea 
c) 99% emotional problems 
d) 92% problems related to health perception, 68% 
unhappy most of the time 
f) 58% not feeling calm and peaceful a source of 
high distress  
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pain in air force, not 

















































































16-40% active TB 
17-32% diarrhoea 
21-24% oral thrush 
 
27% ‘symptomatic’ 





associated with HIV 
status 







HIV for IDU 
 
19% of whites 












28% genital thrush 
25% vision 
problems 
13% condylomata  
12% oral herpes 
11% night sweats 
9% weight loss 
 
Physical function 
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Table C-3: findings in the five domains of non-physical problems, tabulated by population group in which problems were recorded 









 (low-income countries) 
Pregnant  
(high-income countries) 
Psychological 47% depressed 
51% worried 
 

















32% said primary 
response was shock, 
14% sadness 
Anxiety, depression 
and fear declined over 
5-10 week period 
 
Depression not 
associated with HIV 
80% said HIV status caused a 
great deal of concern 
12% low feelings score 
95% at least 1 somatic 
manifestation of worry 
41% problems thinking, 41% risk 
of depression  
Comorbidities include AD, 
ASPD, BPD 
 
Mental health, cognitive function 
and depression  not associated 
with HIV 
Wellbeing   
 
8% attempted suicide 
12% suicidal ideation 
20% death wish 
68% unhappy most of 
the time 
92% problems related 
to health perception 
 
Health perception not 
associated with HIV  
QoL does not change 
between 12 and 24 
weeks after diagnosis 
4% felt suicidal at 
diagnosis 
24% suicidal thoughts 
after 1 week 
16% suicidal thoughts 
after 2 months 
 
100% suicidal thoughts 
95% lost interest in life 
27% poor overall health 
30% poor change in health 
94% glad to know their test 
result 
 
Mean perception of health is 
average  
 
Overall health and QoL lower in 




19% had disclosed 
status after 4 
weeks 
 




quality does not 
change from 12 to 24 
weeks after diagnosis  
 
14% said health 
provider provided 
emotional support 
14% said health 
provider added to 
distress 
Men with symptoms 
were more likely to 
disclose their status 
Disclosing to pastor helped 
women disclose to their 
partner 
24% thought partner would be 
supportive 
46% not sure whether partner 
would be supportive 
35% said family/partner would 
not take their children in if they 
died 
 
Peace  2% angry at 
diagnosis 
58% highly distressed 




meaning in pain to 
assimilate annoyances 
Women received support from 
religious beliefs and practices  
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tangible  support 
46% of people with 
AIDS report hunger 
 
54% report problems 
with household or work 
HIV associated with 
more limited role 




changing ADL to 
reduce neuropathic 
pain 
73% said relatives could not 
help with future HIV problems.  
Current needs: 55% housing, 
45% employment, 32% 
money, 30% childcare, 23% 
food.  
Most pressing need: 43% 
childcare 
36% poor social support, 15% 
poor daily activities, 9% poor 
social activities 
Role function and social function 
not significantly associated with 
HIV 
19% have limited physical 
function in walking uphill 
16% limited at work 
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C.4.iii Pain (11 studies) 
 
Table C-2 displays the findings in the domains of pain and physical problems, by 
population group. In prospective observational studies, pain prevalence ranged 
from 31% to 53% in middle-income country outpatient populations(301, 302), and 
was 76% among patients with AIDS(298) and 69% for inpatients with comorbid 
herpes zoster(296). In comparative studies, HIV infection was not a significant risk 
factor for pain(287, 288). Two studies of seroconversion compared prevalence of 
specific types of pain (e.g. headache) between IDU and non-IDU(292, 293), but the 
sample sizes were too small to draw any comparative conclusions.  
 
In qualitative interviews, patients with neuropathic pain described a three-stage 
process: isolating the symptom cluster, inventing/testing management strategies, 
and assimilating annoyances. The first stage involved recognition, interpretation 
and rationalisation of the new symptoms of neuropathic pain. Secondly, 
participants modified their behaviour, for example planning energy conservation 
and changing their activities of daily living(ADL). Third, the annoyances of 
neuropathic pain became assimilated through acceptance of the differences and a 
search for spiritual meaning in the pain(284). Some newly diagnosed participants 
would catastrophise, interpreting their pain as a sign of advanced disease and 
imminent death. As predicted by the Theory of Unpleasant Symptoms(310), 
patients more anxious about their symptoms reported more severe pain.   
 
The variables “problems due to pain” and “suffering due to body pain” may 
represent the phenomenon of “total pain”. Saunders described how 
multidimensional problems such as anxiety and isolation can be inseparable from 
physical pain. The qualitative evidence illustrates this principle. The physical pain 
of neuropathy was exacerbated by the psychological and spiritual meanings 
attached to it(284). The newness of the symptom, as something outside normal 
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C.4.iv Physical problems (22 studies) 
 
The largest number of studies (n=22) recorded physical symptoms and infections. 
Many did not specify symptoms, and none reported on severity of individual 
symptoms. Physical symptoms were highly prevalent in low- and middle-income 
countries. Prevalence information from high-income countries was confined to 
pregnant women or recent seroconverters. Common symptoms in outpatient 
studies included tiredness(47-96%), weight loss(66-70%), fever(32-42%) and skin 
problems(13-52%).   
 
Weight loss, fever, cough and diarrhoea were the most common symptoms in four 
low- and middle-income country prevalence studies(286, 296, 297, 303), but their 
prevalence varied widely. For people with AIDS in Uganda, the most prevalent 
symptoms were weight loss, itch, tiredness and lack of energy(298). High 
frequencies of sexually transmitted infection (STI) symptoms were also noted 
among newly diagnosed participants in Tanzania (299). In India, 96% of a 
convenience sample reported lack of energy, 40% TB and 20% diarrhoea(302). In 
Brazil, the most common symptoms were asthenia, cachexia, fever and anaemia, 
but TB, diarrhoea and cough were recorded for more than 10% of patients(260). 
 
In pregnancy, fatigue and STIs were often measured. Pregnant women in the USA 
reported fatigue, night sweats and weight loss, and a number of STIs, not 
necessarily symptomatic(295). Pregnant women in Uganda reported poor physical 
fitness score in 76% of cases on the Dartmouth COOP scale(294). 
 
In comparative findings, HIV was associated with impaired physical function for air 
force personnel in Nigeria(287), but not for pregnant women in Uganda(288). HIV 
did not affect the symptom experience of IDU in the USA(308), but in Canada, HIV 
positive IDU reported more symptoms than HIV positive non-IDU, suggesting that 
drug use had more effect than HIV on symptom burden(292). IDU more frequently 
reported fever (81%), anorexia(73%) and diarrhoea(54%). By contrast, in the 
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Three papers used the undefined categories ‘symptomatic’ and ‘asymptomatic’ 
HIV(257, 290, 300). These terms are derived from the surveillance definition of HIV 
and AIDS, not the clinical definition (311-313). This classification distinguished 
between HIV infection with and without case-defining symptoms, but regressed into 
general use of the word ‘asymptomatic’ to describe pre-AIDS HIV(248, 314). The 
risk of ‘symptomatic’ status at diagnosis was 74% according to patient records in 
Haiti(300), and a self-reported 27% in a small prospective study in the USA(290).   
 
The only information on physical symptoms in high-income countries, apart from 
patients with either seroconversion or pregnancy, was derived indirectly from 
asking patients their reason for an HIV test. In Canada, 43% of recent 
seroconverters tested because of symptoms or illness(136), compared to 33% of 
the HIV positive population in Tanzania(299). In the UK, patient records showed 
that 37% of black Africans and 19% of whites tested after symptoms(257). Finally, 




C.4.v Psychological problems (17 studies) 
 
Table C-3 has five columns rather than the eight in Table 2, because no results in 
any of the non-physical domains (i.e. psychological, wellbeing, spiritual, emotional 
or informational/tangible support) were found for inpatients or people with recent 
seroconversion.  
 
For low-income country outpatients, anxiety and depression prevalence were high 
(51-95% and 47% respectively). In middle-income countries, anxiety and 
depression were less prevalent but still high, and 99% of an Indian sample 
reported emotional problems (302). In the USA, 28% scored above the threshold in 
terms of trait anxiety and 18% for depression(305). 
 
Two studies with outlier results were methodologically weak; one problematically 
translated ‘emotional health’ to ‘feelings’ and then to ‘mental state’(294), the other 
failed to describe any instrument or symptom checklist(289). One study recruited 
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only participants who were referred for psychiatric evaluation. The fact that 14 of 
the 15 had a psychiatric diagnosis is not representative of an average population, 
although it illustrates the range of psychiatric conditions comorbid with HIV(285). 
 
Four comparative studies made use of psychological measures. The largest, in 
Nigeria, found post-traumatic stress disorder and lowered mental health were 
associated with HIV(287). In the three smaller studies, all in the USA, HIV status 
was not associated with mental health using the MOS-SF(288) or the BDI(308), 
and it was not possible to determine whether a difference in ‘subjective risk and 
lack of control’ was significant either clinically or statistically(291).   
 
In the USA 32% said in qualitative interviews that their primary response to 
diagnosis was shock while 14% felt sad and depressed(137). The same question 
was addressed using patient records in Haiti, where recorded reactions were 
shock(35%) and resignation(31%)(300). Prevalence of anxiety, depression, 
intrusive thoughts and fear appeared to decline over time in two American cohorts. 
However, one did not include statistical analysis(307), and the other used it 
inappropriately(263). Furthermore, the first study excluded patients with common 
physical HIV symptoms, which biased the cohort towards a generally (and 
therefore psychologically) less morbid population(307).  
 
 
C.4.vi Wellbeing problems (10 studies) 
 
The evidence revealed widespread unhappiness and loss of wellbeing. The largest 
prospective observational study to include wellbeing, in India, found that 92% 
experienced problems related to health perception, and 68% were unhappy most 
of the time(302). In Uganda, 27% of pregnant women reported poor overall 
health(294).   
 
Three papers reported on suicidal thoughts, with widely variable results. In India, 
8% of participants reported they had attempted suicide in the week after learning 
their HIV status, and 20% reported death wish(301). Seven weeks after diagnosis, 
two of 50 people in an American sample felt suicidal(137). One study reported 
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continuous suicidal thoughts by all participants, but failed to describe a credible 
method(289).  
 
Cohort studies did not identify a significant change in wellbeing over time (304). 
The prevalence of suicidal thoughts in a USA study reduced non-significantly(306). 
The single comparative study of wellbeing found that HIV was associated with 
greater health distress in pregnancy but there was no difference in QoL(288).   
 
 
C.4.vii Emotional problems (7 studies) 
 
Evidence of need for emotional support included studies of disclosure of HIV status 
or expected response to disclosure. The evidence showed that participants were 
very concerned about the reactions of their families. In Rwanda, 24% of women 
thought their partner would not be supportive after they disclosed their HIV status 
and 46% were not sure(65). Similarly, in India 43% of participants recorded their 
family indifferent, unsupportive or hostile(301). It was not clear how the question 
was worded and whether these emotions were directly quoted or extrapolated from 
expected actions. Two to four months after HIV diagnosis in the USA, 21% of self-
described ‘asymptomatic’ men had not disclosed their status to their partner or 
close family while 90% of ‘symptomatic’ men had done so(290). In qualitative 
interviews in the DRC, some women described how disclosing their status to their 
church pastor first had given them the confidence to disclose to their partner(105).   
 
 
C.4.viii Spiritual problems (5 studies) 
 
In India, 58% of participants reported that not feeling calm and peaceful was a 
source of high distress for them(302). A comparative study from the USA 
measured hopelessness but not enough context was presented to allow 
interpretation of the results(291). A review of 1168 patient records in Haiti showed 
that 2% of participants responded to their HIV diagnosis with anger(300).  
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The paper on the role of religion in women’s lives in the DRC was written after 38 
of 40 women spontaneously mentioned religion in qualitative interviews(105). 
Women reported shock, sadness and anger at HIV diagnosis, and described the 
use of prayer, the Bible and support from the church to overcome these feelings. 
There were no reports of women who refused treatment because of religious belief, 
but some gained hope from the belief that God would cure them because they 
were innocent. An alternative view was expressed by women who found peace in 
understanding that ‘God had chosen this path for them’(105). Two spiritual 
reactions to neuropathic pain emerged in qualitative interviews(284). One, adopted 
only by the newly diagnosed, was to interpret the pain as punishment from God for 
past actions. The second response was to ‘reach beyond’, and draw inner strength 
from a spiritual connection.  
 
 
C.4.ix Information/tangible support problems (7 studies) 
 
In many contexts, people with HIV were limited in their work, activities and support. 
There was limited evidence of HIV as a risk factor from comparative studies.  
 
In Rwanda, 94% of a sample of pregnant women in the capital city were not aware 
of any support services outside the family and 73% said their family would not be 
able to help in the future, usually because of age, poverty or distance(65). Their 
main reported needs were housing, employment, money, childcare, insurance and 
food, with childcare the most pressing concern for 43%(65). In India 54% of 
participants reported problems with their job or household work(302), and 46% of 
people with AIDS in Uganda reported hunger(298).  
 
Quality of social relationships was measured with a validated tool at twelve weeks 
and 24 weeks after diagnosis in Thailand, and did not change significantly 
according to MANOVA(304). HIV was associated with limitations to role function 
and social function in Nigerian air force personnel(287), but did not achieve 
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C.5 Discussion  
 
The findings demonstrate a high prevalence of problems across all palliative care 
dimensions at the time of HIV diagnosis. The evidence is fragmentary, with many 
studies conducted for reasons other than investigating diagnosis.  
 
 
C.5.i Situating findings in the literature 
 
This review shows that the prevailing view of the adverse emotional and 
psychological effect of an HIV diagnosis(305, 315, 316) is based on little evidence. 
The best evidence of the impact of diagnosis is from a study published 20 years 
ago, with a total sample of only 69(307), which found high anxiety, depression and 
intrusive thoughts a week after HIV diagnosis. These symptoms diminished over a 
four-week period, with less change to anxiety scores. In contrast, data collected in 
the 1980s showed that anxiety peaked just after HIV diagnosis but fell within a 
week(263). The reason could be that at that time, HIV was thought to progress to 
AIDS in only a minority of cases. 
 
Taking an HIV test is a cause of stress. Perry showed in 1990 that suicidal ideation 
was higher before result notification than after, even for those who were 
positive(306). In India, 150 people (46% of whom were HIV-positive) about to take 
a voluntary test had high levels of anxiety, distress and depression, not associated 
with HIV status(317). When the HIV test was developed there was concern that the 
negative psychological consequences of knowing one was HIV-positive might 
outweigh any benefit derived(305). Closed-question studies have shown that fear 
of the anxiety of knowing positive status and fear of the anxiety of waiting for the 
result are two of the main reported reasons not to test (318, 319). In Zimbabwe, 96 
people referred for an HIV test after presenting with symptoms reacted to the 
diagnosis with anger, fear, denial, and fatalism. The study concluded that people 
newly diagnosed with HIV  
“had a host of social, emotional, and informational needs, which often 
seriously impeded their capacity to make constructive use of the knowledge 
of their HIV status”(258).  
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In Rwanda, a quarter of women did not expect their partner’s support and almost 
half were not sure of support from their relatives(65). Follow-up interviews three 
years later showed that in fact the majority of partners were supportive(65). There 
is evidence that families are more supportive than patients expect(320). 
 
There is increasing concern regarding loss to follow-up (LTFU) of newly diagnosed 
patients who do not return for care until their disease is far advanced (238, 321). 
The physical symptoms, worry and depression, loss of wellbeing and sense of 
meaning, and limited practical support identified in this review might prevent 
patients receiving care. Palliative care may improve patient retention because of its 
total care approach and focus on patient experience. 
 
 
C.5.ii Gaps in the evidence 
 
The majority of identified evidence was confined to physical and psychological 
symptoms. Evidence of need for emotional support was largely represented by 
studies of disclosure, which is related to secondary prevention and is not 
necessarily patient-centred. Almost no quantitative research included spiritual 
distress, and the topic arose in qualitative research only because the open 
structure of the method allows participants’ concerns to guide data collection. The 
majority of HIV diagnoses probably take place in a low-income outpatient setting, 
and yet only three studies recruited from this group, of which one only included 
AIDS patients(298) and one was a poor-quality chart review(300). 
 
Theories of psychological adjustment and coping suggest that problems may 
change rapidly(283), and therefore longitudinal studies are important. Although 
eleven of the 34 studies utilised a cohort design, only four cohorts measured 
outcomes more than once within six months of diagnosis(263, 304, 306, 307). 
 
The data on problems of inpatients and problems of recent seroconverters related 
only to physical symptoms and pain. The prevalence of physical symptoms was 
very high in these groups and it seems likely that psychological, spiritual and social 
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C.5.iii Quality of evidence 
 
There were methodological problems with many studies. A major underlying cause 
of problems was that studies were designed for different purposed. The use of 
unsuitable, unvalidated or unspecified tools was also common. 
 
1. Study aims 
 
Studies were conducted for a variety of aims, including:  
- To study the effect of HIV on QoL in pregnancy(294) 
- To identify the clinical characteristics of acute HIV infection(292, 293) 
- To determine HIV prevalence among inpatients with TB(286) 
 
The recruitment of people newly diagnosed with HIV was only incidental to these 
aims. In many cases, careful reading of the methods section of the paper was 
required in order to identify whether participants were newly diagnosed. The 
studies did not aim to measure the needs and problems of people newly diagnosed 
with HIV and thus they were not optimally designed for that purpose. For example, 
longitudinal studies did not take their starting point from diagnosis, the time since 
diagnosis is not always clear, and is often too variable for a homogenous sample.  
 
There were methodological problems with many studies. Ten reported symptom 
prevalence using records completed by care providers, who are known to record 
only a third of the symptoms reported by patients(54, 277), so they are likely to 
underestimate patients’ problems. The time period within which symptoms were 
reported was rarely given. No information on symptom severity, duration or distress 
was recorded in any studies, nor was any association drawn between symptoms 
and QoL. Sample sizes were small in most prospective studies. The terms 
‘symptomatic’ and ‘asymptomatic’ were used without definition.  
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Extraction of information from patient records is a less effective way of obtaining 
information on symptoms. Firstly, the symptoms and problems identified could 
consist only of those about which the health worker asked or the patient 
volunteered information(260). Secondly, HIV service providers identify fewer 
symptoms than patients(54). Thirdly, inpatient studies are biased towards a higher 
than average symptom prevalence, because all participants were ill enough to 
require admission. Reporting quantitative findings from qualitative interviews, as 
two studies did(137, 285), is generally weak because it does not benefit from the 
strengths of either method. The population is unlikely to be representative, and at 
the same time the depth and richness gained from qualitative research is lost.  
 
The four longitudinal studies to have more than one point within the range of the 
review suffered from several methodological flaws. Analysis techniques were 
limited to unpaired t-tests and chi squared tests. These tests assume 
independence between measurements and do not account for the clustering effect 
within individuals. The use of only two time points did not allow for exploration of 
the rate of change over time. 
 
 
2. Use of tools 
 
Several studies did not describe data collection methods in adequate detail. 
Symptom prevalence information was presented without identification of an 
instrument used to collect it(136, 295). In other cases, the authors stated that a 
questionnaire had been developed but it was not presented and had not been 
validated(302). Without this, the validity and reliability of results cannot be 
established. This was a particular issue for one study in Zambia(289) which 
presented 95% prevalence of mental health problems, collected using a new and 
unvalidated instrument. In another study, when participants were asked to name 
their most pressing problem, it was not clear whether they picked an option from a 
closed list or recorded open answers(322). Sometimes the tool was validated in a 
different setting and cultural context from the study location(287). This was more 
common for studies in low-income countries, probably because fewer validated 
tools are available. The range of data collection methods used probably 
contributed to variation in prevalence figures.  
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Most studies(n=24) measured outcomes in only one or two domains, rather than 
taking a holistic view of patients. However, four studies measured outcomes in five 
domains(287, 288, 294, 301) and one included six(302). These often made use of 
QoL questionnaires. Quality of life studies aim to reach latent variables rather than 
directly measure patient experience As a result, a QoL score on its own has little 
meaning, which is why most QoL studies in the review were comparative.  
 
 
C.5.iv Limitations of the review 
 
The words chosen for the search strategy were closely linked to the POS, because 
the review aimed to be patient-centred and the POS is based on patient-reported 
experience and priorities. In some cases the POS item did not include a single 
word that encapsulated the intention of the question, and then another word was 
substituted. For example, ‘feeling life is worthwhile’ was interpreted as ‘wellbeing’. 
More controversially, ‘having enough help and advice for the family to cope’ was 
interpreted as ‘information’.  
 
 The word ‘worry’ was used for the third item, taken directly from the POS question. 
An alternative option would have been to use a subject heading such as 
‘psychology’, which would have returned every paper on HIV and psychology. This 
option may seem logical, given that the review findings were ultimately reported 
under categories including ‘psychological problems’, some of which were 
depression, sadness and cognitive problems rather than worry. Again, the choice 
was to be patient-centred, thus to search for evidence of a specific problem (worry) 
rather than an academic or clinical area (psychological). The review aimed to 
identify prevalence data on reported problems known to be important to patients. In 
the event, the findings were displayed in themes which were wider than the original 
search terms, but the categories followed the data, rather than the other way 
around. 
 
The choice of words obviously governed the selection of papers and it is a 
limitation of the systematic review that the keywords were somewhat subjective. 
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However, the search terms were only used for the initial selection of 5443 papers. 
The reduction from 5443 down to 34 was based on other exclusion criteria and this 
stage probably had the greater effect on the findings. The use of other search 
terms would probably have identified a different, but substantially overlapping, 
initial group, and since 99.4% of papers were excluded, a great deal of difference 
could occur to the starting group without having any real effect on the final 
selection. 
 
It was not always clear when data collection had taken place in relation to 
diagnosis. For example, one study collected information either during pre-test or 
post-test counselling, without distinguishing between the two(309). Inpatient chart 
reviews were sometimes included even though the paper did not state explicitly 
that patients were newly diagnosed, because logistically they had to have been 
diagnosed between admission and discharge(286).  
 
The epidemiological, cultural and social environment has not been considered in 
any depth. Due to the small number of papers, all studies were presented together 
with no subgroup comparisons. Some studies set comorbidity conditions, such as 
TB(286), herpes zoster(296) and peripheral neuropathy(284), and one included 
only patients with a CD4 count below 200(298). In these cases the results are only 
generalisable to other patients in the same circumstances.  
 
Despite considerable effort, some studies could not be obtained because they 
were published in small regional journals with limited access. Publication bias may 
have distorted the findings. Only one researcher appraised the search results and 
applied the review criteria, as opposed to PRISMA recommendations of two(276). 
Due to limited time and resources, papers were all in English. However, the review 
used a broad search strategy and followed established guidance(323).  
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Patient-centred research into the experience of HIV diagnosis is scarce, is of mixed 
quality, and does not represent the majority of people newly diagnosed with HIV. 
Nonetheless the consistency of evidence for problems in many populations 
supports the conclusion that severe, distressing, but manageable multidimensional 
problems are likely among people newly diagnosed with HIV. These problems 
include pain, worry and depression, social concerns, spiritual distress, lack of 
information, and impaired wellbeing. 
 
Pain and symptoms, worry, social and spiritual distress and isolation cause 
unnecessary suffering and should be identified and controlled for that reason 
alone. Additionally, these problems limit quality of life(324), and impact on people’s 
ability to support themselves(325), make good decisions(326), adhere to 
treatment(50, 147), and survive(150). All these problems have been identified as 
highly prevalent and severe in populations with newly diagnosed HIV.  
 
Multidimensional problems can contribute to patient attrition from care(147). The 
burden of multidimensional problems soon after HIV diagnosis may contribute to 
the very high loss to follow-up widely recorded in Africa, beginning immediately 
after HIV diagnosis(157), and responsible for preventable morbidity and 
mortality(158, 321).  
 
 
C.6.i Implications for research 
 
The review demonstrates the considerable gaps in the literature describing 
diagnosis of HIV from the patient-centred perspective. Specific areas where 
evidence is almost entirely lacking include: 
- The first two weeks after HIV diagnosis 
- Patient-centred, multidimensional problems 
- Severity of problems 
- Longitudinal prevalence 
- Representative  sample of outpatients 
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- Low-income settings, particularly sub-Saharan Africa 
- High-quality and rigorous studies using validated outcome tools 
 
There is some evidence from these studies that HIV diagnosis is a time of many 
multidimensional problems but the evidence is inadequate for policy making and 
clinical practice, because it was not collected and analysed with that end in mind. 
No patient-centred multidimensional longitudinal studies of HIV diagnosis were 
identified. Very little is known about the change in prevalence or intensity of 
problems in the first weeks and months after diagnosis. The few longitudinal 
studies available tend to use widely-spaced time points and crude statistical 
analysis.   
 
The evidence for experience at HIV diagnosis is patchy, out of date, and 
unrepresentative, therefore insufficient to create policy or plan effective and 
appropriate care. We have no knowledge of how soon after diagnosis problems 
begin, how long they last and whether they change over time. A large scale, 
methodologically sound, representative cohort study of patient-centred problems at 
HIV diagnosis is urgently needed to ascertain their prevalence and extent in the 
time period most relevant to care: the first appointment after an HIV test. 
 
 
C.6.ii Implications for policy and practice 
 
Diagnosis is by definition the point when HIV care can begin, but for many people 
the HIV test is both their first and last contact with HIV care services(157). For a 
patient-centred approach, the priority at HIV diagnosis should be to establish a 
sustainable relationship with patients and to ensure they have both resources and 
motivation to return for further care.  
 
HIV palliative care can effectively reduce pain, symptoms and anxiety, and improve 
insight and spiritual wellbeing(140). From the available evidence it seems likely that 
multidimensional problems are present from the point of diagnosis. Under current 
practice many of these are probably not identified, as it is known that HIV 
symptoms are consistently under-reported(54). If problems are not assessed or 
recognised then they cannot be managed, nor can effective interventions be 
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developed for them. The care that is delivered to newly diagnosed HIV patients is 
not appropriate to their needs. Clinicians and policy makers do not know how to 






Aim and objectives of the study 
 





To determine the palliative care-related problems experienced by people in Kenya 
and Uganda in the two weeks following diagnosis of HIV, and how those problems 




In adult outpatients with HIV in Kenya and Uganda: 
 
• To determine prevalence and severity of palliative care-related problems 
within two weeks of diagnosis 
 
• To investigate whether demographic variables or CD4 count are associated 
with prevalence and severity of palliative care-related problems at diagnosis  
 
• To determine change in palliative care-related problem severity over a three 
month period 
 
• To investigate whether demographic variables or ART use are associated 
with change in palliative care-related problem prevalence over time  
 
The short period of three months is selected because it is apparent from the 
systematic review that the time closest to HIV diagnosis is the least understood, 









E.1 Design summary 
 
This thesis uses data extracted from an observational prospective cohort collected 
in 2008. The cohort was part of a Public Health Evaluation (PHE) of the Care and 
Support component of PEPFAR, a US$15 billion programme aimed at providing 
HIV prevention, treatment and care over five years. Twelve health facilities 
participated in the evaluation, six in Kenya and six in Uganda. Each facility 
consecutively recruited consenting adults diagnosed within the previous 14 days. 
Data including self-reported QoL, multidimensional problems, and services 
received were collected at baseline and every following month for three months. 
The period of 14 days was selected after consultation with health care workers in 
the field. Testing was done at small clinics or mobile testing centres which would 
refer positive patients to the facility for care. The 14-day period allowed time for 







E.2 Data collection methods 
 
 
E.2.i Study design 
 
As described above, the study used a prospective multi-centre cohort design, with 
rolling consecutive recruitment and a three-month follow-up period.  
 
 
E.2.ii Facility selection 
 
In each country, a random sample of 60 facilities stratified by facility size (in 
number of patients) was selected from a total of over 600 receiving PEPFAR 
funding for Care and Support. From the sample of 60, the six with the highest 
number of patients in the year 2005-2006 were selected for the cohort study. The 
total sample of 120 facilities was used in a cross-sectional survey. The largest six 
from each country’s random sample were used for the prospective cohort because 
facilities needed sufficient staff and resources to perform the extra work of the 
evaluation. The facilities are described in Appendix C.  
 
 
E.2.iii Participant recruitment and enrolment 
 
Participants were consecutively recruited from January 2008, or when the facility 
was ready to begin. All patients who met the following criteria were approached: 
- 18 years of age or over 
- diagnosed HIV positive 
- were aware of their diagnosis 
- had sufficient cognitive ability to answer the questions for the study 





Participants gave informed consent to participate following provision of an 
information sheet and consent form. These documents were translated into local 
languages (Swahili, Luo, Runyakitara and Luganda), and were read aloud by the 
HCW if the participant was nonliterate. Participants were reimbursed travel 
expenses to the facility of US$5 per visit. The recruitment strategy was modified at 
each facility to fit it most successfully into the existing care framework. For 
instance, at some facilities the HIV test results were given by a counsellor who then 
referred the patient to a nurse. In that case, the counsellor would conduct 
recruitment and the nurse would administer the questionnaires. In another example 
of adapting the study to fit the care pathway, at one facility a note was made on the 
front cover of the file of every patient enrolled in the study, as a reminder to collect 
their ‘patient pack’ and complete the questionnaires. 
 
 
E.2.iv Inclusion criteria for the thesis: defining ‘newly diagnosed’ 
 
Figure E-1 below shows the decision tree used to identify longitudinal study 
participants who were defined ‘newly diagnosed’. All relevant data were used to 
make the decision, and any evidence that a participant had been diagnosed HIV 
positive more than 14 days prior to recruitment was sufficient for exclusion. The 
date of recruitment for each person was designated ‘T0’, for Time 0. 
 
The decision to set the limit at 14 days was influenced by the study design and by 
information on the logistics of patient registration in Uganda and Kenya. Staff 
reported that facilities were often overburdened and gave newly diagnosed 
individuals an appointment date several days ahead for their registration (Professor 
Easterbrook, personal communication). On the other hand, the longitudinal study 
measures outcomes at monthly intervals, therefore it seemed unreasonable to 
allow the definition of ‘newly diagnosed’ to encompass those diagnosed as long as 
a month ago, which would assume that no change in outcomes had occurred. 
Fourteen days after HIV diagnosis is the maximum length of time within which the 





Participants were asked directly to give the date when they had been diagnosed 
HIV positive. When the precise day of the month was not known, 15 was used. 
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E.2.v Instrument selection and development 
 
The data collection tools for the longitudinal study were four questionnaires, one 
(demography) used only once per person at baseline and the others used four 
times at monthly intervals. Two of the questionnaires (the MOS-HIV and CSRI) 
were not used in this thesis and are not presented here. The time points were 
designated T0 (entry to the study), T1, T2 and T3. Individual ‘patient packs’ were 
created for data collection, consisting of all the tools bound in order, with the pages 
colour coded by time point, and preceded by a log page containing metadata on 
progress of data collection and management. The front cover of the pack was 
blank apart from the patient’s name. When the final time point was complete, this 
page was torn out, making the data unidentifiable.  
 
 For each facility, questionnaire packs were prepared in two languages; English 
and the most common local language (Swahili, Runyakitara, Luo or Luganda). All 
documents were translated into local languages from the English versions twice, 
independently, by two researchers. Each of these versions was translated back to 
English by a third researcher, with any discrepancies discussed amongst the group 
and an agreed translation decided. This is the best practice method for 
translation(327, 328). Full instruments are in Appendix A. 
 
The APCA African POS 
The development, validation and properties of the POS are described inSection 
B.5.iv. The POS is applicable to people with cancer or HIV in Africa (255) and its 
ten items address the primary physical, emotional and spiritual concerns of patients 
and families. Seven are addressed to the patient and three to the carer. They 
include questions relating to the four dimensions of palliative care: physical (pain, 
symptoms), psychological (worry, sharing feelings), spiritual (peace, feeling life 
worthwhile) and social (help and advice for family).   
The ECOG 
The Eastern Co-operative Oncology Group is a clinician-rated single item measure 




(329), also administered at all four time points(330). Scores range from 0 (normal 
activity) to 4 (unable to get out of bed).  
Demography 
Basic demographic and medical details were collected using a brief questionnaire 
administered at T0 (recruitment to study). Four pieces of clinical information were 
collected at T1: World Health Organisation (WHO) stage, date and result of most 
recent CD4 test if the participant had one, and date of ART initiation, if used. These 
questions were moved from T0 to T1 because in piloting HCWs pointed out that the 
information would not be available to new participants at T0. The demography 
questionnaire also included the DHS Wealth Index questions, widely used to create 
a measure of relative wealth(331). 
 
 
E.2.vi Ethical approval and data storage 
 
The study design was approved by the Research Ethics Committee of King’s 
College London (Ref CREC/06/07-140), the Ethical Review Committee of Kenya 
Medical Research Institute (KEMRI/RES/7/3/1) and the Uganda National Council 
for Science and Technology (UNCST, Ref SS 1964). Twice during the study, 
changes were made to the protocol and these were also approved by each 
committee. Ethical approval documentation is included in Appendix B. 
 
During data collection all questionnaires were stored separately from consent 
forms, in a locked filing cabinet at the facility. Upon study completion, anonymised 
questionnaires were taken from the facility to the APCA offices for storage in 
locked filing cabinets until 2015. These arrangements were in line with ethical 
requirements and the UK Data Protection Act 1998. 
 
 
E.2.vii Data collection and management 
 
Six research assistants in Kenya and Uganda were each responsible for two 




at the facilities to collect and manage data. The research workers themselves were 
trained by KCL staff including myself in a five-day programme with a pilot.  
 
Health workers at the twelve facilities recruited participants, obtained their consent, 
and recorded their answers to the questionnaires, with follow-up appointments at 
monthly intervals for three months. These were referred to as T0 (baseline), T1, T2 
and T3.   
 
Data collection took place between January and September 2008, with recruitment 
to the longitudinal quantitative study terminating in June. With the exception of CD4 
counts, data for the longitudinal study were self-reported by the participants. HCWs 
recruited patients and collected data in the course of their regular duties. Funding 
was provided to the facility directors to support data collection, including purchase 
of a computer. APCA staff trained HCWs to take informed consent and complete 
questionnaires. A researcher maintained contact with each facility through regular 
visits to observe data collection, check the use of appointment diaries and regular 
data entry, and deliver additional training as necessary.  
 
Research assistants were monitored through conference calls with KCL every 
fortnight. On the calls, researchers reported data collection progress at each site 
and raised any problems or concerns. A field manager based in Uganda was in 
constant email contact with the KCL team. KCL produced three issues of a study 
newsletter which were circulated to research assistants and participating facilities 
every two months to build unity and involvement with the project.  
 
Early in data collection it became apparent that participants could not always 
remember the date and result of their last CD4 count. Less than 50% of 
participants were able to provide a CD4 count and it appeared that these were 
biased towards people who were more ill or concerned about their health. 
Accordingly, permission was granted by the three ethics committees overseeing 
the study to search patients’ records for CD4 counts. Researchers visited each 
facility after the cohort was completed, and copied CD4 counts for the study 
participants into a specially designed form which preserved anonymity while linking 
records to participants. CD4 count was the only piece of information obtained in 




E.2.viii Data entry and validation 
 
Immediately after collection, data were entered into a pre-designed EpiData v3.1 
database with conditional checks for internal consistency, by a trained 
administrative staff member. When participants had exited the study, patient packs 
were transferred to the APCA offices where research staff conducted a second 
round of data entry and validation. Discrepancies were corrected by manual 
referral to questionnaires, and results were revalidated until the two datasets were 
identical. The CD4 information from patient records was entered into a separate 
EpiData database and merged into the main dataset, which was exported to Stata 






E.3 Analysis questions 
 
Each of the four objectives is achieved by answering one to three research 
questions, as shown below.  
 
Objective 1: In adults with HIV in Kenya and Uganda, to determine prevalence and 
severity of palliative care-related problems within two weeks of diagnosis 
 
1a: What are the demographic characteristics of the sample of people newly 
      diagnosed with HIV in Kenya and Uganda? 
1b: What are their scores in the seven patient-completed items of the POS? 
1c: What are their total POS scores?  
 
Objective 2: To investigate whether demographic variables or CD4 count are 
associated with prevalence and severity of palliative care-related problems at 
diagnosis  
 
2: At T0, is severity of POS item problems associated with age, gender, CD4  
   count, socioeconomic status, country, physical function or education? 
 
Objective 3: To determine change in palliative care-related problem severity over a 
three month period 
 
3a: Do POS scores change over a three-month period, and if so do they 
     change from one month to the next?  
3b: Does total POS score change over a three-month period?  
 
Objective 4: To investigate whether demographic variables or ART use are 
associated with change in palliative care-related problem prevalence over time  
 
4: Is any change in prevalence of moderate/severe POS item problems 
      over time associated with age, gender, socio-economic status, education 





E.4 Analysis plan 
 
 
E.4.i Introduction  
 
Table E-1 below presents the analysis plan. It consists of four parts, each part 
corresponding to one objective.  
 
 
E.4.ii Definitions of variables in the analysis plan  
 
Dependent variables 
The POS was selected as the outcome measure because the aim is to identify 
palliative care problems at diagnosis, rather than more general health-related QoL. 
The POS is directed at palliative care problems and is responsive to change over 
time. It has been validated in Uganda and South Africa, showing good 
psychometric properties and face validity (256). It consists of ten items, seven 
completed by the patient and three to the carer. Each item has a Likert scale of six 
responses numbered 0-5. The carer items were not analysed, because only a 
small and unrepresentative number of patients (16%) were accompanied by a 
carer. 
 
In the questionnaire, not all POS items are scored in the same direction. In some 
cases 0 is the worst end of the scale and in others it is the best, in order to reduce 
the risk of participants habitually giving the same answer each time. For analysis 
the fourth, fifth, sixth and seventh POS items are recoded to reverse the response 
order, so that for all items 0 represents the best situation (no problem) and 5 
represents the worst.  
 
The POS is designed to be multidimensional and has a low Cronbach’s alpha of 
0.6, indicating that it does not measure a single construct(256). In general terms 




Table E-1: analysis plan 
Part Research question  Dependent variables Independent variables Analysis 
A 
1a. What are the demographic 
characteristics of the sample of people 
newly diagnosed with HIV in Kenya and 
Uganda? 
Gender, age categories, 
education level, country 
Time from diagnosis to T0 
Socio-economic variables 
 Mean, standard deviation, 
percentages 
 
Principal-components factor analysis  
1b. What are their scores in the seven 
patient-completed items of the POS? 
POS scores at T0 
(coded 0,1,2,3,4,5) 
 Percentages 
1c. What are their total POS scores? Addition of the 7 POS item 
scores (0 to 35) 
 Percentages  
B 
2. At T0, is the severity of POS item 
problems associated with age, gender, 
CD4 count, socio-economic status, 
country, physical function or education?






Presence of CD4 result 
Gender, age, education, 




Chi squared tests 
Non-parametric score tests for trend 
 
Multivariate  
Stratum-specific odds ratios (ORs) 
Ordinal logistic regression 
Likelihood ratio tests 
C 
3a. Do POS scores change over a 
three-month period, and if so do they 
change from one month to the next?  
POS scores at M0, M1, M2 and 
M3 
(coded 0,1,2,3,4,5) 
 Proportion of net change and 95% CI 
3b. Does total POS score change over 
a three-month period? 
Addition of the 7 POS item 
scores (0 to 35) at M0-M3 
 Analysis of variance 
D 
4. Is any change in prevalence of 
moderate/severe POS item problems 
over time associated with age, gender, 
socio-economic status, country, 
education or receipt of ART? 
 




Gender, age categories, 
education level, wealth 
quintiles, physical function 
ECOG at all time points 
ART use at all time points 
Bivariate  









a unified score is useful to indicate whether some individuals have multiple and 
complex problems. Total POS score was calculated in the simplest way possible, 
by summing the seven outcome scores to create a single variable scored from 0 
(no problems in any area) to 35 (overwhelming problems in all areas).  
 
For Part A and Part C of the analysis, the complete POS six-point scale is used as 
the outcome, but the statistical techniques used to examine the association of POS 
scores with independent variables do not allow for a six-point outcome scale. In 
Part B, the scale is reduced to a ternary (three-point) score; 0 and 1 are coded 
‘no/mild problem’, 2 and 3 ‘moderate problem’, and 4 and 5 ‘severe problem’. For 
the multivariate fixed-effects logistic regression in Part D a binary outcome is used, 




Gender: a dichotomous variable, male (0) and female (1). 
 
Age: year of age was recorded as a continuous variable. For analysis it is coded 
into an ordinal variable with the three groups 18-25, 26-40, and 41-59 (the 
maximum). The reason for these groupings was to divide the population based on 
their experience of HIV. People aged over 40 in 2008 were at minimum 16 years 
old when HIV was recognised in Uganda, in 1984. The 26-40 year olds were 
children and the 18-25 year olds had not yet been born. The theory was that these 
different perspectives on HIV might influence reaction to diagnosis and perception 
of stigma.  
 
Level of formal education: recorded in five categories (none, primary, secondary, 
diploma and degree). For analysis the diploma and degree groups are combined 
due to their small size. The group with no formal education was small (19 at 
recruitment) but it was kept separate, because complete lack of education is 





Country: A binary variable created from the facility ID number. Kenya is the 
baseline (coded 0) and the variable ‘country’ in models indicates the comparison of 
Uganda (coded 1) with Kenya.  
 
Physical function: the ECOG records physical function on a scale from 0 (fully 
active) to 4 (completely disabled). In analysis response 1 is coded ‘best physical 
function, 2 as ‘middle physical function’, and the responses 2, 3 and 4 are 
combined into one group, ‘worst physical function’, due to the small number of 
participants (n=30). 
 
Disease progression: WHO stage, most recent CD4 count and date of the CD4 
count were recorded at T1. These details were completed at T1 rather than T0 to 
maximise completion, as some participants might not have received their CD4 
results at the time of completing T0. It was anticipated that most CD4 tests would 
be completed within a few days after registration and recruitment. 
 
ART use: Use of ART was recorded each month as a binary variable. Among non-
recipients of ART, it was not possible to distinguish patients who were not eligible 
from those who would have benefited from ART but did not have access to it. All 
facilities in the study offered ART. Details of AIDS-defining illnesses are unknown 
and CD4 counts are not available for all participants. 
 
Wealth Index quintile 
 
 The DHS Wealth Index was developed by MEASURE DHS in collaboration with 
ORC Macro for use in demographic health surveys worldwide(331). The method 
has been widely used in over 44 countries in and beyond Africa(332). It uses an 
assets-oriented approach to determine relative household wealth within a 
population. In the standard Wealth Index questionnaire, the assets are ownership 
of goods (mobile phone, radio etc), house construction materials, fuel use, drinking 
water and sanitation. The responses to these variables are subjected to principal-
components factor analysis to create a continuous score, which is divided into 





The reason for using assets rather than a more straightforward measure of 
expenditure or income to determine wealth status is that in a low-income setting a 
considerable proportion of exchange may not be cash based, and so estimates of 
payment or cash expenditure will be unreliable(331). In many developing countries 
the majority of work is subsistence farming, and payment for services is made in 
kind. Wealth is also thought to have a lower volatility than either income or 
expenditure. Income may be related to time of year, particularly to harvest, while 
expenditure may be much higher at weddings or festivals. The Wealth Index has 
been validated against more complex measures of poverty in India and Nepal and 
performed well(333).  
 
Wealth is considered to be an unobserved latent variable underlying the 
possession of assets. As with other latent variables such as quality of life, principal 
components analysis is used to create a single index. The index is based on 
relative wealth because it has been shown that relative wealth is more closely 
associated with health status than absolute wealth. A further advantage of this 
approach is that it provides information directly relevant to the question of interest, 
i.e. the health status of the poor compared to the better-off. For the same reason, 
the index is divided into categories (traditionally but not necessarily quintiles) so 
that the effects of poverty can be observed within a group(331). The quintiles are 
termed ‘lowest’, ‘second’, ‘middle’, ‘fourth’ and ‘highest’, coded 1-5, with the lowest 
group used as the reference in this analysis. 
 
The Wealth Index variables were included in the demographic questionnaire 
administered at recruitment (Appendix A). They are: 
• Material used to make the walls, roof and floor of the house 
• Type of toilet 
• Main source of drinking water 
• Fuel used for cooking 
• Household ownership of car, bicycle, refrigerator, television, mobile phone 








E.4.iii Missing data 
 
Some participants were lost to follow-up(LTFU) without return, while others missed 
certain appointments and later returned. The number and proportion (as a 
percentage of those recruited) to complete interviews at each time point is 
displayed in a flowchart, showing reasons for LTFU where known. The number of 
participants to complete one, two, three and four interviews is calculated and 
presented in a second flowchart. The number of newly diagnosed participants 
interviewed at each time point is tabulated by facility. 
 
Missing data are categorised as either missing completely at random (MCAR), 
missing at random (MAR) or missing not at random (MNAR). MCAR means that no 
other observations are associated with the probability of missingness. Data are 
MAR when missingness is associated with other covariate, and MNAR when 
missingness is associated with the value of the missing data(334). These 
definitions are of great theoretical importance, but limited practical use. By 
definition it is impossible to know whether data are MNAR because this depends 
on the unobservable values. MCAR is a relatively rare situation in health research 
where missingness is usually associated with illness burden to some degree.  
 
Data can be also missing in two ways, either from a missing item in a questionnaire 
(item non-response) or from the absence of the entire questionnaire (unit non-
response)(335). 
 
1. Item non-response 
 
Item non-response occurs if participants do not wish or are not able to answer 
certain questions and if there are no consequences to leaving them blank. Item 
non-response would have been a problem in this study because the MOS-HIV 
summary scores can only be completed if all 35 items are present. Therefore the 
study design included several mechanisms to improve item response. The 
questionnaires were completed by trained health care workers, with monitoring for 
completion by research assistants every two weeks, and the database into which 




reported back to the study managers every two weeks. Item non-response is 
expected to be very low for all variables, with the exception of CD4 count, the only 
piece of information collected from patient records.  
 
Having a CD4 count will be used as a dichotomous outcome variable to test 
whether it is associated with other variables (MAR) or not (MCAR). It is not 
possible to test whether data are MNAR.  
 
 
2. Unit non-response 
 
Unit non-response occurs when an appointment is missed or a questionnaire is not 
returned. In this study it occurred when participants either attended the facility and 
did not wish (or were not able) to participate in the study, or they did not attend the 
facility. There were no resources for follow-up of patients who did not attend, other 
than those used by the facilities themselves for patient care.  
 
There are many types of imputation but they fall into two main forms, being based 
either on previous data or on previous trajectories. The simplest form of imputation 
based on previous data is last observation carried forward (LOCF), which repeats 
the last known value in all subsequent data points. Alternatives include replacing 
missing data with the mean of all previous data points(335). The assumption is that 
variation between individuals is greater than variation over time, such that variation 
within an individual and over time can be ignored. This assumption is not 
appropriate for my dataset in which outcomes are expected to vary within 
individuals over time. The second form of imputation extends an observed 
trajectory and imputes unobserved data from it. Examples include linear 
regression, Markov chain, and conditional probability imputation(335). This is a 
better option because data are allowed to vary over time, but it artificially constricts 
the variability of data.  
 
Multiple imputation is increasingly preferred(336). It simply repeats a selected 
imputation technique between three and ten times, and combines the results of 
data analysis in each of these newly generated datasets. In this way, the variability 




method remain. All imputation techniques overinflate observed effects(335). 
Patterns within the observed data are magnified and standard errors are reduced, 
even though no new information has been added. Any imputation technique makes 
certain assumptions about the data(336). Similarly, the choice not to use 
imputation makes an assumption about the data, namely that the section which is 
missing is not different from that which is observed.  
 
The analysis plan has four distinct parts, each using a different version of the 
dataset. Parts A and B are cross-sectional at baseline, and so unit non-response is 
not an issue because the sample was complete at baseline. The approach to 




E.4.iv Part A: Participant characteristics 
 
The first objective is to determine prevalence and severity of palliative care-related 
problems within two weeks of diagnosis. Two analysis questions are linked to this 
objective and the first is  
1a:What are the demographic characteristics of the sample of people newly 
    diagnosed with HIV in Kenya and Uganda? 
 
Demographic characteristics of participants are described. The number of days 
from diagnosis to recruitment is displayed in a bar chart and the mode is 
calculated. Socioeconomic variables are recategorised as shown in Table E-2, and 
the number and percentage to report each category are presented in a table.  
 
The recategorised DHS Wealth Index variables from the demography 
questionnaire are incorporated into a principal components factor analysis (PCA) to 
generate a single relative Wealth Index, which is split into five ordinal quintiles of 
equal size following the method used in the Demographic Health Surveys(331, 
332). Socio-economic variables are presented by wealth quintile in a table, to 




loading of each variable onto the wealth factor in the PCA is presented in Appendix 
D.  
 
Participants from the two study countries, Kenya and Uganda, are compared to 
establish whether they can be analysed as a single group or whether there are 
systemic differences between the two. A table is populated with the following 
information, calculated for each country separately: 
 
• Proportion of females as a percentage 
• Mean and standard deviation of age 
• Percentage reporting each of the recalculated education categories in Table 
E-2 
• Median and inter-quartile range of number of days from HIV diagnosis to 
recruitment 
• Proportion with a recorded CD4 count, expressed as a percentage 
• Median and IQR of CD4 count for those who have one 
• Proportion within each of the previously calculated wealth quintiles, 
expressed as a percentage 
 
Tests for significant difference are conducted as follows: difference between Kenya 
and Uganda in terms of binary variables (gender and having a CD4 count) is 
analysed using chi-square tests. Ordinal variables (education level, grouped 
number of days since diagnosis, and wealth quintile) are compared using analysis 
of variance (ANOVA). Continuous variables (age and CD4 count) are compared 







Table E-2: recategorisation of socioeconomic variables for factor analysis 
Variable  Questionnaire values  Analysis values 
Highest level of 
schooling 
attended 
None  None 
Began primary  Began primary 
Began secondary  Began secondary 
Diploma } Diploma or higher Degree  
Material used to 
make walls of 
house 
Thatched/straw } Thatch/mud and poles Mud and poles 
Unburnt bricks  Unburnt bricks 
Burnt bricks with mud  Burnt bricks with mud 





 Burnt bricks with cement 
Material used for 
roof of house 
Thatched } Natural  Wood/planks 
Corrugated iron sheets  Corrugated iron sheet 




Material used for 
floor of house 
Earth, mud, sand  Earth 








Source of drinking 
water 
Bottled } Bottled/piped inside house Piped inside house 
Piped outside house  Piped outside house 
 Protected well } Other safe  Borehole 
 Spring/rain water 
 
Other unsafe 
 Unprotected well 
 River/stream/pond 
 Tanker truck 
Fuel source Electricity 
 
Electricity/gas 
 LPG/natural gas 
 Biogas 
 Paraffin/kerosene } Paraffin/coal  Coal/lignite 











E.4.v Part A: Univariate analysis of problems at baseline 
 
The second analysis question for the first objective is  
1b: What are the scores of people newly diagnosed with HIV in the seven 
     patient-completed items of the POS? 
 
The percentage of participants to report each response category on each POS 
item is calculated and presented in a table. For one item (having enough help and 
advice for the family to cope), subgroup analysis is performed on participants who 
were diagnosed more than three days prior to recruitment, to avoid the bias that 
participants could report little help or advice in the past three days if they had not 
known they were HIV positive. Stacked column charts are plotted to show the 
distribution of each POS item score.  
 
 
The third analysis question is  
 1c: what is the total POS score of people newly diagnosed with HIV?  
 
To answer this, the seven patient-completed POS item scores are added together to 
create a total POS score, and the distribution at T0 is plotted as a histogram. The 




E.4.vi Part B: Multivariate analysis of problems at baseline 
 
The second objective is to investigate whether demographic variables or CD4 count 
are associated with prevalence and severity of palliative care-related problems at 
diagnosis. The research question is: 
2: At T0, is the severity of POS item problems associated with age, gender, 
 CD4 count, socio-economic status, country, physical function or education? 
 
The seven outcome variables each have six possible scores. To reduce the 




three categories, called ‘low/none’ (0 and 1), ‘medium’ (2 and 3) and ‘severe’ (4 
and 5). When recoded into three response levels, the POS item scores are referred 
to as ternary item scores.  
 
Not all participants have a CD4 count. Before using the CD4 results in analysis, 
presence of a CD4 count is tabulated against ternary POS item scores, with chi 
squared tests to check for confounding. If the existence of a CD4 test result is 
associated with outcomes, the CD4 results cannot be analysed against outcomes.   
 
The analysis plan, repeated for each of the seven outcome variables, is as follows: 
1. Bivariate analysis 
 
Values of the seven independent variables (gender, age, education, wealth 
quintile, physical function, country and CD4 count) are tabulated against the 
ternary dependent variable. The definitions of these variables are described in 
Section E.4.ii. Five of them do not vary over time; for physical function, the value at 
baseline is used, and for Cd4 count only the baseline value is used because very 
few participants (15.5%) have more than one recorded CD4 count.. Chi squared 
tests are performed to identify variables which may be associated with the 
outcome. Additionally, for the five ordinal variables (age, wealth quintile, education 
level, CD4 count and physical function), a non-parametric score test for trend is 
performed. A test for trend makes more efficient use of the data than a chi squared 
test, which is only able to detect unlikely deviations from the expected distribution 
of two completely unrelated variables. Any real association between age, wealth, 
education or physical function and an outcome is expected to show a dose-
response relationship. A test for trend is more likely to detect such a relationship, 
which may not register as significant on a chi squared test. However, a distribution 
which deviates from the flat in more than one direction (for example, a higher than 
average association for people of middle income), which might be caused by 
chance, is more likely to have a low p-value on a chi squared test than a test for 
trend. Both are useful, but in case of conflict the test for trend is more appropriate.  
 
A chi squared test assumes a large sample of random, unrelated observations, 
with a minimum of five observations per cell. Both independent and dependent 




in order to lessen the risk of Type II error, but some small cells remain. The usual 
recourse in this case is to use Fisher’s exact test, which is more accurate in the 
case of very unbalanced tables or when cells are small.   
 
The algorithm for deciding whether to use Fisher’s exact test is derived from 
Kirkwood and Sterne(337) and is as follows: 
• For 2x2 tables, if N (the total sample) is greater than 40, the chi2 test is 
always valid. 
• For larger tables, chi2 is valid if 
o The expected value is greater than 1 for all cells, and 
o The expected value is greater than 5 for at least 80% of cells 
 
The expected value (E) of a cell is the total of the row multiplied by the total of the 
column and divided by N. When chi2 is not valid, Fisher’s exact test will be used.  
 
Independent variables that have a less than 10% probability of forming such a 
distribution without a true association will be considered for possible confounding 
and then taken forward into multivariate analysis. This is a higher probability than 
the normal 5%, to reduce the risk of eliminating variables too early.  
 
 
2. Multivariate analysis 
 
The main technique used in the multivariate analysis is an extension of logistic 
regression, which allows an ordinal outcome to be used instead of the usual binary 
one. Hence it is called ordinal logistic regression (OLR). The outcomes are ternary, 
with three values (low, medium and high). The outcome can be analysed in two 
ways. Either separate odds ratios are produced for the odds of medium problems 
to low and high problems compared to low, or a single combined odds ratio is 
produced giving the average odds of medium versus low and high versus medium. 
The first method treats odds of medium problems and high problems as completely 
distinct, as though the outcome was a categorical variable. The second method 
assumes a consistent relationship between covariates and the odds of increased 
problems, treating the outcome as a true directional ordinal variable. The first 





In this analysis, the first method is used initially. This requires the creation of 
indicator or dummy variables to represent the options ‘medium problems’ and ‘high 
problems’. If the outcome is directional, then the OR for high problems should be 
around double the OR for medium problems. If this is the case, then the second 
method is used to fit an ordinal model, and the two are compared using a log 
likelihood test. The categorical model will only be retained if the test proves that it is 
significantly better than the ordinal model. The ordinal model, being simpler, is 
preferable in the absence of a significant difference between the two.  
 
Possible confounding and interaction between independent variables is 
investigated using stratum-specific odds ratios (ORs), which are calculated using 
OLR. It is not possible to calculated an adjusted OR using an ordinal outcome 
(there is no equivalent of a Mantel-Haenszel test). This makes it more difficult to 
interpret whether confounding is present, so a judgement must be made based on 
feasibility, the unadjusted and stratum-specific ORs, and tabulation of the two 
independent variables. Variables which are accepted as associated with the 
outcome are taken forward into multivariate OLR.  
 
First, independent variables are imputed as non-ordered categorical, using 
indicator variables for each value. Where the stratum-specific ORs indicate 
possible effect modification, an interaction term is added to the model. Next, 
several approaches are tried to simplify the initial model, to improve efficiency 
without loss of effectiveness. The interaction term is removed if it seems 
unnecessary (Wald test result shows no significance). Independent variables are 
imputed as ordinal if the log ORs for each response are similar, linear, and do not 
cross zero. At each stage the likelihood test statistic is calculated and a likelihood 
ratio test is used to determine whether the new model is significantly different from 







Box 1: Why report log odds ratios? 
 
Table E-3 is a dummy table showing the information presented from 
an OLR model. The output is explained below.  
 
Table E-3: dummy table to show association of independent variables with 
ternary POS score using OLR 




      
Independent 
variable 2 
      
 
Logs are used because a log odds distribution can conform to a 
Normal distribution and be used to derive a z statistic. The second 
column of the table gives the overall adjusted ratio between log odds 
of the outcome at one level and the next (i.e. the combined log odds 
of severe problems compared to moderate, and moderate compared 
to mild/none). The next column gives the standard error of the log 
OR. The coefficient divided by the standard error gives the z statistic, 
which follows a parametric distribution and is used in a Wald test to 
test the null hypothesis that the log OR is 0, i.e that the odds of the 
outcome are the same in both groups. A comparison of the z statistic 
with a Normal distribution obtains the p-value. In this analysis, the 
null hypothesis is rejected when p is less than 0.05. This indicates 
the observed OR is so far from 1 that it would have a lower than 5% 
probability of occurring by chance.  
 
The OR is derived by finding the exponential of the log term, and is 
presented with its 95% confidence intervals in the last two columns of 
the table. The important point is that the OR is the easiest result to 
interpret, but the statistical test is actually carried out on the log OR. 
For this reason, log ORs are presented to three decimal places but 




E.4.vii Part C: Univariate analysis of problems over time 
 
The third objective is to determine change in palliative care related problem 
severity longitudinally in a three month period. It has two research questions: 
3a. Do POS scores change over a three-month period, and if so do they 
    change from one month to the next?  
3b: Does total POS score change over a three-month period? 
 
To answer both of these questions, the number of days between observations is 
recoded into a variable for month, as described below. 
 
1. Time intervals 
 
The protocol specified that interviews should ideally take place at one-month 
intervals but that if participants were not able to return on the specified day, an 
interview up to seven days before or after was acceptable. In other cases, the time 
between interviews was not constant because participants missed one 
appointment and returned two months later. 
 
The variation in length between interviews was thus not entirely standard, which 
could be a cause of bias. For the PEPFAR PHE, it was reasoned that change in 
outcome would probably be more affected by the number of contacts with health 
services than the passage of time. In the PHE, the time T0 has no particular 
meaning. It indicates either a new diagnosis or a new presenting problem of any 
kind. Therefore the time elapsed since T0 is not a variable in itself, and the fact that 
the time between T0 and T1 is not fixed is not a problem. 
 
For the newly diagnosed group, the situation is different, as T0 represents a point 
in time within 14 days after diagnosis with HIV. The passage of time since 
diagnosis may be associated with change in outcomes independently of care and 
support received during that time, so time must be consistently measured. To 
achieve this, data points are recoded M0, M1, M2 and M3 (for Month), rather than 
the original T0, T1 etc. T0 and M0 are always the same. All M1 observations take 




period), plus or minus seven days. Observations earlier or later than this are 
rejected. The definition of new diagnosis accepted data collection up to 14 days 
after diagnosis, and it was consistent to continue to use 14-day periods of time.  
 
This approach involves recoding some data points, so that for example a data point 
marked T2 but collected 85 days after recruitment is recorded M3. Interviews 
completed four months after T0 are coded M4, and so on. A table is populated with 
the number of interviews to take place in each month. A disadvantage is that some 
data points are lost.  
 
 
2. Analysis plan  
 
The first research question involves measurement of change in POS item scores 
over time in the absence of any covariate. The null hypothesis is that POS scores 
do not change over time. For any two time points, proportion of net change is 
defined as the percentage of individuals whose scores reduce (i.e. get better) 
between the first time point and the second, minus the percentage whose scores 
increase(338). Although the underlying data are non-parametric, the change value 
is modelled as parametric and has a standard error from which a 95% confidence 
interval can be calculated. Change is very robust to parametric assumptions(338).  
 
The proportion of net change test is better for showing change than a Wilcoxon 
matched pairs signed-rank test. A Wilcoxon test assigns ranks before comparison 
of the two variables, allowing completely different paired measures to be 
compared. The process causes the absolute difference between points to be 
lost(338). Furthermore, a Wilcoxon z-test does not indicate direction of change, 
only that the two populations are not identical. 
 
The other advantage of a proportion of net change test is that it can be conducted 
using only spreadsheet software such as Microsoft Excel, or even by hand, and the 
principles involved are no more complicated than the concept of standard error and 
95% confidence intervals. The development of an evidence base for palliative care 




example of a simple, replicable, appropriate and readily interpretable method for 
longitudinal analysis could help researchers in Africa to build an evidence base, 
using the data they already have in the form of patients charts and routinely 
collected information. 
 
For each POS item, the method is 
1) Graph score distributions using stacked bar charts for the time points M0 to 
M3 
2) Calculate the difference between POS item score at M0 and M3 (M3 score 
minus M0 score), for all participants who completed interviews at both times 
3) Calculate the proportion of participants to register each possible value of 
change, from -5 to 5, and display these in a table 
4) Sum the percentages to calculate the proportion whose score decreased 
5) Sum the percentages to calculate the proportion whose score increased 
6) Subtract the proportion whose score increased from the proportion whose 
score decreased to derive the proportion of net change 
7) Calculate the standard error of the proportion of net change using the usual 
formula and use it to obtain 95% confidence intervals 
 
If the 95% confidence intervals of the proportion of net change do not cross or 
include zero, then the null hypothesis is rejected and the variable is deemed to 
change over time. 
 
Following this, the proportion of net change is also calculated for the time periods 
M0 to M1, M1 to M2 and M2 to M3 to establish whether change is steady or 
punctuated. This is only done if the first test demonstrates change over the entire 
time period, as testing series of time points against each other amounts to 
subgroup analysis. This means that a short-term, unsustained improvement is not 
detected, which is acceptable, because in this population such an effect would not 
have worthwhile benefit. In a population near the end of life, short-term 
improvement could be more valuable. 
 
The second research question for Part C is  





Total POS score is calculated as described for Part A, at each time point M0, M1, 
M2 and M3. Mean and standard deviation are presented, and total POS score is 
compared over the four months using analysis of variance. 
 
 
3. Missing data 
 
Available case analysis was used for this objective. The proportion of net change 
technique has individual-level change by paired analysis as its outcome and any 
imputation process would alter this result, either reducing it by using imputation 
based on prior observations, or increasing it by using imputation based on prior 
trajectory. Available case analysis incorporates known assumptions, rather than 
introducing the unknown assumptions of adding to observed data. Furthermore, 
proportion of net change is designed to be a simple technique that does not require 
advanced software or statistical training, both of which are lacking in Africa.  The 
stacked bar charts provide a useful mean to represent the effect of missing data as 
they plot actual numbers of participants rather than percentages.  
 
 
E.4.viii Part D: Multivariate analysis of problems over time 
 
The fourth and last objective is to investigate whether demographic variables or 
ARV use are associated with change in palliative care-related problem prevalence 
over time. It has one analysis question: 
4: Is any change in prevalence of moderate/severe POS item problems over 
    time associated with age, gender, socio-economic status, country,  
    physical function, education or receipt of ART?  
 
The longitudinal extension of multinomial logistic regression can be used to 
analyse the effect of covariates on an ordinal outcome over time.  
 
While traditional techniques require repeated observations at equal distances for 
all participants, represented by the use of monthly intervals in Part C, longitudinal 




(Box 2). The Stata command xtset is used to define the dataset as a cohort with 
repeated observations unequally spaced over time. For each observation, the 
number of days since recruitment (T0) is calculated, and this number of days is 
used as the time variable.  
 
The number of days from T0 to the date of data collection is expected to follow a 
left-censored Poisson distribution, with a long tail to the right. To prevent outlier 
bias, the mean and standard deviation of the time variable are calculated and 
observations more than three standard deviations beyond the mean are rejected. 
 
The six independent variables used previously (age, gender, wealth quintile, 
education level, country, and physical function) are included, plus one other: use of 
ART, a dichotomous variable. Physical function and ART use have the additional 
property that they are time-varying, recorded at each interview. The seven 
dependent variables are analysed as dichotomous, divided into no/low problem, 
coded 0, and moderate/severe problem, coded 1. The longitudinal extension of 
logistic regression is applied. 
 
This coding groups all scores from two to five into a single undifferentiated 
outcome, which reduces sensitivity to degree of problems. In this case the loss of 
detail was accepted because all problems were considered to imply a possible 
need, and to be amenable to possible alleviation. The sample population is of 







Box 2: What is longitudinal analysis?  
 
Longitudinal analysis was developed from multi-level modelling in 
education, to take account of the clustering effect of pupils within 
classes and classes within schools. Repeated observations of the 
same individual at different points in time can be considered as a 
cluster, with the added element of direction. Longitudinal analysis 
methods can also be applied to binary outcomes, as used here(339).  
 
There are two approaches to longitudinal analysis. The first is to 
conduct cluster-specific analysis and record the extent of variation 
between clusters. In this case, remembering that a cluster equals an 
individual, ordinal regression would be conducted for the association 
between covariates and outcome over time for each person in the 
sample, using the same equation for everyone but allowing the 
intercept and/or the slope to vary between individuals(340). The 
extent of this variation forms part of the outcome. The other approach 
is to use a generalised equation which estimates the average 
association between covariate and outcome over time for the entire 
sample. Most of the time the two methods give similar results, but 
they are based on different underlying principles(341). I chose the 
second approach, which when applied to logistic regression is known 
as the population-averaged approach. The cluster-specific approach 
is more appropriate when hypotheses are being tested or when the 
real odds of a given outcome are required. The population-averaged 
approach, as the name implies, analyses at a population level rather 
than an individual level. Its output is interpreted as the average odds 
of any given individual having the outcome. Given that so little 
information exists regarding palliative care-related problems at HIV 
diagnosis, it is more relevant at this point to seek general trends 
which can inform further research and care. Furthermore, the 
population-averaged approach in most cases produces odds ratios 






For each of the seven POS items, the method is as follows: 
1. Create a dichotomous outcome measure, coding no/mild problem as 0 and 
moderate/severe problem as 1 
2. Fit a population-averaged logistic regression model predicting the odds of 
moderate/severe problem adjusting for time in days since T0 
3. Repeat step 3, adding one extra covariate:, in turn, gender, age, wealth 
quintile, education, country, physical function, and ART use 
4. Identify independent variables associated with the outcome with a p-value of 
less than 0.25 in steps 3 and 4 above, and include them in a multivariate 
population-averaged conditional logistic regression model with significance 
set at 0.05 
5. If any covariate is not significantly associated with the outcome, remove the 
covariate with the highest p-value and refit the model. Repeat stepwise until 
all remaining covariates are significantly associated with the outcome 
6. Obtain predicted values from this model 




1. Missing data 
 
Cross-sectional time series logit analysis is a special case of a generalised 
estimating equation(GEE). Specifically, it is a GEE model with a binomial 
distribution of the dependant variable, a logit link function and an exchangeable 
correlation structure. When data are MCAR, GEE analysis is unaffected. 
Additionally, GEE methods have been shown to maximise efficient use of available 
data, with low sensitivity to data MAR. A paper using an experimental dataset with 
GEE found that analysis of observed data was comparable with several imputation 
methods and avoided the problem of underestimated standard errors which is 
common to all imputation(334). I opted for the most conservative approach, which 
in this case was available case analysis of observed data without imputation, since 
there was evidence imputation had little effect on results other than exaggerating 
the precision of standard errors. Change over time was the outcome and any 




F Results  
 
 
F.1 Overview  
 
This chapter presents the results in four parts, each designed to fulfil one objective. 
Part A consists of descriptive cross-sectional analysis at baseline (within two weeks 
after HIV diagnosis). Part B compares prevalence and severity of problems at 
baseline by demographic and clinical characteristics. Part C displays POS scores at 
monthly intervals and measures the change between them. Part D is a more 
complex analysis of change over time, using all observations, and adjusting for the 
effect of demographic and clinical variables. Table F-1 below shows the four parts 
and their attributes. Part A includes neither time nor other covariates; B and D 




Table F-1: overview of results 
  Effect of time 
 Part A Part C 








F.2 Recruitment and retention of participants 
 
In Kenya, of the 696 people approached, 641 gave a valid date of their HIV test, and 
266 of the HIV test dates (41.5%) fell on the day of recruitment or up to 14 days 
previously. Of those 266, 18 were rejected because their records showed a CD4 test 
had been performed more than 14 days before T0, and one more was rejected 
because ART initiation preceded the 14 day limit. This left 247 newly diagnosed 
participants from the Kenya cohort. 
 
In Uganda, the 640 potential participants included 606 with a valid HIV test date, and 
196 (32.3% of those with a date) reported being diagnosed HIV positive within 14 
days prior to T0. Five were excluded because they had a CD4 count predating this 
time, leaving 191. The 191 from Uganda added to the 247 from Kenya gave a total of 
438 newly diagnosed participants. These results are summarised for both countries 
in Figure F-1.  
 
During the three months of the study, some participants were permanently lost to 
follow-up, while others missed one or two appointments and later returned. The 
reasons for LTFU and the number of interviews completed at each time point are 
shown in Figure F-2 below. The majority of participants who were lost to follow-up 
completed only one interview. During the study eleven participants died and seven 
became unable to complete data collection. In most cases, the reason for non-
completion was unknown. 
 
Of the 1593 data points collected, the patient was accompanied by a carer at 148 
(9.3%). The proportion of patients with a carer present reduced over time, from 
15.8% (n=72) at baseline to 9.0% (n=35) at T1, 6.2%(n=23) at T2 and 4.8% (n=18) 
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The twelve facilities selected for Phase 2 of the PEPFAR evaluation included one 
which did not recruit any new patients during the study period. This was site U6, in 
Uganda, which lacked funds to initiate any more patients onto ART in that year. The 
eleven facilities which contributed to the newly diagnosed group are listed in Table 
F-2 and named in Appendix C. K2 recruited only three newly diagnosed individuals 
during the study period. U2 recruited the most (80), due to its specialisation in 
voluntary counselling and testing. It also had a relatively high LTFU, which the staff 





































Died    8  
Unable   2  
Refused    1 
Left study   7 
Unknown 28 
Total  46
Died    1 
Left study   2 
Unknown 15 
Total  18 
Died   2  
Unable  5  
Unknown 11 










The study design indicated four equally spaced time points one month apart. The 
protocol specified that deviations of two weeks in either direction were acceptable. 
Some participants had longer periods of time between appointments. In Kenya, the 
civil unrest in January and February 2008 following a disputed presidential election 
caused widespread barriers to travel. Health facilities reportedly gave their patients 
two months’ supplies of medication to enable them to stay at home.  
 
Table F-2: interviews completed by facility 
Facility Interviews completed at time point 
 T0 T1 T2 T3 
 
K1 40 40 39 37 
K2 3 2 2 2 
K3 76 65 61 61 
K4 65 55 51 51 
K5 24 18 16 16 
K6 39 35 31 29 
U1 18 17 17 17 
U2 80 56 56 60 
U3 27 26 24 22 
U4 35 34 34 34 
U5 31 26 26 27 








F.3 Preliminary recoding of the dataset 
 
 
F.3.i Time interval recoding 
 
In Figure F-3 below, the number of interviews completed by each person is 
represented, rather than the specific time points. While Figure F-2 showed that 
participants who had completed three interviews were very unlikely to fail to attend 
the fourth, Figure F-3 shows that 39 participants completed three interviews. This 















Died    8 
Unable   2 
Refused    1 
Left study   7 
Unknown 28 
Died    1 
Left study   2 
Unable   6 
Unknown 19 
Died    2 
Unable 13 
Unknown 20 
Figure F-3: CONSORT chart of 






F.3.ii Other recoding 
 
Participants occasionally reported that they did not known whether they had received 
a component of care for 13 of the 54 components, at seven of the facilities, as shown 
in Table F-3. 
 
Table F-3: ‘don’t know’ responses 
Component ‘Don’t know’ 
responses 
Facility 
n %  
Patient HIV support groups 5 0.3 U3 
Prevention with positives 1 0.1 U2 
ARVs 1 0.1 U3 
Assessment of ARV treatment 1 0.1 U3 
Assessment of pain 1 0.1 U2 
Strong opioids 3 0.2 K5, U2, U3 
Weak opioids 7 0.4 K5, U2, U3 
Non-opioid analgesics 4 0.3 K1, U3 
Treatment for oral candidiasis 1 0.1 K3 
TB testing 1 0.1 K4 
Treatment for other opportunistic 
infections 
2 0.1 K1 
Multivitamins 1 0.1 U3 







F.4 Part A: Participant characteristics 
 
In the 14 days before M0 438 participants were diagnosed, usually (78.3%) in the 
first week. The distribution of number of days from HIV diagnosis to recruitment was 
skewed to the left with the modal value being zero (Figure F-4). Participants 
consisted of 270 women (61.6%) and 168 men, aged 18 to 59 (mean 32.9).  
 
Figure F-4: distribution of number of days from HIV diagnosis to M0 
 
 
At recruitment, over two thirds of participants (69.9%) were fully active in terms of 
physical function using the ECOG scale( Table F-4). Most of the remainder were 
physically restricted but still able to carry out light work. More severe disability was 
rare (6.9% in total). It is unknown whether disability was caused by HIV or was 
incidental to it. No further details on its nature, cause or impact were collected. 
 
Table F-4: physical function at T0 
 n % 
Total 438 100.0 
Fully active 306 69.9 
Restricted in physically strenuous activity 102 23.3 
Ambulatory but unable to work 23 5.3 
Limited self-care 5 1.1 
Completely disabled 2 0.5 
 
Table F-5 shows the DHS Wealth index population characteristics. The average 














burnt brick or cement blocks, had some primary education, owned a radio and 
mobile phone, used a shared latrine, and cooked on charcoal or firewood. Time to 
travel from home to the health facility ranged from five minutes to six hours, with a 
third of respondents answering that it took one hour. Number of dependants ranged 
from none (for 11%) to 20, with a median of three. 
 
Table F-5: demographic characteristics of newly diagnosed individuals 
Population characteristic N (%) 
Highest level of schooling attended  
None 19 (4.3) 
Began Primary 229 (52.3) 
Began secondary 147 (33.6) 
Diploma + 43 (9.8) 
Wall material  
Thatch/mud and poles 115 (26.3) 
Mud/unburnt bricks 27 (6.2) 
Burnt bricks with mud 69 (15.8) 
Metal sheet/cement block 101 (23.1) 
Stone/wood/burnt bricks 126 (28.8) 
Floor material  
Earth 138 (31.5) 
Cement/concrete 281 (64.2) 
Other finished 19 (4.3) 
Roof material  
Natural 31 (7.1) 
Corrugated iron 380 (86.8) 
Finished 27 (6.2) 
Type of toilet  
Private flush 44 (10.1) 
Private VIP latrine 48 (11.0) 
Traditional pit covered 98 (22.4) 
Traditional pit uncovered 79 (18.0) 
Public/shared 146 (33.3) 
Bush/field/other 23 (5.3) 
Source of drinking water  
Pipe-borne inside/bottle 74 (16.9) 
Pipe-borne outside 174 (39.7) 
Other safe 87 (19.9) 
Other unsafe 103 (23.5) 
Fuel Source  
Electricity/gas 21 (4.8) 
Paraffin/coal 68 (15.5) 
Charcoal 197 (45.0) 
Firewood/straw/grass 148 (33.8) 
Own car 51 (11.6) 
Own bicycle 145 (33.1) 
Own fridge 87 (19.9) 
Own TV 189 (43.2) 
Own mobile phone 322 (73.5) 




The information presented above on home construction, fuel, water and sanitation 
use, ownership of goods and education was used in a principal components analysis 
to generate a single factor which was then split into equal wealth quintiles. Details of 
how each component loaded onto the factor are presented in Appendix D. Table F-6 
presents the percentage of participants reporting assets by quintile.  
 
The lowest, poorest quintile was defined by having an earthen-floored home without 
a tiled roof, and by never possessing a car, refrigerator, flush toilet or indoor piped 
water. People who lived in a home built of poles and mud or thatch, cooked on 
firewood or drank unsafe water were normally in the lowest quintile. The second 
quintile was more likely to use bricks rather than poles and corrugated iron rather 
than thatch, and some of this group had outside piped water. The middle quintile was 
more likely than the second to have a cement or finished floor instead of earth. In the 
fourth quintile, some people had a finished (probably tiled) roof, the use of paraffin or 
coal became much more common, and ownership of televisions and refrigerators 
increased. This quintile also contained the most users of an outside or shared toilet. 
Two thirds of those who owned a car or refrigerator, three quarters of those who 
cooked on gas or electricity, almost everyone with a flush toilet and the majority of 
those with a tiled roof or finished floor were in the wealthiest quintile of the sample. 
Nobody in the wealthiest quintile used an unsafe water source or lived in a thatched 
home.  
 
The variables with the greatest variation by quintile are those relating to home 
construction, a flush toilet, piped water, car ownership and use of electricity or gas. 
Bicycles and radios were similarly distributed across all five quintiles. A corrugated 
iron roof was also equally common regardless of quintile. Use of a public or shared 







Table F-6: asset possession by socioeconomic quintile 












Floor material      
  Earth 63.8 32.6 2.9 0.7 0.0 
  Cement 0.0 15.3 28.5 30.3 26.0 
  Finished 0.0 0.0 15.8 15.8 68.4 
Wall materials      
  Thatch/mud & poles 63.5 29.6 3.5 3.5 0.0 
  Bricks – mud or unburnt 9.4 28.1 27.1 18.8 16.7 
  Metal sheet/cement block 1.0 12.9 18.8 26.7 40.6 
  Stone/wood/burnt bricks 4.0 11.1 30.2 31.8 23.0 
Roof material      
  Natural 83.9 6.5 3.2 6.5 0.0 
  Corrugated iron 16.1 22.6 22.6 22.1 16.6 
  Finished 0.0 0.0 0.0 11.5 88.5 
Type of toilet      
  Public/shared/outside 21.3 20.1 21.3 28.4 8.9 
  Latrine 23.1 23.6 22.7 17.3 13.3 
  Private flush 0.0 2.3 0.0 4.6 93.2 
Source of drinking water      
  Bottle/piped inside 0.0 9.5 14.9 5.4 70.3 
  Piped outside 0.6 16.7 26.4 38.5 17.8 
  Other, safe 25.3 35.6 20.7 14.9 3.5 
  Other, unsafe 63.1 20.4 11.7 4.9 0.0 
Source of cooking fuel      
  Electricity/gas 0.0 0.0 16.0 8.0 76.0 
  Paraffin/coal 1.5 7.4 16.2 39.7 35.3 
  Charcoal 1.5 19.3 28.4 29.4 21.3 
  Firewood/straw/grass 56.8 30.4 10.8 1.4 0.7 
Household possessions      
  Car 0.0 11.8 7.8 13.7 66.7 
  Bicycle 24.8 19.3 15.2 20.7 20.0 
  Refrigerator 0.0 2.3 5.8 25.3 66.7 
  Television 0.5 10.6 10.6 34.9 43.4 
  Mobile phone 11.8 14.9 21.1 25.8 26.4 








F.4.i Kenya and Uganda compared 
 
The populations from the two countries were compared in terms of demographic 
characteristics and measures of health at baseline in order to establish whether 
there were important differences or whether they could be treated as a single group 
(Table F-7).  
 
Table F-7: comparison of Kenyan and Ugandan populations at baseline 
  Kenya Uganda 
N  247 191 
Gender (% female)  63.6 59.2 













Days since diagnosis 
(median, IQR) 
 4 (1-8) 1 (0-5) 
Has any recorded CD4 
count (%) 
 92.3 51.3 
Baseline CD4 count 
(median, IQR) 
 251 (100-407) 331 (188-488) 
















Median CD4 count was lower in Kenya than Uganda, but 92.3% of participants in 
Kenya had a baseline CD4 test result compared to only 51.3% in Uganda. At any 
time during the study, over 90% of people in Kenya had at least one CD4 test result, 
whereas almost half in Uganda never did. The two groups are therefore unlikely to 
be directly comparable, as the Kenya group includes the great majority of the study 
population, while the Uganda group comprises only half. The Kenya population were 
also significantly poorer, using the wealth quintiles described above, with an ANOVA 
test on a five per cent significance level (F=4.89, p=0.028). There was no significant 





F.5 Part A: Description of multidimensional problems at baseline 
 
The results of the seven patient-completed items in the POS at study recruitment, up 
to 14 days after HIV diagnosis, are displayed in Table F-8. 
 
Table F-8: POS scores at M0 
POS item % of individuals scoring (n=438) 
 0 1 2 3 4 5 
Pain 33.1 22.6 24.9 13.2 5.3 0.9 
Symptoms 34.3 28.5 22.8 11.2 2.1 1.1 
Worry 31.5 22.4 26.0 9.4 5.7 5.0 
Share feelings 11.6 7.1 12.8 15.5 21.0 32.0 
Life worthwhile 42.7 21.2 14.8 11.2 5.0 5.0 
Peace 24.4 21.7 23.1 11.6 8.0 11.2 
Help and advice 8.7 6.9 7.8 12.1 17.4 47.3 
Help and advice (if diagnosed >3 
days before T0) (n=189) 
11.6 7.4 9.0 12.2 15.3 44.4 
 
At recruitment, up to 14 days after HIV diagnosis, 19% of individuals experienced 
pain of 3, 4 or 5 in the previous three days. At the same time 14% reported scores of 
3, 4 or 5 for symptoms; 20% for worry; 21% for difficulty finding life worthwhile; and 
31% for peace. The highest burdens were found for problems sharing feelings, and 
need for help and advice. Over two thirds of participants (69%) reported this level of 
problems sharing their feelings, with almost a third (32%) not able to share their 
feelings at any time in the previous three days (score of 5). Almost half (47%) had 
received no help and advice (score of 5), and a further 29% scored 3 or 4. 
 
The item regarding help and advice was analysed again for participants who had 
been diagnosed more than three days previously, on the grounds that the very 
recently diagnosed would not have been able to receive help before they knew their 
diagnosis. This restriction made a slight improvement to scores, but still left 44% who 
had received no help or advice in the previous three days.  
 
The same information is presented graphically in Figure F-5. The figure shows that 
the distributions for the two items in the physical domain (pain and symptoms) were 
similar to each other, with around a third of participants reporting no problem and 




bars) were more common than mild pain. In the psychological domain, the 
distribution of worry scores was similar to that for pain, with the exception that very 
severe problems (red and dark red) were somewhat more common. Feeling life 
worthwhile was the area in which participants were most likely to record no problem 
at all, although more than half of responses did indicate a difficulty feeling worth in 
life. Severe and moderately severe problems occurred at the same frequency as for 
worry, but mild problems were less common. In the spiritual domain, over 10% of 
participants reported the worst possible score for difficulty feeling at peace. Peace 
scores were lower than scores for any of the psychological or physical items. 
However, the worst scores of all were for the two items in the social domain. Over 
30% reported the worst possible score for difficulty sharing their feelings, and almost 
50% for difficulty receiving help and advice for their family. The score distributions for 
these two items are clearly distinct from the pattern of the other five. 
 
Figure F-5: POS scores at M0 
 
 
The distribution of total POS scores at M0 is displayed in Figure F-6. The data 
appear to be Normally distributed with few data points in the very top end of the 
scale, which would signify the maximum possible level of problems. Of the 438 
respondents 3.2% had a POS score below 5, 13.7% had a total POS score of 5 to 9, 












36.2% scored 10 to 14, 31.8% scored 15 to 19, 13.3% scored 20 to 24 and 1.8% 
scored 25 to 35.  
 
Figure F-6: distribution of total POS score at M0 
 
 
Figure F-6 illustrates that the proportion with no problems is very low. For example, 
although as shown in Figure F-5 approximately one third of participants have no 
pain, one third no symptoms, and one third no problems, only 7.1% (n=31) score 0 




















F.6 Part B: Risk factors for multidimensional problems at baseline 
 
Having established that multidimensional problems are highly prevalent in this 
recently diagnosed HIV-positive outpatient population, the second objective is to 
investigate whether demographic variables or CD4 count are associated with 
prevalence and severity of palliative care-related problems at diagnosis. 
 
CD4 count was obtained for 297 participants (67.8%). Ternary POS item scores 
were tabulated against presence of a CD4 count at T0, to check for possible 
confounding, but association with presence of a CD4 count was not found for any 






Table F-9 shows that pain is positively associated with limited physical function at 
the 10% level, and negatively associated with wealth. The data tabulations give more 
detailed information about these relationships. People with middle physical function 
are almost twice as likely to have severe pain, and half as likely to have no pain, as 
those with the best, while 30% of those with the worst physical function report severe 
pain. The association between wealth and pain is pronounced, but it is not perfectly 
linear. The fourth group actually has the highest prevalence of severe pain and does 






Table F-9: bivariate association of independent variables with pain severity 
Variable Value  Pain Chi2 test for 
association 
NP test for 
trend 
 Low/ 
mild Moderate Severe Chi
2 p Z p 
  n 244 167 27     
Gender Male 168 54.8 36.3 8.9 3.66 0.161   
 
 
Female 270 56.3 39.3 4.4     
Age 18-25 89 62.9 29.2 7.9 4.81 0.308 1.47 0.140 
 26-40 276 55.1 39.1 5.8     
 
 
41-59 73 49.3 45.2 5.5     
Education None 19 36.8 47.4 15.8 9.00 0.174 -2.03 0.042 
 Primary 229 54.6 39.7 5.7     
 Secondary 147 55.8 38.8 5.4     
 
 
Diploma+ 43 69.8 23.3 7.0     
Wealth 
quintile 
Lowest  88 45.5 47.7 6.8 26.24 0.001 -3.98 <0.001 
Second  88 40.9 53.4 5.7     
 Middle 87 60.9 34.5 4.6     
 Fourth  89 58.4 33.7 7.9     
 
 
Highest  86 73.3 20.9 5.8     
Physical 
function 
Best  306 66.0 30.4 3.6 67.98 <0.001 7.31 <0.001 
Middle  102 36.3 56.9 6.9     
 
 
Worst  30 16.7 53.3 30.0     
Country Kenya 247 58.3 35.2 6.5 2.03 0.363   
 Uganda 191 52.4 41.9 5.8     
  n 171 109 17     
CD4 count 0-100 70 18.7 29.4 35.3  0.077* -1.85 0.064 
 101-200 47 18.1 14.7 0     
 201-350 71 22.2 26.6 23.5     
 350+ 109 40.9 29.4 41.2     
*Fisher’s exact test 
 
The non-parametric test for trend shows a significant association with education, 
suggesting that those with less education are more likely to have pain, but this 
finding is not significant using a chi2 test. Observation of the data suggests it may be 
driven by the unusually high proportion reporting severe pain in the lowest education 
level (15.8%, compared to a range of 5.4-7% in the other education levels). 
 
It is a general rule that greater wealth is associated with better education. To test the 
hypothesis that the observed association with education was confounded by wealth, 






Table F-10: distribution of education over wealth quintile (%)  
Wealth quintile  Education level 
  None Primary Secondary Diploma+ Total 
 n 19 229 147 43 438 
Lowest  88 7.8 68.2 19.3 4.6 100.0 
Second  88 5.7 70.5 20.5 3.4 100.0 
Middle 87 3.5 42.5 47.1 6.9 100.0 
Fourth  89 4.5 49.4 38.2 7.9 100.0 
Highest  86 0 30.2 43.0 26.7 100.0 
 
Table F-10 shows a clear linear trend, with wealthier people more likely to have more 
formal education. A chi squared test found very strong evidence for an association 
between the two variables (chi2=76.28, p<0.001). 
 
Next, stratum-specific estimates for the odds ratio (OR) for the effect of education on 
pain prevalence by wealth quintile were calculated. The summary adjusted OR was 
compared with the unadjusted OR of the effect of education on pain prevalence, in 
order to determine whether wealth confounded the relationship between education 
and pain.  
 
Table F-11: the association of pain prevalence with education, by wealth quintile 
Wealth quintile n Log 
OR 
OR for effect of 
education on pain 
Z p 95% CI of 
OR 
All (unadjusted) 438 -0.273 0.76 -2.05 0.040 0.59-0.99 
Lowest  88 -0.163 0.85 -0.48 0.630 0.44-1.65 
Second  88 0.039 1.04 0.11 0.909 0.53-2.05 
Middle 87 0.219 1.25 0.67 0.503 0.66-2.37 
Fourth  89 -0.204 0.82 -0.67 0.504 0.45-1.48 
Highest  86 -0.142 0.87 -0.44 0.663 0.46-1.64 
 
In Table F-11, the unadjusted OR for the effect of education on pain is 0.76, with a p-
value of 0.040. The stratum-specific ORs are all closer to zero than the unadjusted 
value, some higher and some lower, with no discernible trend. Wealth quintile 
appears to completely confound the apparent relationship between education and 
pain. Education was therefore dropped from the analysis. 
 
To test whether wealth and physical function were associated with each other, the 
two were tabulated (Table F-12), showing that poorer people were more likely to 
have limited physical function (chi2=17.65, p=0.024). These results were even more 





Table F-12: distribution of wealth quintiles over physical function (%) 
Wealth quintile  Physical function  
  Best Middle Worst  total 
 n 306 102 30 438 
Lowest  88 69.3 25.0   5.7 100.0 
Second  88 53.4 34.1 12.5 100.0 
Middle 87 72.4 23.0   4.6 100.0 
Fourth  89 78.7 15.7   5.6 100.0 
Highest   86 75.6 18.6   5.8 100.0 
 
To test both for trend and for interaction, stratum-specific ORs were calculated for 
the effect of physical function on pain, within each wealth quintile.  
 
Table F-13: the association of pain prevalence with physical function, by wealth quintile 
Wealth quintile Log 
OR 
ORs for effect of 
physical function on 
pain severity 
Z p 95% CI of ORs 
All (unadjusted) 1.203 3.33 7.24 <0.001 2.40-4.61 
Lowest   2.05 1.97 0.049 1.00-4.19 
Second   2.30 2.52 0.012 1.20-4.40 
Middle  4.92 2.07 <0.001 2.16-11.24 
Fourth   3.94 3.41 0.001 1.79-8.66 
Highest    5.01 3.93 <0.001 2.24-11.20 
 
Table F-13 shows that the unadjusted OR for the effect of physical function on pain 
was 3.33 (p<0.001); an increase of 1 in physical impairment score more than tripled 
the odds of pain. Stratum-specific ORs for the effect of physical function on pain 
ranged from 2.05 to 5.01, with wide confidence intervals (Table F-13). There was no 
evidence for a confounding effect of wealth on the relationship between physical 
function and odds of pain.  
 
A ordinal logistic regression (OLR) model was fitted, first using indicator variables to 
model the independent variables as categorical, and then treating them as ordinal. 
The covariates were physical function, wealth quintile, and Cd4 count, but CD4 count 
was found to be no longer associated with pain so it was dropped. The categorical 
model showed clear trends which were supported in the ordinal model, and the log 
likelihoods were not significantly different (chi2=3.61, p=0.307). The simpler ordinal 





Table F-14: association of physical function and wealth quintile with pain severity using OLR  
 Log OR SE Z p OR 95% CI of OR 
Physical function 1.160 0.167 6.93 <0.001 3.19 2.30-4.43 
Wealth quintile -0.235 0.071 -3.29 0.001 0.79 0.69-0.91 
 
The results in Table F-14 show that one point on the ECOG scale was associated 
with a threefold increase in the odds of moderate pain compared to mild or severe 
pain compared to moderate. An increase in wealth quintile was associated with 
reduced odds of pain. The effect of wealth was much weaker than the effect of 





Only 14 people report severe symptoms, which is the lowest prevalence of severe 
problems of any outcome. As a result, all four of the non-binary independent 
variables fail to meet the validity requirements of a chi-square test here, either 
because more than a fifth of the table cells have an expected value below five (age 
and wealth quintile) or because a cell has an expected value below one (education 
and physical function). Fisher’s exact test was used instead. The 5x3 table of wealth 
quintile against symptom score was too large to calculate Fisher’s exact test, using 
the maximum memory which my PC’s operating system would allocate to Stata 
(512Mb). The non-parametric test for trend indicates a probable association with 
symptom prevalence.  
 
Prevalence and severity of symptoms are associated with wealth quintile, education 
and physical function. Poorer people and those with less education are more likely to 
report symptoms. Symptoms are also more common among people with limited 







Table F-15:bivariate association of independent variables with symptom severity 
Variable Value  Symptoms Chi2 test for 
association 
NP test for 
trend 
 Mild/ 
none Moderate Severe Chi
2 p Z p 
  n 275 149 14     
Gender Male 168 59.5 38.1 2.4 2.36 0.307   
 
 
Female  270 64.8 31.5 3.7     
Age 18-25 89 64.0 31.5 4.5  0.608* 0.84 0.401 
 26-40 276 64.1 33.0 2.9     
 
 
41-59 73 56.2 41.1 2.7     
Education None 19 47.4 36.8 15.8  0.028* -1.88 0.060 
 Primary 229 62.9 34.1 3.1     
 Secondary 147 59.9 38.1 2.9     
 
 
Diploma+ 43 79.1 18.6 2.3     
Wealth 
quintile 
Lowest  88 59.1 37.5 3.4  - -2.60 0.009 
Second  88 51.1 44.3 4.6     
 Middle 87 65.5 29.9 4.6     
 Fourth  89 65.2 33.7 1.1     
 
 
Highest   86 73.3 24.4 2.3     
Physical 
function 
Best 306 73.5 24.5 2.0  <0.001* 7.12 <0.001 
Middle   102 40.2 56.9 2.9     
 
 
Worst  30 30.0 53.3 16.7     
Country  Kenya  247 65.2 31.6 3.2 1.51 0.469   
 Uganda 191 59.7 37.2 3.1     
  N 188 98 11     
CD4 count 0-100 70 16.5 33.7 54.6  0.009* -3.15 0.002 
 101-200 47 17.0 14.3 9.1     
 201-350 71 27.1 18.4 18.2     
 350+ 109 39.4 33.7 18.2     
*Fisher’s exact test 
 
 
Wealth and physical function are both associated with pain as well as symptoms. In 
Section 0 above, they were tabulated (Table F-12), showing a statistically significant 
association between them (chi2=17.65, p=0.024). Education is also associated with 
wealth quintile, as seen in Table F-10 (chi2=76.28, p<0.001). 
 
The association of physical function and wealth quintile with symptom prevalence 
was analysed using stratum-specific ORs. The results (Table F-16) show that the OR 
for the effect of physical function on symptom prevalence increases with wealth from 




was observed in the stratum-specific ORs for pain prevalence in Table F-13, but it is 
more pronounced.  
 




ORs for the effect of 
physical function on 
symptom prevalence
z p 95% CI of ORs 
All (unadjusted) 1.172 3.23 6.89 <0.001 2.32-4.51 
Lowest  0.300 1.35 0.85 0.397 0.67-2.70 
Second  0.884 2.42 2.70 0.007 1.27-4.60 
Middle 1.709 5.23 3.93 <0.001 2.36-12.95 
Fourth  1.619 5.05 3.40 0.001 1.99-12.83 
Highest  1.699 5.47 3.95 <0.001 2.35-12.70 
 
 
Next, the effect of education on the odds of symptoms was examined by wealth 
quintile, showing that after adjusting for wealth, the association between education 
and symptoms was weak and non-significant (Table F-17). This was the same result 
as had been found in the pain analysis. Accordingly, education was dropped from 
the model.  
 
Table F-17: the association of symptom prevalence with education, by wealth quintile 
Wealth quintile Log 
OR 




z p 95% CI of 
ORs 
All (unadjusted) -0.264 0.77 -1.90 0.058 0.58-1.01 
Lowest -0.022 0.98 -0.07 0.948 0.50-1.90 
Second -0.149 0.86 -0.42 0.676 0.43-1.73 
Middle -0.197 0.82 -0.57 0.571 0.41-1.63 
Fourth -0.148 0.86 -0.47 0.641 0.46-1.61 
Highest  -0.149 0.86 -0.46 0.647 0.46-1.63 
 
An OLR model was fitted with physical function, wealth quintile and CD4 count as 
covariates, using indicator variables and an interaction term, Both the interaction and 
CD4 count proved non-significant so they was removed. Then the model was 
compared with one fitting the independent variables as ordinal. The second model 






Table F-18: association of physical function and wealth quintile with symptom severity using 
OLR  
 Log OR SE Z p OR 95% CI of ORs 
Physical function 1.148 0.171 6.72 <0.001 3.15 2.26-4.41 
Wealth quintile -0.147 0.074 -2.00 0.046 0.86 0.75-1.00 
 
Table F-18 shows that the results for symptoms were similar to the results for pain; a 
strong association with physical function (limited function increasing the odds of 
symptoms) and a weak association with wealth quintile, in the opposite direction 





Table F-19: bivariate association of independent variables with worry severity 
Variable Value  Worry Chi2 test for 
association 
NP test for 
trend 
 Mild/ 
none Moderate Severe Chi
2 p Z p 
  n 236 155 47     
Gender Male 168 61.9 28.0 10.1 7.58 0.023   
 
 
Female  270 48.9 40.0 11.1     
Age 18-25 89 55.1 33.7 11.2 0.27 0.992 0.10 0.922 
 26-40 276 53.6 35.5 10.9     
 
 
41-59 73 53.4 37.0 9.6     
Education None 19 57.9 26.3 15.8 5.90 0.435 1.62 0.105 
 Primary 229 57.2 33.2 9.6     
 Secondary 147 51.7 36.1 12.2     
 
 
Diploma+ 43 41.9 48.8 9.3     
Wealth 
quintile 
Lowest 88 56.8 33.0 10.2 9.52 0.300 0.70 0.481 
Second 88 50.0 37.5 12.5     
 Middle 87 57.5 29.9 12.6     
 Fourth 89 60.7 34.8 4.5     
 
 
Highest  86 44.2 41.9 14.0     
Physical 
function 
Best  306 57.2 35.0 7.8 11.54 0.021 2.83 0.005 
Middle  102 48.0 36.3 15.7     
 
 
Worst  30 40.0 36.7 23.3     
Country  Kenya 247 57.1 32.4 10.5 2.54 0.281   
 Uganda  191 49.7 39.3 11.0     
 n 168 102 27      
CD4 count 0-100 70 24.4 22.6 3.14 0.791 1.04 0.297  
 101-200 47 17.9 11.8      
 201-350 71 24.4 23.5      





Table F-19 above shows that two independent variables are associated with worry at 
the 10% level. Women have a higher probability than men of experiencing moderate 
worry, but not severe worry, where the proportions are very similar. Also there is a 
clear trend for poor physical function to be associated with greater prevalence of 
worry and with more severe worry. There is no discernible relationship between 
worry and wealth quintile, although a bivariate trend was seen previously for both 
pain and symptoms.  
 
The two variables gender and physical function were tabulated in order to detect any 
association between them (Table F-20). Using two degrees of freedom, a chi2 test 
found no association between the variables (chi2=1.29, p=0.526). Therefore it would 
not be possible for either of them to confound the association between the other and 
worry. 
 
Table F-20: distribution of gender over physical function (%) 
Gender  Physical function 
  Best Middle Worst  Total 
 n 306 102 30 438 
Male 168 67.3 24.4 8.3 100.0 
Female 270 71.5 22.6 5.9 100.0 
 
To test for interaction, the stratum-specific ORs of worry for women compared to 
men were calculated for each level of physical function (Table F-21). The results 
show that the association between gender and worry is only significant for 
participants with the best physical health and disappears entirely for those with the 
worst. The possibility of interaction was investigated further. 
 
Table F-21: association of prevalence of worry with gender, by physical function 
Physical function Log 
OR 




z p 95% CI of 
ORs 
All (unadjusted) 0.466 1.59 2.39 0.017 1.09-2.34 
Best 0.575 1.78 2.39 0.017 1.11-2.84 
Middle  0.374 1.45 0.96 0.337 0.68-3.12 
Worst  0.016 1.02 0.02 0.982 0.26-3.96 
 
The first OLR model included an interaction term between physical function and 




ratio test showed they were not beneficial. A further model showed that physical 
function could be modelled as linear, rather than categorical (while gender was 
coded 0/1 and so using indicator variables made no difference to it). This simplest, 
most efficient model was retained to represent the data and is shown below(Table 
F-22). Each level of limitation in physical function (from best to middle, or from 
middle to worst) increases the odds of worry by 1.56. Women have significantly 
higher odds of worry than men.  
 
Table F-22: association of physical function and gender with worry severity using OLR 
 Log OR SE Z p OR 95% CI of OR 
Physical function 0.446 0.153 2.91 0.004 1.56 1.16-2.11 
Gender  0.489 0.196 2.45 0.014 1.62 1.10-2.37 
 
These results should be compared with the prevalence figures in Table F-19 above. 
People with severe worry constitute 6% of the total sample but 30% of those with the 
worst physical function, making impaired physical function strongly predictive of 
severe worry in this small group. Men and women have a similar prevalence of 
severe worry, but 40% of women, compared to 28% of men, report moderate worry. 
The interpretation of these findings is that at HIV diagnosis women are more likely to 
be worried than men, but the people at greatest risk of severe, complex worry, 




F.6.iv Difficulty sharing feelings 
 
Table F-23: bivariate association of independent variables with severity of problems sharing 
feelings 
Variable Value  Problems sharing feelings Chi2 test for 
homogeneity 
NP test for 
trend 
 Mild/ 
none Moderate Severe Chi
2 p Z p 
  n 82 124 232     
Gender Male 168 23.2 33.3 43.5 10.03 0.007   
 
 
Female  270 15.9 25.2 58.9     
Age 18-25 89 11.2 24.7 64.0 6.69 0.153 2.22 0.027 
 26-40 276 20.7 28.6 50.7     
 
 
41-59 73 20.6 31.5 48.0     
Education None 19 15.8 26.3 57.9 5.86 0.439 -1.09 0.274 
 Primary 229 18.8 28.4 52.8     
 Secondary 147 15.7 27.9 56.5     
 
 
Diploma+ 43 30.2 30.2 39.5     
Wealth 
quintile 
Lowest 88 22.7 34.1 43.2 16.12 0.041 0.54 0.588 
Second  88 22.7 23.9 53.4     
 Middle 87 11.5 23.0 65.5     
 Fourth  89 12.4 29.2 58.4     
 
 
Highest  86 24.4 31.4 44.2     
Physical 
function 
Best  306 15.4 25.8 58.8 23.65 <0.001 -4.63 <0.001 
Middle  102 21.6 33.3 45.1     
 
 
Worst  30 43.3 36.7 20.0     
Country Kenya 247 19.0 21.9 59.1 12.38 0.002   
 Uganda 191 18.3 36.7 45.0     
  N 168 82 47     
CD4 count 0-100 70 20.8 24.4 31.9 11.32 0.079 -1.70 0.089 
 101-200 47 15.5 17.1 14.9     
 201-350 71 25.0 15.9 34.0     
 350+ 109 38.7 42.7 19.2     
 
Four independent variables are associated with this outcome in bivariate analysis 
(Table F-23). Women report more difficulty sharing their feelings than men, there is a 
trend for younger people to have more problems than older people, and Kenyans 
have more problems than Ugandans. Finally, people with impaired physical function 
have fewer problems sharing their feelings than people with the best. This is 
surprising, as all other dependent variables examined so far (pain, symptoms, and 
worry) are negatively associated with physical function. Wealth is significantly 
different from the expected distribution on a chi squared test but there is no 





The 41-59 age group is mostly male (64%) while 81% of the 18-25 group is female. 
There is a clear trend for men to be older than women (chi2=34.92, p<0.001), as is 
usual for an HIV-positive population in Africa. Since age is associated with gender, 
confounding is a possibility. Stratum-specific ORs for the association of gender with 
difficulty sharing feelings were calculated and compared with the unadjusted 
OR(Table F-24). A significant association was only observed in the 26-40 age group. 
This is the largest group, which makes statistical significance more likely, but the 
associations in the other age groups were also weaker (ORs closer to 1).  
 
Table F-24: association of difficulty sharing feelings with gender, by age category 
Age category Log 
OR 
OR for the effect of 
gender on difficulty 
sharing feelings 
z p 95% CI of 
OR 
All (unadjusted) 0.577 1.78 3.09 0.002 1.24-2.57 
18-25 0.131 1.14 0.25 0.805 0.40-3.21 
26-40 0.615 1.85 2.63 0.009 1.17-2.94 
41+ 0.405 1.50 0.88 0.380 0.60-3.74 
 
Gender, age, physical function, CD4 count and country were taken forward into OLR 
to determine whether they were associated with the severity of problems. At first, an 
interaction term between gender and age was included, but it was found not to be 
significant. Country, age and CD4 count were also dropped from the model, and 
physical function was more efficiently modelled as linear. The final model is shown in 
Table F-25.  
 
Table F-25: association of physical function and gender with difficulty sharing feelings using 
OLR 
 Log OR SE Z p OR 95% CIs of OR 
Gender 0.558 0.189 2.95 0.003 1.75 1.21-2.53 
Physical function -0.670 0.149 -4.50 <0.001 0.51 0.38-0.69 
 
As shown in Table F-23, 59% of people with the best physical function have great 
difficulty sharing feelings, compared to 45% of the middle group and only 20% of the 
worst. It is not clear why limitation to physical function should improve the ability to 
share feelings, or whether the result is driven by a confounding variable. The ‘worst 
function’ group is very small (30 people) and so the possibility of spurious results is 
increased. However, the trend continues in the larger ‘middle function’ group, which 




F.6.v Difficulty finding life worthwhile 
 
Table F-26: bivariate association of independent variable with severity of difficulty feeling life 
worthwhile 
Variable Value   Problems feeling life 
worthwhile 
Chi2 test for 
association 
NP test for 
trend 
 None/ 
mild Moderate Severe Chi
2 p Z p 
  n 280 114 44     
Gender Male 168 68.5 22.6 8.9 2.43 0.297   
 
 
Female  270 61.1 28.2 10.7     
Age 18-25 89 52.8 32.6 14.6 16.95 0.002 -2.51 0.012 
 26-40 276 64.9 27.9 7.3     
 
 
41-59 73 74.0 11.0 15.1     
Education None 19 52.6 31.6 15.8  0.658* -1.58 0.113 
 Primary 229 62.5 28.0 9.6     
 Secondary 147 64.6 24.5 10.9     
 
 
Diploma+ 43 74.4 18.6 7.0     
Wealth 
quintile 
Lowest  88 51.1 37.5 11.4 14.22 0.076 -3.08 0.002 
Second  88 60.2 27.3 12.5     
 Middle 87 67.8 24.1 8.1     
 Fourth  89 65.2 25.8 9.0     
 
 
Highest  86 75.6 15.1 9.3     
Physical 
function 
Best  306 67.3 21.9 10.8 13.81 0.008 2.40 0.016 
Middle  102 60.8 31.4 7.8     
 
 
Worst  30 40.0 50.0 10.0     
Country Kenya 247 71.3 19.0 9.7 15.48 <0.001   
 Uganda 191 54.5 35.1 10.5     
  n 205 62 30 3.70 0.717 -0.30 0.762 
CD4 count 0-100 70 23.9 22.6 23.3     
 101-200 47 16.1 16.1 13.3     
 201-350 71 21.0 29.0 33.3     
 350+ 109 39.0 32.3 30.0     
* Fisher’s exact test 
 
Table F-26 shows that younger people, poorer people, people with limited physical 
function and Ugandans are less likely to feel life worthwhile. The trends are much 
more evident for the none/mild and moderate categories than for the severe 
category. For example, there is a consistent pattern that with every increase in age 
group, the proportion of people reporting no or mild problem feeling life worthwhile 
decreases and the proportion reporting a moderate problem increases. However, the 
proportion reporting a severe problem does not fit this relationship. The same is true 





Table F-12 above showed that wealth quintile and physical function are associated 
with each other in a negative trend (z=-2.37, p=0.018). It seems likely that 
confounding might exist. Since wealth quintile is the variable more strongly 
associated with this outcome, it is more likely to be a confounder. Stratum-specific 
ORs for the effect of physical function on feeling life worthwhile were calculated by 
wealth quintile. The results are shown in Table F-27. There is an approximate trend 
for physical function to have more effect on outcome with higher wealth, but the 95% 
confidence intervals of the odds ratios overlap. One stratum (the fourth) has a much 
higher OR than average and is the only one to show a statistically significant 
association with physical function. This could be a chance event. There is not 
enough evidence for effect modification to justify adding in the complexity of an 
interaction term, therefore wealth quintile and physical function continue to be 
treated as separate independent variables.  
 
Table F-27: association of prevalence of problems feeling life worthwhile with physical 
function, by wealth quintile 
Wealth quintile Log OR 
OR for effect of physical 
function on difficulty 
finding life worthwhile 
z p 95% CI of OR 
All (unadjusted) 0.352 1.42 2.33 0.020 1.06-1.91 
Lowest  -0.215 0.81 -0.62 0.532 0.41-1.58 
Second 0.090 1.09 0.29 0.769 0.60-2.00 
Middle 0.209 1.23 0.55 0.580 0.59-2.58 
Fourth  1.278 3.59 3.47 0.001 1.74-7.38 
Highest  0.448 1.57 1.20 0.231 0.75-3.26 
 
The four independent variables age, physical function, wealth quintile and country 
were used in ordinal logistic regression. Indicator variables were used first but a 
linear model proved equally effective (chi2=2.67, p=0.751). Physical function was no 
longer significantly associated with the outcome after adjusting for country, relative 
wealth and age. 
 
Table F-28: association of country, wealth quintile, physical function and age with severity of 
problems feeling life worthwhile using OLR 
 Log OR SE Z p OR 95% CI of OR
Country  0.705 0.205 3.45 <0.001 2.10 1.41-3.12 
Wealth quintile -0.245 0.073 -3.36 0.001 0.78 0.68-0.90 





Table F-28 shows that finding life worthwhile is most closely associated with country 
(OR=2.10), with problems more common in Uganda than Kenya. Increasing wealth 
and age reduce the odds of problems.  
 
 
F.6.vi Difficulty finding peace  
 
Table F-29: bivariate association of independent variables with severity of problems feeling at 
peace 
Variable Value  Problems feeling at peace Chi2 test for 
association 
NP test for 
trend 
   Mild/
none Moderate Severe Chi
2 p Z p 
  n 202 152 84     
Gender Male 168 46.4 35.7 17.9 0.33 0.846   
 
 
Female  270 45.9 34.1 20.0     
Age 18-25 89 42.7 36.0 21.4 20.42 <0.001 -3.22 0.001 
 26-40 276 40.9 37.7 21.4     
 
 
41-59 73 69.9 21.9 8.2     
Education None 19 63.2 21.1 15.8 5.10 0.531 1.82 0.069 
 Primary 229 48.9 32.8 18.3     
 Secondary 147 41.5 38.1 20.4     
 
 
Diploma+ 43 39.5 39.5 20.9     
Wealth 
quintile 
Lowest 88 48.9 30.7 20.5 1.33 0.995 0.29 0.772 
Second  88 45.5 35.2 19.3     
 Middle 87 44.8 36.8 18.4     
 Fourth  89 47.2 36.0 16.9     
 
 
Highest  86 44.2 34.9 20.9     
Physical 
function   
Best  306 51.0 33.0 16.0 16.94 0.002 4.00 <0.001 
Middle  102 40.2 36.3 23.5     
 
 
Worst  30 16.7 46.7 36.7     
Country Kenya 247 56.7 27.5 15.8 25.49 <0.001   
 Uganda 191 32.5 44.0 23.6     
  n 151 101 45 4.91 0.555 0.17 0.863 
CD4 count 0-100 70 23.8 21.8 26.7     
 101-200 47 16.6 11.9 22.2     
 201-350 71 25.8 23.8 17.8     
 350+ 109 33.8 42.6 33.3     
 
Table F-29 shows that older people are more likely to feel at peace. Specifically, 
those aged over 40 are more likely to feel at peace. The percentage figures show 
that the two younger groups are similar to each other in score distribution, with 21% 
having severe problems and 41-43% mild problems, but the over-40 group has only 




with fewer problems finding peace, and Ugandans are significantly more likely than 
Kenyans to say they did not feel at peace. It is interesting to note that there is no 
evidence associating wealth quintile with peace, although Table F-26 shows that 
wealthier people are more likely to say they find life worthwhile. 
 
Any association between physical function and age is likely to be negative rather 
than positive, both because of increased probability of disability with age, and the 
probability of more advanced HIV progression. However, the two variables affect 
peace in opposite directions; age positively, and physical function negatively. 
Therefore it is unlikely they confound each other. The age of the populations in the 
two countries is known to be similar (Table F-7) and so they also cannot be 
confounders.  
 
All three variables were included in OLR. Initially physical function and age were 
modelled as categorical variables, but physical function proved to show a consistent 
trend which was modelled equally well as an ordinal variable. Age remained a 
categorical variable because the results for the strata were very different and the 
ordinal model had a significantly lower log likelihood (chi2=11.81, p=0.003).  
 
Table F-30: association of physical function, age and country with severity of problems finding 
peace, using OLR 
 Log 
OR SE Z p OR 
95% CI of 
OR 
Physical function 0.531 0.149 3.56 <0.001 1.70 1.27-2.28 
Age:       
26-40 0.078 0.232 0.34 0.736 1.08 0.69-1.70 
41-59 -1.195 0.329 -3.63 <0.001 0.30 0.16-0.58 
Country  0.838 0.188 4.46 <0.001 2.31 1.60-3.34 
 
The results show that limited physical function and being in Uganda are associated 
with increased odds of problems feeling at peace (Table F-30). Those aged over 40 
have fewer problems, but the other two age groups are no different from each other. 
Being aged over 40 has the strongest association with the outcome (OR=0.30), 






F.6.vii Difficulty obtaining help and advice 
 
Table F-31: bivariate association of independent variables with need for help and advice 
Variable value  Need for help and advice Chi2 test for 
association 
NP test for 
trend 
 None/ 
mild Moderate Severe Chi
2 p Z p 
  n 68 87 283     
Gender Male 168 16.1 22.0 61.9 1.00 0.606   
 
 
Female  270 15.2 18.5 66.3     
Age 18-25 89 14.6 25.8 59.6 3.50 0.478 0.12 0.905 
 26-40 276 14.9 18.1 67.0     
 
 
41-59 73 19.2 19.2 61.6     
Education None 19 0 26.3 73.7 37.28 <0.001 -4.32 <0.001 
 Primary 229 11.4 17.5 71.2     
 Secondary 147 23.1 15.0 61.9     
 
 
Diploma+ 43 18.6 46.5 34.9     
Wealth 
quintile 
Lowest 88 14.8 18.2 67.1 17.22 0.028 -2.49 0.013 
Second  88 12.5 19.3 68.2     
 Middle 87 11.5 17.2 71.3     
 Fourth  89 12.4 18.0 69.7     
 
 
Highest  86 26.7 26.7 46.5     
Physical 
function 
Best  306 14.4 17.3 68.3 10.66 0.031 -2.57 0.010 
Middle  102 14.7 27.5 57.8     
 
 
Worst  30 30.0 20.0 50.0     
Country Kenya 247 22.7 19.4 57.9 22.64 <0.001   
 Uganda 191 6.3 20.4 73.3     
  n 52 66 179     
CD4 count 0-100 70 30.8 22.7 21.8 2.00 0.920 0.17 0.863 
 101-200 47 13.5 16.7 16.2     
 201-350 71 23.1 22.7 24.6     
 350+ 109 32.7 37.9 37.4     
 
Table F-31 shows that problems getting enough help and advice are more likely for 
people with less education, less wealth and better physical function, and for people 
in Uganda. 
 
The percentage figures in Table F-31 show that the prevalence of severe problems 
by wealth quintile is fairly uniform, apart from the highest quintile, where the 
distribution is very different. In the other four quintiles the prevalence of severe 
problems ranges in a tight band from 67% to 71%, while the highest quintile has a 
prevalence of 47%. To test this, the non-parametric test for trend was repeated using 




showing that it had been driven only by that difference. Only the wealthiest fifth of the 
population benefit in terms of having fewer problems receiving help and advice.  
 
Kenya is a more affluent country than Uganda, and more of the Kenya facilities are 
in urban areas. To test whether country confounds the unexpected relationship 
between wealth and the outcome, wealth quintile was tabulated against country 
(Table F-32). Ugandans are more likely to appear in the middle and fourth quintiles 
than Kenyans, and there is a positive overall trend, with Ugandans more likely to be 
wealthy. When analysed using both a chi squared test and a test for trend, the 
probability of obtaining these findings by chance is lower in the chi2 test, which does 
not detect direction, than in the trend test (chi2=14.66, p=0.005; z=2.20, p=0.028). 
This suggests that the distribution is different from what would be expected by 
chance, but the difference is without clear direction. The unusual findings in the 
lowest quintile, with only 13% of Uganda respondents grouped with 26% of Kenyans, 
probably contribute substantially to the trend result. As shown by this example and 
the previous one, tests for trend are vulnerable to reporting overall trends when the 
first or last stratum is very different from the average.  
 
Table F-32: distribution of country of data collection over wealth quintile 
Country  Wealth quintile  
  Lowest Second Middle Fourth Highest Total 
 n 88 88 87 89 86 438 
Kenya 247 25.5 20.7 16.2 17.4 20.2 100.0 
Uganda 191 13.1 19.4 24.6 24.1 18.9 100.0 
 
 
Table F-10 in Section F.6.i shows the association between education and wealth 
quintile. In particular, the highest quintile has an unusual education distribution. 
While there is a clear trend throughout the table, the richest quintile displays much 
more extreme values than a linear trend would predict. Everyone in the highest 
quintile has some education and 27% have a diploma or degree, while the next 
highest proportion is 9%.  
 
Earlier, in the analysis of pain, the apparent relationship between education and pain 




that the apparent relationship between wealth and problems receiving help is 
confounded by education. To test this, stratum-specific ORs were calculated to show 
the effect of wealth quintile on the outcome, controlling for education(Table F-33).  
 
Table F-33: association of wealth quintile with severe problems obtaining help and advice, by 
education level 
Education level Log OR 
OR for the effect of 
wealth on difficulty 
obtaining help/advice 
z p 
95% CI of 
OR 
All (unadjusted) -0.173 0.84 -2.49 0.013 0.73-0.96 
None -0.395 0.67 -0.87 0.386 0.28-1.64 
Primary -0.017 0.98 -0.16 0.876 0.80-1.21 
Secondary -0.156 0.86 -1.17 0.241 0.66-1.11 
Diploma+ -0.008 0.99 -0.04 0.972 0.65-1.52 
 
The results in Table F-33 show that within strata, the OR for the effect of a one-step 
increase in wealth quintile on outcome is no longer statistically significant. A strong 
effect is only seen in the group with no education, which is the smallest, and is liable 
to distortion due to the fact that no-one in the group reported low/mild problems. The 
apparent relationship between wealth and outcome was caused by the fact that 
people with more education, who have less difficulty receiving help and advice, are 
also more likely to be financially better off. 
 
The OLR model was fitted using indicator variables for the categorical outcomes, but 
all three outcomes showed an underlying trend in the ORs and the log likelihood was 
very little different from an linear model. Therefore the variables were modelled as 
linear, shown in Table F-34. All three independent variables have a statistically 
significant association with the odds of problems obtaining help and advice. Limited 
physical function, a higher level of education, and being in Kenya reduce the odds of 
problems.  
 
Table F-34: association of physical function, education level and country with severity of 
problems getting help and advice, using OLR 
 Log OR 
SE Z p OR 95% CI of OR 
Physical function -0.492 0.160 -3.07 0.002 0.62 0.45-0.84 
Education level -0.620 0.136 -4.54 <0.001 0.54 0.41-0.70 






F.6.viii Summary of risk factors at baseline 
 
Table F-35 summarises the results of ordinal logistic regression for all seven items. 
None of the outcomes are associated with CD4 count so it is not included in the 
table. Physical function is the independent variable most likely to be associated with 
outcomes, the only exception being difficulty finding life worthwhile. Poor physical 
function is associated with more pain, symptoms, worry, and difficulty finding peace, 
but less difficulty sharing feelings or obtaining help and advice. However, the 
strength of the association is much higher than average for the problems in the 
physical domain – pain and symptoms. Problems are more common in Uganda for 
the spiritual and psychosocial domain items (difficulty finding life worthwhile, finding 
peace, and obtaining help and advice), although not for ability to share feelings.  
 
Wealthier people have a lower probability of pain, symptoms and problems finding 
life worthwhile, but the effect is not as great for pain as for the other two. More 
educated people have much better odds of getting help and advice, but education is 
not associated with any other outcomes. Women worry more and have more 
difficulty sharing their feelings. Older age increases the probability of finding peace 
and worth in life, Age was the only independent variable to have a non-linear 
association with an outcome, in the case where people over 40 have a lower 
prevalence of problems feeling at peace compared to the baseline of 18-25 year 
olds, but the 26-40 age group was not affected. Being aged above 25 helps patients 
find life worthwhile but only being aged over 40 helps them feel at peace. 
 
Some patterns between outcomes are evidence in the table. Pain and symptoms are 
very similar to each other, both more common for poorer and physically limited 
people, with similar odds ratios for each, 0.79 and 0.86 for wealth quintile, 3.19 and 
3.15 for function. Worry and difficulty sharing feelings also form a pair, except that 
their relationship with physical function is reversed. Both are more common for 
women but limited physical function increases worry and reduces difficulty sharing 
feelings. The other three outcomes are distinct from each other. Each has a unique 



















Best   
Country 
Kenya 
 OR p OR p OR p OR p OR p OR p 




<0.001   




<0.001   
Worry 1.62 
(1.10-2.37) 
0.014       1.56 
(1.16-2.11) 





0.003       0.51 
(0.38-0.69) 
<0.001   
Life  
worthwhile 
  0.66 
(0.47-0.92)
0.014   0.78 
(0.68-0.90)
0.001   2.10 
(1.41-3.12) 
<0.001 












    0.54 
(0.41-0.70)












F.7 Part C: Change in multidimensional problems over time 
 
 
F.7.i Recoding continuous time into monthly intervals 
 
As described in the methods, interviews were coded according to the number of 
days which had passed since recruitment (M0). The first three months were the 
period of analysis, as specified in the objectives. Table F-36 below shows the 
number of interviews coded to each time. Interviews which took place outside the 
specified intervals (e.g. between 38 and 52 days after M0) were excluded. All 438 
participants completed an interview on the day of recruitment, and 299 completed an 
interview between 23 and 37 days later (30 days plus or minus seven). Two hundred 
and fifty-nine completed an interview 30 days after that, and 232 completed an 
interview between 83 and 97 days after recruitment.  
 
Table F-36: interviews by time period 
 Time period (days from M0) Interviews 
M0 0 438 
M1 23 to 37 299 
M2 53 to 67 259 
M3 83 to 97 232 
Retained  1259 
Excluded   296 
Total  1524 
 
Not all participants who completed an interview at M2 also contributed data at M1. 
There was interim missing data as well as loss to follow-up. The patterns of data 
collection are shown in Table F-37. Of the 438 participants, 185 completed four 
interviews at exact monthly intervals within an allowance of seven days. Some 
participants missed M1(n=16), M2(12) or both(19), and some were lost to follow-up 
after M2(46), after M1(56) or after M0 (92). Twelve participants missed M1, returned 






Table F-37: interview completion patterns 
 Completed interview Number of 
participants M0 M1 M2 M3 
 Y Y Y Y 185 
 Y Y Y  46 
 Y Y  Y 12 
 Y Y   56 
 Y  Y Y 16 
 Y  Y  12 
 Y   Y 19 
 Y    92 
Total      438 
 
 
F.7.ii Missing data  
 
The mean total POS score by month, with 95% confidence intervals, was calculated 
separately for each group of participants who shared a missingness pattern (Table 
F-38). Missingness pattern refers to the sequence of observations that were 
completed. For example, the pattern ‘01-3’ means the participant completed 
interviews at M0, M1 and M3, but missed M2.  The table shows that total POS score 
was generally higher at M0 for participants who later had missing data than for the 
185 participants who completed all four observations at monthly intervals. However, 
the 95% confidence intervals of the mean total POS score for all the groups that had 






Table F-38: mean total POS score by missingness pattern 
  Mean total POS score (95% CI) 
































































- - - 
Total  438     
 
 
F.7.iii POS scores at each time point 
 
Score distributions were plotted by month as stacked bar charts for each POS item 
in turn. The number of participants is represented, rather than the percentage, and 





Figure F-7: please rate your pain in the past three days 
 
 
Score distributions were plotted by month as stacked bar charts for each POS item 
in turn. The number of participants is represented, rather than the percentage, and 
this number is displayed as a label for all values greater than ten.  
 
Figure F-7Figure F-7 above shows that the number of people reporting no pain (in 
blue) decreases slightly over time, from 145 to 118. However, the size of this group 
proportional to the total increases, because the sample size decreases from 438 at 
M0 to 232 at M3. A possible explanation for these results would be that participants 
who report more severe pain at M0 are more likely to be lost to follow-up. This bias 
could cause a perceived improvement over time when in fact the experience of 
individuals had not changed. Distinguishing between a sample-level improvement 
due to responder bias and a genuine individual-level improvement in scores can only 
be done using longitudinal analysis, in Part D. 
 
 



































Figure F-8: have any other symptoms been affecting how you felt? 
 
 
In Figure F-8 above, the distribution of scores over time is similar to the previous 
figure. The number of people reporting the most severe problems reduces while the 
number reporting no problems remains almost the same, from 150 to 133. 
 
Figure F-9: have you been feeling worried about your illness? 
 
 
In Figure F-9, the number reporting no worries remains relatively constant at around 
150 while the sample size decreases. Scores 3, 4 and 5 reduce, but the number who 
report score 2 scarcely changes after M2. 
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Figure F-10: have you been able to share how you are feeling with family or friends? 
 
 
The distribution of responses to the question ‘have you been able to share how you 
are feeling’ shown in Figure F-10 is entirely different from those for the previous 
three items. The worst response (not at all) persists throughout the time period, and 
at M3 28% of participants (n=66) had still been unable to share their feelings at all in 
the past three days. The proportion reporting no problem is very low and actually 
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Figure F-11: have you felt that life was worthwhile? 
 
 
The distribution of scores for finding life worthwhile (Figure F-11) is more similar to 
the distributions for the items concerning pain, symptom and worry. One difference is 
that the number of people reporting that life is worthwhile all the time decreases 
between M0 and M1, from 187 to 144. It is not possible to tell from the chart whether 
this was caused by problems increasing or by participants with no problem finding 
life worthwhile being lost to follow-up.  
 


































































Figure F-12 shows that problems feeling at peace were more prevalent than in 
several of the other outcomes. The distribution appears similar to Figure F-11, 
finding life worthwhile, except that scores are suppressed. Feeling at peace all the 
time is less common than finding life worthwhile all the time at every time point, and 
the responses 2 and 3 are considerably more common. 
 
Figure F-13: have you had enough help and advice for your family to plan for the future? 
 
 
The distribution of scores in Figure F-13 is similar to that for the ability to share 
feelings in Figure F-10. The more severe problems (4 and 5) are highly prevalent, 
especially at M0. Over time they decrease but the number of people reporting low or 
moderate problems(0, 1, 2 or 3) does not change markedly.  
 
 
F.7.iv Total POS score at each time point 
 
The distribution of total POS scores is shown in Table F-39. Over time the mean 
POS score reduces significantly (F=56.03, p<0.001 using ANOVA) and after M0 no 
participants record a total score greater than 29. The proportion recording 15 and 
over reduces by more than half (47.0% to 21.1%).  
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Table F-39: total POS score by month 
Total POS score  M0 M1 M2 M3 
 n 438 299 259 232 
0-4  3.2 7.4 12.0 19.0 
5-9  13.7 27.8 35.5 29.3 
10-14  36.1 40.1 35.5 30.6 
15-19  31.7 17.4 14.3 16.4 
20-24  13.2 6.4 2.3 4.3 
25-29  1.8 1.0 0.4 0.4 
30-35  0.2 0 0 0 
Mean  14.2  11.4 10.0 9.9 
95% CIs  13.7-14.6 10.8-12.0 9.4-10.6 9.2-10.5 
SD  5.0 5.0 4.8 5.3 
 
 
F.7.v POS score changes over time 
 
Proportion of net change is the number of people whose problem worsened 
subtracted from the number whose situation improved, expressed as a percentage. It 
is important to remember throughout this analysis that a high score represents a 
worse problem, and the optimal POS score for all items is zero.  
 
Table F-40 shows the distribution of change in scores between M0 and M3, for each 
POS item. In the upper half of the table are the percentage of respondents to report 
each possible change. For the pain item for example, 0.4% of respondents report 
that pain is five points lower at M3 than it was at M0, showing the maximum possible 
improvement on the scale, from a 5 at M0 to a 0 at M3. Meanwhile, 2.2% report that 
pain has reduced by four points, showing their pain drops either from 5 to 1 or from 4 
to 0. Pain score is unchanged for 36.6% of the sample. All results shaded green are 
an improvement, and results in red are a deterioration. 
 
In the bottom half of the table these results are summarised. The green row 
represents the total number of people who benefited and the red the total number 
whose problems got worse. A little under half (43.6%) of participants report that their 
pain score is lower at M3 than M0; 36.6% report no change, and 19.9% report that it 




those whose pain gets worse, is 43.6-19.9=23.7, within a 95% confidence interval of 
20.9 to 26.5. This confidence interval is well above zero, showing a statistically 




Table F-40: percentage reporting score change from M0 to M3 (n=232) 





Better by 5 0.4 0.4 3.0 0.4 3.5 3.9 7.3 
Better by 4 2.2 1.7 3.0 6.5 3.5 4.3 9.1 
Better by 3 7.8 5.2 6.9 8.2 8.6 6.5 12.5 
Better by 2 11.2 11.6 17.7 15.1 7.3 9.9 16.0 
Better by 1 22.0 28.9 20.3 11.2 12.9 16.8 13.4 
The same 36.6 33.6 30.6 28.9 43.1 34.1 22.0 
Worse by 1 12.1 13.8 9.5 7.3 13.4 15.1 9.1 
Worse by 2 5.2 2.2 6.9 8.6 5.2 3.9 3.9 
Worse by 3 2.2 2.6 1.3 9.9 1.3 3.0 3.9 
Worse by 4 0.4 0 0.9 2.2 0.4 1.7 2.2 
Worse by 5 0 0 0 1.7 0.9 0.9 0.9 
Better  43.6 47.8 50.9 41.4 35.8 41.4 58.3 
Worse  19.9 18.6 18.6 29.7 21.2 24.6 20.0 
Net change 23.7 29.2 32.3 11.7 14.6 16.8 38.3 
Standard error 2.8 3.0 3.1 2.1 2.3 2.5 3.2 














As the bottom row of Table F-40 shows, all the confidence intervals are positive, 
meaning that all seven POS items register a statistically significant net change 
between M0 and M3. On average, the extent and severity of problems reduces. The 
biggest improvement is in need for help and advice, and level of worry. These are 
the two items with the highest prevalence of severe problems at baseline, as shown 
in Figure F-5.  
 
The table also shows that despite this net improvement during the three-month 
period, for each item, between 18% and 30% of participants find the problem got 




able to share their feelings. As a result, this item has the lowest proportion of net 
change (11.7%).  
 
It is clear that POS item scores improve for all items, in all domains, during the three 
months of observation for participants who complete interviews at three monthly 
intervals. A statistically significant change was found for all items over the M0-M3 
time period, so the analysis was repeated for the shorter time intervals within this 
period to establish whether change was steady or fluctuant. 
 
 
Table F-41: percentage reporting change from M0 to M1 (n=299) 





Better by 5 0 0.3 2.3 1.0 3.7 1.7 2.3 
Better by 4 2.0 0.3 1.0 4.7 1.7 4.7 3.7 
Better by 3 6.7 6.7 5.7 8.4 6.4 7.7 7.4 
Better by 2 9.7 11.4 15.4 9.0 6.7 9.7 15.7 
Better by 1 21.1 22.4 22.4 13.0 15.1 18.7 21.1 
The same 40.8 39.1 34.5 31.4 40.8 35.1 32.8 
Worse by 1 9.0 11.4 9.4 13.0 13.4 8.7 8.7 
Worse by 2 7.7 7.4 7.7 7.7 4.7 7.7 2.0 
Worse by 3 2.7 0.7 0.3 6.7 4.0 3.7 4.0 
Worse by 4 0.3 0 0.7 2.3 1.0 1.3 1.7 
Worse by 5 0 0.3 0.7 2.7 2.7 1.0 0.7 
Better  39.5 41.1 46.8 36.1 33.6 42.5 50.2 
Worse  19.7 19.8 18.8 32.4 25.8 22.4 17.1 
Net change 19.8 21.3 28.0 3.7 7.8 20.1 33.1 
Standard error 2.6 2.7 2.9 1.2 1.8 2.6 3.1 














Problem incidence and severity decrease for all seven items in the month following 
recruitment (Table F-41), but almost as many people report that sharing their 
feelings and finding life worthwhile have become more difficult as those who reported 
benefit. The largest improvement is that over half of people report receiving more 
help and advice compared to the previous month. Proportion of net change in finding 




baseline almost half of participants (42.7%) say that they always find life worthwhile 
(Figure F-5).  
 
Table F-42: percentage reporting change from M1 to M2 (n=231) 





Better by 5 0.4 0.4 0.9 1.3 2.6 1.3 0.9 
Better by 4 0.4 0.0 0.9 5.6 1.7 0.4 3.5 
Better by 3 0.4 1.3 1.3 3.9 3.0 5.6 6.5 
Better by 2 8.7 6.9 11.3 9.5 3.9 6.5 14.3 
Better by 1 21.2 21.2 17.3 17.3 17.8 16.0 17.8 
The same 49.8 45.0 45.9 36.4 49.4 46.8 33.8 
Worse by 1 12.6 13.9 9.5 9.5 13.9 14.3 9.5 
Worse by 2 5.6 9.1 10.4 7.8 3.5 6.5 7.8 
Worse by 3 0.9 1.7 1.3 4.8 2.6 0.9 3.0 
Worse by 4 0.0 0.4 0.4 3.0 0.4 0.9 1.7 
Worse by 5 0.0 0.0 0.9 0.9 1.3 0.9 1.3 
Better  31.1 29.8 31.7 37.6 29.0 29.8 43.0 
Worse  19.1 25.1 22.5 26.0 21.7 23.5 23.3 
Net change 12.0 4.7 9.2 11.6 7.3 6.3 19.7 
Standard error 2.1 1.4 1.9 2.1 1.7 1.6 2.6 














There are 299 participants who completed an interview between 23 days and 37 
days after recruitment to the study (which took place up to 14 days after their HIV 
diagnosis), and 259 completed an interview between 53 and 67 days after 
recruitment. Scores at the two time points for the 231 who completed interviews at 
both are compared in Table F-42. For most items, proportion of net change is less 
than it had been between M0 and M1. The exceptions are for peace, where it 
remains the same, and finding life worthwhile. On average, there is greater 
improvement in ability to share feelings during the second month after diagnosis than 
during the first. The number of people experiencing decreased symptoms is only a 
little greater than the number whose symptoms worsened. Pain scores do not 
change a great deal for most people. Half of participants report no change, and of 
the remaining half, for 68% the increase or reduction in pain is by a single point on 





The largest proportion of net change is for help and advice, where 43% of people 
report more help and advice than the previous month as compared to 23% who 
report less. The table shows that about a third of people report no change and 
another third report a score either one or two points lower than at M1.  
 
Compared to the preceding month, it is more common to report no change. For five 
of the seven items, between 45% and 50% of participants report the same score as 
M2 as at M1. Ability to share feelings and need for help and advice are more likely to 
alter.  
 
Table F-43: percentage reporting change from M2 to M3 (n=201) 





Better by 5 0.0 0.0 1.0 1.5 2.0 0.0 1.0 
Better by 4 0.0 0.5 0.5 4.0 0.5 2.0 2.5 
Better by 3 2.5 1.0 1.5 6.5 3.0 3.5 5.0 
Better by 2 9.0 9.5 8.0 8.5 4.5 6.0 10.0 
Better by 1 13.4 16.9 12.9 16.9 10.0 11.0 15.9 
The same 48.3 47.3 58.2 32.8 60.7 48.3 39.8 
Worse by 1 14.9 16.4 9.5 13.9 9.5 17.9 8.0 
Worse by 2 10.5 4.5 6.0 7.0 7.5 5.5 10.5 
Worse by 3 0.5 3.5 1.5 2.5 0.5 2.5 5.0 
Worse by 4 1.0 0.5 0.5 4.5 1.5 1.0 2.5 
Worse by 5 0.0 0.0 0.5 2.0 0.5 2.5 0.0 
Better  24.9 27.9 23.9 37.4 20.0 22.5 34.4 
Worse  26.9 24.9 18.0 29.9 19.5 29.4 26.0 
Net change -2.0 3.0 5.9 7.5 0.5 -6.9 8.4 
Standard error 0.9 1.1 1.5 1.7 0.5 1.8 1.8 














The change in multidimensional problem severity and prevalence between two 
months and three months after recruitment is shown in Table F-43. The proportion of 
net change is lower for all items than in the previous month, except for peace, where 
the magnitude of change is maintained and the direction reversed. More people have 





For most people, problems in the areas of worry or peace do not change in the third 
month after recruitment. However, problems sharing feelings or getting help and 
advice are still changing, sometimes by the entire length of the scale. The proportion 
of net change for worry and ability to share feelings are similar, but there is much 
total change, both for better and for worse in ability to share feelings. Much of this 
cancels out, leaving a small overall reduction in problems. The implication of these 
findings is that problems sharing feelings come and go quickly over time, while worry 
which is maintained two months after diagnosis is a more fixed trait.  
 
The proportion of net change results for each item over the total three-month period 
and month by month are summarised in Table F-44. For six of the seven items, the 
largest proportion of net change occurs in the first month, and for five of the seven 
there is least change in the third month. The results for ability to share feelings are 
unique, in that the majority of improvement is delayed until the second and third 
months following recruitment. 
 
Most pain reduction takes place in the first month after recruitment, with some further 
gain in the second month followed by a small but significant reversal, as the number 
of people with pain increases slightly. The majority of symptom amelioration similarly 
takes place by M1. After this there is only slight increase in the number of people 
whose symptom burden is reduced, but the reverse in direction of net effect seen 
with pain never takes place. Worry abates for a large number of people in the first 
month after recruitment, and a smaller number in the months after M1.  
 
Proportion of net change is low but constant in the first two months after recruitment 
when patients are asked whether they find life worthwhile. After M2 there is virtually 
no change. The proportion of people to feel at peace increases in the month up to 
M1, and improves a little more up to M2, but in the next month this gain is completely 
reversed. The people who feel less at peace outnumber those who felt more at 
peace. The largest proportion of net change is seen in the number of people who felt 
they have enough help and advice. The majority of this gain occurs in the first month, 





Overall, the patterns of change over time are similar for four outcomes: pain, 
symptoms, worry, and difficulty accessing help/advice. in all four cases, improvement 
is rapid at first and reduces over time. Difficulty finding peace behaves similarly, with 
the difference that net change does not only slow down but reverses direction in the 
third month as participants have more difficulty finding peace. Difficulty sharing 








F.7.vi Summary of change over time 
 
Table F-44: proportion of net change over each time interval 
 
Pain Symptoms Worry Sharing feelings Life worthwhile Peace 
Help & 
advice 
 Proportion of net change and 95% CI 
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F.8 Part D: Risk factors for multidimensional problems over time 
 
Because time to an event usually follows a Poisson distribution, with a tail to the 
right, the analysis plan stated that outliers (observations that occurred more than 
three standard deviations from the mean) would be excluded. The mean number of 
days from T0 to interview completion is 45.3 (standard deviation 39.1) so the point 
three standard deviations above the mean is 162.6. Figure F-14 below shows the 
number of days from T0 to data collection for all observations. As expected, it is 
constrained on the left with a long tail to the right. The four successive peaks, 
decreasing in size, show the effect of a fixed monthly pattern. Over time the sample 
size decreases and random variation increases. Thirteen data points were 
completed more than 162 days after T0 (maximum 242), and these were excluded 
as planned, leaving 1511 observations of which 438 are at T0 and 1073 are follow-
up observations. A complete dataset would have had 438 x 4 = 1752 observations, 
so missingness was 13.8%. 
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The following analysis identifies risk factors for prevalence of pain (defined as a pain 
score of 2, 3, 4 or 5) over time. 
 








Gender -0.082 0.145 -0.57 0.569 0.92 0.69-1.22 No 
Age 0.161 0.116 1.39 0.166 1.17 0.94-1.48 Yes 
Wealth quintile -0.245 0.050 -4.85 <0.001 0.78 0.70-0.86 Yes 
Education -0.120 0.096 -1.25 0.210 0.89 0.73-1.07 Yes 
Physical function  1.067 0.110 9.66 <0.001 2.91 2.34-3.61 Yes 
Country 0.178 0.141 1.26 0.207 1.19 0.91-1.57 Yes 
ART use -0.059 0.128 -0.46 0.645 0.94 0.73-1.21 No 
Time from T0 -0.011 0.001 -7.25 <0.001    
 
Of the seven independent variables apart from time, five were associated with 
prevalence of pain at 25% significance(Table F-45). These consisted of two 
variables with a less than 0.1% probability of occurring by chance (namely, physical 
function and wealth quintile) and three with a greater than 10% probability of 
association by chance (age, education and country). Physical function had the OR 
furthest from 1, indicating the strongest association.  
 
Physical function and wealth quintile, which were the most convincingly associated 
with pain prevalence in multivariate analysis, were the only two variables to retain an 
association at the 5% level in a multivariate model. There was weak evidence of 
older age predicting pain, with the 95% confidence intervals just crossing one, while 
education and country no longer showed an effect on pain prevalence. In 
accordance with the downward stepwise method, education (which had the highest 
p-value) was removed and a model was fitted using the remaining covariates 
Country was still non-significant so it was removed next. Age was now weakly 
associated with the outcome (OR=1.26) with low significance (p=0.056). The 
removal of age as a covariate made very little difference to the other elements of the 
model, apart from reducing the constant. The fact that other parameters did not alter 
suggests that the association between age and pain prevalence, while only weakly 





Table F-46: results of population-averaged multivariate logit model of pain prevalence 
 Log OR SE Z p OR 95% CI of 
OR 
Days since T0 -0.010 0.002 -6.42 <0.001 0.99 0.99-0.99 
Wealth quintile -0.217 0.052 -4.17 <0.001 0.81 0.73-0.89 
Physical function 1.039 0.111 9.33 <0.001 2.83 2.27-3.52 
Constant -0.121 0.181 -0.67 0.506   
 
In the final model in Table F-46, time appears to have very little effect, with an OR of 
0.99. However, it must be remembered that this is the effect on pain prevalence of a 
single day. Over the 163 days of observation in the model, the effect of time was 
substantial, as shown graphically in Figure F-15 where the fitted odds of pain over 
time are presented. Darker shades of blue indicate more wealth. 
 
Figure F-15: predicted response curves for the model in Table F-46 
 
 
Figure F-15 shows that wealth quintile is associated with reduced probability of pain, 
at all times, but the effect of physical function is larger. The prevalence of pain is 
high and only those with the best function achieve probability below 20% in three 




shorter. This is because no participants in this group completed interviews more than 
120 days after recruitment.  
 
These graphs, and the others used in this section, are used only as a visual 
representation of the model. The graph lines do not trace the probability of an 
individual having a certain problem. They are averaged on a log scale rather than an 





Table F-47: results of population averaged logit models fitting one variable at a time to 
symptom prevalence 




Gender -0.151 0.150 -1.01 0.313 0.86 0.64-1.15 No 
Age 0.184 0.121 1.51 0.130 1.20 0.95-1.52 Yes 
Wealth quintile -0.137 0.052 -2.62 0.009 0.87 0.79-0.97 Yes 
Education -0.112 0.100 -1.12 0.263 0.89 0.73-1.09 No 
Physical function  1.116 0.112 9.96 <0.001 3.05 2.45-3.80 Yes 
Country 0.402 0.146 2.75 0.006 1.49 1.12-1.99 Yes 
ART use -0.191 0.139 -1.37 0.172 0.83 0.63-1.09 Yes 
Time from T0 -0.011 0.002 -6.89 <0.001    
 
Five covariates (age, wealth quintile, physical function, country and ART use) were 
significant at the 25% level in Table F-47. Physical function had the strongest 
association. Most associations were weak, with ORs of 0.83-0.89. A population-
averaged logistic regression model was fitted to the probability of symptoms over 
time. 
 
Age and country, which had the weakest association with the outcome in bivariate 
analysis in Table F-47, continued to have a weaker association in the fitted model. 
Country had an OR of 1.35 and p-value of 0.052, just outside significance. After the 
removal of age, the effect of country became statistically significant, with the p-value 






Table F-48: results of population-averaged multivariate logit model of symptom prevalence 
 Log OR SE Z p OR 95% CI of OR 
Days since T0 -0.009 0.002 -5.27 <0.001 0.99 0.99-0.99 
Wealth quintile -0.114 0.055 -2.07 0.039 0.89 0.80-0.99 
Physical function 1.129 0.115 9.79 <0.001 3.09 2.47-3.88 
Country 0.306 0.156 1.97 0.049 1.36 1.00-1.84 
ART use  -0.380 0.152 -2.50 0.013 0.68 0.51-0.92 
Constant -1.159 0.286 -4.05 <0.001   
 
Table F-48 shows that the odds of symptoms reduced over time, and that poverty, 
physical impairment and living in Uganda were associated with higher symptom 
prevalence. Of these, physical function made the most difference, tripling the odds of 
symptoms for every increase. Also, participants who took ART had a lower symptom 
prevalence than those who did not. Figure F-16 shows the fitted curves from the 
model in Table F-48. 
 
Figure F-16: predict response curves for the model in Table F-48 
 
The blue lines represent the population average probability of symptoms over time 
for those with the best physical function. The green lines show the populations with 
middle physical function and the orange those with the worst. Within each colour, the 




lightest. Populations from the two countries are graphed separately, and those taking 
ART are also separated out. 
 
It is clear that physical function is the covariate with the largest effect on symptom 
prevalence. The differences between the two countries and between the ART and 
non-ART populations are relatively minor in comparison.  
 
Only 30 people in the sample of 438 were recorded in the worst category of physical 
fucniton (ECOG score 2, 3 or 4). In this model, the 30 patients have been subdivided 
by five wealth quintiles, two countries and two treatment options, giving 20 groups. 
Some of these groups did not contain a single patient, which is the reason why only 














Gender 0.245 0.144 1.70 0.089 1.28 0.96-1.69 Yes 
Age 0.018 0.113 0.16 0.876 1.02 0.81-1.27 No 
Wealth quintile -0.044 0.048 -0.92 0.359 0.96 0.90-1.05 No 
Education 0.101 0.093 1.09 0.276 1.11 0.92-1.33 No 
Physical function  0.468 0.104 4.50 <0.001 1.60 1.30-1.96 Yes 
Country 0.501 0.137 3.66 <0.001 1.65 1.26-2.16 Yes 
ART use -0.227 0.129 -1.76 0.078 0.80 0.62-1.03 Yes 
Time from T0 -0.012 0.001 -7.82 <0.001    
 
Four covariates (gender, physical function, country and ART use) were significant at 
the 25% level in bivariate analysis in Table F-49. They were carried forward into a 
population-averaged logistic regression model was fitted to the probability of 
symptoms over time. ART use, which had good significance but a weak OR in 
bivariate analysis, was no longer significantly associated with the odds of worry in 





Table F-50: results of population-averaged multivariate logit model of worry prevalence 
 Log OR SE Z p OR 95% CI of OR 
Days since T0 -0.011 0.002 -7.55 <0.001 0.99 0.99-0.99 
Gender 0.295 0.146 2.03 0.043 1.34 1.01-1.79 
Physical function 0.454 0.105 4.31 <0.001 1.57 1.28-1.94 
Country 0.467 0.139 3.35 0.001 1.60 1.21-2.10 
Constant -1.307 0.244 -5.35 <0.001   
 
In this new model, three covariates are associated with the outcome at p<0.05(Table 
F-50). The probability of worry decreases over time. Women, people in Uganda, and 
people with impaired physical function have higher odds of worry, but the ORs are 
not very high for any variable.  
 
Figure F-17: predicted response curves for the model in Table F-50 
 
 
Figure F-17 shows the predicted results from the model in Table F-50. The graphs 
show that the probability of worry decreases over time. The curve begins to flatten 
out after about 100 days, seen most clearly in the group with best physical function. 




on the probability of worry, also shown by the fact that ORs for gender, country and 
function in Table F-50 are similar.  
 
 
F.8.iv Difficulty sharing feelings 
 
Table F-51: results of population-averaged logit models fitting one variable at a time to 
prevalence of difficulty sharing feelings 
 Log 
OR 




Gender 0.213 0.150 1.42 0.155 1.24 0.93-1.66 Yes 
Age -0.146 0.121 -1.20 0.230 0.86 0.68-1.10 Yes 
Wealth quintile 0.157 0.052 3.01 0.003 1.17 1.06-1.30 Yes 
Education -0.101 0.099 -1.02 0.308 0.90 0.75-1.10 No 
Physical function  -0.387 0.111 -3.49 <0.001 0.68 0.55-0.84 Yes 
Country -0.167 0.147 -1.14 0.256 0.85 0.63-1.13 No 
ART use 0.030 0.136 0.22 0.827 1.03 0.79-1.35 No 
Time from T0 -0.005 0.002 -2.99 0.003    
 
When analysed individually, four variables were associated with difficulty sharing 
feelings at 25% significance(Table F-51). These were gender, age and wealth 
quintile (weak associations) and physical function, with a slightly stronger association 
(OR=0.68) that was highly significant (p<0.001). 
 
In a multivariate model using these four variables plus time, gender was the 
covariate with the largest p-value above 0.05 (OR=1.17, p=0.304), so it was 
removed. Refitted without gender, age became fractionally more closely associated 
with the outcome, although the OR did not move outside the previous confidence 
intervals. However, age was still not significant at the 5% level, so it was removed.  
 
Table F-52: results of population-averaged multivariate logit model of prevalence of problem 
sharing feelings 
 Log OR SE Z p OR 95% CI of OR 
Days since T0 -0.005 0.002 -3.39 0.001 1.00 0.99-1.00 
Wealth quintile 0.141 0.052 2.71 0.007 1.15 1.04-1.27 
Physical function  -0.365 0.111 -3.27 0.001 0.69 0.56-0.86 
 
Table F-52 shows that difficulty sharing feelings became less prevalent over time, 




participants. None of these effects were particularly strong. The effect of time in days 
was indistinguishable from zero (that is, an OR of 1) to two decimal places.  
 
 
Figure F-18: predicted response curves for the model in Table F-52 
 
The consequences of the small effects in Table F-68 are shown graphically in Figure 
F-18. The slope is shallow compared to the graphs of other outcomes, showing that 
being able to share feelings remained a problem throughout the observation period. 
Even the group with the lowest probability of problems in this area (which was the 
poorest quintile with the worst physical function) still had a 50% probability of 







F.8.v Difficulty finding life worthwhile 
 
Table F-53: results of population-averaged logit models fitting one variable at a time to 
prevalence of problem feeling life worthwhile 
 Log 
OR 




Gender 0.146 0.161 0.91 0.364 1.16 0.84-1.59 No 
Age -0.411 0.129 -3.18 0.001 0.66 0.51-0.85 Yes 
Wealth quintile -0.221 0.055 -4.02 <0.001 0.80 0.72-0.89 Yes 
Education -0.159 0.106 -1.50 0.134 0.85 0.69-1.05 Yes 
Physical function  0.574 0.106 5.43 <0.001 1.78 1.44-2.19 Yes 
Country 0.962 0.153 6.29 <0.001 2.62 1.94-3.53 Yes 
ART use -0.274 0.135 -2.03 0.043 0.76 0.58-0.99 Yes 
Time from T0 -0.007 0.001 -4.58 <0.001    
 
All covariates apart from gender were associated with the probability of difficulty 
finding life worthwhile, so they were carried forward into a multivariate model. In 
multivariate analysis, education was no longer associated with finding life worthwhile 
(OR=0.94, p=0.604), so it was dropped. Without education, the significance of ART 
crossed the significance threshold (p=0.054), but the OR was substantially different 
from one (0.75), suggesting a real effect. Wealth quintile, with an OR closer to one 
(OR=0.78), had a much lower p-value (p<0.001), probably because it has more 
degrees of freedom which makes the same result less probable due to chance. 
Following the analysis plan in which 5% significance was required for inclusion, ART 
was removed, as shown in Table F-54. 
 
Table F-54: results of population-averaged multivariate logit model of prevalence of problem 
feeling life worthwhile 
 Log OR SE Z p OR 95% CI of OR 
Days since T0 -0.007 0.002 -4.71 <0.001 0.99 0.99-1.00 
Age -0.398 0.126 -3.16 0.002 0.67 0.52-0.86 
Wealth quintile -0.253 0.056 -4.48 <0.001 0.78 0.70-0.87 
Physical function  0.488 0.111 4.39 <0.001 1.63 1.31-2.02 
Country 1.042 0.156 6.69 <0.001 2.83 2.09-3.84 
 
Odds of difficulty finding life worthwhile are lower for older people and people in a 
higher economic quintile, while problems are more likely for those with impaired 






This model includes variables with respectively three, five, three and two categories, 
(age, wealth quintile, physical function, and country) making 90 possible 




F.8.vi Difficulty finding peace 
 
Table F-55: results of population-averaged logit models fitting one variable at a time to 
prevalence of problem feeling at peace 
 Log 
OR 




Gender 0.040 0.150 0.27 0.788 1.04 0.78-1.40 No 
Age -0.477 0.123 -3.88 <0.001 0.62 0.49-0.79 Yes 
Wealth quintile -0.022 0.051 -0.42 0.675 0.98 0.88-1.08 No 
Education 0.082 0.098 0.83 0.404 1.09 0.90-1.32 No 
Physical function  0.646 0.103 6.26 <0.001 1.91 1.56-2.33 Yes 
Country 1.090 0.146 7.45 <0.001 2.97 2.23-3.96 Yes 
ART use -0.470 0.112 -3.99 <0.001 0.63 0.50-0.79 Yes 
Time from T0 -0.006 0.086 -0.07 0.941    
 
In bivariate analysis, age, physical function, county and ART use were associated 
with the probability of problems feeling at peace(Table F-55). Significance was very 
high for all four (p<0.001). These covariates were carried forward into multivariate 
analysis. 
 
Table F-56: results of population-averaged multivariate logit model of prevalence of problem 
feeling at peace 
 Log OR SE Z p OR 95% CI of 
OR 
Days since T0 -0.007 0.001 -4.84 <0.001 0.99 0.99-1.00 
Age -0.515 0.124 -4.15 <0.001 0.60 0.47-0.76 
Physical function  0.700 0.111 6.34 <0.001 2.01 1.62-2.50 
Country 0.991 0.151 6.56 <0.001 2.69 2.00-3.62 
ART use -0.508 0.130 -3.91 <0.001 0.60 0.47-0.78 
 
Table F-56 shows that all covariates are significantly associated with the odds of 
peace, suggesting little association between covariates. The prevalence of problems 
decreases over time. Each level of impairment in physical function doubles the odds 
of problems feeling at peace (OR=2.01) and country has an even bigger effect 





Figure F-19: predicted response curves for the model in Table F-56 
 
Four covariates were associated with the probability of problems feeling at peace 
over time, with country having the largest effect. All distributions overlapped with 
each other, and so the model could only be represented by using twelve 
graphs(Figure F-19). They show that people who with the worst physical function 
who lived in Uganda, and did not take ART were almost certain to have problems 
feeling at peace at recruitment. The slope was steeper than that for sharing feelings 
but relatively flat compared to other items, showing that problems feeling at peace 
did not change a great deal over time.  
 
 
F.8.vii Difficulty obtaining help and advice 
 
In bivariate analysis, country was strongly associated with the prevalence of 
problems obtaining help and advice (OR=3.36, p<0.001). ART use had an equally 
high significance but a weaker OR (OR=0.63, p<0.001). Education and wealth 





Table F-57: results of population-averaged logit models fitting one variable at a time to 
prevalence of problem getting help/advice, with 0/1 as baseline 




Gender -0.070 0.170 -0.41 0.683 0.93 0.67-1.30 No 
Age -0.092 0.135 -0.68 0.496 0.91 0.70-1.19 No 
Wealth quintile -0.081 0.058 -1.38 0.166 0.92 0.82-1.03 Yes 
Education -0.311 0.109 -2.85 0.004 0.73 0.59-0.91 Yes 
Physical function  0.068 0.122 0.55 0.580 1.07 0.84-1.36 No 
Country 1.211 0.177 6.83 <0.001 3.36 2.37-4.75 Yes 
ART use -0.466 0.131 -3.55 <0.001 0.63 0.48-0.81 Yes 
 
The four variables wealth quintile, education, country and ART use were fitted in a 
multivariate model. Wealth quintile was then removed, because it was not 
significantly associated with outcome (OR=0.94, p=0.283). The final model is shown 
in Table F-58.  
 
Table F-58: results of population-averaged multivariate logit model of prevalence of problem 
getting help/advice 
 Log OR SE Z p OR 95% CI of OR 
Days since T0 -0.010 0.002 -6.28 <0.001 0.99 0.99-0.99 
Education   -0.415 0.108 -3.84 <0.001 0.66 0.53-0.82 
Country 1.193 0.178 6.70 <0.001 3.30 2.33-4.68 
ART use -0.404 0.138 -2.93 0.003 0.67 0.51-0.87 
 
Education and ART use have a small but significant effect on the odds of problems 




Figure F-20: predicted response curves for the model in Table F-58 
 
 
The predicted probabilities from Table F-58 are displayed in Figure F-20. Problems 
became less prevalent over time. In Kenya change is quite linear but in Uganda it 
increases over time. Participants on ART had fewer problems accessing help and 
advice. Problem start from a very high prevalence, particularly in Uganda where the 
probability is almost 100% at baseline for those not taking ART.  
 
 
F.8.viii Summary of risk factors over time and compared to baseline 
 
Table F-59 below summarises the findings of multivariate longitudinal analysis. 
Taken as an average, all outcomes improve over time at the individual level. The 
effect of time has high significance but a very weak OR. The difference between 






The independent variables of most importance in predicting outcomes are physical 
function, country, wealth quintile and ART use. These variables are associated with 
multiple outcomes across different domains of care. By contrast, gender and 
education are each associated with only one outcome, and age is associated with 
two which are similar to each other (difficulty finding life worthwhile and finding 
peace).  
 
Limited physical function is associated with more problems in five areas, and fewer 
problems sharing feelings, and is not associated at all with access to help/advice. 
Physical function is more strongly associated with symptoms and pain, the physical 
problems, than with other outcomes. Ugandans have more problems than Kenyans 
in five outcomes, especially in psychological and spiritual domains, where the effect 
is strong. ART is associated with fewer problems in three areas: symptoms, finding 
peace and obtaining help and advice. These three represent respectively physical, 
spiritual and social problems and their score distributions in previous analysis are 
very different from each other. The OR is fairly similar for all three, ranging from 0.60 
to 0.68. 
 
Men and women have similar problems except that there is a weak effect for women 
to have more worry, while older age is associated with less spiritual and existential 
burden. More educated people are better able to obtain help and advice. Increased 
wealth is weakly associated with reduced odds of pain, symptoms and difficulty 
finding life worthwhile, but increased difficulty sharing feelings. Ability to share 
feelings is an exception to several trends, being more of a problem for wealthier 
people with the best physical function.  
 
In cross-sectional analysis the results for pain and symptoms were very similar to 
each other, but here, although they still have similar odds ratios for the relationships 
with wealth quintile and function, symptoms are also more common in Uganda and 
less common with ART, while pain is not associated with either. The only two 
outcomes to share the same combination of covariates are pain and ability to share 
feelings, and they are opposed to each other. Poverty and limited function make pain 




covariates, rather than the outcomes. In general terms, poverty, younger age, limited 
physical function, residence in Uganda and lack of ART are risk factors for 
multidimensional problems.  
 
The results from the two summary tables of longitudinal analysis, Table F-35 for Part 
B and Table F-59 for Part D, are combined in Table F-60. In many respects they are 
similar. Variables associated with an outcome cross-sectionally are likely to also be 
associated with change in the outcome over time.  
 
The two countries have symptom and worry scores that are similar at baseline, but 
over time people in Uganda have a greater probability of physical symptoms and 
worry. At recruitment, women have more difficulty sharing their feelings, with a 
strong OR, but this effect disappears over time. Wealth quintile is associated with 
difficulty sharing feelings over time, but the effect is very weak, given that an ordinal, 
evenly distributed variable such as wealth quintile is very effective at detecting an 
association. Problems finding life worthwhile are not associated with physical 
function at diagnosis but over time, those with limited function have more problems. 
Conversely, those with limited physical function report fewer problems obtaining help 
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In this chapter, the findings from all four parts of the analysis (A – univariate at 
baseline, B – multivariate at baseline, C – univariate over time, and D – multivariate 
over time) are first summarised in order, then grouped by outcome and appraised. 
The strengths and limitations of the study are assessed and in light of these, the 
implications for practice, policy and research are drawn out.  
 
 
G.1 Summary of main findings by objective 
 
 
The main findings are presented by objective below.  
 
Objective 1: To determine prevalence and severity of palliative care-related 
problems within two weeks of diagnosis of adults with HIV in Kenya and 
Uganda 
 
The findings show a large burden of palliative care-related problems at HIV 
diagnosis, in all areas, but especially in the social domain. Bearing in mind that the 
study sample consists of relatively young adults with good physical function 
recruited from the general population and in the so-called asymptomatic stage of a 
manageable condition, the burden of palliative care-related problems is severe.  
 
 
• Objective 2: To investigate whether demographic variables or CD4 count are 
associated with prevalence and severity of palliative care-related problems 
at diagnosis  
 
The cross-sectional analysis of key independent variables shows some over-
arching trends. Patients with impaired physical function have more physical, 
psychological and spiritual problems, but fewer difficulties getting help and advice 




have physical and existential problems. Psychosocial and spiritual problems are 
more severe in Uganda than Kenya, and older people seem to be less troubled by 
spiritual problems.  
 
 
Objective 3: To determine change in palliative care-related problem severity 
over a three month period  
 
During three months under care, all problems are reduced for the sample as a 
whole. Physical problems (pain and symptoms) improve most rapidly, with the 
majority of gain within the first month. The more existential and interpersonal 
problems (being able to share feelings, feeling life worthwhile and being at peace) 
show less change over time and improvement occurs more slowly. Problems 
sharing feelings are resolved more in the second month than the first. In the third 
month, problems feeling at peace increase again.  
 
 
Objective 4: To investigate whether demographic variables or ART use are 
associated with change in palliative care-related problem prevalence over time  
 
Patients with physical impairment experience less reduction in most problems, but 
have less difficulty sharing feelings over time. Those of higher socioeconomic 
status report greater pain reduction over time and fewer problems finding life 
worthwhile but have more difficulty sharing feelings. Being on ART is associated 
with gains in several areas but the effect has weak significance. Psychological and 
spiritual problems are maintained for longer in Ugandan patients. Women report 
more worry over time, while more educated people have fewer problems obtaining 





G.2 Recruitment, retention and representativeness of sample 
 
Full retention, defined as completion of four interviews, was 75% (n=325). This is a 
relatively high retention rate(337), improving the generalisability of results. 
However, the 25% who completed fewer observations are likely to be different from 
those who completed all four in ways that may bias the results. LTFU was normally 
recorded as ‘reason unknown’. This suggests that the participant was not seen by 
the HCW who collected the data, as the HCW would have attempted to learn and 
code a reason. It follows that the lost participants probably did not come to the 
health centre at all. Thus, the majority of patients lost to study follow-up probably 
experienced a hiatus in their care. This is speculation based on an absence of 
data, but high attrition from HIV care is common, especially for patients not 
receiving ART(321). 
 
The reasons for programme attrition have been examined in terms of structural 
barriers(342), psychological factors(147), and pragmatic behaviour change(343). A 
major structural barrier is the cost of transport to the care facility(154). In the study, 
patients were reimbursed the cost of transport, but this does not entirely remove 
the barrier. It was still necessary for patients to pay for transport to the health 
facility up front and some may not have been able to do so. In the qualitative 
interviews in Phase 1 of the PEPFAR PHE, patients reported that expenditure in 
terms of time is another problem, as clinic visits (plus transport and waiting times) 
frequently take all day, meaning the loss of a day’s work. Symptoms may also 
hinder retention. Fatigue is one of the most common symptoms of HIV(58); patients 
may lack the energy to undertake the journey. One of the precoded options for the 
reason for LTFU was ‘unable to return to health centre’. This was rarely reported, 
but that could be because in the event that patients could not return, information to 
that effect would not have reached the health centre.  
 
An unknown proportion of those lost to follow-up were still receiving care but chose 
not to participate in the study. In Africa, the proportion of potential recruits who 
consent to join a study is generally much higher than in Europe. Possible reasons 
for this include the perverse incentive of a cost reimbursement; the hope of 
improved care; and a cultural expectation of deference to the authority of health 




research assistants it was clear that very few patients refused to participate. It is 
possible that participants left the study either because their hopes of better care or 
other incentives were not materialised, or because they had never wanted to 
participate and had consented out of obedience. Therefore, drop-out could 
constitute a form of refusal by default.  
 
Retention is not a study outcome because it was manipulated by the design. 
Participants were paid US$5 to reimburse the cost of travel at follow-up 
appointments, and therefore had an additional incentive to return to the health 
facility. However, there is evidence that multidimensional problems can be a cause 
of LTFU. In focus group discussions, patients in Tanzania reported that pain, 
sickness, hunger and loss of hope were obstacles to retention(147). A meta-
ethnography of qualitative studies of HIV care attrition found that one reason 
patients do not return to the health centre is lack of perceived benefit(151). 
Palliative care delivers patient-centred improvements, which could encourage 








G.3 Multidimensional problems at and following HIV diagnosis 
 
The findings relating to each of the seven outcomes are considered one by one, 






As in other diseases, HIV pain has many possible causes and presentations. A 
study of AIDS patients in Denmark(344) found 69% of patients had constant pain 
interfering with daily living. The most common type was neuropathic pain in the 
extremities, but other causes included opportunistic infections, lymphoma and 
Kaposi’s sarcoma. In South Africa, the most common sites of pain for AIDS 
patients were the lower limbs(66%), mouth(51%), head(43%) and throat(40%)(45). 
Common causes of mouth and throat pain are oral candidiasis, herpes simplex and 
Kaposi’s sarcoma. Headaches could be due to infection, tumour, sinusitis, systemic 
infection or stress. Chest pain is frequently caused by tuberculosis and respiratory 
infections(344). 
 
Sensory neuropathy is a common and painful problem, affecting around 40% of 
people taking ART(345). The first line therapies recommended by NICE for painful 
HIV sensory neuropathy are pregabalin and amitriptilyine, but a recent systematic 
review found that neither performed any better than placebo(345). The only 
therapies to show an effect were cannabis, Nerve Growth Factor and topical 
capsaicin, and the effect of opioids had not been studied.  
 
At baseline, 66.9% of participants reported pain, and 19.4% a pain score of 3, 4 or 
5, denoting more severe pain (up to overwhelming pain at 5). These figures are 
comparable with the findings from outpatients in India of 53% pain (302) and 31% 
severe pain(301), shown in the systematic review chapter. The only information on 
pain prevalence among newly diagnosed outpatients in a low-income country is a 
report of 76% prevalence for AIDS patients in Uganda(298). In this thesis, of a 




report pain in the first two weeks after HIV diagnosis, which is not much lower than 
the prevalence among people with AIDS. Indeed, the definition of AIDS in the 
paper was a CD4 below 200, which was a criterion for ART initiation in the eleven 
health facilities where data were collected. Since neither CD4 count nor ART was 
associated with pain, the results suggest that pain is relatively common in all 
disease stages, and highly prevalent at diagnosis.  
 
Participants from higher socioeconomic quintiles were less likely to report pain, 
both at baseline and over time, possibly because they were able to pay for pain 
relief. In both Kenya and Uganda, essential drugs should be freely available 
through health centre pharmacies. However, supply does not meet demand, and 
stock-outs are a frequent problem(346). A pharmacy review prior to the longitudinal 
study showed that in Uganda, all five health facilities represented here had the 
weak opioid codeine in stock, but three had run out within the previous three 
months(347). Only two facilities stocked morphine and one of them had 
experienced a stock-out. In Kenya, four of the six facilities had codeine, one 
reported a stock-out, and none had morphine(346). These supply problems reflect 
national trends. In this situation, patients have no option but to take their 
prescription to a private pharmacy and pay for the drug.   
 
Interestingly, socioeconomic quintile was only associated with the odds of 
moderate pain at baseline, and not with the odds of severe pain. A possible 
explanation for this is that opioids for the treatment of severe pain are not available 
privately, and so wealth is no advantage to obtaining them. Analgesics for 
moderate pain can be bought privately, and wealthier people may be able to seek 
health care at an earlier stage, so wealth would be of benefit. Moderate pain may 
also be more amenable to non-pharmacological therapies or more likely to be self-
limiting. 
 
Although poverty is a risk factor for pain and physical symptoms, cash transfer is 
unlikely to be an appropriate response. Cash transfer schemes are a medium to 
long term intervention, mainly aimed at prevention. It is impossible by definition to 
identify people beforehand who may be at greater risk of symptoms at diagnosis. If 
they could be so identified, they would be diagnosed at the time. Free care is 





Pain scores improve in the first and second months after diagnosis, but in the third 
month, net change is negative, showing that pain worsens a little. A floor effect 
could have contributed to this finding. As an increasing proportion of patients 
reached a pain score of 0, the possibility of further improvement disappeared, thus 
a small and non-significant increase in pain might be the result of regression to the 
mean. However, at the individual level, while the proportion of people whose 
scores improve falls from 39.5% in the first month to 24.9% in the third, the number 
whose pain gets worse rises from 19.7% to 26.9%. A floor effect would not predict 
this. Overall, 19.9% of the sample report more pain at M3 than at baseline. 
 
A possible explanation is that the majority of pain was managed with non-opioids, 
but second-line treatments were not available (i.e. the WHO pain ladder(12) was 
not followed) for patients whose pain recurred. A small number of patients reported 
severe pain at diagnosis which was not relieved over time. A pharmacy review for 
Phase 1 of the PHE found that only two facilities stocked morphine(348), and these 
patients in severe pain may have needed morphine and been unable to access it. 
They could also have been suffering from neuropathic pain which is only partially 
responsive to opioids.  
 
The use of opioids is extremely low in both study countries and in Africa as a 
whole, which consumes ten daily doses per million people per day, compared to 
1564 per million per day in North America(349). Uganda and Kenya are 
respectively the fourth and sixth largest consumers of narcotics in sub-Saharan 
Africa (behind South Africa, Namibia, Botswana, and Zimbabwe at fifth) but they 
rank 132nd and 134th worldwide.  As a consequence, effective pain relief is very 
difficult. A Human Rights Watch report highlighted the failure of health services in 
Kenya to provide pain relief for children(350).  
 
Despite the low use of morphine, Uganda is in fact a model of opioid availability in 
Africa, as it was the first country to permit nurses to prescribe morphine(228). So 
far, only a small number of health services have made use of this option. Reasons 
for under-provision, identified in both Uganda(351) and Kenya(350), include: 





• An unclear legal situation with heavy penalties for of opioids 
• Strict regulations to prevent smuggling and misuse, with can hamper legal 
prescription 
• Lack of centralised supply in Kenya 
• Difficulty meeting the requirements for storage, such as double-locked 
cabinets 
 
Interventions have not been studied in this thesis. The assumption in the preceding 
paragraphs is that pain scores were reduced because pain was managed with 
medical intervention. There may also be a form of regression to the mean, if pain is 
one of the factors motivating people to go for an HIV test. In that case, the time of 
diagnosis would be associated with a higher than average level of pain. However, 
non-opioid analgesics are one of the most common therapies and pain is highly 
prevalent in HIV, so it seems likely that most of the reduction was caused by health 
care at the eleven facilities. 
 
In the multivariate longitudinal analysis, pain over time is more likely for patients 
who are poorer and especially those with impaired physical function. There is a 
weak trend for older people to have a higher risk of pain, and ART is not 
associated with the outcome. A two-year study in Kenya also found that pain 
prevalence was not reduced by ART(352), although ART is expected to reduce the 
frequency of infections which could cause pain.  A possible reason for the lack of 
association is that ART initiation can be accompanied by immune reconstitution 
inflammatory syndrome (IRIS), as the recovering immune system starts to respond 
to previously undetected pathogens(353). Neuropathy is also a side effect of 
ART(354).  
 
Pain may be considered the most discrete and classifiable of the seven 
multidimensional problems examined in this thesis. However, what patients mean 
by ‘pain’ is not necessarily a physical problem, and pain has been defined as ‘what 
the patient says hurts’(355). Dame Cicely Saunders developed a model of ‘total 
pain’, showing that physical, psychological, spiritual and social problems could not 
necessarily be disentangled. The conclusion of the total pain theory is that physical 
pain cannot be adequately managed in isolation, without treatment of non-physical 




“pharmacological, psychotherapeutic, cognitive-behavioral, anesthetic, 
neurosurgical, and rehabilitative”(37). Ongoing or recurrent high pain scores may 





In this sample 65.8% of participants were affected by symptoms at baseline, 14.4% 
reporting a score of 3, 4 or 5. The results for symptoms are similar to those for 
pain, unsurprisingly, as the two often co-occur and pain can be considered simply a 
particularly common and burdensome symptom. As with pain, a small proportion of 
people appear to have intractable problems while most improve over time. The 
results of Part C show that the majority of symptoms are managed quickly, within 
one month. After the first month, symptom burden continues to reduce but at a 
much slower pace, and a small minority continue to have high, unalleviated 
symptom burden.  
 
One third of participants do not report symptoms at baseline, and similarly one third 
do not report pain. However, the POS covers only a three-day interval, being 
designed to detect short-term change. HIV is characterised by an illness trajectory 
which is not steep and sudden as in cancer but unpredictable and fluctuating. It is 
very likely that if the time period for symptom detection had been extended further 
a higher prevalence would have been found.  
 
The PHE did not gather any information on the types of symptoms experienced. In 
the systematic review, common symptoms include fatigue, fever, itching, weight 
loss, diarrhoea, cough and skin problems. The most similar population to report 
symptoms found in the systematic review is a group of people with AIDS in 
Uganda, in which the prevalence of symptoms was 67% itching, 61% tiredness, 
53% cough, 52% skin problems(298), 35% STI symptoms(299).  
 
Symptoms can be caused either by HIV itself, by opportunistic infections or by 
comorbidities. Conditions which appear to be independent comorbidities have been 




malaria(356), thus a malaria symptom such as fever is a part of HIV management 
because HIV increased the person’s risk of developing the symptom. Given that 
the number of conditions for which HIV is known to increase susceptibility is 
constantly expanding, it is practically impossible to separate HIV symptoms from 
non-HIV symptoms, and a patient-centred approach does not require the 
distinction to be made. All symptoms reported by HIV patients are relevant to HIV 
palliative care. HIV symptoms appear to be more frequent and to appear earlier in 
the disease trajectory in Africa than in high-income countries(357, 358). This was 
originally thought to be evidence of a more virulent strain of HIV but is now thought 
to reflect the higher background prevalence of infections and general 
morbidity(359). 
 
At baseline, pain and symptoms are both associated only with wealth quintile and 
physical function. Physical function has a strong effect (OR=3.2 for both), showing 
that people with limited physical function, and especially those with the worst, are 
at a much higher risk of pain and symptoms. It is likely that to some extent this 
direction should be reversed; people with a heavy symptom burden have reduced 
physical function. A simple screen of physical function by health care workers could 
be useful to identify the patients at highest risk of pain and symptoms. 
 
Participants with limited physical function are likely to have a restricted ability to 
work, as shown in South Africa(360) and inferred in Kenya(352) from ART initiation 
studies. Decreased productivity puts patients at risk of poverty, debt and other 
social problems. A defining feature of extreme poverty is that a high proportion of 
income is spent on food(114), limited income due to ill health is a direct cause of 
malnutrition and further limits ability to work(112). Lowered work productivity due to 
HIV is recognised as a major stress on family income and arguably the primary 
threat to integrity of a family unit(115). Lack of food is also an established cause of 
non-adherence to ART, as patients do not take twice-daily medication if they only 
have enough food for one meal per day(361). The necessity of poverty alleviation 
as palliative care was graphically described in the case of Zimbabwe: 
“Controlling pain and leaving the patient with severe hunger pangs seems 
pointless as does empowering the family caregiver with basic nursing skills 






The association of physical domain outcomes (pain and symptoms) with wealth 
quintile is relatively weak. Wealth quintile, as a variable, is optimally designed to 
detect any association. It consists of five categories of equal size, and therefore 
weight, analysed as a continuous ordinal variable. Any trend or deviation from pure 
randomness in the relationship between the outcome and wealth quintile would 
probably be detected, but none is. The fact that there are five categories limits the 
strength needed to show significance, but it also limits the strength likely to be 
found. Weak associations are detected and may not mean a great deal. 
 
During these three months, all participants were receiving HIV care (not palliative 
care) and a high proportion of them were initiated on ART. It is not possible to 
determine the proportion of symptom reduction attributable to ART, to symptom-
specific care, to treatment of causes (e.g. TB treatment against cough) or to a self-
limiting effect over time. 
 
The longitudinal results show that people taking ART have fewer symptoms over 
time, but the effect is small, and much less than the effect of physical function. 
There is evidence from Kenya that ART is associated with reduced 
symptoms(352), with two caveats; pain and fatigue remained common throughout 
the two years of observation, and improvement was at the level of the individual. 
Similarly, in this study, pain was not associated with ART use although other 
symptoms were. People taking ART generally have more advanced disease than 
those not taking ART, and therefore, even though symptoms decrease for them 
over time, they may still have more symptoms and worse physical health than other 
patients with HIV(363). In South Africa, a cross-sectional study found that people 
taking ART had fewer physical symptoms and were better able to work.  
 
Physical symptoms and pain are often overlooked in the earlier stages of HIV, 
which are inaccurately described as ‘asymptomatic’(364). Assessment and 
management of symptoms for HIV outpatients in Africa is also lacking. These 
results show that pain and symptoms are prevalent and severe, and require 
assessment and treatment as soon as practicable after HIV diagnosis and regularly 




spiritual and social), the physical dimension is the place of fewest problems. All 





In this dataset, worries are more prevalent and severe than physical problems at 
HIV diagnosis. Over two thirds of participants are worried at diagnosis, 11% of 
them scoring 3, 4 or 5. Participants with limited physical function and women are 
more likely to worry. These two associations have an equal strength and similar 
significance. Unlike the physical domain outcomes, there is no evidence that 
poorer people are more likely to worry.  
 
In the literature, the systematic review results of worry at diagnosis show that in 
Uganda, 51% of outpatients with AIDS were worried(298). The population with 
AIDS may be similar to those with limited physical function in the current study. In 
Rwanda, 80% of pregnant women said that their HIV diagnosis caused them a 
great deal of concern(65).  
 
Overall, worry is reduced over time, with the great majority of improvement 
occurring in the first month. A small group of people continue to have severe worry 
up to M3. Between M2 and M3, 58.2% of participants experience no change in 
worry score, which is the highest proportion to show no change of all seven 
outcomes except for feeling life worthwhile (60.7%). These findings suggest that 
while many patients’ initial worries at diagnosis reduce with time, some participants 
experience chronic, unrelieved worry.  
 
Worry is one of two outcomes associated with gender cross-sectionally, and the 
only one to maintain the association over time. In the study, women are more likely 
than men to report worry. The descriptive results in Table F-19 help to illuminate 
the odds ratios for gender. The table shows that 40% of women report moderate 
worry compared to 28% of men, but women and men have a similar probability of 
severe worry (11.1% vs 10.1%). Meanwhile, 16% of those with middle physical 




that women are more likely than men to report worry, although whether they 
experience more worry or are simply more willing to report it is very difficult to 
establish. It appears that women on average worry more than men in this sample, 
but the highest levels of worry are uncommon in both genders and are more often 
associated with additional burdens, such as limited physical function. The direction 
of this relationship cannot be ascertained from cross-sectional data. To some 
extent, worry may impede functioning, but it is also likely that people with limited 
function have more problems (they are known to have more physical symptoms) 
and fewer resources, and so worry more. 
 
The reduction in worry over time is associated with gender and physical function 
(also seen in the cross-sectional association at baseline), and also country, with 
Ugandans more worried than Kenyans. The fact that worry is associated with 
country longitudinally but not at baseline suggests that the difference between the 
two countries increases over time, as Kenyans improve more rapidly than 
Ugandans.  The difference could be due to cultural or community response to HIV 
or care may be better at the six Kenya health facilities than the five in Uganda. A 
Client Services Receipt Inventory was used in the PEPFAR evaluation to record 
care received, but the version had several limitations. Scoring is binary (care 
components are either received or not received in a given month) with no indication 
of dosage, effectiveness or need. It was designed in this way for a wide-scale 
survey of 120 sites so that data could be combined and analysed, but the detail of 
care provision was lost in the process. As a consequence, the results are difficult to 
relate to outcomes.  
 
Worry is a normal appropriate human response to news such as an HIV diagnosis 
and the existence of worry in the sample is entirely expected. Those with 
exacerbated worries may have them because their circumstances are more difficult 
or possibly because of a mental health problem. The POS is not diagnostic of 
anxiety disorder or of any other psychological condition. The APCA African POS 
has not been tested in a reference healthy population, so ‘normal’ worry scores are 
unknown. In any case the distinction between ordinary worry and pathological 
worry is unclear, which is frequently a problem in both research and clinical 
care(365). The 2001 WHO Global Health Report on mental health represents 




sustained mood change to a point at which symptoms interfere with life 
activities(366).  
 
People with HIV are at heightened risk for anxiety, which may also predate HIV 
diagnosis(365). A nationally representative survey of people with HIV in the USA 
found 16% prevalence of anxiety (eight times higher than general population)(367). 
Using these figures, it is not possible to distinguish psychiatric morbidity as a risk 
factor for HIV infection from HIV as a risk factor for psychiatric problems. In Africa, 
the former is likely to be less pronounced, because the much higher population 
prevalence of HIV will reduce the excess risk caused by any single risk factor. In 
South Africa, 7% of 149 people within a year of HIV diagnosis had anxiety 
disorder(71). In India, 36% of outpatients had anxiety disorder at diagnosis(301). 
Biological effects of HIV also contribute to anxiety and depression, as HIV invasion 
of the central nervous system causes neurotoxicity in sub-cortical areas of the 
brain(82).   
 
Anxiety disorders and depression are more common in women than men, both 
generally(366) and with HIV(368). Brandt argues that women, particularly HIV 
positive women, are more affected by poverty than men (369). In my results, 
disability (limited physical function) is an independent risk factor for severe worry 
and being female is a risk factor for moderate worry, which may not have been 
detected in studies that used less sensitive instruments or a smaller sample. 
Anxiety and fear were shown to decline over time in a series of studies in the early 
1990s(263, 305, 306, 370). 
 
 
G.3.iv Difficulty sharing feelings 
 
A patient who has difficulty sharing their feelings with the people around them has 
limited access to emotional support. Emotional support for people with HIV is 
strongly associated with physical and psychosocial adjustment. In Europe, people 
with HIV who are satisfied that they have enough emotional support report 




with HIV disclose their status to others is so that they can receive emotional 
support(372).  
 
The analysis for the outcome of difficulty sharing feelings revealed three unusual 
characteristics. Firstly, problems are highly prevalent and very severe. Almost 90% 
of participants have difficulty sharing their feelings at baseline, and 32% report not 
being able to tell anyone how they were feeling in the previous three days. Such a 
high level of problems is only exceeded by one other outcome (help and advice). 
 
Secondly, the largest proportion of change over time occurs in the second month 
after diagnosis, not the first month as with the other six outcomes. Over a third of 
people (36.1%) report that sharing feelings becomes easier during the first month, 
but almost as many say it is more difficult, leaving a net improvement of only 3.7%. 
Proportion of net change is significantly better (i.e. the confidence intervals do not 
overlap) in the next two months, with 11.6 and 7.5 net change respectively. 
 
Thirdly, the covariates which usually predict greater problems are associated with 
this outcome in the opposite direction. At baseline, better physical function is 
associated with more problems sharing feelings. Over time, people with the best 
physical function and the highest relative wealth have the most problems. 
 
Difficulty sharing feelings has the lowest proportion of net change of all seven 
outcomes. The reason is that while a fairly typical 41% of people report better 
scores over time, 30% report that their problems get worse. Unlike the distribution 
for worry, where most scores changed very little, scores for this outcome fluctuate 
between extremes throughout the study period. Table F-40 to Table F-43 show that 
of the seven outcomes, it is the one in which scores are most likely to increase or 
decrease by four or five points in a month, moving the full range of the scale. 
Supporting this result of low net change, the longitudinal analysis in Part D 
produced graphs with a very shallow curve, showing little change over time. 
Difficulty sharing feelings is the outcome with the second highest level of problems 
at baseline and therefore it has great potential for improvement over time, but this 
improvement does not occur. Progress is slow, many people find their problems 





These results suggest that being able to share feelings is a situation in flux. The 
item may have detected changing emotional state, rather than the more constant 
psychological trait detected by the worry item. Ability to share feelings about being 
diagnosed HIV positive may be a process, rather than an event, and it may change 
frequently, with unpredictable results over time. The prevalence, severity and 
persistence of problems show that this is a very important area for patients.  
Inability to share feelings causes emotional distress, who consequences include 
loneliness, isolation, lack of self-care, depression, and inability to access help(373). 
People with these problems are less likely to adhere to treatment or maintain 
contact with health services (374), and are at risk of accelerated disease 
progression(375).  
 
Sharing feelings is more difficult for women than men at diagnosis(OR=1.75), but 
over time this association disappears. To share feelings openly implies disclosing 
HIV status. Consequences of disclosure can include ostracism, violence, and 
family rejection, particularly for women(122). Some studies have found that women 
are less likely than men to disclose their HIV status(368, 376), which would limit 
their ability to share feelings. A large study in Uganda found that 83% of both men 
and women reported disclosing to at least one person on the day they were 
diagnosed(377). These participants may not have been typical, as they received 
care through The AIDS Support Organisation (TASO), a grass-roots HIV service 
which places great emphasis on disclosure and family care. The study also did not 
indicate to whom participants had disclosed. Of 397 people with HIV in Kenya 
(72% female), 93% had disclosed their status to someone but only 27% had 
disclosed to their primary sexual partner(378), demonstrating that a high level of 
disclosure may coexist with the maintenance of secrecy. The present study did not 
record disclosure and so it is not possible to do more than speculate about the 
connection between ability to share feelings and ability to communicate HIV status.  
 
Incidence of disclosure may be related to reason for testing. Voluntary testers may 
be more prepared to disclose their status, while women who test during antenatal 
screening are less likely to disclose their status than any other group(376). This 
could be because voluntary testers have previously considered what they would do 




tested antenatally may lack the resources to disclose that information. Pregnant 
women may also have more reason to be afraid of family rejection.  
 
The association between ability to share feelings and wealth quintile may be 
spurious. At baseline, those in the middle and fourth quintiles are more likely to 
have no/mild problem sharing feelings, compared to the two quintiles below them 
and the one above. The difference is significant in a chi squared test (p=0.041) but 
not in a test for trend (p=0.588), indicating a non-linear relationship, but given that 
wealth quintiles are created from a continuous variable formed in a principal 
components analysis, non-linear associations are unlikely. In the longitudinal 
analysis, ordered categorical variables are treated as numerical scales, without 
expansion terms to separate the categories. This means that the association with 
two quintiles appeared to be a trend across all five. It is also important to note that 
the coefficients for associations with physical function and wealth quintile are both 
relatively small. Perhaps the best way to interpret the findings is that anyone can 
have difficulty sharing their feelings, regardless of their circumstances or their 
previous scores.   
 
An alternative explanation is that sharing feelings is easier when the problem is 
seen as ‘legitimate’, just as ‘invisible’ symptoms such as pain and fatigue are 
under-reported(379). The finding could also be due to a kind of response shift, in 
which other problems (such as pain, worry, or need for help and advice) take 
precedence over the need to share feelings. In the USA in 1995, men described as 
‘symptomatic’ were more likely to have disclosed their status two to four months 
after diagnosis than those who were ‘asymptomatic’(290). These terms are not 
defined in the paper and are more likely to refer to WHO staging criteria than actual 
symptom experience. The study supports the finding that people with worse 
physical function have fewer problems sharing their feelings. 
 
One problem with the question is that it is not clear whether sharing feelings openly 
with people other than family/friends, for example a counsellor, would be included. 
In palliative care, relationships between the patient and informal caregivers are 
very important. Sharing feelings with a member of staff, even a trained counsellor, 
would not be considered an adequate substitute for doing the same with people 




question, nor were demographic details such as marital status and living 
arrangements which might be used as an indicator of family closeness.  
 
The effect of interventions is also unknown. Counselling would have been available 
and recommended for all study participants. The extent, quality, frequency and 
effectiveness of counselling or other care is unknown. It is not possible to 
determine to what extent the change in ability to share feelings was affected by the 
passage of time, by health care interventions, or by external circumstances. 
 
 
G.3.v Difficulty finding life worthwhile 
 
Psychological morbidity has been a neglected area of research in low- and middle- 
income countries(380), especially Africa(378). Reasons given in the literature 
include limited health services, lack of valid and appropriate tools(60), a cultural 
marginalisation of psychosocial distress symptoms, and, in Africa,  a prioritisation 
of HIV-related medical treatment above psychosocial support programmes(368). 
This deficiency is reflected in the systematic review of multidimensional problems 
at HIV diagnosis, where the area of ‘wellbeing’, which was mapped on to ‘difficulty 
finding life worthwhile’, was the only dimension to have no relevant data from 
outpatients in low-income countries. The cross-sectional findings show it is a 
significant problem, as 21% of participants report a score of 3, 4 or 5 at diagnosis.  
 
A recent study of people with HIV or cancer in South Africa and Uganda showed 
this area was significant to patients, who rated having a sense of meaning in their 
lives as more important than physical comfort or activity(88). Mean MVQoLI 
wellbeing score for the HIV patients was -1.75, the worst score of the five domains, 
and significantly lower than the score for the cancer group. In the sample as a 
whole (81% with HIV), 30% agreed or strongly agreed with the statement ‘I have 
less of a sense of meaning in my life now than I have had in the past’. 
 
Difficulty finding life worthwhile can be considered psychologically as depressed 
mood or from a sociological perspective as a consequence of the threat to sense of 





1. Psychological perspective 
 
This study found that emotional difficulties are frequent at diagnosis. Similarly, in 
the literature 47% of newly diagnosed people with AIDS in Tanzania felt sad(298) 
and in India 68% were unhappy most of the time(302).  
 
Patient-reported outcome research is always vulnerable to issues of meaning and 
translation, and it is for this reason that validity and reliability of questionnaires 
must be demonstrated, preferably in the language and cultural context where the 
tools are implemented. In the area of emotional problems, these issues are 
particularly complex. Even if all the relevant information was provided in the papers 
it would be difficult to judge whether the Hindi word translated as unhappiness 
corresponds exactly with the Swahili word translated as sadness.  
 
The results presented here are the first to demonstrate individual-level change over 
time in psychological outcomes and to measure them so soon after diagnosis. The 
time is clinically relevant because diagnosis is the point of entry to care and 
individual-level change is important because it reveals highly fluctuant patterns 
over time, and shows that life worth must be assessed not just once but repeatedly 
in order to identify problems. 
 
 At baseline, women are more likely to worry and to have difficulty sharing their 
feelings, but not to have difficulty finding life worthwhile. The lack of association is 
unlikely to be a result of underpowering, because gender is the only covariate to 
show no association with the life worth outcome in both cross-sectional and 
longitudinal bivariate analysis. One possible explanation is an unusually high level 
of problems reported by men, who may be particularly susceptible to suppressed 
sense of worth in life following an HIV diagnosis. The theory conforms with the 
consistent finding that men are less likely than women to test for HIV (even after 
adjusting for prenatal testing), and then to enrol in care or to initiate ART(15). Loss 
of life worth may prevent men from returning for care. 
 
Cross-sectionally, country, age and wealth quintile are associated with the 




value (<0.001), which suggests that the understanding of whether life is worthwhile 
may be affected by cultural values that differ between the two countries. 
Longitudinally, country still has the strongest effect. By contrast, age and wealth 
quintile show associations with high statistical significance but a weak OR, with the 
95% confidence intervals reaching 0.90 in both cases. There is good evidence that 
age and wealth quintile are associated with the outcome but they do not appear to 
have much effect on it. 
 
Poverty could affect the outcome through channels that may not be immediately 
obvious, such as nutrition. There is cross-sectional evidence that micronutrients 
have a protective effect on depressive symptoms, and therefore deficiency caused 
by a poor diet can inhibit the ability to find life worthwhile.  An RCT in Tanzania 
found that micronutrient supplements for pregnant HIV positive women reduced 
depression symptoms and improved quality of life(381). In this 62% female sample, 
with a mean age of 33, it is very likely that a high proportion of women were 
pregnant, especially since they were defined by recent diagnosis and one of the 
most common reasons for HIV diagnosis in East Africa is antenatal care(16). The 
association between wealth quintile and finding life worthwhile could have been 
partly caused by nutrient deficiency. On the other hand, the outcome was not 
associated with gender, so if this explanation is correct, nutrient deficiency would 
have to be comparable in men and women.  
 
The total proportion of net change over time is low (14.6%). Only two other 
variables have a proportion of net change below 20% (difficulty sharing feelings 
and feeling at peace), and both these variables are highly fluctuant, with many 
people showing improvement over time and almost as many showing added 
burden, leading to a small net gain. By contrast, feeling life worthwhile shows a 
small gain simply because there is little net change in the first two months and 
none in the third. The majority of people (61%) experience no change in their 
status during the third month, and a further 20% change their score by only one 
point. Severe problems persist over time for some individuals, even though on 
average the burden decreases. This lack of change suggests that it is more difficult 
to affect a person’s sense of life worth than to manage physical and psychological 
symptoms such as pain and worry. Many people continue to have great difficulty 





Change over time is associated with age, physical function, wealth and country, 
making up more independent variables than were associated with any other 
outcome. The association with ART has a p-value of 0.054, which just misses 
statistical significance. A larger sample might have shown that being on ART was 
associated with finding life worthwhile.  
 
Not feeling life is worthwhile may be a normal response without any indication of 
mental illness, but it is also a characteristic of depression.  In the UK version of the 
POS, a high score in the ‘life worth’ question is followed by a recommendation for a 
depression screen. It is critically important not to mistake a difficulty finding life 
worthwhile for clinical depression, and this study does not contain any diagnostic 
validated tool for depression. The APCA African POS does not even carry the 
same recommendation as the UK version. However, depression is common in 
HIV(76) is associated with accelerated disease progression, and is also difficult to 
measure, as many of the physical symptoms of depression can themselves be 
caused by HIV(382). Depression symptoms are predictive of unprotected sex and 
risky behaviours, leading to the risk of further transmission and re-infection(50). 
Thus depression is a key concern in HIV and is briefly discussed here.  
 
A systematic review found evidence that 20% of people with HIV had deliberately 
harmed themselves and 29% reported suicidal ideation during the previous 
week(383). Furthermore, 9.4% of deaths of people with HIV were attributable to 
suicide. Africa accounted for only three of the 66 studies in the systematic review, 
reflecting the general deficit of HIV mental health research in resource-poor 
countries.  
 
The literature shows a high burden of psychiatric morbidity associated with HIV in 
Africa, particularly in the first year after diagnosis. In a group of 46 HIV patients in 
Kampala, Uganda, 83% had psychiatric disorders, including 54% major depression 
(384). The only longitudinal study of depression identified in Africa was conducted 
by Olley et al, who recruited 149 HIV patients within a year after diagnosis in South 
Africa and interviewed them using the Mini International Neuropsychiatric 
Interview(MINI). More than half(56%) were diagnosed with a psychiatric disorder, 




with anxiety disorder less common(7%)(71). Six months later, 65 of the group (with 
a similar morbidity profile to the other 84) were re-assessed, showing that 48% had 
a psychiatric disorder (statistically unchanged from the baseline prevalence), and 
26% had depression(385). Depression at six months was predicted only by 
disability score (OR=1.29). The authors suggested that the very high prevalence of 
problems was caused by stigmatisation and stress in South Africa. Paired analysis 
was not conducted so there is no indication of individual-level change over time. In 
effect, these were two cross-sectional studies within the same small population, not 
a true longitudinal study.  
 
 
2. Sociological perspective 
 
The question of life worth and existential wellbeing can also be viewed from a 
sociological perspective. In this approach, life worth is threatened by loss of self-
image and identity following HIV diagnosis. Biographical disruption theory posits 
that people associate their sense of self with their physical body, such that a loss of 
confidence in the body because of illness or disability is conceived as an attack on 
personal identity and self-worth(386).  In the theory, the three elements of personal 
biography are conception of self, conception of body and biographical time; a 
person’s self-identity rests in who she knows herself to be, her physical body and 
her memory. Chronic illness is viewed as a biographical disruption that breaks the 
chain uniting these three elements (273).  
 
The meaning of an illness cannot be separated from its context, as meaning 
depends on the consequences and significance of the illness to the individual(387). 
The significance of an illness is affected by the imagery around the disease, which 
may affect how individuals see themselves and believe themselves to be 
perceived(386). For example, a diagnosis of arthritis legitimates the symptoms, 
contains the possibility of cure, and can be perceived as a relief(387).  In the case 
of stigmatising conditions such as cancer, the significance of the disease is 
heightened and the main response may be grief(388). The meaning of an illness 
depends very much on culture. A study of chronically ill people posited the 
existence of an ‘American way of illness’, in which sense of self was based on the 




(social isolation, restricted life, becoming a burden and being discredited) 
challenged these values and contributed to a loss of self and consequent 
suffering(386).  
 
Stigma appears to have some universal traits, transcending culture. Invisible 
contagion, sexual transgression, and unnatural death are three of the most 
common sources of stigma, and HIV touches every one of these(389). In many 
contexts, HIV bears the stigma of moral judgements, separating ‘innocent victims’ 
of HIV from those seen to have brought it on themselves(34). Thus, HIV is likely to 
carry a great deal of significance and to be particularly disruptive to the sense of 
self, inhibiting the sense that life is worthwhile. 
 
In Cape Town, internalised stigma (measured using a validated instrument(390)) 
was common in a convenience sample of 1063 people with HIV(391). Over a 
third(35%) agreed with the statement “I sometimes feel worthless because I am 
HIV positive”. Men were especially prone to internalised stigma; 51% of men 
versus 38% of women agreed that “it is my own fault that I am HIV positive” while 
47% of men compared to 37% said “I feel guilty that I am HIV positive”. After 
adjusting for gender, ethnicity (black versus other) and physical symptoms, 
internalised stigma was associated with depression on the CES-D. To some extent 
this may be inevitable, as the Cognitive and Affective Depression Scale of the 
CES-D includes items like “I thought my life had been a failure”, “I felt that people 
disliked me”, which share common ground with internalised stigma. In the same 
way, some of the problems reported in response to the item ‘Have you found that 
life was worthwhile’ may be indicative of depression and some may be indicative of 
internalised stigma or other conditions. From a patient-centred perspective, all of 
these are equally important and whether they are caused by HIV or completely 
unrelated to it, they are still palliative care-related problems at HIV diagnosis.  
 
The concepts of biographical disruption and biographical work have been directly 
applied to people with HIV in a qualitative study(35).  This paper had some 
limitations, including an unexamined certainty that people with HIV who had not 
progressed to AIDS and did not have haemophilia had no health problems. It also 







G.3.vi Difficulty finding peace 
 
Spiritual wellbeing is understood to comprise two components, existential wellbeing 
(a sense that life has meaning, purpose and value)  and religious wellbeing 
(comfort derived from connectedness to a higher power)(392). Feeling at peace is 
strongly correlated with emotional and spiritual wellbeing in patients with advanced 
disease(280). At baseline, 75.6% of participants did not always feel at peace and 
19.2% never or not very often felt at peace, therefore spiritual distress can be 
interpreted as highly prevalent and frequently severe in this population.   
 
Peace outcome scores improve over time, but, interestingly, problems worsen in 
the third month. Only one other variable (pain) shows a worse score in M3 than 
M2, and in that case the change is very small and follows two months of great 
improvement. By contrast, problems finding peace increase more in the third month 
than they decline in the second.  These findings may reflect a delayed spiritual 
crisis. While other outcomes are most severe at diagnosis, difficulty feeling at 
peace recurs in the third month after HIV diagnosis, perhaps when the more 
immediate problems have been addressed. The study did not follow patients long 
enough to establish whether the spiritual problems in this second peak are 
managed. An HIV hospice study in the UK also found that while physical and 
psychological symptoms improved, spiritual problems were not resolved(393).  
 
At baseline, peace is more likely for people who are older than 40, have best 
physical function, and live in Kenya. The same three variables plus ART use are 
associated with feeling at peace over time, but the graphs show the weaknesses of 
this model. The dataset was divided into 36 groups of very unequal size, two of 
which were empty (for example, no participants were Kenyan, aged 18-25, taking 
ART and reported worst physical function). In the smaller groups, particularly the 
findings for the worst physical function group, spurious results may have occurred. 
Nonetheless it is clear that age made a considerable difference (OR=0.6), with 
older people more likely to feel at peace. The descriptive analysis in Table F-29, 




probably driven by the oldest age group. People aged over forty are more likely to 
feel at peace than the other two age groups, despite having on average more 
limited physical function. 
 
In qualitative interviews in South Africa, a patient with AIDS reported that physical, 
emotional, psychological and social problems inhibited spiritual wellbeing: 
“No, I do not feel at peace because of the pain. I lack money for getting 
basic needs of life. The difficulty I have in feeding myself and the children 
makes me unhappy and therefore no peace.” (L. Selman, unpublished data) 
The quote illustrates how different dimensions can interact to create the 
phenomenon of total pain.  
 
Spiritual wellbeing is considered a state or outcome that can be achieved, whereas 
spirituality in general can incorporate beliefs, practices and a worldview(392), one 
aspect of which is religious belief and practice(394). The great majority of people in 
Kenya and Uganda, 87% and 86% respectively, say that religion is very important 
in their lives(395). In both countries, the majority of people define themselves as 
Christian, but often maintain a syncretic relationship with traditional beliefs, even 
when they might be considered incompatible. For example, 32% of Christians in 
Kenya and 53% in Uganda believe in reincarnation(395). HIV is sometimes thought 
of as a punishment for sin. When asked their opinion of the statement ‘AIDS is 
God’s punishment for immoral sexual behaviour’, the majority agreed with it (71% 
in Kenya and 66% in Uganda), as shown in Table G-1(395). Thus a person newly 
diagnosed with HIV might feel guilt and shame over being punished, which would 
hinder peace.   
 
Table G-1: ‘Do you agree with the statement “AIDS is God’s punishment for immoral sexual 













Kenya 49 22 9 17 3 1500 
Uganda 47 19 14 17 4 1040 
 
 
In another example of syncretism, many people combine use of Western medicine 
with traditional healing, the most accessible and preferred source of health care in 




that 64% of them had used traditional medicine since their HIV diagnosis, and 
usage was similar among those taking ART(397). Traditional medicine is rooted in 
spirituality and it is likely that people with HIV receive some spiritual care from 
traditional healers. Within Western healthcare in general, the spiritual aspect is 
frequently marginalised or neglected, due to HCWs’ reluctance and lack of 
confidence(280). This may be less common in sub-Saharan Africa, where religious 
belief is very common (as shown above) and where a substantial proportion of 
health care is provided by religious organisations(398). In the qualitative interviews 
that formed part of the Public Health Evaluation alongside this cohort study, facility 
staff reported providing spiritual care including prayer with patients, spiritual 
counselling, arranging for a priest or spiritual leader to visit and helping patients 
come to terms with dying(363). Spiritual care was seen as a part of community and 
family life, so staff taught family carers to provide comfort and spiritual guidance to 
the patient. 
 
In India a prevalence survey reported that 58% of patients were highly distressed 
by not being calm or peaceful(302). This could be equated with never/not very 
often feeling at peace, but it is actually measuring the level of distress caused by 
the problem, rather than its frequency or severity. The questionnaire was not 
provided, adding to the difficulty of interpretation, as the question phrasing can only 
be inferred from the reported answer. In any case, even if the tool was available, 
the cultural context might mean it was interpreted differently(382).  
 
The majority of the literature on spirituality and HIV is based in the USA, where 
Ironson and colleagues have conducted a series of studies showing that following 
diagnosis, increased spirituality(269) and spiritual transformation are common, and 
predictive of improved well-being and survival(399). This research was conducted 
by retrospective interviews, asking people diagnosed many years previously to 
recall their emotions and spiritual condition at the time of HIV diagnosis. These 
methods are questionable. Psychology studies have shown that emotionally 
charged events are remembered with increased intensity but diminished 
accuracy(400). It is also known that memories can be altered and that a large 
proportion of memory is retrospectively constructed(270). Thus, interviews at many 
years’ distance are not a viable way of gathering information about the experience 




phenomenon, and important information is probably lost in its reduction to a 
quantifiable variable, ‘ST’. In Ironson et al’s work, ‘ST’ is normally associated with 
recovery from drug use, which in East Africa plays a very minor role in HIV 
transmission(1). Therefore the majority of the literature on spirituality and HIV 
diagnosis is either methodologically flawed or has little relevance to the majority of 
people diagnosed with HIV. 
 
 
G.3.vii Difficulty obtaining help and advice 
 
Problems obtaining help and advice are the most burdensome of all seven 
outcomes at diagnosis, with a median score of 4. As the area of greatest problems 
at baseline, this outcome has the most potential for improvement, and indeed it 
shows the best improvement over time (proportion of net change 38.3). 
Nonetheless, after three months over 20% of participants still report having had no 
help or advice in the previous three days. A great deal of unmet need remains, and 
proportion of net change declines steadily from month to month, suggesting that 
problems may continue to be unresolved. 
 
Participants with limited physical function have fewer problems obtaining help and 
advice at baseline. Half of those with the worst physical function reported severe 
problems, compared to 58% of those with middle function and 68% of the best 
function group. This association disappeared entirely over time. The same 
association was observed with ability to share feelings, although it persisted over 
time. Physical function was scored by the HCW on the basis of observation. 
Patients with more evident, recognisable needs have fewer problems in areas that 
on social interaction. This could indicate that patients who appear well, and have 
best physical function, have difficulty getting their needs recognised as legitimate.  
 
Education and wealth quintile are closely associated in this dataset. Wealth quintile 
was associated with the outcome in bivariate analysis, but this was almost certainly 
a product of confounding by education. The effect of education on ability to obtain 
help and advice is substantial and statistically significant, both at baseline and over 




prevent full understanding of written health information. There may also be 
language barriers, as in Kenya and Uganda health information is often delivered in 
English, which is learned in school but rarely spoken at home. An unusual example 
of a language barrier was found during data collection. The questionnaires were 
translated into Luo, a minority language of western Kenya, but HCWs reported that 
they preferred to read from the Swahili version and translate mentally into Luo, 
because even though Luo was the first spoken language of themselves and their 
patients, they were not accustomed to seeing it in written form. Swahili and English 
were the languages of literacy. As well as these issues of direct communication, 
people with more education may find it easier to question and challenge health 
workers, using a shared vocabulary and understanding, or education may be linked 
to social status which empowers the patient to ask questions and elicits more 
respect from the HCW.  
 
Only 6% of participants in Uganda reported low/no problems at baseline, compared 
to 23% in Kenya. Problems obtaining help and advice were notably more prevalent 
in Uganda, and this trend continued over time, showing the highest OR for any 
variable or outcome (3.30). The difference may have been partly caused by 
interpretation of the item. The full question is ‘Have you had enough help and 
advice for your family to plan for the future?’ It was designed to explore issues of 
bereavement support, legacies, making a will, looking after children, etc. In the 
systematic review, it was glossed as ‘information/tangible support’. A pioneering 
study in South Africa found that 11% of people with AIDS, unprompted, reported 
their worst problem was worry over who would take care of the children after they 
were gone(35). In a younger and more active population, facing the knowledge of a 
shortened lifespan but not imminent death, this question may have been 
interpreted differently. Cognitive interviews during validation showed that this item 
had the weakest face validity(256), as discussed under study limitations. 
 
Without knowing exactly what participants meant by a need for help and advice, it 
must be assumed that they meant the needs reported most commonly in the 
literature. There is substantial evidence from Africa that people with HIV need 
material help and practical advice. The need for material support or advice is cited 
as a major reason to disclose HIV status(401), and the most frequently cited 




Rwanda, women recently diagnosed with HIV reported that they needed housing, 
employment, money, childcare and food, more frequently than healthcare(65). 
Nutritional support is important and inadequate(402). In a non-randomised 
comparison in West Africa, nutritional support at family level improved survival, 
adherence and CD4 count for people with HIV(403).  
 
Over time, the majority of people report improved access to help and advice, but 
the proportion whose scores improve declines from 50.2% in the first month to 
34.4% in the third, while the proportion reporting more problems increases from 
17.1% to 26.0% at the same time. The fact that half of participants report a better 
score at M1 than M0 may be partially caused by a ceiling effect. For the majority of 
participants who scored the maximum of 5 at baseline, improvement or equality 
over the month were the only alternatives. Apart from this effect, it appears that 
efforts to improve patients’ access to health and advice are less successful two or 
three months after HIV diagnosis than immediately after.   
 
Participants on ART had fewer problems obtaining help and advice. These patients 
would have had a lower CD4 count than others, qualifying them for ART initiation. 
CD4 count was not associated with any outcomes cross-sectionally although ART 
was associated with three outcomes over time. This seems unexpected, as the 
main outcomes of ART are suppressed viral load and raised CD4 count, so 
outcomes improved by ART should also be affected by CD4 count. Also, access to 
help/advice unlike all other outcomes is not associated with physical function over 
time, which would suggest that it was not likely to be affected by an intervention 
aimed primarily at improving physical health.  
 
The evidence indicates that it is not the antiretrovirals which improve ability to 
access help/advice, but some other aspect of ART. Patients on ART receive 
regular appointments and extra support and counselling(241), especially at 
treatment initiation, and this increased access to staff may have enabled 
participants to get the help and advice they sought.  
 
Alternatively, perhaps the ‘help’ that patients wanted and said they had not 
received was ART. The results indicate that pre-ART patients also have palliative 




has been raised from 200 to 350 cell/μl since these data were collected, following 
WHO recommendations. However, it is likely that pre-ART patients with a CD4 
count above 350 will continue to have similar problems, since none of these 
problems were associated with CD4 count over time. In many settings pre-ART 
care is extremely poor, as shown by the very high loss to follow-up(158, 321). 
Scarce resources have been targeted towards the patients in most need, but better 
pre-ART care could help to redress and prevent problems, improving long term 




G.3.viii Total POS score 
 
Although this thesis measures each problem separately and identifies its 
covariates, all seven problems are likely to affect each other, according to the 
theory of total pain. The seven palliative care-related problems described above 
can occur simultaneously and create complex needs for patients, which are more 
likely to require specialist care. The results for total POS score demonstrate that a 
minority of patients have severe, multiple complex problems. 
 
The APCA African POS has rarely been analysed using a total patient score. 
Unpublished results from a natural experiment in Tanzania provide the only 
comparison. Participants were recruited if they had a POS score for pain or 
symptoms of 3, 4 or 5, the worst half of the scale. In the control group, the mean 
total POS score was 18.9 at the beginning and 16.4 after ten weeks(404). These 
scores are higher than those found in the newly diagnosed group whose mean 
score was 14.2 (95% CIs 13.7-14.6) at baseline, but this is to be expected, 
because the newly diagnosed cohort were representative of all patients whereas 
the Tanzania sample were specifically selected for higher than average pain and 
symptoms.  
 
The total POS score has played only a minor role in this thesis. It has been used 
only in descriptive univariate analysis, to illuminate some of the relationship 




patient-centred perspective and to remain as close as possible to the direct patient-
reported outcomes rather than to alter them. 
 
The validation of the APCA African POS calculated Cronbach’s alpha for all ten 
POS items rather than the seven used here. The result was 0.6, indicating 
moderate internal consistency, as was expected from a tool that was not intended 
to be unidimensional. Usually, a Cronbach’s alpha of less than 0.7 would indicate 
that it is not acceptable to create a summary score from the items. Confirmatory 
factor analysis of the UK POS also established that it is not a unidimensional scale, 
which is further reason not to use a single summary score as a statistical 
outcome(405).  
 
On the other hand, although statistically the total POS score performs poorly, there 
are a number of indices with low internal consistency in clinical use. These tools 
usually have a very specific purpose. A score with low internal consistency is more 
likely to be used to identify those at risk and requiring additional assessment than 
to measure any specific problem. A common example is the five-item Apgar score, 
used one minute after birth to assess a baby’s condition. Its  components of heart 
rate, respiratory effort, colour, muscle tone and response to stimuli do not closely 
correlate with each other, but the Apgar score remains valid and useful because 
they are all indicators of a possible problem(406). Similarly the total POS score can 
be used to identify participants likely to have severe complex needs. The 
distribution of total POS scores has been presented here to demonstrate that 
severe complex needs do exist in this population of newly diagnosed patients and 
that a minority of them are likely to benefit from specialist palliative care. Given its 
limitations, the total POS score has been used descriptively only and is not an 
outcome in any multivariate analysis. The improvement in total POS score over 
time is expected, given that each individual POS outcome was shown to improve 
over time, and it does not provide additional evidence of improvement. 
 
 





Pain, symptoms and worry have similar score distributions at baseline, ability to 
find life worthwhile causes somewhat fewer problems, and lack of peace somewhat 
more. By contrast, ability to share feelings and lack of help and advice stand out 
clearly as the areas where severe problems  are the norm, not the exception. While 
pain, symptoms, worry, peace, and feeling life is worthwhile are all individual 
conditions, the other two items have in common the fact that they are social and 
relational. The very high common and severe problems in these areas compared to 
others suggest that people newly diagnosed with HIV are likely to feel isolated and 
alone. The difference may reflect a distinction between personal wellbeing and 
social integration 
 
At baseline, three outcomes (peace, feeling life worthwhile, help and advice) have 
better scores in Kenya. Over time, five outcomes (the same three plus pain and 
worry) have better scores in Kenya, and no outcomes are better in Uganda. These 
associations are independent of wealth quintile, although participants in Uganda 
are poorer than those in Kenya. Country is the covariate most strongly associated 
with the psycho-spiritual outcomes peace and life worth, and has an even stronger 







G.4 Generalisability of findings 
 
The findings presented here represent a substantial contribution to the literature on 
patient-reported problems at HIV diagnosis. The rest of the evidence as identified 
in a systematic review was very limited. Eleven studies took place in low-income 
countries, but five of these recruited only pregnant women(65, 79, 105, 289, 294),  
and three more were chart reviews of inpatient with a comorbidity (286, 296, 297). 
Six studies came from middle-income counties but their quality was very 
variable(260, 287, 301-304). Finally 17 studies were conducted in high-income 
countries, but three of these recruited pregnant women only(285, 288, 295), three 
recruited people with recent seroconversion(136, 292, 293), and a further seven 
took place before the development of HAART in 1996(263, 290, 291, 305-308). 
Most of these are not representative of a contemporary population newly 
diagnosed with HIV. Also, none of the studies in the systematic review used a 
multi-centre design, so any idiosyncrasies of the study site would not have been 
apparent and would have affect the results. By contrast, the data used in this thesis 
came from consecutively recruited newly diagnosed people presenting for care in 
two countries and represent the most realistic and representative sample ever 
presented. 
 
The paucity of research in the area make these findings valuable and relevant 
beyond the context in which they were collected, but care must be taken not to 
extend their application too far, simply for lack of alternatives. For example, the 
West African pandemic is very different from East Africa (more concentrated, lower 
overall prevalence, and presence of HIV-2(16)), quite apart from the linguistic, 
cultural, economic and situational variation. However, evidence of multidimensional 
needs at HIV diagnosis in West Africa currently comprises one cross-sectional 
checklist of physical symptoms(303) and one quality of life questionnaire with 56 
Air Force recruits(287), both from Nigeria. Multidimensional problems are virtually 
unknown and evidence of change over time is completely absent. Similarly, HIV 
diagnosis from a patient-centred perspective in South America is a mystery apart 
from one chart review of symptom prevalence in Brazil(260). The findings 
presented here from Kenya and Uganda increase the probability that people in 




the first months after HIV diagnosis, but they by no means compensate for the lack 
of quality patient-centred evidence from those settings. 
 
The eleven facilities in the study were selected from all those in Kenya and Uganda 
receiving PEPFAR Care and Support funding. The largest facilities from a random 
sample were chosen in each country, the reason being that facilities hosting the 
study needed to have sufficient patients and staff capacity. Previous findings as 
part of the evaluation showed that the larger facilities offered a wider range of 
care(346, 347), although quality of care was not measured. Therefore, it is likely 
that these eleven facilities provided better multidimensional care better than that 
available to the average patient. The improvement in outcomes seen in this sample 
is probably a best case scenario. 
 
The analysis presented here did not take account of differences between sites, or 
to put it another way of clustering by site. This was partly because the sites differed 
greatly in the number of participants recruited from each, with one site represented 
by only three participants. Adjustment for clustering would give too much weight to 
small sites. I could have dropped the smallest sites from the analysis but the 
general problem would have remained.  
 
G.4.i Generalisability between Kenya and Uganda 
 
Participants were consecutively recruited with very few refusals, and therefore they 
are representative of patients newly diagnosed with HIV who seek care at the 
eleven facilities where data were collected. The eleven sites were the largest (in 
terms of annual patient numbers) in each country from a stratified random sample 
of PEPFAR-funded facilities. Large facilities were selected so that they would have 
the capacity and resources to host the study. Very generally, larger sites deliver a 
better quality of care, especially in resource-poor contexts where smaller facilities 
are less likely to have necessary staff, equipment or drugs. Phase 1 of the PHE 
found clear associations between facility size and the range of care delivered, 
although care quality and outcomes were not recorded(346, 347). Thus, these 
facilities differ in known ways from the majority of PEPFAR-funded sites, and differ 
in unknown ways from health facilities in Kenya and Uganda which are not funded 





Physical function scores were generally good, with 70% of participants reporting 
the best possible ECOG score of zero, but multidimensional problems were highly 
prevalent. Previous studies have often recruited populations with advanced 
disease or AIDS(298), but these findings show that multidimensional problems are 
also common earlier in the HIV disease trajectory. The sample was 62% female, 
which is a normal gender ratio for a group of people receiving HIV care. Men are at 
slightly lower risk than women of HIV in Africa, but the main reason for the 
discrepancy is that men are less likely to have an HIV test or to present for 
care(16). 
 
The extent of difference in outcomes between Kenya and Uganda was 
unexpected. It is unclear whether these national differences are caused by cultural 
interpretation of the questions, socioeconomic background, difference in care 
provision, or some other factor. Problems with symptoms and worry were similar at 
baseline but the countries diverged over time. The only common trend to all 
national difference was that problems were always more severe in Uganda than 
Kenya. The fact that Kenya and Uganda, neighbouring countries with close cultural 
and economic ties, produce such different results casts doubt on the 
representativeness of findings beyond these two countries. However, the 
systematic review shows that evidence of problems at HIV diagnosis is extremely 
limited in quantity, quality and representativeness, especially in its application to 
African outpatients. The findings presented in this thesis are more likely to be 
appropriate to outpatient settings in the rest of Africa than any data previously 
published.  
 
Kenya is a more developed country than Uganda, with a higher life expectancy, 
degree of urbanisation and Gross Domestic Product(20), but it also has a greater 
proportion of its population living below the poverty line, showing that the extra 
income is not equally shared. It does not seem likely that the differences observed 
between Uganda and Kenya were caused by economic factors. The outcome most 
affected by country – access to help and advice – was not associated with wealth 
quintile at all, and neither were worry and difficulty finding peace which were both 
more prevalent in Uganda over time. On the other hand, pain was closely 





The strongest associations with country were seen for difficulty finding life 
worthwhile, finding peace, and accessing help and advice. The first is highly 
dependent on cultural expectations of what gives worth to life. The second 
attempts to define the contentious and culturally variable concept(394, 407) of 
spiritual wellbeing. The third outcome was shown in cognitive interviews to be the 
most problematic item, with varied interpretations. Thus it appears that the 
differences between the two countries may have been caused by cultural and 
linguistic interpretations of the items. The four translations of the POS used in this 
study were not validated after translation. If they had been, it would now be easier 
to estimate how much difference between Uganda and Kenya is real, and how 
much is a product of the questionnaire. 
 
On the other hand, translation errors would be expected to be random; either 
country might end up with a higher prevalence of problems. In this case, Kenya 
always has fewer problems in every case where there is a difference, which argues 
for a systematic bias such as a different patient demographic or better care. 
 
The difference between Kenya and Uganda also implies that there would have 
been clustering by site. Site occupies a middle level between country and 
individual. Since there were only five sites in one country and six in the other, the 
national difference could have been caused by extreme results in one or two 
facilities. The effect of facility-level clustering could be examined using multi-level 
modelling, to identify whether structural factors are associated with the outcomes. 
 
 
G.4.ii Generalisability to high-income countries  
 
The extent to which these results can be generalised to the rest of the world 
depends partly on how much the experience of being HIV positive is common 
across boundaries and cultures, and this is uncertain. Differences between the 
experience of HIV in a low-income and a high-income country include risk factor for 






1. Risk factors for infection 
 
In Africa the main routes of infection are heterosexual sex and vertical 
transmission. As a result, a third of people with HIV are children aged under 15 and 
60% of the adults are women(16). In high-income countries where vertical 
transmission is very rare and the epidemic is much more concentrated, the majority 
of people with HIV are men, and women with HIV are disproportionately likely to be 
IDU or sex workers. These populations have specific health needs of their own 
which are not typical for all women. The natural history of HIV in children is much 
less well known than it is for adults. Children are also at higher risk than adults of 
morbidity and mortality from enteropathic infections and diarrhoea. Therefore the 
different risk factors for infection lead to HIV positive populations with entirely 
different demographic characteristics, health risks, and prognoses. 
 
 
2. Background health status  
 
Even without HIV, life expectancy would be lower in Africa. When the initial 
expectations of a healthy life are different it is not simple to compare the relative 
impact of HIV between settings. The incidence of many infectious diseases is much 
higher in Africa, due to warmer climate and limited access to health services. A 
person with HIV is more likely to encounter someone with active TB and therefore 
more likely to have HIV and  TB co-infection, with increased symptom burden(408). 
Several large-scale seroconversion cohort studies in Uganda found increased all-
cause mortality risk(409), rapid progression to WHO stage 2 and high symptom 
burden compared to high-income country cohort, but CD4 counts appeared to be 
within the same range(357, 358). The reason was that the common indicators for 
WHO Stage 2 and 3 (weight loss, prolonged fever, pulmonary TB, skin problems 
and bacterial infections) were highly prevalent in the HIV-negative population(357, 
410). The question then arises whether HIV progression was really accelerated or 
not. If the outcome is morbidity and mortality, HIV progresses faster in Africa. If the 
outcome is CD4 count then there appears to be little difference. From the patient-
centred perspective, the former is more accurate, since morbidity directly affects 





3. Health care resources 
 
The time between infection and diagnosis is on average longer in Africa, thus 
newly diagnosed people are more likely to present with advanced illness. Delays 
are caused by limited access to testing facilities and to health care workers who 
might recognise HIV symptoms. ART services are expanding rapidly but in 2008 
only 44% of those who needed treatment in Africa were accessing it(29). Life 
expectancy, quality of life and symptom prevalence are all affected by ART, so it is 
not possible to establish the contribution that universal access makes to the better 




Societal response to HIV affects the experience of living with it. Since lack of social 
support is a risk factor for depression, and depression is a risk factor for 
accelerated disease progression, stigma may actually limit life expectancy. In this 
study, the areas of greatest burden are inability to share feelings and a lack of help 
and advice for the family, both of which are largely social problems.  
 
5. Biological variation 
 
Some argue that the progression of HIV disease is faster in Africa than in high-
income countries after accounting for all other confounders, due to either 
physiological differences in immune response of the people with HIV, or a more 
virulent strain of virus(409).  
 
The demographic features and disease burden described above for Africa also 
affect black Africans with HIV in high-income countries. In the UK, black Africans 
on average present for an HIV test with more symptoms than people of other ethnic 
groups (257). Black women with HIV have fewer lifetime sexual partners than white 
women but are nearly always infected through sexual intercourse, and are more 
likely to have AIDS and TB at diagnosis(411). These findings demonstrate that the 




Several of the factors discussed above are in a state of change, and the relative 






G.5 Study strengths  
 
This is the first known study of multidimensional problems in newly diagnosed 
African outpatients, who comprise the majority of people diagnosed with HIV. It 
makes a substantial contribution to the body of evidence regarding HIV diagnosis. 
It is the largest and most methodologically rigorous prospective study ever 
published on HIV diagnosis, and it presents the most reliable evidence yet 
obtained for the experience of HIV diagnosis in any population, and from any 
scientific field. The study’s quality rests in the representativeness of the sample, 
the suitability of the tools and the statistical analysis.  
 
The sample is recruited consecutively with few refusals and is thus representative 
of people attending for care at eleven public HIV care centres in two countries. It is 
very large, consisting of 438 people interviewed up to four times. All participants 
were recruited within two weeks of HIV diagnosis, which has scarcely been 
attempted since the earliest studies of reaction to diagnosis in the 1980s(263). 
Thus the dataset is highly original and probably unique. Building contact between 
the person with HIV and health care services is easiest and most effective if done 
at HIV diagnosis; easiest because the person is already in contact with a health 
worker at that point, and most effective because it is as early as possible. 
Therefore, this sample closely represents the patient group relevant to care.  
 
This is the first longitudinal study of outpatients in a low-income country and the 
first study anywhere to collect data more than three times within six months of 
diagnosis. These areas were identified as lacking from longitudinal research in the 
systematic review. Completion rate is good and LTFU is low. Multidimensional 
outcomes are analysed and compared, whereas previous studies have usually 
measured outcomes in only one or two areas. The outcome tool was developed for 
the purpose and validated in the settings, which improves the reliability of findings. 
Data were collected prospectively and the period of recollection is only three days, 
limiting recall bias, which is a risk in studies of emotionally charged events(270). 
The outcomes are centred on patient experience rather than latent variables. The 





The study used novel longitudinal analysis techniques which have never been 
employed in any patient-centred study of HIV diagnosis. As a result this is the first 
and only study to adjust for variation between individuals when analysing change 
over time. Four different methods of analysis were used, each selected to best fulfil 
one of the objectives. Measures were taken to prevent ‘data dredging’ and the 
production of spurious findings. A detailed analysis plan was written in advance, 
and statistical tests were kept to a minimum. Conservative methods were used, for 
example analysing the ternary POS outcome scores at ordinal rather than 
categorical, which halved the quantity of output but increased power.  
 
Only three studies of outpatients at HIV diagnosis in low-income countries were 
identified in the systematic review of HIV diagnosis. One is a retrospective study of 
patient records in Haiti, with unclear methodology(300). Another is a study of AIDS 
patients, who are not typical of the average person at HIV diagnosis(298). The third 
investigates predictors of HIV status disclosure(299) and views the newly 
diagnosed person as a potential vector of disease, rather than a patient in need of 
care.  
 
In line with the study aim, findings are clinically oriented and patient-centred. POS 
items were chosen as the outcome because they are directly patient-reported 
without alteration. As much as possible, POS items have been analysed 
individually resisting the use of combination or overall scores, to maintain patient-
centredness. The total POS score has been used only in univariate analysis to 
show the existence of patients with multiple complex needs.  For all outcomes, 
univariate data are presented before any more complex analysis is undertaken, 
and the first section of the longitudinal analysis uses a readily interpretable 
technique, proportion of net change, to make the data more accessible to 
clinicians. As another example of clinical relevance, the first appearance of the 
patient after diagnosis (T0) was consistently used as the baseline in longitudinal 
analysis rather than the day of diagnosis itself, because care could only be 
delivered from T0 onwards and so linking back to diagnosis would have set up 
unreachable targets for care.  
 
Three questions are of particular interest for clinicians: is it possible to predict who 




whose problems recur? The multivariate analysis of risk factors at baseline 
answers the first of these questions, but it uses all the data. Since for most of the 
outcomes moderate problems are more prevalent than severe ones, risk factors for 
moderate problems will tend to overshadow those for the most severe, even with 
an outcome imputed as linear.  
 
The multivariate analysis of change over time goes some way towards 
understanding those whose problems improve the least, which certainly includes 
the patients whose problems get worse over time. However, an alternative method 
would have been to identify these patients at the start and compare them to 
patients who recover, essentially using a case-control design. This could be a more 
appropriate method given that for several items only a small number of participants 








G.6 Study limitations 
 
 
G.6.i Study design 
 
The decision to investigate palliative care-related problems of newly diagnosed 
participants as a group was not made until after the beginning of data collection. 
Thus the study is a secondary analysis, albeit one in which the new analysis is very 
close to the original purpose of the study and conducted by the same person. I 
drafted the aims and objectives were drafted before any primary analysis had been 
undertaken, so nothing was known of the characteristics of the newly diagnosed 
population. Also, I was heavily involved in the study design and conduct from its 
inception. I designed the questionnaire packs, wrote training material, built the 
database, trained research assistants and HCWs, monitored data entry, and was 
responsible for statistical analysis and writing reports. Because of this, I was very 
familiar with the dataset and able to contextualise it, having the benefits of primary 
analysis. 
 
The dataset is very large for a palliative care study, but the use of multivariate 
analysis with up to seven independent variables led to some very small subgroups. 
In particular, the group with the worst physical function is very important (since they 
have greater needs in almost all areas) but numbers only 30 people. It would have 
been difficult to oversample this group since the design used total consecutive 
sampling of new patients. Recruitment at smaller health facilities, closer to patients’ 
homes, might have resulted in a greater proportion of people with restricted 
function. Access to the larger health centres with a wider catchment area could 
require more investment of time, energy and money, which may have biased the 
study against recruitment of poorer, disabled or more severely ill patients.  
 
Each of the eleven facilities recruited between 100 and 125 participants to the 
PHE, but the number per facility who were newly diagnosed varied from three to 
80.The facilities themselves were selected for their suitability for the PHE, as the 
largest six per country of a random sample of PEPFAR-funded facilities. Some 




been referred to the larger PEPFAR facility and then been recruited to the study. It 
was for this reason that the inclusion criteria allowed participants to be diagnosed 
up to 14 days prior to recruitment, as this visit could well have been their first 
opportunity to receive HIV care. An ideal sample would have recruited from primary 
level clinics which conducted frequent HIV tests, and would have recruited 
participants on the day of HIV diagnosis. 
 
Data collection was performed by HCWs employed by the health centres, who 
were trained and supported by independent research assistants from APCA. This 
is a possible source of bias, as HCWs could be motivated to show that their facility 
was successfully managing problems, especially since the main purpose of the 
PHE was to evaluate services for a major funder.  
 
There was considerable change over time during the study, which was especially 
rapid in the first month. It would have been interesting to collect data more 
frequently. There is evidence in the literature that change in psychological state in 
the first days after diagnosis can be very rapid(263). The POS describes only a 
period of three days and was designed to be sensitive to change in short period of 
times. The systematic review identified no longitudinal studies with more than four 
data points. This limitation makes it difficult to study trajectory or to model non-
linear data.  
 
Only adults aged 18 and over were included in this study, because the APCA 
African POS is not validated for use in children. The majority of under-18s are 
diagnosed in infancy, and for this group the experience of diagnosis is of course 
very different. Clinical guidelines encourage gradual disclosure to the child, in 
stages as appropriate to their age and understanding, but without unnecessary 
delay(412). Those diagnosed in adolescence have a situation more comparable 
with that of the adults in this study (i.e. an abrupt diagnosis and initiation into care). 
In HIV prevalence surveys, adolescents aged 15-18 are usually grouped together 
with adults(16), but their problems and needs at diagnosis may well be unique, and 
they should be studied separately rather than simply included with adults to enable 






The study is representative only of people who have a health care consultation 
within two weeks of HIV diagnosis, either because they were diagnosed on the 
same day or because they were referred from a different testing facility and kept 
the appointment. They do not reflect the experience of those who delayed seeking 
health care after their diagnosis. In Cameroon, a retrospective survey of 3151 
outpatients with HIV found that 43% delayed their first medical consultation for 
more than a month after their diagnosis, with 15% delaying for more than six 
months(266). In this study, the people in contact with care services reported very 
severe problems, above all in accessing help/advice and sharing their feelings. It is 
likely that these problems would have been even more severe for people who did 
not receive any further care in the two weeks or three months following their 




G.6.ii Outcome tool 
 
The outcome instrument, the POS, is multidimensional, whereas a typical QoL 
instrument aims to be unidimensional. Each question is aimed at eliciting 
information about a different area of need according to the WHO definition of 
palliative care(11). Multiple questions on a single topic are avoided in order to keep 
the tool as brief as possible, which results in a low Cronbach’s alpha(256). For this 
reason, all analysis has presented the seven items separately before creating a 
combined score. It is also clinically more useful to analyse by item. 
 
The tool was not revalidated after translation. The scores in the two countries differ 
most for the outcomes of peace and feeling life is worthwhile, which are difficult to 
define. Some of the difference between countries may be caused by cultural or 
linguistic understanding of the question. Even when back-translation ensures that a 
questionnaire is exactly the same in the new language, the concepts it uses may 
not be translatable.  
 
The item ‘Have you had enough help and advice for your family to plan for the 




Cognitive interviews during the validation of the APCA African POS found that this 
question had the poorest face validity. Of 46 responses, 13 showed 
comprehension difficulties, although detail is not provided on how participants 
interpreted the question(256). Clearly the question does not mean the same thing 
to all participants. Therefore, although the responses show that a vast need exists 
in this area, it is not clear exactly what that need consists of or how it should be 
met.  More specific information is needed to understand the nature of patients’ 
problems. Qualitative methods might be a more appropriate way to research this 
area, since it is only possible to develop a valid questionnaire once a shared 
meaning is established.  
 
The version of the POS that was used in validation included text phrases only for 
the two ends of the scale, numbers 0 and 5(256). For example the first question, 
‘Please rate your pain in the last three days’ asked patients to rate their pain ‘from 
0(no pain at all) to 5(overwhelming; the worst pain you can imagine)’. In piloting for 
the PHE, HCWs reported that patients found it difficult to match their experience to 
a number and they would prefer to select from a list of phrases. The POS response 
sheet was therefore modified, so that the possible answers for the pain question 
became ‘0(not at all), 1(slight pain), 2(moderate pain), 3(severe pain, interferes 
with activities of daily life), 4(very severe pain), 5(overwhelming; the worst pain you 
can imagine)’. These phrases were translated and back-translated into the various 
languages used in the study. The consequence of this modification is to force a 
certain interpretation of the scale upon the participant. I have not used these 
phrases in the thesis as they were not validated. 
 
In this thesis, the item scales have been presented alongside each other as though 
they were comparable. While each item is separate from the others, there is an 
underlying assumption that they represent the application of the same 0-5 scale in 
different areas. The same analysis is applied to each of the seven items. In Part A, 
for instance, I interpret the results to mean that the need for help and advice is the 
area of most severe problems because the proportion to report a score of 5 was 
highest for that item. This assumes that the different items can be compared with 
each other. In the validated POS, each item was anchored at each end,. The best 
possible score was always ‘no problem’ (phrased as ‘no pain’, ‘not at all’, ‘able to 




possible score was ‘overwhelming, ‘all the time’, ‘not at all’, or ‘none’. They 
described extremes and therefore they could be considered comparable, although 
the problems they described were very different. The lowest score always meant 
no problem at all and the highest always meant an all-consuming problem.  
 
With the addition of new intermediate text phrases, the issue of comparability was 
confused. For example, a score of 3 can mean ‘severe pain’, ‘worried a lot of the 
time’, ‘been able to share feelings occasionally’, or ‘had help and advice for a few 
things’. It is unclear whether all these situations should be considered as equal, 
such that the percentage of participants scoring 3 or above in each area could be 
evaluated usefully. Without the text phrases, participants would have been 
assessing their own situation for each item as ‘3, if 0 is no problem and 5 is the 
worst possible problem’, which might result in a fairer comparison between items.  
 
Feedback from research assistants in the field indicated that participants preferred 
text phrases to numbers. To use them, a POS with text phrases would need to be 
tested and validated. There are plans also to develop and field test a POS ladder, 
allowing participants to point at a certain position on the scale, similar to a Visual 
Assessment Score (VAS).  
 
It is a disadvantage of secondary analysis that the outcome tool cannot be altered 
or refined. The POS is ideal for the patient-centred aim of this study but some of its 
features, such as brevity, are less advantageous in this population of relatively 
active young adults than in a group of terminally ill hospice patients for whom the 
tool was in part designed.  
 
Alternative outcome tools 
 
The POS is patient-centred. The same instrument is used in both clinical care and 
research, demonstrating that its responses are meant to be useful at the patient 
level, whereas some tools are designed to be averaged over a population and give 
distorted results when applied to one person. It is not disease-centred; problems 
recorded on the POS do not have to be caused by HIV. Nor is it centred on the 
HCW; problems need not be manageable. The POS measures holistic, patient-





Asking about specific symptoms could have elicited more information than asking 
about symptoms in general. Dr Hellen Kariuki at the University of Nairobi reported 
that patients expect fatigue and tiredness to be inevitable in illness, and so they do 
not complain of these symptoms (personal communication). In the USA, patients 
with HIV report three times as many symptoms as their clinicians do(54), and the 
patient-reported symptoms correlate better with clinical outcomes(54, 413). It would 
have been interesting to compare symptom prevalence results with the literature. 
The MSAS would have been ideal. It is a validated instrument(414) and has been 
used in populations with AIDS in Uganda(298) and the USA(46) and on men 
receiving ART in the UK(10).  
 
The PHE also made use of the MOS-HIV, a culturally adapted(66, 415) QoL 
instrument and the most widely used in HIV, notably as a secondary outcome in 
ART trials(416). I chose not to use the MOS-HIV subscores or combined scores as 
outcomes in my analysis. This was because the aim was to be patient-centred and 
to adhere as closely as possible to the patients’ self-reported experience, by 
measuring palliative care-related problems at diagnosis, which the MOS-HIV is not 
able to do. Basic information on the prevalence and severity of problems in 
different areas is required before it is appropriate to explore latent variables or to 
summarise problems into combined scores.  
 
 
G.6.iii Missing data 
 
I made the decision not to use imputation or Heckman-type selection 
modelling(417) in this thesis to adjust for missing data. Instead I analysed observed 
data only. Either choice involves assumptions. In this case I made the assumption 
that the unobserved data was not informatively different from the observed data.  
 
The analysis of missingness patterns for Part C of the analysis revealed that the 
total POS scores at baseline of people who later had missing data were on 
average higher than the mean score for people with a complete data record. The 
effect was not significant (the 95% confidence intervals overlapped), but this was 




intervals were quite wide. If the groups had been of similar size, their confidence 
intervals would not have overlapped. Therefore it would have been more 
conservative to have used either Heckman selection or imputation to adjust for 
missing data and the lack of such adjustment is a limitation of the thesis. Future 
work using this dataset will adjust for missingness. However, as I explain below, 
there is reason to think that missingness will not substantially affect the results and 
will tend to underestimate rather than overestimate problems. 
 
The proportion of net change analysis shows that POS item score at one time is 
associated with score at a later time. If it was not, the distribution of change values 
would be flat, rather than parametric. Therefore the missing POS sores at later time 
points are likely to have been on average higher than the observed scores, and 
thus data should be considered MNAR. Participants who dropped out of the study 
or missed a data point probably had more multidimensional problems than those 
who remained. As a result, the improvement in scores over time has been inflated, 
some of it being caused by bias due to LTFU.  
 
The results presented here tend to underestimate the prevalence and severity of 
multidimensional problems. Multidimensional problems are worse and more 
common between one and three months after HIV diagnosis than has been 
reported. This attrition bias is known. An additional an unknown selection bias is 
also likely to have occurred, because the sample does not represent those 
individuals who did not attend for care within two weeks of their HIV diagnosis, who 
may represent the majority of people diagnosed. In Johannesburg, 85% of patients 
with CD4>200 did not return for their CD4 test result within six months after HIV 
diagnosis(145), and in Durban 31% were LTFU within three months between their 
HIV test and CD4 test(157). These two biases are similar. Every adult who 
presented for care within two weeks of diagnosis was recruited, with very low 
refusal. The main reason for loss to follow-up at later time points was failure to 
appear at the health facility, therefore representing not only LTFU from the study 
but also from clinical appointments. The sample represents patients who are 
actually seen by health care workers and in that sense it is of direct clinical 
relevance. The patients LTFU after their first post-diagnosis appointment and the 
much larger group who are LTFU before that probably have an even higher burden 





In Part D of the analysis, the logit models are less affected because all observed 
data points are used, rather than only those within specific time periods as for the 
proportion of net change in Part C. Form this full dataset only 13.8% of 
observations were missing. A common rule of thumb for the effect of attrition on 
validity is that less than 5% LTFU probably causes little bias but more than 20% 
poses serious threats to validity(418). For values in between, the effect depends on 
other factors including the study design and analysis methods. The methods used 
for Part D were chosen because they are robust to informative missingness(334) 
The risk factors for multidimensional problems over time described in Part D are 
mainly the same as the risk factors for multidimensional problems cross-sectionally 
described in Part B, which had no missing data. Therefore the results in Part D are 
probably less affected by attrition bias. Where there is an effect, it will tend to 
inflate the extent of change over time.  
 
 
G.6.iv Wealth Index 
 
Relative poverty undeniably has considerable impact on access to care and on 
health outcomes, but it is not a single, objective quality and there is no gold 
standard way to measure it. The DHS method used here has been validated(333) 
and is one of the most widely accepted methods used in the Demographic Health 
Surveys project in collaboration with the World Bank. In this study, the basic 
Wealth Index questionnaire was used without alteration. It is possible to add 
additional context-specific assets to the list, if home construction, ownership of 
goods, and quality of daily resources (water, sanitation, fuel) are expected to fail to 
pick up important information. Not enough was known about Kenya and Uganda to 
tailor the questionnaire to the context.  
 
Variables with the highest loading on the Wealth Index in principal components 
analysis were, in order: an earth floor (negative), owning a television, owning a 
flush toilet, owning a refrigerator, a house of mud and brick (negative), owning a 
mobile phone, using well water (negative). Rare items which are strongly 
associated with poverty are likely to have high loadings. The Wealth Index has 




scores ‘better’ than thatch because the poorest members of the population have 
thatched roofs. This can lead to a situation where a slum has a higher score than a 
village, although the quality of life and health status of the slum dweller may be 
lower(419). Related to this, it is not clear whether the difference between Kenya 
and Uganda is representative of the two countries. Kenya has a higher GDP than 
Uganda and its facilities in this study are more urban (see Appendix C).  
 
The score is called a Wealth Index rather than a poverty index. The entire cohort is 
relatively poor, with only 16% having indoor piped water, 12% a household car and 
10% a flush toilet. I have referred to some participants as wealthier than others but 
it might be more appropriate to say that they are less poor. Even within an 
environment of widespread financial constraints, the very poorest participants have 
the greatest needs.  
 
 
G.6.v Data accuracy  
 
In the PHE, data management was good, using coded questionnaires and a 
matched database, with double entry and validation. These techniques were not 
possible for the collection of CD4 count data, which were extracted from patient 
records. It was not practicable to do this twice and so data collection consisted of a 
research assistant copying CD4 counts and dates by hand onto a spreadsheet. 
Mistakes detected during cleaning included duplication, reversal of month and day, 
repetition of CD4 count, and writing the current year by mistake. Only errors which 
are impossible, systematic or very unlikely could be identified and checked. The 
CD4 results are the weakest point of the dataset and it is partly for this reason that 
I have made little use of them.  
 
Other errors may also exist. Around 20 people in the original sample reported they 
were newly diagnosed but their patient records showed a CD4 count predating 
their supposed HIV test, therefore they were not included. All available information 
on dates (date of CD4 count, of registration, of data collection and entry, of WHO 
staging, etc.) was cross-checked to seek out other errors and whenever there was 




attempted to minimise the number of false positives by accepting the loss of some 
false negatives (participants who might have been newly diagnosed but whose 
information was lacking or inconsistent). Even so, it is possible that this sample of 
438 includes individuals who were actually diagnosed HIV positive long before 
recruitment. However, the sample size is so large that a small number of false 
positives like this would be unlikely to influence the findings.  
 
In a large clinic in South Africa, the most resource-rich country in the region, the 
majority of people who come for VCT and are diagnosed HIV positive do not enter 
care(145). The connection between testing and care is frequently and perhaps 
repeatedly broken. As people with HIV negotiate the barriers that prevent them 
accessing care, they may return to the same health centre or a different one, and 
re-test. Therefore the sample of 438 people within two weeks of diagnosis in this 
study may not be newly diagnosed for the first time. In terms of patient-centred 
health care provision, this is not a priority. The group may not entirely consist of 
people who have just discovered they have HIV, but it is representative of the 
patients who require from-diagnosis care. These patients were recruited at the 
point of diagnosis and that incident is their link to health care. If the link has been 
broken in the past, all the more reason to address their needs on this occasion. 
 
In the UK, there have been cases of people concealing a previous HIV diagnosis 
and treatment, who were identified by resistance to ARVs (420). In the absence of 
a robust referral network, it would be possible for people to register more than once 
and receive a double script of ARVs, despite efforts to prevent this. A lost 
connection to care is probably the more likely scenario. 
 
HCWs reported that many participants were diagnosed at small health posts or 
mobile testing centres, and referred to the participating facility for care. An 
unknown proportion of newly diagnosed people did not follow up this referral within 
two weeks of diagnosis and hence were not included in the study sample. It is likely 
that the individuals who did not attend for care after their diagnosis, or who delayed 






G.6.vi Analytic methodology 
 
Loss to follow-up was low, with 75% of participants (n=325) completing all four time 
points, but the 25% who left the study are likely to differ from those who stayed, 
possibly in ways that would affect the findings. In setting the criteria for Part C 
analysis, which required data to fall within specific times from diagnosis, I reduced 
the number of participants with four valid observations to 185. This was a 
substantial loss of data. The 185 may have been different from the total 325 who 
completed four observations, or from the total 438 who began the study. 
 
Throughout the analysis plan I used p<0.05 as the threshold for retention of 
independent variables, as is standard practice, but the choice is arbitrary. There is 
nothing inherently important about p<0.05. In the analysis of variables associated 
with symptoms, country had a p-value of 0.052 until age was removed, when it 
reduced to 0.049. The change was minute, but because it crossed the significance 
threshold of 0.05, country remained in the model as a predictor of symptom 
burden. I discuss the OR, standard error and confidence intervals in my 
interpretation of the results, rather than focus solely on the p-value. 
 
The number of statistical tests performed increases the risk of Type II error. I took 
several precautions to reduce this risk. I analysed change over the full time period 
before breaking it down by month and if there had been no overall change over 
three months I would not have proceeded further. In Part D, every independent 
variable is analysed against every outcome, which produces 56 separate statistical 
tests. However, these are used only to select variables to take forward to 
multivariate analysis. I do not draw conclusions from the univariate results as the 
risk of Type II error is too high. Most of the analysis in part B is process rather than 
outcome. It is used to make decisions regarding the structure of the final model. 
 
The twelve facilities selected for the PHE (of which eleven recruited newly 
diagnosed participants) were selected based on size. They are not typical of HIV 
care centres in Kenya and Uganda or even of PEPFAR-funded centres. The PHE 
found that larger facilities offer a wider range of care, although they are less likely 




the results that all participants were recruited from facilities that had this feature in 
common.  
 
The ordered categorical variables wealth quintile, age category and physical 
function were used as though they were continuous. The distance between one 
stage and the next is assumed to be constant. This is fairly common practice in 
regression models, and it is the reason why, in the graphs in Part D, the lines for 
each quintile are always an equal distance apart. An alternative method would 
have been to use dummy variables, one for each possible value. This would have 
increased the number of independent variables relative to the sample size, and 
possibly made the models unstable so that they did not resolve. It would also have 
raised the possibility of finding results that did not form a trend, such as a tendency 
for middle-income people to have more problems than both the wealthier and 
poorer quintiles. Age category, wealth quintile and physical function are all 
categorical representations of an underlying linear variable. I considered that non-
trend results were more likely to be artefacts of the analysis. Given the big sample 
size, strong statistical power, and number of outcomes, the risk of Type II error was 
high and so I tried to minimise it by using single independent variables instead of 
dummies. 
 
In the multivariate longitudinal analysis, the six-item scale was transformed into a 
binary one, with consequent loss of detail. It is possible that a high level of 
problems might have very different risk factors, consequences and impact on 
quality of life from a moderate problem. In fact, the multivariate cross-sectional 
analysis found this to be the case, in some areas, but not many. For the most part, 
the same risk factors were associated with the outcomes in both strata, and also 
over time when stratifying was not used.  
 
Age categories were 18-25, 26-40 and 41-59, with the aim of detecting a 
relationship between lifetime experience of HIV and perception of stigma. The two 
variables associated with age were difficulty finding peace and finding life 
worthwhile, which are influenced by perception of HIV, but it is not possible to 
distinguish the cohort effect of experience from the age effect of maturity. This is a 
frequent problem when trying to ascertain the effect of age on an outcome. Using 




the data to divide the group into approximate tertiles rather than have one group 
bigger than the other two combined. 
 
The demographic and clinical questionnaire included a closed question on ‘reason 
for attending facility today’, and an open text box for ‘place referred from’. This 
information could have been very useful in understanding whether symptoms or 
worries motivated people to have an HIV test. Unfortunately, the questions were 
not sufficiently covered in training, results proved to be highly variable between 
facilities depending on how they were interpreted, and the data were not usable.  
 
The logit models in Part D may appear to overload the data. For example, the 
model in Figure F-16 contains a theoretical 60 categories, of which seven are 
empty. In fact, the technique maximises power because all 1511 observations 
contribute to the development of the model and the categories are population-
averaged, so they do not rely solely on the data within that category.  
 
The proportion of net change method reduces the complexity of data and does not 
take full advantage of the longitudinal dataset. It was done because no longitudinal 
methods allow for a skewed, non-parametric, short-scale ordinal variable such as a 
POS item, and also because it is a simple, replicable technique and an example for 
other analysis, as discussed in Section G.7. In longitudinal analysis, the problem 
was resolved by turning the ordinal variable into a binary one, with consequent loss 
of information. In order to retain the detail of the outcome measure it was 
necessary to lose the detail of the time measure, and group time into categories 
(M0, M1 etc). This reduced the sample size, as time points which did not fit into a 
category were dropped, but the very large size of the sample meant this could be 
an acceptable trade-off.  
 
It is not possible to distinguish unmet need from absence of need for care, and this 
is particularly noticeable with ART. While all eleven facilities had ART, funds and 
supplies could be limited, and are limited and in order to maintain therapy for 
existing patients, some facilities would halt ART initiation for a time. Combined with 
the literature showing that many patients eligible for ART are not enrolled(157),  it 
is likely that some people in the study were suitable to begin ART, but not receiving 




guaranteed method to determine need for ART from the data available. The study 
is a representative sample of outpatient care, in that some patients do not need 
ART, some are taking it, and some are in want of it. Three outcomes were 
associated with ART (and one more just missed significance) but it is not possible 
to separate the non-ART group by need. 
 
I did not investigate correlations between the seven outcomes, or model the effect 
of one outcome on another over time. There were two reasons for this. Firstly, 
there would be a great many possible models, with a correspondingly high 
probability of spurious results. Secondly, correlation is very likely to occur and this 
would not prove causation or even a non-confounded association. Intrinsic to the 
philosophy of palliative care is the concept that the different dimensions are 
interconnected and that problems in one area cannot be treated effectively without 
addressing other areas too. Correlation between pain and worry, or peace and 
finding life worthwhile, is so likely to happen that it is not a good use of a statistical 
test, because the null hypothesis is probably untrue. A factor analysis of the results 
would be a logical next step to identify the strength of associations between items 
but it was beyond the scope of this thesis. 
 
In longitudinal analysis, I chose to use the population-averaged approach rather 
than the individual-specific approach, even though personal trajectories and the 
variation between individuals are of great interest in palliative care. This is the first 
prospective multidimensional study of newly diagnosed outpatients in Africa, and 
has no hypotheses for lack of evidence to support any. In pioneering research such 
as this, population-level analysis is more appropriate, which can later be developed 
to explore the variation and complexity within the major trends found here. I also 
carried out some individual-specific longitudinal logistic regression (using fixed 
effects), and found, as is typical(338), that the results were quite similar to those 
presented here but a little more extreme. This analysis is not presented here 




G.7 Methodological contributions 
 
This thesis demonstrates the value of ordinal logistic regression (OLR) for cross-
sectional and longitudinal POS analysis, and proportion of net change as a simple, 
effective and widely replicable method for analysing POS scores change over time. 
 
Four different kinds of analysis were employed in this thesis, of which each uses a 
different subset of the data, fulfils a different objective, and has its own advantages 
and disadvantages. Three of the four were completely novel applications of the 
POS. The discussion chapter shows how the four parts of the analysis support 
each other.  
 
The priorities (following from the aim and objectives) were to retain separate 
outcome variables rather than combine them, to study the effect of time, and to 
conduct a replicable and rigorous analysis. Given seven outcomes, seven 
independent variables, four observations per person and 438 participants, the risk 
of spurious results was high, so a detailed plan was produced and followed. The 
more complex methods were only used when necessary. Simpler analysis has the 
benefits of ready interpretation, accessibility to clinicians in the field, and proximity 
to patient-reported experience. More sophisticated techniques remove data further 
from the patient. One reason for the use of extensions of logistic regression was 
that they produce odds ratios and a p-value, widely used for reporting and very 
familiar to the intended audience of these findings.  
 
A six-point non-parametric ordinal outcome such as a POS score is too short for a 
linear variable and too long to model as categorical. Recoding the six-point scale 
into three or two increases the range of statistical techniques which can be brought 
to bear, including ordinal logistic regression. OLR is a very effective way to observe 
trends even though small changes may be lost, which was appropriate for the data. 
A trend for a variable to be associated with generally more severe outcome scores 
was more likely to be valid than, for example, the association of a variable with an 
outcome score of 3 as opposed to 0, 1, 2, 4 or 5. If I had retained a six-point scale I 
would have increased the risk of observing such trivial findings, which would 
obscure the larger trends. This thesis describes exploratory analysis in an 




is not uncommon in palliative care, which is multidimensional (thus requiring many 
outcomes) and which lacks an evidence base in many non-malignant conditions. 
This thesis presents a range of analytical techniques which may be applied to 
cross-sectional or cohort data on multidimensional problems in little-known 
populations. 
 
Longitudinal research into HIV diagnosis is greatly lacking, as shown in the 
systematic review, and only the most basic before-and-after analysis has been 
conducted. The standard analysis protocol for univariate measurement of change 
in POS scores over time is to use paired t-tests between time points (Bausewein 
and Downing, in press). This method is recommended to clinicians for its simplicity 
but was not used here for three reasons. Firstly, the data are so far from parametric 
that it is not appropriate. Secondly, the t-test only indicates whether change is 
present, not the size of change. Thirdly, it was very likely that change would be 
present, so the null hypothesis of no change was not valid. Proportion of net 
change is a simple, effective technique to present the extent and direction of 
change over time at the population level, and the slowing rate of change(338). It 
can be conducted quickly and reliably using ordinary spreadsheet software or (for a 
small dataset) by hand, making it very suitable for use in resource-limited contexts, 
and it does not require repeated statistical tests or incur the risk of Type II error. To 
my knowledge this is the first use of proportion of net change in palliative care.  
 
By contrast, the time-based (rather than month-based) longitudinal OLR requires 
expensive statistical software and the training to use it. Longitudinal analysis 
techniques with ordinal outcomes have been developed relatively recently. 
Longitudinal techniques are very valuable in palliative care and are particularly 
useful in a population defined by the time since an event, such as HIV diagnosis 
here. The methods used maximise efficiency and data usage. The longitudinal 
extension of logistic regression used 1511 of the 1524 observations collected 






H Implications and conclusions 
 
H.1 Is palliative care needed at diagnosis?  
 
Multidimensional problems, of the type which in other contexts and populations are 
managed by palliative care, are prevalent and severe at HIV diagnosis. That in 
itself does not mean that palliative care is needed in this context and population. 
Need is defined as capacity to benefit and there are at least two situations in which 
a problem may be present without implying a corresponding need:  
a) No intervention exists which could solve the problem 
b) The problem is already solved  
 
This study is the first to raise the possibility of palliative care at HIV diagnosis. No 
evidence has been published of the effectiveness of interventions at this time 
because it is not usual to report on newly-diagnosed people as a distinct group. A 
systematic review of palliative care in HIV showed positive results(140). It seems 
likely that interventions shown to work in populations with long-term HIV infection 
will also be effective in the post-diagnosis period, but there is a need for further 
research. Also, most palliative care interventions are complex and poorly 
understood, and evidence of effectiveness is lacking throughout the field, as shown 
by the limited number and quality of papers included in the systematic review.  
 
As for the possibility that the problem is already solved, the data here show that all 
scores decrease over time. After three months, severe pain and symptoms are 
very scarce. It could be argued that current practice of non-palliative HIV care, 
other non-health interventions or simply the passage of time resolve palliative care-
related problems at diagnosis. Some improvement is to be expected. Prior to 
diagnosis, participants probably had very little contact with health care services 
(otherwise they would have tested earlier). This study did not examine the role of 
current interventions, but they will have included common items such as non-opioid 
analgesics, antibiotics, topical cream for skin conditions etc. Some patients would 
have started TB treatment, which rapidly controls cough and night sweats and 
reduces fatigue. A regression to the mean effect may also be in effect. Participants 




probably played a role in the decision to test for at least some of the sample. 
Therefore the day of diagnosis would coincide with a spike in palliative care-related 
problems even among those who tested negative, because these problems would 
have prompted them to test.  
 
However, the gradual population-averaged improvement observed under current 
care is not sufficient. Most people diagnosed with HIV do not remain in care. 
Patient retention is a major public health issue(421), especially in the period before 
ART eligibility assessment, and for those patients who are not eligible at 
diagnosis(143). Outside the ART programmes (where retention is managed much 
more carefully), most people with HIV do not return for regular clinic 
appointments(321). Patients lost to follow-up have much poorer outcomes with 
higher mortality and morbidity than those who remain in care(422)l(157). Health 
services have a limited opportunity in which to provide care before these patients 
are lost to follow-up. The high patient attrition suggests that either the barriers to 
care are insurmountable, or the perceived benefits do not outweigh costs. The 
barriers include the cost of transport(423) and service fees(238), 
 
Lack of patient-centred care deters patients from remaining in health care. 
Qualitative interviews with patients in Uganda and Kenya found that they sought 
out facilities with a reputation for kind and respectful staff(346, 347). One of 
patients’ main complaints against facilities was rudeness or contempt from staff. A 
relationship of trust was deeply important to patients, was highly praised when it 
was found and regretted when it was absent. Patient-centred care such as 
palliative care to build a rapport with patients from the first clinic visit could 
encourage and support retention. Management of symptoms which impede 
retention (such as fatigue, pain and vomiting) could also help patients to remain 
and to initiate ART at the appropriate time, without delays.  
 
Retention was manipulated in this study be the use of transport reimbursement, so 
it cannot be studied as representative. In the literature, there is evidence that 
palliative care-related problems are barriers to retention in care. These include 
pain, hunger, hopelessness, and symptoms such as fatigue, confusion and 
nausea/vomiting(147). Current care may help to manage these problems, given 





In the first weeks after HIV diagnosis, patients are asked to take in a great deal of 
information and rapidly make decisions with long-term consequences. Practically 
they must return to the clinic at least once for a CD4 test result, which requires lost 
time from work, childcare, and money for transport. If put on the ART initiation 
pathway they will go through pre-ART counselling at which their readiness to 
undertake lifelong therapy is assessed. Patients are encouraged to disclose their 
status as soon as possible. Disclosure involves deciding to whom they can safely 
disclose their status, negotiating the conversation and dealing with the 
consequences which may include radical changes in family circumstances, 
violence or rejection. In more general terms [patients must plan how to adapt their 
daily life to deal with their HIV infection and treatment needs, and psychologically 
they need to accept the diagnosis as a reality.  
 
The multidimensional burden identified in newly diagnosed patients is likely to 
impede their efforts to manage their diagnosis and plan for the future. Qualitative 
interviews in Zimbabwe found that newly diagnosed people had a good factual 
understanding of HIV but conceptualised it as social and physical death(258).They 
were unable to make good use of their  knowledge and resources, instead 
employing avoidant coping strategies (denial and secrecy). Denial of HIV status is 
a cause of loss to follow-up, late ART initiation, and non-adherence, all of which 
are risk factors for mortality and morbidity. Not only for their immediate benefit, but 
also for long-term outcomes, multidimensional problems must be managed quickly, 
as their consequences may be severe.  
 
In summary, there is evidence that  
• Multidimensional problems  are prevalent and severe at HIV diagnosis 
• On average problems are reduced over time, for unknown reasons 
• Many people do not remain in care long after diagnosis 
• Multidimensional problems inhibit retention in care, disclosure, self-care and 
ART adherence 






Therefore I conclude that palliative care is needed at HIV diagnosis. It is an 
intervention of proven effectiveness in other contexts, it has low risks and its 
absence has serious and long-lasting negative effects. The consequences of this 
conclusion are discussed below.   
 
H.2 Implications for policy and practice 
 
As outlined in Sections B.2 and B.4, palliative care was originally envisioned as 
care for all with life-limiting conditions, but its policies and practice were developed 
in cancer. Wasson and George presented the ethical argument for expansion of 
palliative care to non-cancer conditions in 2001(424), basing it on justice (defined 
as fairness, equality and equity) and documented evidence of need. The HIV 
palliative care policies of the WHO(8, 129), UNAIDS and APCA(131), including 
their decision that palliative care begins at HIV diagnosis (quoted in Section B.3) 
have until now been based on justice but the evidence of need has been lacking.  
 
Skilled, proactive multidimensional assessment is needed within two weeks of 
diagnosis, and preferably on the same day. Staff should aim to manage at least 
some problems on the day of diagnosis and thus give patients the motivation to 
return for further care. Care on the day of diagnosis will also help to prevent 
patients being lost to follow-up between diagnosis and first appointment, and 
returning home with the multidimensional burden reported here. Follow-up should 
continue for at least three months with repeated holistic assessment to identify new 
problems, particularly in psychosocial dimensions, and perhaps especially once 
physical pain and symptoms have been controlled. Recurrence and the 
appearance of new problems are to be expected. The WHO Pain Ladder(12) must 
be followed for pain management. Appointments should be as few as is 
commensurate with good care, to reduce the burden of travel time and costs on the 
patient. Multidimensional problems are not associated with CD4 count, therefore all 
patients must be assessed for palliative care needs at diagnosis, including those 
with a high CD4 count and WHO stage 1 or 2. 
 
In sub-Saharan Africa, HIV palliative care is integrated with mainstream HIV 




palliative care-related problems and the limited health resources, make integration 
the only feasible model of palliative care(217). Adequate palliative care will require 
training and support for clinical staff of all levels including doctors, nurses, medical 
officers and medical assistants. ‘Task shifting’, the transfer of health care tasks to 
staff with less training and fewer qualifications, has arisen in response to the HIV 
epidemic and shortage of health workforce(425). Palliative care training must be 
developed for all health care workers, of many disciplines, including those with 
minimal skills. Short palliative care training courses for generalist health staff in 
Africa already exist, and increasingly they are moving away from a focus on end of 
life care to incorporate the full trajectory of HIV disease. At the same time, quality 
must be maintained, and effective, efficient support systems must be developed to 
maximise the value of one palliative care specialist to a large number of generalist 
HIV staff.  
 
Specialist palliative care must be available by referral for the minority of patients 
with multiple complex problems. Referral links must be strengthened with hospice 
teams for the management of intractable pain, severe psychological symptoms, 
and complex family needs. African hospices should develop small local centres or 
mobile services along the lines of Little Hospice Hoima and Mobile Hospice 
Mbarara, the services offered by Hospice Africa Uganda. Hospice staff should visit 
HIV outpatient centres to provide regular clinical support. It will never be possible to 
take African palliative care to scale through the traditional hospice model. The 
majority of care must be delivered by HIV HCWs, with palliative care specialists 
providing supervision, training and management of complex cases. Patients not in 
need of specialist palliative care should be referred back to an HIV health centre 
for continuing care.  
 
Patients with limited function have a much higher multidimensional problem 
burden. For those who cannot make the journey to a health centre, home based 
care is necessary. These patients are likely to have pain and symptoms but are 
also at greater risk of psychological and spiritual problems which must not be 
overlooked while attending to more obvious problems. Community health workers 
should include generalist palliative care, using the Palliative Care Toolkit as a 
guide(130), but palliative care should not be exclusively community-based. It is not 




deliver palliative care without support, and there are not enough more highly 
trained HCWs to deliver home-based care as standard to everyone with HIV. 
 
A multidimensional clinical assessment tool is needed which can be used regularly 
to monitor progress. Such a tool has been developed and is currently in use for a 
randomised controlled trial of palliative care alongside ART in Tanzania. It was 
based on around 20 instruments used in hospices and palliative care centres in 
Africa, and contributed in response to a call for examples.  As a process outcome 
of the RCT, the tool will be assessed in terms of utility, acceptability and suitability, 
and it should be either improved or disseminated for wider use and development 
based on these findings.  
 
Drug availability is another cornerstone of palliative care. Only two of the eleven 
facilities in this study stocked morphine. Lack of morphine has been framed as a 
denial of basic care and a violation of human rights(350). The delivery of morphine 
to all those who need it in Kenya and Uganda requires education of doctors, 
changes in prescription rules, and political will. These requirements are an element 
of the Public Health Model of palliative care(217). All steps of the Pain Ladder must 
be accessible to patients, including treatment of neuropathic pain.  
 
The high prevalence and persistence of psychological, existential and spiritual 
problems over time indicate that training for spiritual care and counselling is a 
particularly important area. All the facilities in the study employed counsellors and 
nurse counsellors(346, 347), but in qualitative interviews it emerged that some 
counselling has become a form of didactic education rather than an opportunity for 
the patient to share concerns(426). Staff awareness of barriers to communication 
must be improved so that problems are recognised, especially to improve 
communication with patients who have little or no education 
 
The study shows that symptoms are common at diagnosis but gives no information 
as to which symptoms they are. Until further evidence is available, clinical care 
should proceed on the assumption that the most common HIV symptoms are likely 
to occur at diagnosis. These are described in SectionB.1.iii; pain, fatigue, difficulty 
sleeping, weakness, weight change, skin problems etc. Treatment of these 




centres to experience drug stock-outs, sometimes caused by a limit to the amount 
they are permitted to order in one batch(363). The PHE included a pharmacy 
review and a paper is in progress detailing the findings from this and 
recommendations for improvement. 
 
Palliative care in Africa also includes nutritional supplements or food, micro-finance 
programmes(231), legal advice, orphan care(234) and other forms of social 
support, which must be provided as needed. All these recommendations will 
require investment, but they are likely to be less expensive than the consequences 
of neglected problems at diagnosis. Prompt palliative care at diagnosis will be a 
worthwhile investment from the perspective of both the patient and the health care 
team, as good care could prevent future problems and support retention. A model 
using data from Cote d’Ivoire predicted the consequences of four interventions to 
reduce LTFU and found them all to be highly cost-effective due to their benefits to 
survival (422). The interventions used to prevent LTFU were (1) free ART at point 
of care; (2) free symptom management drugs; (3) resources to give HCWs in 
general health centres the skills of those in HIV-only centres; (4) a meal and 
transport costs refunds for patients attending scheduled appointments.  
 
The number of people diagnosed with HIV per year in African countries is very 
difficult to establish. UNAIDS publishes annual reports detailing estimated 
prevalence and incidence by country, but diagnosis is not a commonly reported 
indicator. By contrast, high-income countries such as the UK and the USA monitor 
and publish exact numbers of positive HIV tests. Table H-1 displays diagnosis 
figures and estimates for Uganda, the UK, the USA and sub-Saharan Africa. In 
2009, 6630 people were newly diagnosed with HIV in the UK, or 18 every day. 
Almost 43,000 people aged over 13 were diagnosed in the USA. Uganda does not 
publish such information. The number of infections in Uganda in 2009 is estimated 
at 135,000 according to UNAIDS and it is believed that 20% of people with HIV 
have been diagnosed(427). Making the very large assumption that the rate of 
testing keeps pace with the rate of infection, around 27,000 people are currently 
diagnosed with HIV every year in Uganda. (More diagnoses take place in the USA 
than Uganda despite the much lower prevalence, for two reasons; the population is 
larger, and a greater proportion of people with HIV learn their status.) The same 




believed to become infected every year(16), giving approximately 360,000 new 
diagnoses annually. At this scale, estimates are even less accurate. The range 
given in the table is extrapolated from the confidence interval around the published 
prevalence figure of 1.8 million, but it would probably be appropriate to add an 
additional error margin to the estimate of numbers diagnosed.  
 
Table H-1: estimated number of newly diagnosed people per year by geographical region 
Country Number of people 
diagnosed per year 
Data source Year Data 
reliability 
Uganda c.27,000 Based on 20% of 
infections(427) 
- Poor 
UK 6630 Health Protection Agency,  
total report(428) 
2009 Very good 





UNAIDS 2010 Report(16)  
and Universal Access 
Progress Report(29) 
2009 Poor  
 
 
Universal access to ART requires a scale-up of testing services to match the 
incidence of infection(29), since a test is the gateway to ART. The number of newly 
diagnosed people per year should therefore increase, especially in low-income 
countries where the majority of people live who lack access to ART. This increase 
may be difficult to detect, as current data on the number of new diagnoses per year 
are so poor. Ministries of health should attempt to report better estimates of the 
number of people diagnosed per year in their countries. This information is needed 
to plan services and predict needs. It is a paradox that figures on incidence and 
prevalence of HIV are estimated from real data on the number of people diagnosed 
(or tested anonymously), yet the estimates are widely available whereas the raw 
data are hard to obtain. This is an indication that diagnosis is not viewed as 







H.3 Implications for research 
 
Evidence of problems is not meaningful unless interventions to solve those 
problems are developed and tested. Further evidence is needed of the 
effectiveness of integrated palliative care on patient-centred outcomes, in HIV 
generally and at diagnosis in particular. In some cases, particular interventions 
must be tested, but it is especially important to prove the effectiveness of the 
patient-centred individual assessment which typifies palliative care. As described 
above, integrated care is the only viable model. Randomised controlled trials of 
palliative care alongside ART are underway in South Africa and Kenya, but like 
many studies they exclude the newly diagnosed (one month since ART initiation is 
required). Interventions developed for general HIV populations or for other 
diseases and conditions should be tested at diagnosis in randomised controlled 
trials.    
 
Any estimate of palliative care problems based solely on physical symptoms and 
pain is likely to grossly underestimate the level of need. Social and spiritual 
problems are more prevalent and severe than physical and psychological 
symptoms in this sample, but these areas are not well understood. Need to share 
feelings and lack of help/advice are the areas of greatest need and least certainty. 
Research should concentrate on these areas which have been shown to be of 
great importance to patients. Similar research is needed in other countries and 
contexts, given the differences found between Uganda and Kenya. This study 
proves that data collection on the day of HIV diagnosis is possible, with very low 
refusal rates.  
 
The POS indicates the areas in which problems occur. More research must identify 
in more detail the nature of symptoms and concerns, to inform the development of 
care protocols. Complementing this, qualitative interviews should be conducted 
with newly diagnosed participants to form a more accurate assessment of the 
problems which are most important to patients and to understand their origins and 
barriers to care. Interviews at such a vulnerable time must be undertaken 





In palliative care, the unique experience of the individual is central. This thesis has 
presented averages and overall associations. Further work with this dataset should 
explore the individual-level trajectories of change over time, possibly using visual 
graphical analysis. Qualitative research will also be invaluable to understand the 
diversity of individual experience and needs. The meaning to patients of the seven 
outcomes measured here should be investigated further using qualitative 
interviews. In particular, need for help and advice is the least understood and the 
most severe problem.  
 
Future development of the POS should involve reconsideration of the question on  
help and advice for the family. Over half the sample reported the worst possible 
score at baseline, which would often suggest a ceiling effect, but in this case the 
option is ‘received no help and advice at all’, the natural limit of the question. To 
identify those in greatest need it may be necessary to split this question into two or 
more, such as distinguishing between practical matters and information needs. As 
discussed above in the implications for policy and practice, the findings that 
palliative care-related problems are common at HIV diagnosis and are not related 
to disease stage will require palliative care services to expand to reach more 
people with chronic, rather than terminal, illness. Audit, clinical and research 
assessment tools such as the POS must be continuously monitored to ensure they 
are appropriate for the population in which they are used. As the POS is 
increasingly applied in populations with early-stage HIV for whom practical matters, 
information and decision-making are of great importance, the seventh POS 
question should be examined to ensure it accurately reports patient-centred 







The aim of this thesis was to determine the palliative care-related problems 
experienced by people in Kenya and Uganda in the two weeks following diagnosis 
of HIV, and how those problems change over the subsequent three months. 
Palliative care is 
 “an approach that improves the quality of life of patients and their families 
facing the problems associated with life-threatening illness, through the 
prevention and relief of suffering by means of early identification and 
impeccable assessment and treatment of pain and other problems, physical, 
psychosocial and spiritual” (11). 
 
The findings show that people newly diagnosed with HIV are indeed “facing the 
problems associated with life-threatening illness”. The problems that typically occur 
at the end of life are also highly prevalent and severe at HIV diagnosis, such as 
lack of help and advice(65% severe problems), difficulty sharing feelings(53%),  
loss of peace(19%), worry(11%), feeling that life is not worthwhile(10%), pain(6%) 
and symptoms(3%), and for many patients they persist over time. Social and 
relational problems are especially common at diagnosis, leaving patients unable to 
communicate their concerns or receive the support they need. Psychological and 
physical problems are widespread and may impede access to care. Patients whose 
physical function is limited seem to have fewer difficulties receiving 
help/advice(OR=0.6) and sharing their feelings(OR=0.5) but have a much higher 
burden of physical(OR=3.2), psychological(OR=1.6) and spiritual(OR=1.7) 
problems.  
 
On average, over time, the burden of problems goes down in all areas, but 
considerable variation is hidden within this average and many patients experience 
worsening problems or a recurrence. Patients who do not find their lives worthwhile 
experience little improvement, and spiritual problems are more prevalent after three 
months than two. After initiation of ART, patients report lowered symptom burden 
(OR=0.7), fewer problems getting help and advice (OR=0.7), and more peace 
(OR=0.6), but the effects are weak. ART recipients continue to experience 





Little is known about the care patients receive during this time and the effect of any 
interventions on outcomes, but the group is representative of patients at large 
health centres in receipt of PEPFAR funding to provide multidimensional care and 
support, so the care is expected to be better than average for an HIV outpatient in 
Africa. Cross-sectional findings are supported in the sparse HIV diagnosis 
literature, while the longitudinal results are some of the first ever presented.  
 
The findings provide the first evidence in support of the policies of the WHO, 
UNAIDS and APCA regarding palliative care at diagnosis in Africa. This thesis 
presents the most extensive and highest quality evidence yet discovered for 
multidimensional problems at diagnosis. In particular, it is the first study to draw a 
representative sample of newly diagnosed outpatients in Africa, who comprise the 
majority of people diagnosed with HIV, and the first in the world to measure 
multidimensional patient-centred problems at that time. Generalisability to other 
contexts is limited because the two countries in the study had quite different 
results, but until further research is produced, the findings should be used to inform 
decision making in other contexts, as the best available example. 
 
This thesis has also presented methodological contributions to the literature in the 
form of a model for exploratory analysis of multidimensional outcomes cross-
sectionally and over time. It has pioneered the use of ordinal and longitudinal 
extensions of logistic regression for analysis of short non-parametric ordinal scales 
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Appendix A: data collection instruments 
 








 Please rate your pain 
(from 0 = no pain to 5 = 
worst/overwhelming 
pain) during the last 3 
days 
0 = No pain at all
1 = Slight pain 
2 = Moderate pain 
3 = Severe pain (interferes with activities of daily 
life) 
4 = Very severe pain 




Have any other 
symptoms (e.g. nausea, 
coughing or constipation) 
been affecting how you 
feel in the last 3 days? 
0 = no, not at all
1 = slightly 
2 = moderately 
3 = severely 
4 = very severely 
5 = overwhelmingly 
 
Q3 
Have you been feeling 
worried about your 
illness in the past 3 
days? 
0 = Not at all worried
1 = Worried very occasionally 
2 = Worried some of the time 
3 = Worried a lot of the time 
4 = Worried most of the time 
5 = Worried all of the time 
 
Q4 
Over the past 3 days, 
have you been able to 
share how you are 
feeling with your family or 
friends? 
0 = Not at all
1 = Only once 
2 = Occasionally 
3 = Fairly frequently 
4 = Often 
5 = Yes, I’ve talked freely 
 
Q5 
Over the past 3 days 
have you felt that life was 
worthwhile? 
0 = Not at all
1 = Not very often 
2 = Occasionally 
3 = Some of the time 
4 = Most of the time 
5 = Yes, all the time 
 
Q6 
Over the past 3 days, 
have you felt at peace? 
0 = Not at all
1 = Not very often 
2 = Occasionally 
3 = Some of the time 
4 = Most of the time 
5 = Yes, all the time 
 
Q7 
Have you had enough 
help and advice for your 
family to plan for the 
future? 
0 = None
1 = Very little 
2 = For a few things 
3 = For several things 
4 = For most things 
5 = As much as wanted 
 
 
















ASK THE CARER Questions 8, 9 and 10 ONLY if consent 
given by patient and carer 
Q8 
How much information 
have you and your family 
been given? 
0 = None
1 = Very little 
2 = Some 
3 = Quite a lot 
4 = A great deal 
5 = As much as wanted 
7 = N/A, no carer/consent not given 




How confident does the 
family feel caring for 
____? 
0 = Not at all
1 = Not confident about many things 
2 = Confident about a few things 
3 = Confident about some things 
4 = Confident about most things 
5 = Very confident 
7 = N/A, no carer/consent not given 
8 = carer not present at time of interview 
 
Q10 
Has the family been 
feeling worried about the 
patient over the last 3 
days? 
0 = Not at all worried
1 = Worried very occasionally 
2 = Worried some of time 
3 = Worried a lot of the time 
4 = Worried most of the time 
5 = Worried all of the time 
7 = N/A, no carer/consent not given 
8 = carer not present at time of interview 
 
 ECOG (rated by the interviewer)  
Q11 
Physical function of 
patient 
0= fully active, able to carry on all pre-disease 
performance without restriction 
 
1=Restricted in physically strenuous activity but 
ambulatory and able to carry out light work, e.g., 
light house work, office work 
 
2=Ambulatory and capable of all selfcare but 
unable to carry out any work activities. Up and 
about more than 50% of waking hours 
 
3=Capable of only limited selfcare, confined to 
bed or chair more than 50% of waking hours 
 
4=Completely disabled. Cannot carry on any 











P1 Please indicate the patient's gender male=1, female=2
I would like to ask you a few questions about your background:
P2 How old are you (years)?
P3 What is the highest level none=1




P4 What is the main material natural earth, mud, sand=1
used to make the floors finished cement=2





P5 What is the main material natural thatched/straw=1
used to make the  walls rudimentary mud and poles=2
of your house? un-burnt bricks=3




burnt bricks with cement=8
P6 What is the main material used natural thatched=1






P7 What type of toilet do you use at home? private flush=1
private VIP latrine =2
private traditional pit (covered)=3
private traditional pit (uncovered)=4
public/shared=5
bush/field/other=6
P8 How far from the facility do you 
live? (kilometres) If not known, don't know=888 km




P9 What is the main source of safe bottled=0
drinking water for your house? piped inside house=1







P10 What type of fuel does your electricity=01, lpg/natural gas=02
household mainly use biogas=03, paraffin/kerosene=04
for cooking? coal=05, charcoal from wood=06
firewood=07, straw/shrubs/grass=08
dung=10, no food cooked in household=11
P11.1 Does anyone in the car yes = 1, no = 2





Now I would like to ask you a few questions about your HIV diagnosis:
P12 What date did you enrol into this facility? dd/mm/yy
unknown day= 15, unknown month= 06, unknown year =888888
P13 why did you visit this facility today? new illness/well-being issue = 1
referred = 2 (from where)
obtain medication = 3 Place from which referred (2), 
HIV test result = 4 or other reason for attending (5):
other = 5 (specify) ________________
P14 date diagnosed HIV+ dd/mm/yy
unknown day= 15, unknown month= 06, unknown year =888888
P15 date started on ARV treatment dd/mm/yy
unknown day= 15, unknown month= 06, unknown year =888888
777777=not on ARV
P16 Current WHO clinical stage (1-4) 8=don't know
P17 Most recent CD4 count don't know=8888
P18 date of most recent CD4 count dd/mm/yy
unknown day= 15, unknown month= 06, unknown year =888888
P19 How many dependants do you have?
















Dr Richard Harding 
Department of Palliative Care, Policy and Rehabilitation 
King’s College London 
Weston Education Centre 
Cutcombe Road 
London  SE5 9RJ 
Friday 11th January 2008 
Dear Dr Harding 
CREC/06/07-140 PEPFAR Public Health Evaluation Palliative Care 
Thank you for the requested modifications sent by Vicky Simms.  I am pleased to inform you that 
the changes to the Information Sheets have been approved. 
We wish you every success with this work. 
   
Yours sincerely 
Rowena Lamb 

















P2 Patient longitudinal study  September 2007 
    
 
 
Patient Information Sheet - PEPFAR Evaluation of Care 
 
We would like to invite you to participate in a service evaluation. Before you 
decide about taking part, it is important for you to understand why the 
evaluation is being done and what it will involve.  Please listen to the 
following information and ask if anything is unclear.  
 
We are looking at how people attending this facility are cared for, and if it might be 
made better. We are asking every new patient, or patient who has a new problem, 
to take part. You and about 100 other patients have been approached in this 
facility.  
 
You do not have to take part. If you do, you can withdraw from an interview at any 
time, or in between interviews, and you don’t have to give a reason. Taking part, 
withdrawing, or not taking part will not affect the care you receive at all. If you take 
part you will be given this sheet to keep and sign a consent form to show that you 
have agreed to participate.  
 
I will interview you at your usual place of care at a time as close as possible before 
your appointment. You will not have to see anyone not involved in your care. I will 
ask you questions about you and your health, e.g. how you have been feeling, 
have you had any pain. The questions will take no more than 30 minutes to 
answer. I would also like to ask a family member who cares for you a few questions 
about their well-being, if applicable and only if you allow us to. You can participate 
in the evaluation even if you do not want me to talk to your family. I will ask you a 
set of questions every month for 3 months. After that there will be no more things 
for you to do for this evaluation.  
 
The information I write down during the interview will be confidential. Your personal 
details (e.g. name and address) will not be given to anyone and your answers will 
be kept separately. We will use all responses to write up reports on how we think 
patients should be cared for. Nothing you say will be identified as coming from you. 
You may withdraw your responses at any time until they are used in the final 
report. 
 
This evaluation is organised by King’s College London (UK), an African Care 
association (APCA) and this care facility. It is funded by PEPFAR, part of the US 
government. The Ugandan/Kenyan and KCL (ref CREC/06/07-140) Ethics 
Committees have reviewed and approved this study for your protection.  
 
If you’d like to talk to someone about the evaluation please contact APCA 
Uganda/Kenya <delete as applicable> 
 
<insert relevant name, address and telephone number>
314
Consent form P2 pt longitudinal        
 




PEPFAR Evaluation of Care - Consent Form 
Participant’s Statement: 
 
• I confirm that I have read and understand the information sheet dated 
September 2007 for the above study and have had the opportunity to ask 
questions. 
 
•  I understand that if I decide at any other time during the evaluation that I no 
longer wish to participate in this project, I can notify the researchers involved and 
be withdrawn from it immediately without my medical care or legal rights being 
affected. 
 
• I consent to the processing of my personal and medical information for the 
purposes of this evaluation. I understand that such information will be treated as 
strictly confidential. 
 
• I agree to my responses being stored anonymously at APCA and KCL for 7 
years. 
 
• I agree to take part in the above study. 
 
¾ I do/do not/not applicable  (circle as applicable) agree to the health 
worker asking the member of my family accompanying me today some 












confirm that I have carefully explained the nature and demands of the proposed 









Appendix C: description of clinical facilities 








K1 Sindo Sub District Hospital missing 246 
K2 Nyeri Provincial General Hospital 3031 377 
K3 Thika District Hospital 4334 463 
K4 Bomu, Mombasa 1126 796 
K5 Kericho District Hospital 4963 547 
K6 Chulaimbo  5975 422 
U1 TASO Rukungiri 4772 401 
U2 AIDS Information Centre (AIC) Kampala missing missing 
U3 Mulago Infectious Disease Institute (IDI) 9698 828 
U4 Joint Clinical Research Centre (JCRC) 
Kampala 7062 5774 
U5 Mbarara 5602 683 
 
The table above shows the total number of patients, and number of new patients, 
registered at each of the eleven facilities in 2007 according to PEPFAR figures.  
The information was not available for AIC Kampala, which provides counselling 
and testing services to a large number of people who are not defined as patients 
according to PEPFAR criteria.  Further information on each facility is given below. 
 
Kenya 
Bomu – Bomu Medical Centre is an NGO based in Mombasa and a USAID Centre 
for Excellence in HIV/AIDS care. It has numerous links with international charities 
and organisations including CDC, the Stephen Lewis Foundation and Family 
Health International. In the model of Kenyan public hospitals, Bomu has a CCC 
(Comprehensive Care Centre) providing all its HIV services, in line with the usual 
model of HIV care in Kenya. 
 
Chulaimbo – Chulaimbo Subdistrict Hospital  is on the outskirts of Kisumu in 
western Kenya. Following a contested presidential election in December 2007, civil 
unrest caused severe problems for two months, with Kisumu one of the worst 






Kericho –The Kenya Medical Research Institute/Walter Reed Project Clinical 
Research Center is a United States Military HIV Research Program field centre. Its 
primary objective is to develop an HIV vaccine. Several long-term cohort studies 
are operating from Kericho. 
 
Nyeri – Nyeri Provincial General Hospital is the referral hospital for Central 
Province. The study was based at Nyeri CCC, situated in the grounds of the 
hospital.  
 
Sindo - Sindo District Hospital in Nyanza, in western Kenya was also affected by 
civil unrest following the election.  Violence was targeted at particular ethnic 
groups. Staff adopted a policy of giving patients two months’ supply of drugs 
instead of one, to save them a visit.  Although Sindo Hospital is a public hospital, 
the CCC is operated by an NGO specialising in family-centred HIV care. 
 
Thika – about two hours’ drive from Nairobi, Thika District Hospital has recently 
built a new CCC with funding from donations.  Like Chulaimbo, Nyeri and Sindo, it 
is a government-run public hospital. 
 





























AIC – the AIDS Information Centre in Kampala opened in 1990, with the aim of 
preventing HIV infection by encouraging testing. It now has eight branches around 
the country and is the leading provider of counselling and testing services in 
Uganda. It recently began to provide ART. 
 
IDI - The Mulago Hospital infectious Disease Institute.  Mulago Hospital in Kampala 
is one of Uganda’s two teaching hospitals. IDI was established in 2004 as a centre 
for both clinical care and research, supported by the Academic Alliance for AIDS 
Care and Prevention in Africa and several other partners including Pfizer. Although 
it is based in a public hospital, IDI is run as an NGO and provides free services.  
 
JCRC – The Joint Clinical Research Centre is a collaboration between the 
Ministries of Health and Defence and Makerere University School of Medicine. It 
has provided ART to over 30,000 clients since 1996, making it possibly the largest 
ART provider in sub-Saharan Africa (JCRC website).  JCRC has collaborations 
with a number of universities and undertakes many research projects every year.  
 
Mbarara – Mbarara Regional Referral Hospital is a public hospital in western 
Uganda, around 180 miles from Kampala. All patients with HIV are referred to the 
ISS (Immune Suppression Syndrome) clinic, where the study was based. Mbarara 
is the most government-centred of the Uganda facilities. 
 
TASO Rukungiri – The AIDS Support Organisation is a model for grassroots HIV 
care, support and activism in developing countries.  Founded in 1987 by a small 
group of people with HIV, it has provided care and support to over 200 000 people. 
The programme began providing ART in 2004 and has scaled up provision to 20 










































Appendix D: loadings onto wealth index factor in 
principal components analysis 
 
 
Table 0-1: loadings onto wealth factor 
variable loading 
Earth floor   -0.314 
Unsafe water  -0.195 
Own a television 0.143 
Private flush toilet 0.133 
Own a refrigerator 0.122 
Mud and poles/unburnt brick/brick with mud walls  -0.122 
Own a mobile phone 0.111 
Protected well/borehole/rain water  -0.101 
Own a car 0.081 
Natural roof  -0.068 
Piped water inside house 0.046 
Electricity/natural gas/LPG for cooking fuel 0.034 
Public/shared/bush latrine 0.024 
Own a radio 0.024 
Corrugated iron roof  -0.021 
Own a bicycle minus -0.014 
Tiled/cement/asbestos/tin roof 0.011 
Polished wood/tile/carpet floor  -0.009 
Paraffin/kerosene/coal cooking fuel 0.006 
Piped water outside house  <0.001 
Charcoal for cooking fuel <0.001 
Latrine <0.001 






Appendix E: Publications 
 
Simms V., Higginson I.J., Harding R. (2011). What palliative care-related problems 
do patients experience at HIV diagnosis? A systematic review of the literature. 








What Palliative Care-Related Problems
Do Patients Experience at HIV Diagnosis?
A Systematic Review of the Evidence
Victoria M. Simms, MSc, Irene J. Higginson, PhD, and Richard Harding, PhD
King’s College London, Cicely Saunders Institute, London, United Kingdom
Abstract
Context. Palliative care is an essential element of HIV care throughout the
disease trajectory, but there is a lack of information to guide clinical care at HIV
diagnosis.
Objectives. This systematic review aimed to identify and appraise the evidence
of palliative care-related problems at HIV diagnosis.
Methods. The search strategy combined the term ‘‘HIV’’ with seven key words
derived from the World Health Organization deﬁnition of multidimensional
palliative care, in a systematic search of four databases. Abstracts and papers were
screened to identify those recording problems within six months of HIV diagnosis
in adults. Sample descriptions, aims, methods, and prevalence ﬁndings were
extracted from these papers into common tables.
Results. Of 5443 titles retrieved, 65 met the inclusion criteria and 34 were
retained. Papers included 27 original studies and seven secondary analyses of
patient’s records, with great heterogeneity in design, sample deﬁnition, and
outcome measures. Physical and psychological symptoms were highly prevalent
(pain 11%e76%, weight loss 8%e89%, fever 32%e89%, diarrhea 6%e54%,
anxiety 36%e95%, and depression 18%e47%). At HIV diagnosis, well-being was
impaired, suicidal thoughts were frequent, and peace and calmness were reduced.
Participants lacked emotional support and feared the reaction of their families.
Practical problems included hunger, homelessness, reduced ability to work, and
need for childcare. Studies had methodological failings such as the use of
unvalidated tools and lack of clarity reporting results.
Conclusion. People who have recently been diagnosed with HIV have
multidimensional palliative care-related problems. HIV care and support services
need to assess and manage problems using integrated palliative care, with referral
for complex problems. Patient centeredness must be a principle of HIV clinical
research. J Pain Symptom Manage 2011;42:734e753.  2011 U.S. Cancer Pain
Relief Committee. Published by Elsevier Inc. All rights reserved.
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Introduction
Palliative care requires the early identiﬁca-
tion; thorough assessment; and effective treat-
ment of all problems, physical, psychological,
spiritual, and social, in life-limiting illness.1
There is evidence that palliative care for HIV
is effective in the domains of pain and symptom
control, anxiety, insight, and spiritual well-
being,2 although the literature is limited; most
studies predate the availability of antiretroviral
therapy (ART), almost all are of patients with
advanced disease, and very few have been con-
ducted in sub-Saharan Africa where two-thirds
of people with HIV live.3
World Health Organization (WHO) policy
states that ‘‘palliative care should be incorpo-
rated as appropriate at every stage of HIV dis-
ease, and not only when the patient is dying,’’1
and that palliative care should be used along-
side ART as needed, not as a substitute. Simi-
larly, the Joint United Nations Program on
HIV/AIDS (UNAIDS) guidelines conﬁrm that
all people living with HIV should be provided
with effective palliative care,4 and the WHO
advocates the integration of palliative care
into comprehensive care and support for peo-
ple living with HIV from diagnosis to the end
of the life.5 To fulﬁll this requirement, it is nec-
essary to understand what constitutes appropri-
ate palliative care intervention at the different
stages of HIV disease. There is evidence that
people with HIV have palliative care-related
problems in both early6 and advanced disease,7
which persist with the use of ART.8However, the
delivery of care to meet these policies is chal-
lenged by a lack of detailed information about
palliative care-related problems at the time of
HIV diagnosis.
The majority of the HIV palliative care litera-
ture relates to the end of life, reﬂecting the dis-
cipline’s origins in terminal care. Modern
palliative care encompasses thewhole trajectory
of life-limiting illness from diagnosis to death.
However, more recent studies of palliative care
in earlier stages of HIV disease may not make
reference to the time since diagnosis. Knowl-
edge of themultidimensional problems that pa-
tients experience atHIVdiagnosis is required to
plan services, inform patient and family assess-
ment, educate staff, and guide clinical care.
The aimof this studywas to systematically review
the literature to identify and appraise the
evidence of multidimensional palliative care-
related problems at HIV diagnosis. A secondary
aim was to identify gaps in the literature.
Methods
Review Question
The review question was ‘‘What palliative
care-related problems do adults experience at
the time of HIV diagnosis?’’
Search Strategy
The review was carried out following Centre
for Reviews and Dissemination procedures and
using the Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses checklist.9
Databases and Date of Search
OVID Medline, PsycINFO, Embase, and
PubMedwere searched from1981 to September
2009 (the search date).
Terms
The search terms were taken from the WHO
deﬁnitionofpalliative care.10 Fromeachdimen-
sion, a search term was identiﬁed, linked to
a subject heading where possible, and used
as a key word otherwise. The search terms
were as follows:
 Paindusing the accepted palliative care
deﬁnition that pain is what the patient
says hurts;11
 Symptomsdrepresenting physical problems
from a patient-centered perspective. Self-
reported symptoms have been shown to
be more complete and clinically relevant
than health provider (HP)-reported
problems;12
 Worrydrepresenting psychological prob-
lems. Worry is a symptom of all anxiety dis-
orders13 and is frequently associated with
depression;14
 Well-Beingdrepresenting quality of life
(QoL) and wish to live;
 Supportdthe family and informal care-
givers are important aspects of palliative
care. Social support in the literature is di-
vided into two concepts: emotional and
tangible/information support;
 Peacedthe question ‘‘Are you at peace?’’ is
a measure of spiritual well-being, validated
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independently in palliative care popula-
tions in Uganda, South Africa,15 and the
U.S.;16
 Informationdrepresenting informational
and tangible support, as distinct from
emotional support.17
Each subject heading/key word was com-
bined with ‘‘HIV seropositivity’’ using AND. Lit-
erature scoping showed that no key word or
standard term was in use to describe the newly
diagnosed population.
Inclusion and Exclusion Criteria
The inclusion criteria included the follow-
ing: 1) original study (qualitative or quantita-
tive) or review; 2) study of people with HIV
(any country or group); 3) adults (18 years
or older); 4) includes at least one of the seven
problems; 5) English language; and 6) does
not exclude newly diagnosed people, deﬁned
as those diagnosed within the previous six
months.
Exclusion criteria included the following:
1) analysis group includes people diagnosed
with HIV more than six months previously;
2) analysis group includes people who are
HIV negative; 3) analysis group includes peo-
ple who do not know they are HIV positive;
4) retrospective data collection; 5) false posi-
tive tests or HIV delusion; 6) full paper could
not be retrieved, after attempt to contact
authors; and 7) case study, editorial, or disser-
tation abstract.
The period of six months after HIV diagno-
sis was selected because it is a common exclu-
sion criterion in observational studies and
controlled trials,18,19 showing that this group
is viewed as being different from the average
person with HIV.
All results were combined and cleaned.
Abstracts were screened using the inclusion
criteria, but retained if the abstract did not
contain sufﬁcient information to judge rele-
vance. All remaining articles were read and
those that passed the exclusion criteria were
retained for review. Studies using retrospective
data collection were not accepted for the sys-
tematic review, based on evidence from psy-
chological studies that emotional events, such
as HIV diagnosis, are remembered with height-
ened vividness and intensity but impaired
accuracy.20
Analysis
Data were extracted into a standard profor-
ma. Variables included authors, date of publi-
cation, setting, time from diagnosis to data
collection, aim, study design, tools, analysis,
and population. Findings were classiﬁed into
the seven problems used as search terms.
Results were compared within and between
studies, but meta-analysis was not conducted
because of the heterogeneity of samples and
tools.
Secondary analysis was carried out by the re-
view authors where appropriate and possible.
For example, if only two data points of a cohort
occurred within the six-month window, the re-
sults from these two points were compared us-
ing t-tests.
Study populations were classiﬁed using cate-
gories observed in scoping of the literature on
recent diagnosis. Potential categories included
recent seroconversion (SC); pregnancy; injec-
tion drug use; and hospital inpatients. Addi-
tionally, the countries where data collection
took place were classiﬁed as low income, mid-
dle income or high income, using the World
Bank classiﬁcation system.21 Results were tabu-
lated by population group and by theme to
compare both the prevalence of problems at
HIV diagnosis in different populations and
the development of the research base.
Results
Thirty-four studies were retained (Fig. 1).
Fourteen were conducted in North America,
11 in Africa, three in Asia, three in Europe,
and three in Central and South America
(Table 1). According to the World Bank classi-
ﬁcation, 17 studies took place in high-income
countries, seven in middle-income countries,
and 10 in low-income countries.
Study Designs and Methodologies
Seven studies used patients’ records for sec-
ondary analysis and 27 collected primary data.
Two papers presented qualitative results,22,23
and two collected data using in-depth interviews
but presented ﬁndings quantitatively.24,25 Study
designs comprised 11 cohorts (usually with only
two or three time points), eight observational
cross-sectional studies, two case-control studies,
one before-and-after trial, and one randomized
736 Vol. 42 No. 5 November 2011Simms et al.
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controlled trial (RCT). However, in many cases
the primary research question, analysis, and de-
sign reported in the paper were not relevant to
the review. In seven cohorts, only one measure-
ment occurred within six months of diagnosis.
For the purpose of the review, these data were
presented as cross sectional. Similarly, only the
baseline results from the RCT and before-and-
after trial were reported.
Sixteen studies included a comparison or
control group of people who were not newly di-
agnosed with HIV. The most common design
(seven studies) was a prospective, unmatched,
two-arm cohort, with a newly diagnosed HIV
positive group compared with one that was
HIV negative. The same comparison was used
in a retrospective record review,26 a cross-
sectional survey,27 a matched cohort,28 and
a matched case-control study.29 Additionally,
two cross-sectional surveys30,31 andoneprospec-
tive cohort32 compared newly diagnosed partic-
ipants with people with a pre-existing HIV
diagnosis.
Two studies, a prospective cohort33 and a case
control,34 compared newly diagnosed injection
drug users (IDU) with newly diagnosed non-
IDU. For these studies, results are presented
separately for the two newly diagnosed groups.
When the outcomes were symptom preva-
lence or score on a validated instrument with
clinical utility, such as the Beck Depression
Index, thenonly the results from thenewly diag-
nosed armof the cohort are presented in the re-
view. Results from control groups or study arms
are only presented if they are needed to inter-
pret the ﬁndings in the newly diagnosed group.
For example, QoL instrument scores are essen-
tially comparative.
Populations and Settings
Two case-control studies29,34 and one two-
arm cohort study,33 all in high-income coun-
tries, recruited only patients with serological
evidence of recent or current SC. Five studies
in low-income countries23,30,35e37 and three
in the U.S.24,28,38 recruited only pregnant
women. Three studies took place in inpatient
settings, all in low- and middle-income coun-
tries.26,39,40 Three studies took place in low-
income countries41e43 and there were six
studies of outpatients in middle-income
countries.27,44e47 Eleven studies were con-
ducted in high-income countries. Six of
them, all from the U.S., predated the intro-
duction of highly active ART in 1996,31,48e52
and ﬁve were conducted in the era of
ART.22,25,32,53,54
Pain (11 Studies)
Table 2 displays the ﬁndings in the domains
of pain and physical problems, by population
group. In prospective observational studies,
pain prevalence ranged from 31% to 53% in
middle-income country outpatient popula-
tions,46,55 and was 76% among low-income
country patients with AIDS41 and 69% for in-
patients with herpes zoster.39 In comparative
studies, pain was not associated with HIV infec-
tion.27,28 Two studies of SC compared preva-
lence of pain between IDU and non-IDU,33,34
but the sample sizes were too small to draw
any comparative conclusions. In qualitative in-
terviews, patients with neuropathic pain de-
scribed a three-stage process to manage pain.
Neuropathic pain was exacerbated by its being
outside previous experience and by the psy-
chological and spiritual meanings attached.
Excluded n = 390
 -Not a study of 
  patient problems in HIV 
 -Dissertation abstracts  
Excluded n = 4140
 -not an original study  
 -not in English  
Excluded n = 31
 -Not concerning newly 
  diagnosed n = 17 
 -No descriptive data 
  presented n = 1 
 -No data on patient experience  
  (lab results only) n = 4 
 -Seroconversion without 
  knowledge of diagnosis n = 5 
 -Date of diagnosis not clear n = 4 
Full copies  
 retrieved and 
assessed for  
 eligibility  
n = 1002
Meeting inclusion  
criteria 
n = 65
Unable to obtain paper  n = 11
Excluded n = 937 
 - Not a study of newly 
  diagnosed population  
 -Newly diagnosed not  
  reported and 
  analyzed separately 





Titles retrieved  
 and screened  
n = 5443
Fig. 1. Flow diagram of review process.
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Physical (22 Studies)
Physical symptoms were highly prevalent in
the general population of low- and middle-
income countries. Prevalence information
from high-income countries was conﬁned to
pregnant women or recent seroconverters.
Common symptoms included tiredness (47%e
96%), weight loss (66%e70%), fever (32%e
42%), and skin problems (13%e52%).
Weight loss, fever, cough, and diarrhea were
the four most common symptoms in four low-
and middle-income country prevalence stud-
ies.26,39,40,45 For people with AIDS in Uganda,
the most prevalent symptoms were weight loss,
itching, tiredness, and lack of energy.41 High
frequencies of sexually transmitted infection
(STI) symptoms also were noted among newly
diagnosed participants in Tanzania.42 In India,
96% of a convenience sample reported lack
of energy, 40% tuberculosis (TB), and 20%
diarrhea.55 In Brazil, the most common symp-
toms were asthenia, cachexia, fever, and
anemia, but TB, diarrhea, and cough were re-
corded for more than 10% of patients.44
Pregnantwomen in theU.S. reported fatigue,
night sweats, and weight loss, and a number of
STIs, not necessarily symptomatic.38 Pregnant
women in Uganda, using the Dartmouth
COOP scale, reported a poor physical ﬁtness
score in 76% of cases.36
In comparative ﬁndings, HIV positive IDU in
Canada reported more symptoms than HIV-
positive non-IDU, suggesting that drug use
had more effect than HIV on symptom bur-
den.33 By contrast, in the Netherlands, non-
IDU had higher symptom burden for fever
and tiredness at SC.34
The only information on physical symptoms
in high-income countries, apart from patients
experiencing either SC or pregnancy, was de-
rived indirectly from asking patients their rea-
son for taking an HIV test. In Italy, 7% of
people with HIV from ‘‘low-risk’’ groups re-
ported testing because of ‘‘alarming symp-
toms.’’54 Forty-three percent of recent
seroconverters in Canada took an HIV test be-
cause of symptoms or illness,29 compared with
33% of the HIV-positive population in Tanza-
nia.42 In the U.K., patient’s records showed
that 37% of black Africans and 19% of whites
tested HIV positive after symptoms.53 Finally,
learning of a positive HIV diagnosis could itself
be a cause of symptoms. In the U.S., 8% of re-
spondents reported a physical reaction such as
sweating, dry mouth, and dizziness.25
Psychological (17 Studies)
Table 3 has only ﬁve columns rather than the
eight in Table 2, because no results in any of the
nonphysical domains (i.e., psychological, well-
being, spiritual, emotional, or informational/
tangible support) were found for inpatients in
low-income and middle-income countries or
recent seroconverters.
For low-income country outpatients, anxiety
and depression prevalence were high (51%e
95% and 47%, respectively). In middle-income
countries, anxiety and depression were less
prevalent but still high, and 99% of an Indian
sample reported emotional problems.55 In the
U.S., 28% scored above the study case-deﬁning
threshold in terms of trait anxiety and 18% for
depression.48
Two studies with outlier results were method-
ologically weak, one problematically translating
‘‘emotional health’’ to ‘‘feelings’’ and then to
‘‘mental state,’’36 and the other failing to de-
scribe any instrument or symptom checklist.30
Four comparative studies used psychological
measures. The largest, in Nigeria, found post-
traumatic stress disorder and lowered mental
health were associated with HIV.27 In the three
smaller studies, all in the U.S., HIV status was
not associated with mental health.28,32,52
Qualitative interviews in the U.S. revealed
the primary response to diagnosis to be shock,
sadness, and depression.25 In Haiti, reactions
were shock, resignation, sadness, denial, and
fear.43 Prevalence of anxiety, depression, in-
trusive thoughts, and fear appeared to decline
over time in two American cohorts,50,51 al-
though statistical analysis was inappropriate.
Well-Being (10 Studies)
This was constructed using various outcomes
including problems relating to health percep-
tion, unhappiness,55 poor overall health,36
attempted suicide,46 and thoughts of sui-
cide.25,30Cohort studies didnot identify a signif-
icant change in well-being over time.47,49
Emotional Support (Eight Studies)
Family reaction is a particular concern, with
lack of support expected,37 indifference and
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hostility experienced,46 and resulting lack of
disclosure among those with less advanced ill-
ness.31 Qualitative evidence suggested that
spiritual support aided disclosure.23
Spiritual (Four Studies)
Not feeling calm and peaceful was a source of
high distress,55 and further studies investigated
hopelessness32 and anger.43 Spiritual care pro-
viders gave effective assistance in managing
shock, sadness, and anger at diagnosis, and
alsomediated acceptanceof diagnosis by thepa-
tient and family.23 Inner spiritual resources also
assist the newly diagnosed to interpret andman-
age neuropathic pain.22
Information/Tangible Support (Seven Studies)
In many contexts, people with HIV were re-
stricted in their work, activities, and social sup-
port. There was limited evidence of association
from comparative methods.
Problems included lack of awareness of any
support services outside the family;37 need
for housing, employment, and child care;37
problems with their job or doing household
work;55 hunger;41 and limitations to role func-
tion and social function.27
Discussion
Importance of Palliative Care at Diagnosis
The ﬁndings demonstrate a high prevalence
of problems across all palliative care dimen-
sions within six months of HIV diagnosis.
Diagnosis is a particularly important time for in-
tervention, for several reasons. First, WHO5,56
and UNAIDS4 policies stipulate that HIV pallia-
tive care should begin at diagnosis. Second, pal-
liative care is patient centered, and from the
perspective of the patients, diagnosis, rather
than infection, is the beginning of the disease.
Third, palliative care incorporates prevention
of suffering and its relief; therefore, quality
HIV palliative care should be delivered as early
as possible to maximize this opportunity. Fi-
nally, there is an increasing concern regarding
loss to follow-up of newly diagnosed patients
who do not return for care until their disease
is far advanced.57,58 The physical symptoms,
worry and depression, loss of well-being and
sense ofmeaning, and limited practical support
identiﬁed in this review might prevent patients
from remaining in care. Palliative care
may improve patient retention because of its
total care approach and focus on patient
experience.
Situating Findings in the Literature
The accepted view of the adverse emotional
and psychological effects of an HIV diagno-
sis48,59,60 appears to have a poor evidence base.
The best evidence of the impact of diagnosis
came from a study almost 20 years old, with a to-
tal sample of only 69,51 which found high anxi-
ety, depression, and intrusive thoughts a week
after HIV diagnosis. It seems that, to date, the
newly diagnosed have been thought to have
a high psychological burden, but the multidi-
mensional nature of their needs has been unex-
plored. The necessity for a multidimensional
approach is reﬂected in a study that found
many newly diagnosed people ‘‘had a host of so-
cial, emotional, and informational needs, which
often seriously impeded their capacity to make
constructive use of the knowledge of their HIV
status.’’61 Taking an HIV test is stressful in itself.
Anxiety, distress, depression, and suicidal idea-
tion are highly prevalent at testing, indepen-
dent of HIV status.49,62
Gaps in the Evidence
The majority of evidence concerned physical
and psychological symptoms. Evidence of need
for emotional support was largely represented
by studies of disclosure, which is related to pre-
ventionof further infections and is not necessar-
ily patient centered. Almost no quantitative
research was actively directed at understanding
spiritual distress, while qualitative papers ex-
plained that the topic was raised by participants
and had not formed part of the interview sched-
ule. Only three studies recruited outpatients in
low-income countries and yet the majority of
HIV diagnoses probably occur in this setting.
Theories of psychological adjustment and cop-
ing suggest that problemsmay change rapidly63
and, therefore, longitudinal studies are impor-
tant. Although11of the 34 studies used a cohort
design, only four collected datamore than once
within six months of diagnosis.47,49e51
The data on problems of inpatients and
problems of recent seroconverters related
only to physical symptoms and pain. The prev-
alence of physical symptoms was very high in
these groups and it seems likely that
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338
psychological, spiritual, and social problems
also would have caused burden, but there has
been no research in these areas.
Quality of Evidence
Many studies had methodological problems.
Ten reported symptom prevalence using re-
cords completed by care providers rather than
patients. Provider-completed patients’ records
have been shown to underestimate symptoms
reported by patients.12,64 The time period
within which symptoms were reported was
rarely given. No information on symptom sever-
ity, duration, or distress was recorded in any
studies, nor was any association drawn between
symptoms and QoL. Most studies focused on
only one area of care and did not aim to mea-
sure multidimensional need.
The categories ‘‘symptomatic’’ and ‘‘asymp-
tomatic’’ were used,31,43,53 which are derived
from the surveillance deﬁnition of HIV, not
the clinical deﬁnition.65e67 This classiﬁcation
distinguished between HIV infection with and
without case-deﬁning symptoms, but regressed
into general and inaccurate use of the word
‘‘asymptomatic’’ to describe pre-AIDS HIV.68,69
Several studies did not describe data collec-
tion methods in adequate detail. The instru-
ments used, such as the Memorial Symptom
Assessment Scale-Short Form, the Hospital
Anxiety and Depression Scale (HADS), and
the Medical Outcome Study-Short Form, had
frequently not been validated and piloted in
the population and setting where they were
used, or else symptom prevalence information
was presented without speciﬁcation of an in-
strument.29,38 Sample sizes were small in
most prospective studies. The nature of ques-
tions was not always clear. For example, when
participants were asked what their most press-
ing problem was, it was not clear whether
they picked an option from a closed list or re-
corded open answers.37 It was not always possi-
ble to interpret study ﬁndings in terms of
clinical signiﬁcance.
The four longitudinal studies to have more
than one point within the range of the review
suffered from several methodological ﬂaws.
The use of only two time points did not allow
for exploration of the rate of change over
time. The analysis techniques used were lim-
ited to unpaired t-tests and Chi-squared tests.
These tests assume independence between
measurements and do not account for the clus-
tering effect within individuals.
Limitations of the Review
It was not always clear when data collection
had taken place in relation to diagnosis. For
example, retrospective studies of hospital re-
cords were sometimes included because, logis-
tically, diagnosis could only have taken place
between admission and discharge, but the pa-
per did not draw attention to this point.26
The epidemiological, cultural, and social en-
vironment has not been considered in any
depth. Because of the small number of papers,
and heterogeneity of settings, outcomes, and
samples, all studies were presented together
with no subgroup comparisons. Other studies
set comorbidity conditions, such as TB,26 her-
pes zoster,39 and peripheral neuropathy,22
and one included only patients with a CD4
count below 200.41 In these cases, the results
are only generalizable to similar groups.
Despite considerable effort, some studies
could not be obtained because they were pub-
lished in small regional journals with very lim-
ited access. Because of shortage of time and
resources, papers were limited to the English
language. Publication bias may have distorted
the ﬁndings of the review. However, the review
used a broad search strategy and followed es-
tablished guidance.9
Conclusion
At HIV diagnosis, patients have a range of
distressing but manageable problems, includ-
ing pain, worry and depression, social con-
cerns, spiritual distress, lack of information,
and impaired well-being. There is evidence
that HIV palliative care can be effective in
the domains of pain, symptoms, anxiety, in-
sight, and spiritual well-being.2 Better out-
comes can be achieved and patient’s
retention in care may be improved. It is clear
from the literature that many HIV symptoms
and problems are not identiﬁed by clini-
cians,64 and from our review that multidimen-
sional problems are present from the point of
diagnosis. Therefore, from diagnosis onward,
quality HIV care must include assessment of
multidimensional problems, an integrated pal-
liative care approach to management, and
750 Vol. 42 No. 5 November 2011Simms et al.
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referral to specialist palliative care for complex
problems, alongside ART. At the same time,
patient centeredness must be a principle of
HIV clinical research to identify and solve
the problems that are most important to
patients.
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